
<html lang="en"     class="pb-page"  data-request-id="e6a364e1-d00c-48ea-bb54-a94985d4e060"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm4001049;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2013.56.issue-16;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors" /></meta><meta name="dc.Creator" content="Ubaldina  Galli" /></meta><meta name="dc.Creator" content="Cristina  Travelli" /></meta><meta name="dc.Creator" content="Alberto  Massarotti" /></meta><meta name="dc.Creator" content="Gohar  Fakhfouri" /></meta><meta name="dc.Creator" content="Reza  Rahimian" /></meta><meta name="dc.Creator" content="Gian Cesare  Tron" /></meta><meta name="dc.Creator" content="Armando A.  Genazzani" /></meta><meta name="dc.Description" content="Nicotinamide phoshophoribosyltransferase (NAMPT) plays a key role in the replenishment of the NAD pool in cells. This in turn makes this enzyme an important player in bioenergetics and in the regul..." /></meta><meta name="Description" content="Nicotinamide phoshophoribosyltransferase (NAMPT) plays a key role in the replenishment of the NAD pool in cells. This in turn makes this enzyme an important player in bioenergetics and in the regul..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 31, 2013" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4001049" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4001049" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4001049" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4001049" /></link>
        
    
    

<title>Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4001049" /></meta><meta property="og:title" content="Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0026.jpeg" /></meta><meta property="og:description" content="Nicotinamide phoshophoribosyltransferase (NAMPT) plays a key role in the replenishment of the NAD pool in cells. This in turn makes this enzyme an important player in bioenergetics and in the regulation of NAD-using enzymes, such as PARPs and sirtuins. Furthermore, there is now ample evidence that NAMPT is secreted and has a role as a cytokine. An important role of either the intracellular or extracellular form of NAMPT has been shown in cancer, inflammation, and metabolic diseases. The first NAMPT inhibitors (FK866 and CHS828) have already entered clinical trials, and a surge in interest in the synthesis of novel molecules has occurred. The present review summarizes the recent progress in this field." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4001049"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4001049">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4001049&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4001049&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4001049&amp;href=/doi/10.1021/jm4001049" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 6279-6296</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm4001659" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ubaldina++Galli">Ubaldina Galli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Travelli">Cristina Travelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alberto++Massarotti">Alberto Massarotti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gohar++Fakhfouri">Gohar Fakhfouri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reza++Rahimian">Reza Rahimian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gian+Cesare++Tron">Gian Cesare Tron</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Armando+A.++Genazzani">Armando A. Genazzani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Dipartimento di Scienze del Farmaco, UniversitÃ  degli Studi del Piemonte Orientale âA. Avogadroâ, Largo Donegani 2, 28100 Novara, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</span></div><div class="corresp-info"><strong>*</strong>Phone: +39-0321-375857. Fax: +39-0321-375621. E-mail: <a href="/cdn-cgi/l/email-protection#aaded8c5c4eadac2cbd8c784dfc4c3dac7c484c3de"><span class="__cf_email__" data-cfemail="483c3a2726083820293a25663d262138252666213c">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4001049&amp;href=/doi/10.1021%2Fjm4001049" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 6279â6296</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 16, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 January 2013</li><li><span class="item_label"><b>Published</b> online</span>31 May 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 August 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4001049" title="DOI URL">https://doi.org/10.1021/jm4001049</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6279%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DUbaldina%2BGalli%252C%2BCristina%2BTravelli%252C%2BAlberto%2BMassarotti%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D16%26contentID%3Djm4001049%26title%3DMedicinal%2BChemistry%2Bof%2BNicotinamide%2BPhosphoribosyltransferase%2B%2528NAMPT%2529%2BInhibitors%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6296%26publicationDate%3DAugust%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4001049"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3983</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">88</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4001049" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ubaldina&quot;,&quot;last_name&quot;:&quot;Galli&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Travelli&quot;},{&quot;first_name&quot;:&quot;Alberto&quot;,&quot;last_name&quot;:&quot;Massarotti&quot;},{&quot;first_name&quot;:&quot;Gohar&quot;,&quot;last_name&quot;:&quot;Fakhfouri&quot;},{&quot;first_name&quot;:&quot;Reza&quot;,&quot;last_name&quot;:&quot;Rahimian&quot;},{&quot;first_name&quot;:&quot;Gian&quot;,&quot;last_name&quot;:&quot;Cesare Tron&quot;},{&quot;first_name&quot;:&quot;Armando&quot;,&quot;last_name&quot;:&quot;A. Genazzani&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;6279-6296&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4001049&quot;},&quot;abstract&quot;:&quot;Nicotinamide phoshophoribosyltransferase (NAMPT) plays a key role in the replenishment of the NAD pool in cells. This in turn makes this enzyme an important player in bioenergetics and in the regulation of NAD-using enzymes, such as PARPs and sirtuins. Furthermore, there is now ample evidence that NAMPT is secreted and has a role as a cytokine. An important role of either the intracellular or extracellular form of NAMPT has been shown in cancer, inflammation, and metabolic diseases. The first NAMPT inhibitors (FK866 and CHS828) have already entered clinical trials, and a surge in interest in the synthesis of novel molecules has occurred. The present review summarizes the recent progress in this field.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4001049&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4001049" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4001049&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4001049" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4001049&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4001049" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4001049&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4001049&amp;href=/doi/10.1021/jm4001049" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4001049" /></input><a href="/doi/pdf/10.1021/jm4001049" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4001049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4001049%26sid%3Dliteratum%253Aachs%26pmid%3D23679915%26genre%3Darticle%26aulast%3DGalli%26date%3D2013%26atitle%3DMedicinal%2BChemistry%2Bof%2BNicotinamide%2BPhosphoribosyltransferase%2B%2528NAMPT%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D16%26spage%3D6279%26epage%3D6296%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290703" title="Pyridines">Pyridines</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jmcmar.2013.56.issue-16/production/jmcmar.2013.56.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0026.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Nicotinamide phoshophoribosyltransferase (NAMPT) plays a key role in the replenishment of the NAD pool in cells. This in turn makes this enzyme an important player in bioenergetics and in the regulation of NAD-using enzymes, such as PARPs and sirtuins. Furthermore, there is now ample evidence that NAMPT is secreted and has a role as a cytokine. An important role of either the intracellular or extracellular form of NAMPT has been shown in cancer, inflammation, and metabolic diseases. The first NAMPT inhibitors (FK866 and CHS828) have already entered clinical trials, and a surge in interest in the synthesis of novel molecules has occurred. The present review summarizes the recent progress in this field.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Otto Heinrich Warburg, over 80 years ago, hypothesized that basic metabolism was profoundly altered in cancer cells, but only recently it is becoming apparent that this could be exploited as a therapeutic strategy in cancer.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Among the specific targets being explored, the biosynthetic pathways leading to NAD are receiving considerable attention.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Indeed, in cancer cells, NAD synthesis and/or replenishment is constantly required because of the high proliferation rate, the high energy requirements, and the high activity of NAD-depleting enzymes (PARPs, sirtuins, etc.). It is interesting to note that already in the 1960s Gholson proposed that a constant cellular NAD turnover existed. Later, Rechsteiner suggested that the half-life of NAD in cultured cells is approximately 1 h.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Biosynthetic Pathways Leading to NAD in Mammals</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53038" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53038" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As NAD is rapidly consumed in cells, replenishing pathways must exist. While NAD is conserved through evolution as an electron acceptor/donor, it has been shown that there are differences between prokaryotes and eukaryotes on how this replenishment takes place. It is therefore not surprising that the enzymes involved in its synthesis in microorganisms have been proposed as druggable targets for the development of novel antibiotics.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">NAD can be synthesized from various precursors containing the pyridine moiety (nicotinic acid (NA), nicotinamide (Nam), and nicotinamide riboside (NR)) and from tryptophan. The pathways leading to NAD biosynthesis have been carefully reviewed elsewhere.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> While lower eukaryotes and prokaryotes use nicotinic acid (a form of vitamin B3) as a major NAD precursor, mammals predominantly use nicotinamide (another form of vitamin B3) rather than nicotinic acid for NAD biosynthesis. In lower organisms, such as bacteria and yeast, Nam is converted to NA by nicotinamidase, but this activity appears to be lacking in mammals.</div><div class="NLM_p">The de novo biosynthesis of NAD starts with the essential amino acid <span class="smallcaps smallerCapital">l</span>-tryptophan, which is taken up from the diet through the rate-limiting enzymes indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO), both requiring molecular oxygen, and which have also been proposed to be druggable targets in humans.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">It is likely, nonetheless, that in humans the main source of cellular NAD is from salvage pathways, which require the uptake of precursors other than tryptophan (i.e., NA, Nam, and NR) from the diet or their reuse intracellularly after the activity of NAD-utilizing enzymes. In mammals, Nam is thought to be the main niacin-derived NAD precursor, although the enzymatic pathway that uses NA is conserved. The schematic representation of these pathways is presented in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of the salvage NAD pathways. Multiple pathways allow NAD biosynthesis from the different sources (QA, NA, Nam, and NR), and these are reviewed elsewhere.<a onclick="showRef(event, 'cit5b cit5c'); return false;" href="javascript:void(0);" class="ref cit5b cit5c">(5b, 5c)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given that most NAD-utilizing reactions liberate nicotinamide, it is not surprising that mammals have elected the most direct and economical route as their major NAD source. Briefly, this pathway involves the synthesis of NMN from nicotinamide and 5-phosphoribosyl pyrophosphate (PRPP) by the enzyme NAMPT and the subsequent conversion of NMN and ATP to NAD by nicotinamide mononucleotide adenylyltransferase (NMNAT).</div><div class="NLM_p last">The present review focuses on the therapeutic potential and medicinal chemistry of NAMPT inhibitors.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Nicotinamide Phosphoribosyltransferase (NAMPT)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31853" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31853" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The enzymatic activity of NAMPT was originally reported by Preiss and Handler in 1957.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The main form of human NAMPT consists of 491 amino acids with a molecular weight of approximately 55 kDa. The X-ray crystal structure of NAMPT has also been determined and has established that NAMPT belongs to a dimeric class of type II phosphoribosyltransferases.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Gel filtration and co-immunoprecipitation assays have confirmed that NAMPT is indeed present as a dimer in cells. Furthermore, mutagenesis experiments have shown that NAMPT mutants that do not dimerize properly display a decreased enzymatic activity.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> A number of splice variants and truncated protein forms have been detected (reviewed in ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a>), but the physiological role of these is at present unknown and requires further investigation. Likewise, in humans a number of single nucleotide polymorphisms (SNPs) have also been found, and some of these have been associated with increased risk of disease (e.g., acute respiratory distress syndrome, diabetes) or with other risk factors (high-density lipoprotein, triglycerides) (reviewed in ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a>). However, a nonsystematic approach to the link between SNPs of the NAMPT gene and disease as well as an incomplete understanding of the functional consequences of these SNPs has reduced the impact of such findings. Last, the activity of human NAMPT is profoundly affected by histidine autophosphorylation at residue His247, with the phosphorylated form displaying at least 1000-fold higher activity. In brief, activation of NAMPT by His247 phosphorylation causes stabilization of the enzymeâphosphoribosyl pyrophosphate complex, permitting efficient capture of Nam and likely representing a phosphoenzyme intermediate of the reaction.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> To our knowledge, no other regulatory post-translational modifications have been described, but bioinformatics suggest that a number of residues conserved across species could be phosphorylated, ubiquitinated, or acetylated. Given the pleiotropic roles described below, it is likely that at least some of these post-translational modifications play a role in NAMPT function and role.</div><div class="NLM_p">In the cell, NAMPT is abundant in the cytosol and present in the nucleus,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> while there is controversy on whether it might also be present in the mitochondria.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> To great surprise, the protein NAMPT is not exclusively intracellular, as an extracellular secreted form has been described. This protein is usually referred in the literature as visfatin, as it was initially described as being secreted by the adipose tissue, or as PBEF, as it functions also as an enhancing factor for pre-B-cell maturation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In the present review, to avoid confusion, we will use the term eNAMPT and the term iNAMPT when referring to the extracellular or intracellular form, respectively. Whether the extracellular form presents specific differences in terms of truncations or post-translational modifications is at present unclear and requires urgent further clarification. Similarly, whether its extracellular effects are all linked to an enzymatic function or not is still a matter of debate. A possibility raised by the literature is that a yet unknown receptor exists that is able to bind to eNAMPT and transduce at least some of its effects. For example, extracellular application of eNAMPT is able to trigger ERK and MAPK phosphorylation.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Last, it has been shown that a regulated positive secretory process exists,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> although the exact mechanism of release is at present under investigation. As the protein does not present a secretory signal peptide or a caspase I cleavage site, the most accredited hypothesis, yet to be confirmed in most cell types, is that eNAMPT is secreted through a nonclassical secretory pathway, which is not blocked by inhibitors of the classical endoplasmatic reticulum (ER)âGolgi secretory pathway, such as monensin and brefeldin A.<a onclick="showRef(event, 'ref9 ref16'); return false;" href="javascript:void(0);" class="ref ref9 ref16">(9, 16)</a> A growing number of cell types have been shown to release eNAMPT, including adipocytes, hepatocytes, cardiomyocytes, and activated immune cells, e.g., LPS-activated monocytes.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Physiological Roles of NAMPT</h3><div class="NLM_p">Although NAMPTâs well-established role is in bioenergetics, maintaining intracellular NAD levels, over the past 10 years there has been a growing body of research suggesting that NAMPT functions are pleiotropic. However, given the limitations of the experimental approaches used (e.g., pharmacological, molecular), it is not yet possible to assign specific functions to either iNAMPT or eNAMPT or understand whether both forms work in concert.</div><div class="NLM_p">First, it has been shown by a number of laboratories and by a variety of experimental approaches that NAMPT activity is a key regulator of NAD consuming enzymes. Among the key enzymes that use NAD as substrate are poly (ADP-ribose) polymerases (PARPs), mono (ADP-ribose) transferases (ARTs), and sirtuins. For example, considerable attention recently has been given to the ability of NAMPT to modulate sirtuin activity, as these enzymes appear to be regulated by cellular NAD levels. For instance, in human vascular smooth muscle cells, reduced NAMPT expression results in premature senescence, whereas a significant delay in senescence is observed upon overexpression of NAMPT.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Furthermore, two other studies have shown that NAMPT participates in the circadian clock.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The core clock components of the circadian machinery regulate the recruitment of SIRT1 to the NAMPT promoter to increase NAMPT expression. This is followed by NAD biosynthesis, which in turn will activate sirtuins as well as other NAD-dependent enzymes. In a negative feedback loop, SIRT1 will repress the clock components and thereby NAMPT expression.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> It is suggested that through this mechanism, NAMPT and SIRT1<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> may play a crucial role in the circadian regulation of metabolism.</div><div class="NLM_p">Second, a possibility that has not been fully explored on further functions of NAMPT is that its direct product NMN (see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) may have a role in signaling, which has indeed been suggested by some.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Likewise, as nicotinamide is an inhibitor of a number of NAD-utilizing enzymes, it could be envisaged that NAMPT could act as a scavenger of nicotinamide itself.</div><div class="NLM_p last">Third, growing evidence suggests that eNAMPT is a cytokine that binds to a yet unknown extracellular receptor. As such, it has been shown, for example, to potentiate the functions of stem cell factor (SCF) and interleukin-7 (IL-7) in enhancing pre-B colony formation from normal human or mouse bone marrow.<a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">(14b)</a> Moreover, the possible role of eNAMPT as an immunomodulating mediator has been investigated. eNAMPT exerts direct proinflammatory effects on macrophages by increasing MMP expression and activity,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and the treatment with eNAMPT induces the production of cytokines in human PBMCs, dependent on MAPK signaling, and induces chemotaxis in monocytes.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Furthermore, an essential role of eNAMPT in myelopoiesis has been postulated. eNAMPT induces granulocytic differentiation of CD34+ hematopoietic progenitor cells through sirtuin activation and up-regulation of G-CSF and the G-CSF receptor.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Similarly, it had also been postulated that eNAMPT exerted insulin-mimetic actions by binding directly to the insulin receptor, but this report was eventually retracted.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Nonetheless, there is ample evidence that a cross-talk exists between eNAMPT signaling and insulin signaling pathways. It is at present unclear whether eNAMPT requires its enzymatic activity for these functions and whether enough substrate (PRPP or nicotinamide)<a onclick="showRef(event, 'ref9 ref26'); return false;" href="javascript:void(0);" class="ref ref9 ref26">(9, 26)</a> would be present in the extracellular space to yield either NMN or, eventually, NAD (although there is no evidence that NMNAT, the enzyme required to yield the final product, is present extracellularly).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Evidence of an Involvement of NAMPT in Disease</h3><div class="NLM_p">The first strong evidence that the bioenergetics of cancer cells were different from that of healthy nonaffected cells dates from the beginning of past century, with Otto Warburg, a Nobel Prize winner, as a central figure in this hypothesis.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In brief, Otto Warburg suggested that tumor cells switch from oxidative phosphorylation to aerobic glycolysis for their energy conversion. The glycolytic pathway has a less favorable ratio of ATP produced per NAD(P) molecule reduced. Furthermore, the known importance of sirtuins and PARPs in cancer also might suggest that NAMPT, one of its upstream regulators via production of NAD, might be involved.<a onclick="showRef(event, 'cit5b'); return false;" href="javascript:void(0);" class="ref cit5b">(5b)</a> Last, it has been amply shown that NAD turnover in cancer or proliferating cells is significantly increased over healthy or nonproliferating cells. These original, maybe speculative, observations on the possible involvement of NAMPT in cancer have now been supported by various approaches in cancer cells or patients. Many of these observations are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, while the strongest evidence of all, relying on pharmacological tools, is described at the beginning of the medicinal chemistry section and in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. In brief, in most cancer tissues evaluated, the mRNA and/or protein levels of NAMPT have been found to be elevated. Furthermore, when serum or blood levels of eNAMPT were investigated, these were also found to be increased. Interestingly, in a number of tumors a positive correlation between either tissue or circulating levels and stage progression has been reported (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Last, in a recent study an elevated level of circulating eNAMPT has been correlated with an increased risk of developing postmenopausal breast cancer.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Evidence That NAMPT Is Involved in Cancer<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">condition</th><th class="colsep0 rowsep0" align="center">level of investigation</th><th class="colsep0 rowsep0" align="center">main finding</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Breast cancer</td><td class="colsep0 rowsep0" align="left">Tissutal protein</td><td class="colsep0 rowsep0" align="left">Associated with poor disease-free and overall survival</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">78</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Oostmenopausal breast cancer (PBC)</td><td class="colsep0 rowsep0" align="left">Serum level</td><td class="colsep0 rowsep0" align="left">Elevated (associated with risk of PBC)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">79</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Gastric cancer</td><td class="colsep0 rowsep0" align="left">Tissutal protein and mRNA</td><td class="colsep0 rowsep0" align="left">Increased</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">80</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Serum level</td><td class="colsep0 rowsep0" align="left">Increased (positive correlation with stage progression)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">81</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Tissutal protein</td><td class="colsep0 rowsep0" align="left">Increased (correlation with VEGF-A expression, negatively correlated with survival)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">82</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Lymphomas</td><td class="colsep0 rowsep0" align="left">Tissutal protein</td><td class="colsep0 rowsep0" align="left">Increased (highly expressed in Hodgkinâs lymphoma)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">83</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Prostate cancer</td><td class="colsep0 rowsep0" align="left">Tissutal protein</td><td class="colsep0 rowsep0" align="left">Increased</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">84</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ovarian cancer</td><td class="colsep0 rowsep0" align="left">Tissutal protein</td><td class="colsep0 rowsep0" align="left">Increased</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">85</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Colorectal cancer</td><td class="colsep0 rowsep0" align="left">Blood level</td><td class="colsep0 rowsep0" align="left">Increased (correlated with stage progression)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">86</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Malignant astrocytomas: anaplastic astrocytoma (AA, grade III) and glioblastoma (GBM, grade IV)</td><td class="colsep0 rowsep0" align="left">Serum level tissutal protein and mRNA</td><td class="colsep0 rowsep0" align="left">Increased (correlated with tumor grade, coexpression with p53 in GBM tissue was associated with poor survival)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">87</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Esophageal cancer</td><td class="colsep0 rowsep0" align="left">Serum levels, tissutal mRNA</td><td class="colsep0 rowsep0" align="left">Increased (independent factor of mortality)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">88</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Melanoma</td><td class="colsep0 rowsep0" align="left">Tissutal protein and mRNA</td><td class="colsep0 rowsep0" align="left">Increased (independent of BRAF mutations and Clarkâs levels)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">54</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">PubMed was used to retrieve the evidence using âNAMPT or PBEF or visfatinâ AND âcancerâ as a search string. Evidence collected through microarrays or tissues arrays, albeit present, was excluded. Evidence on the role of NAMPT in other diseases, including inflammation or metabolism, is also abundant in the literature.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Experimental Evidence on the Therapeutic Potential of FK866 and Cancer<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cancer type</th><th class="colsep0 rowsep0" align="center">main finding</th><th class="colsep0 rowsep0" align="center">experimental model</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Multiple myeloma</td><td class="colsep0 rowsep0" align="left">Cytotoxic (autophagy), antitumor activity</td><td class="colsep0 rowsep0" align="left">CellÂ lines/xenograft</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">41</a>,Â <a onclick="showRef(event, 'cit42b'); return false;" href="javascript:void(0);" class="ref cit42b">42b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Breast cancer</td><td class="colsep0 rowsep0" align="left">Cytotoxic in combination with olaparib, increase antitumoral potential of olaparib in xenograft (reduction tumor volume)</td><td class="colsep0 rowsep0" align="left">Cell lines/xenograft</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'cit44b'); return false;" href="javascript:void(0);" class="ref cit44b">44b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Leukemia</td><td class="colsep0 rowsep0" align="left">Cytotoxic in myeloid leukemic cells (correlation with p53 function and acetylation)</td><td class="colsep0 rowsep0" align="left">Cell lines</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">89</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Cytotoxic alone or in combination with MNNG, Ara-C, daunorubicin, and melphalan</td><td class="colsep0 rowsep0" align="left">Cell lines</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">90</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Cytotoxic alone or in combination with sirtinol, cambinol, and EX527</td><td class="colsep0 rowsep0" align="left">CellÂ lines/human primary cells</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">91</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Cytotoxic (apoptosis)</td><td class="colsep0 rowsep0" align="left">Cell lines</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'cit36c'); return false;" href="javascript:void(0);" class="ref cit36c">36c</a>, <a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">58</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Synergism with TRAIL (apoptosis)</td><td class="colsep0 rowsep0" align="left">Cell lines/human primary cells</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">92</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Non-small-cell lung (NSCL) cancer</td><td class="colsep0 rowsep0" align="left">Cytotoxic (correlation with EGFR mutation), antitumor activity</td><td class="colsep0 rowsep0" align="left">CellÂ lines/xenograft</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'cit44c'); return false;" href="javascript:void(0);" class="ref cit44c">44c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Gastric cancer</td><td class="colsep0 rowsep0" align="left">Cytotoxic alone or in combination with fluorouracil</td><td class="colsep0 rowsep0" align="left">Cell lines</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">80</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Suppression of gastric cell migration</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Additive effect in combination with 1-MT</td><td class="colsep0 rowsep0" align="left">Cell lines/xenograft</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'cit44a'); return false;" href="javascript:void(0);" class="ref cit44a">44a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Neuroblastoma</td><td class="colsep0 rowsep0" align="left">Cytotoxic (autophagy), synergism with etoposide/cisplatin/chloroquine (necrosis)</td><td class="colsep0 rowsep0" align="left">Cell lines</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'cit43b'); return false;" href="javascript:void(0);" class="ref cit43b">43b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Bladder cancer</td><td class="colsep0 rowsep0" align="left">Additive effect in combination 1-MT</td><td class="colsep0 rowsep0" align="left">Cell lines/xenograft</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'cit44a'); return false;" href="javascript:void(0);" class="ref cit44a">44a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Mammary carcinoma</td><td class="colsep0 rowsep0" align="left">Cytotoxic (apoptosis)</td><td class="colsep0 rowsep0" align="left">Cell lines</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">93</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Enhancement of radiation sensitivity</td><td class="colsep0 rowsep0" align="left">Cell lines/allograft</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Liver carcinoma</td><td class="colsep0 rowsep0" align="left">Cytotoxic (apoptosis)</td><td class="colsep0 rowsep0" align="left">Cell lines</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'cit36c'); return false;" href="javascript:void(0);" class="ref cit36c">36c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Renal carcinoma</td><td class="colsep0 rowsep0" align="left">Antitumoral, antiangiogenic, and antimetastatic activity</td><td class="colsep0 rowsep0" align="left">Allograft (RENCA model)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">94</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cervix adenocarcinoma</td><td class="colsep0 rowsep0" align="left">Cytotoxic in HeLa cells</td><td class="colsep0 rowsep0" align="left">Cell lines</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">12</a>, <a onclick="showRef(event, 'cit43b'); return false;" href="javascript:void(0);" class="ref cit43b">43b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Glioma</td><td class="colsep0 rowsep0" align="left">Cytotoxic (cell cycle arrest)</td><td class="colsep0 rowsep0" align="left">Cell lines</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">12</a>, <a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">95</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Increase MMS and MX cytotoxicity in temozolomide chemoresistant T98G glioblastoma cell line</td><td class="colsep0 rowsep0" align="left">Cell lines</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">96</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Lymphoma</td><td class="colsep0 rowsep0" align="left">Cytotoxic in human lymphoma B-cells in combination with FX11, increased antitumor activity of FX11</td><td class="colsep0 rowsep0" align="left">Cell lines/xenograft</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">97</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Pancreatic cancer</td><td class="colsep0 rowsep0" align="left">Cytotoxic in combination with FX11</td><td class="colsep0 rowsep0" align="left">Cell lines/xenograft</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">97</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Additive effect in combination with FX11 in xenograft</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ovarian Cancer</td><td class="colsep0 rowsep0" align="left">Cytotoxic effect in combination with NA (increase the therapeutic potential in NaPRT-lacking cancers)</td><td class="colsep0 rowsep0" align="left">Cell lines/xenograft</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">98</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Antitumoral activity (decreased tumor volume and [<sup>18</sup>F]FLT uptake)</td><td class="colsep0 rowsep0" align="left">Xenograft</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'cit44d'); return false;" href="javascript:void(0);" class="ref cit44d">44d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Colon cancer</td><td class="colsep0 rowsep0" align="left">Cytotoxic (reduction of TCA and glycolysis)</td><td class="colsep0 rowsep0" align="left">Cell lines</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">99</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Melanoma</td><td class="colsep0 rowsep0" align="left">Not cytotoxic</td><td class="colsep0 rowsep0" align="left">Cell lines</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">54</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Literature was retrieved using the string âFK866 or APO866â and cancer. Further evidence in the literature exists with other NAMPT inhibitors, mainly <b>2</b>, and on other diseases, mainly in the inflammation field.</p></div></div></div><div class="NLM_p">One of the initial fields of research that focused on circulating NAMPT was human metabolism, given the observation that eNAMPT was secreted by adipocytes<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and the availability of commercial kits to detect eNAMPT levels. A vast number of studies have been published, most of them showing an increase of eNAMPT in patients presenting metabolic or endocrine disorders. Most studies have focused on diabetes or obesity,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> but other conditions, including cardiovascular and endocrine<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> have been investigated. Yet contradicting data exist regarding eNAMPT and metabolic diseases, mainly regarding the plasma levels that are reached in diseases, with at times a 100-fold disparity between reports. Furthermore, in some fields, for example, obesity, contradicting results are present on whether eNAMPT increases or decreases. A possible explanation for this is that patientsâ characteristics are not superimposable in the different studies. A second possibility, as mentioned below, is that eNAMPT is increased in inflammatory states, and in the field of metabolism this may be a strong confounding factor. Third, it has been shown recently that eNAMPT follows a circadian rhythm, with high levels in the morning and low levels at night.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> As this was not known previously, it might have been an uncontrolled bias in many reports. Last, it has been shown that the different kits commercially available (RIA, EIA, ELISA) do not yield superimposable results, and this is likely to contribute to the discrepancy.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> While it is possible that post-translational modifications occur to allow for secretion of eNAMPT, whether the discrepancy between kits is due to the fact that they have been based on recombinant NAMPT remains to be ascertained.</div><div class="NLM_p">As mentioned previously, there is growing evidence that iNAMPT and eNAMPT are involved in modulating the immune system. It is therefore not surprising that circulating eNAMPT has been shown increased in numerous inflammatory conditions, including rheumatoid arthritis, lupus, inflammatory bowel disease, sepsis, and infection.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Furthermore, NAMPT mRNA and/or protein levels have been shown to be also increased in inflammatory cells such as polymorphonucleate cells (PMNC) and neutrophils.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> More convincing evidence regarding the involvement of NAMPT in inflammatory diseases has come by the use of NAMPT inhibitors, as highlighted below.</div><div class="NLM_p last">While cancer, metabolism, and inflammatory diseases have been the most investigated, other diseases that not necessarily fall in these conditions have also been studied and may be found in the literature.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Medicinal Chemistry of NAMPT Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57847" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57847" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first attempt to identify NAMPT inhibitors dates back to 1972, when a series of nicotinamide analogues were evaluated. While these studies suffered from the limitation of not having the purified enzyme or a detailed understanding of the enzymatic mechanism, this paper did suggest that nicotinamide analogues could act as inhibitors of the enzyme reaction, albeit at high concentrations, an observation that was capitalized on in later years.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> FK866 and CHS828</h3><div class="NLM_p">The turning point in the field was the description of the first nanomolar inhibitor of NAMPT in 2002, originally termed FK866 (<b>1</b>, (<i>E</i>)-<i>N</i>-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>; also known as WK175 or APO866).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of FK866.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the original manuscripts,<a onclick="showRef(event, 'cit36b cit36c'); return false;" href="javascript:void(0);" class="ref cit36b cit36c">(36b, 36c)</a> it was shown that FK866, via NAD and subsequent ATP depletion, led to apoptosis. The hallmarks of apoptosis, such as cytochrome <i>c</i> release, caspase activation, and mitochondrial depolarization, could all be attributed to NAMPT inhibition and the subsequent decrease in cellular NAD(P) levels. Cell death is delayed and takes place 24â48 h after treatment. Furthermore, FK866 does not have an effect on NaPRT.<a onclick="showRef(event, 'cit36c'); return false;" href="javascript:void(0);" class="ref cit36c">(36c)</a> In the original report, the mechanism of inhibition was reported to be noncompetitive, although subsequent reports suggested that FK866 and nicotinamide should compete for the same site.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> FK866 displays an incredibly higher affinity (<i>K</i><sub>i</sub> = 0.3 nM) for the site compared to nicotinamide (<i>K</i><sub>m</sub> = 2 Î¼M), and this may explain the discrepancy.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In the same article it was shown that cells that possess an intact and active salvage pathway that can use nicotinic acid are less sensitive to this treatment.</div><div class="NLM_p">Interestingly, in the same paper it was also emphasized that nicotinamide or nicotinic acid can be viewed as possible antidotes, as they are able to revert the growth inhibiting properties of FK866 (for nicotinic acid, only in those cells that express NaPRT; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). This finding has also been replicated with other compounds, namely, CHS828 (<b>2</b>) (see below).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p">In a subsequent paper,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> the X-ray crystal structure of human NAMPT in the presence of FK866 was solved (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVJ">2GVJ</a>). The X-ray structure reveals that NAMPT is a homodimer with a head to tail interaction and a contact surface area of each monomer of â¼4200 Ã (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). There are two binding sites for nicotinamide formed by the union of the two monomers. The structure revealed a long and narrow tunnel (15 Ã Ã 6 Ã) at the interface between subunits and in communication with the NMN interaction pocket. The present review will concentrate primarily on the discussion of FK866 interactions, as reviews concentrating on the structural features on NAMPT have been recently published.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of human NAMPT in complex with FK866 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVJ">2GVJ</a>). One monomer is shown in blue, the other in gold. Carbon atoms of FK866 are shown in green sphere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The crystal structure of NAMPT bound to FK866 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVJ">2GVJ</a>) shows that the drug binds in the narrow tunnel at the interface between subunits. Two molecules of FK866 can bind to a dimer, and yet whether both are required to abolish activity has never been investigated. The pyridine of FK866 is sandwiched between the side chains of Phe193 of one monomer and the Tyr18â² (enumeration of amino acids is based on human NAMPT) of the other, occupying the same position where the pyridine of the nicotinamide is located. The main binding interaction is a ÏâÏ offset stacking. The oxygen atom of the amide behaves as a hydrogen bond acceptor interacting with the hydroxyl group of the Ser275 side chain, while the nitrogen atom of the amide is involved in a hydrogen bond with a retained molecule of water (W1). The retained molecule of water, stabilized by a network of hydrogen bonds between Asp219, Ser241, and Val242, is conserved among all of the human and rat crystal structures (12 out 17 X-ray crystal structures of NAMPT have this conserved molecule of water).</div><div class="NLM_p">The tail group plays an important role because of its ability to anchor the molecule because of the interaction of the phenyl group with a hydrophobic cleft formed by Ile309, Pro307, Val350, Ile378, and Ala379. In this case the benzoylpiperidine group is within van der Waals interaction distance of about 10 residues (Tyr188, Lys189, Ala379, Ile378, Asn377, Glu376, Val350, Arg349, Pro307). Although a series of van der Waals interactions between the alkyl chain and the hydrophobic residue of the amino acids of the tunnel can be observed, it is unlikely that the interaction of the alkyl chain with the protein adds much to the affinity and instead serves primarily as a linker between the pyridine cap group and the benzoylpiperidine tail group (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Different details of X-ray crystal structure of human NAMPT in complex with FK866 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVJ">2GVJ</a>). One monomer is shown in blue, the other in gold. Carbon atoms of FK866 are shown in green sticks. NMN (adapted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVG">2GVG</a>) is in yellow sticks, and the retained molecule of water is a red sphere. Hydrogen bond interactions are plotted as yellow dotted lines. (a) Detail of the FK866 tail group binding pocket. (b) Detail of the overlapping of FK866 and NMN binding sites. (c) Binding mode of FK866.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Unfortunately, no manuscript ever appeared on the chemical optimization of this compound and the information that can be gathered by the patent literature is insufficient to yield an exhaustive structureâactivity relationship. Nonetheless, this compound has been fundamental in the understanding of the therapeutic potential of NAMPT inhibitors in both cancer and inflammation. While other compounds, namely, <b>2</b>, have also participated in the process of elucidating the potential therapeutic role of this class of molecules, FK866 has probably played a more prominent role because it represented a first-in-class and it has been available from commercial and noncommercial sources (i.e., National Institutes of Health) for a number of years. <b>2</b> is now also commercially available.</div><div class="NLM_p">Indeed, a number of authors have shown a strong cytotoxic effect in vitro of FK866 in tumor cell lines (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Most reported cell types are responsive to this chemotherapic agent. While some authors suggested that NAMPT expression inversely correlates with inhibitor sensitivity,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> others have not reproduced such finding.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> While it is beyond the scope of this manuscript to review these data in detail, a number of common themes should be highlighted: (i) FK866 displays low nanomolar potency in both cytotoxicity and enzyme inhibition assays (<10 nM); (ii) while the original report suggested that this agent acted primarily through the induction of apoptosis, autophagy most likely also plays a major role in many cell types;<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> (iii) NAMPT inhibition leads to NAD depletion in a time-dependent fashion, and this in turn brings about the modulation of a number of pathways that act in concert as the executers of cytotoxicity. For example, NAD depletion leads to mitochondrial dysfunction, ATP depletion, and a decreased activity of sirtuins and PARPs,<a onclick="showRef(event, 'cit36c ref43'); return false;" href="javascript:void(0);" class="ref cit36c ref43">(36c, 43)</a> and it is extremely difficult to dissect a single pathway solely responsible for the effects observed. (iv) NAMPT inhibitors, when tested in appropriate models and protocols, strongly synergize with other chemotherapeutic agents or with autophagy inhibitors (see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p"><b>1</b> has also been used in animal models, and again, it has been shown to be effective in reducing tumor growth, tumor volume, and/or metastatic processes (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Doses that reduce the tumor burden in rodent models range from 10 to 20 mg/kg given ip.<a onclick="showRef(event, 'ref41 cit42b ref44'); return false;" href="javascript:void(0);" class="ref ref41 cit42b ref44">(41, 42b, 44)</a></div><div class="NLM_p">Last, FK866 has also been an invaluable tool to bring about the hypothesis that NAMPT inhibitors may have an important therapeutic role in inflammatory diseases. Indeed, it has been shown to have a striking protective role, among others, in animal models of autoimmune encephalitis, rheumatoid arthritis, sepsis, and spinal cord injury.<a onclick="showRef(event, 'cit43a ref45'); return false;" href="javascript:void(0);" class="ref cit43a ref45">(43a, 45)</a> In one of the key papers that demonstrated the effect of these inhibitors in animal models of rheumatoid arthritis, the magnitude of the effect of FK866 was superimposable to that of etanercept.<a onclick="showRef(event, 'cit33a'); return false;" href="javascript:void(0);" class="ref cit33a">(33a)</a> In this instance, a significant reduction of cytokines, a reduced activation of the immune system, and a reduced SIRT activity appear to be among the mediators of this effect. Indeed, it would not be surprising if the industrial interest in these molecules will now concentrate on inflammatory or trauma-related diseases.</div><div class="NLM_p">Another important pillar in the elevation of NAMPT inhibitors to potential therapeutic agents was the characterization of <b>2</b> ((<i>E</i>)-1-(6-(4-chlorophenoxy)hexyl)-2-cyano-3-(pyridin-4-yl)guanidine, also known as GMX1778), a pyridinylcyanoguanidine. This compound was disclosed by Leo Pharma in 1997, but its mechanism of action was unknown at the time.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> This molecule can be considered a close analogue of the antihypertensive potassium channel opener pinacidil (<i>N</i>-cyano-<i>N</i>â²-pyridin-4-yl-<i>N</i>â³-(1,2,2-trimethylpropyl)guanidine), which is not a NAMPT inhibitor. Its potent cytotoxic profile<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> spurred research toward the identification of the mechanism of action, and after almost 10 years of pharmacological efforts, it was demonstrated that NAMPT was the main biological target for the cytotoxic activity of <b>2</b> and that the compound is a competitive inhibitor.<a onclick="showRef(event, 'ref38 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref40">(38, 40)</a></div><div class="NLM_p">SAR studies highlighted the importance of the pyridine ring in <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In this instance, when the pyridine is substituted in position 4 instead of 3, there is an increase in potency of 10- to 100-fold. Furthermore, substitution of a pyridine with a phenyl ring yields inactive compounds. The length of the alkyl chain is also important for improving the activity. In particular hexyl, heptyl, and octyl are the best linkers while the shorter chain linkers give compounds that display a lower activity. Finally a bulky tail group that protrudes toward the solvent exposed surface is important for determining the potency, with a phenoxy group displaying the best potency.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> It is interesting that no X-rays or NMR conformational studies on <b>2</b> have been reported in order to unveil which conformer of cyanoguanidine prevails in solution and which is the preferred conformation at the binding site.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. SAR studies on <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly, it has also been suggested that <b>2</b> is a substrate for NAMPT and it is phosphoribosylated while binding and inhibiting NAMPT.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The phosphoribosylated <b>2</b> does not lose its potency of inhibition but, given the positive formal charge, remains trapped in the cell, thereby increasing its concentration at the site of action. Whether other molecules, including FK866, can also be enzyme substrates remains to be ascertained.</div><div class="NLM_p">Further modifications of <b>2</b> have been described (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> As various modifications of the side chain and the pyridine ring did not lead to more potent compounds compared to <b>2</b>, these authors designed and synthesized a series of constrained analogues on the cyanoguanidine core (<b>3</b> and <b>4</b>). Although some analogues were cytotoxic, they displayed a different spectrum of activity compared to <b>2</b> and no proof of their ability to inhibit NAMPT has been reported to date.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Constrained analogues and water-soluble prodrug of <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A water-soluble prodrug of <b>2</b> has also been prepared (<b>5</b>, (<i>E</i>)-4-(3-(6-(4-chlorophenoxy)hexyl)-2-cyanoguanidino)-1-(3-oxo-2,4,7,10,13,16-hexaoxaheptadecyl)pyridin-1-ium, named GMX1777, EB1627, or teglarinad). This was made in order to prepare a drug that could be administered intravenously. <b>5</b> is a pyridinium salt containing an esterase-cleavable carbonate unit and a solubilizing PEG linker. This compound is freely soluble in water up to 97 mg/mL.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> It is important to stress that the easy to make hydrochloride, hydrobromide, and mesylate salts did not provide compounds with sufficient water solubility.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><div class="NLM_p">Cellular chemoresistance to NAMPT inhibitors in in vitro models has been documented. The most relevant studies have been performed using <b>2</b>. Continuous exposure of increasing concentrations of NAMPT inhibitors to cell lines has resulted in mutations of the enzyme. In particular, the H191R mutation was detected in two different cell lines; this mutation results in abrogation of inhibitor binding, as suggested by computer modeling. Furthermore, the H191R mutation reduces NAMPT activity by 50%. Moreover, the deletion of Asp93 has been found to be located in cells resistant to both <b>2</b> and FK866.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> In another report, a G217R mutation has been reported in a <b>2</b> resistant cell line, once again reducing the binding of <b>2</b> to the active site of NAMPT. Contrary to the H191R mutation, NAMPT bearing the G217R mutation maintains enzymatic activity.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> All these mutations have been found located in either the binding site or dimer interface, and it has been suggested that these mutations may directly or indirectly adjust the shape of the binding site, resulting in an accessible site for Nam or NMN but not for large NAMPT inhibitors. Last, it has been shown that nicotinic acid can protect cells that express NaPRT,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and therefore, it could be postulated that up-regulation of NaPRT could be a mechanism of resistance, although we are not aware of data in this direction.</div><div class="NLM_p last">Both FK866 and <b>2</b> have entered clinical trials (<a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a>). While no data are available regarding preclinical toxicology and very little are available regarding preclinical pharmacology, it must be assumed that the results were of sufficient reassurance to regulators. Reported phase I/II clinical trials on FK866 used a continuous 96 h infusion every 28 days. Reported phase I/II trials on <b>2</b> used an oral administration once or five times a week every 3 or 4 weeks, and a reported phase I trial on <b>5</b> used 24 h infusions every 3 weeks.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Phase I clinical trials were conducted in patients with either solid tumors or lymphomas.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> These trials overall suggest that trombocytopoenia and gastrointestinal toxicity (the latter in particular for the oral formulation) are the most severe dose-limiting side effects of this class of drugs. Other toxicities possibly linked to NAMPT inhibitor therapy were anemia, hypoalbuminemia, hyperglycemia, and electrolyte dysfunction.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> While it might not be expected to obtain significant clinical effects in phase I, given that patients are usually severely compromised, no significant patient responses have been observed with either of the three drugs.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Phase II clinical trials have been initiated for FK866 and <b>5</b> in the following settings: T-cell lymphoma, refractory chronic lymphocytic leukemia, and advanced melanoma (<a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a>). Neither the outcome of these nor the preclinical evidence that has led to the development of NAMPT inhibitors in these directions has been disclosed. Indeed, it may well be that these settings were not ideal. For example, it has been recently shown that melanoma cell lines do not respond to FK866.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> It is therefore likely that these trials were initiated before a more thorough understanding of preclinical models was established, and it is therefore possible that novel trials can capitalize on this knowledge. In particular, for phase II trials, there is now increasing evidence that these drugs should be given in combination with other regimens. To our knowledge, no trial has focused on the inflammatory properties of these drugs. Last, the pharmacokinetics of FK866 in humans appears not necessarily ideal, with a very short half-life and a very fast clearance of the drug in urine in an unmodified form or as the <i>N</i>-oxide form.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The half-life of <b>2</b> appears longer (3â8 h),<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> but it remains to be ascertained whether the dosing schedule is appropriate. As most molecules synthesized in this area of research bear the pyridine ring, the <i>N</i>-oxide route of metabolism might represent a common theme and should be evaluated early in the screening process. Yet to our knowledge a thorough description of the pharmacokinetic parameters of these two front-runners (e.g., plasma protein binding, routes of metabolism) has not been published.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Newer NAMPT Inhibitors</h3><div class="NLM_p">A number of academic and industrial groups have explored the possibility of developing novel NAMPT inhibitors. Indeed, industry has been particularly active on this front, with dozens of patents disclosed over the past years. While the rationale for development may not have been necessarily based on FK866 or <b>2</b>, and most of the molecules described below have nonobvious novelty features, for simplicity reasons the molecules will be described according to whether the most relevant information, compared to FK866 or <b>2</b>, could be derived from (a) replacement or chemical modification of the pyridine ring, (b) replacement of the vinilogous amide group, (c) replacement of the tail group (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Most molecules described in the literature present more than one modification, and we have described the articles according to where we felt the most interesting modification was applied from a scientific perspective.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Schematic division of FK866 in three regions of interest for the medicinal chemist: (a) pyridine group; (b) vinylogous amide group; (c) tail group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It is interesting that when the compounds we describe below have been tested in both enzymatic assays and cellular assays, the IC<sub>50</sub> and EC<sub>50</sub> values have been, in most instances, of the same order of magnitude. Therefore, while off-target effects cannot be ruled out, it is likely that most compounds synthesized so far are rather specific.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> (a) Replacement or Chemical Modification of the Pyridine Group</h4><div class="NLM_p">The rapid clearance of FK866, probably due to the formation of the highly soluble <i>N</i>-oxide metabolite, has spurred scientists to try to replace the pyridine ring with other hetereocyclic rings. Yet there is no published report that presents data conclusively assessing that the nitrogen atom of the pyridine presents a very high metabolic liability, and therefore, this hypothesis must still be confirmed.</div><div class="NLM_p">As the substitution of the pyridine with a phenyl ring leads to inactive compounds,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> attempts to replace the pyridine ring with other heterocyclic rings containing at least one nitrogen atom (indole, pyrimidine, 1-<i>H</i> pyrazole, pyrrole) or a nitrobenzene and 2- and 3-substituted anilines, alone or with a diol group as a ribose mimetic, gave inactive compounds except for the pyrrole derivative (<b>6</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> This compound showed similar cytotoxic effects compared to FK866 in the breast cancer MCF7 cell line (1.29 Î¼M vs 0.68 Î¼M) but was significantly less active in other cancer cell lines where FK866 showed nanomolar potency. Furthermore, the authors stated that their compound had an activity of 1.4 Î¼M on human leukemia cells (K562) while FK866 was inactive at concentrations up to 20 Î¼M. However, there are conflicting reports in the literature, as in another paper<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> it was demonstrated that FK866 had an IC<sub>50</sub> of 7.2 nM (96 h) on the same cancer cell line. Furthermore, the nanomolar potency of FK866 has been demonstrated by most laboratories working in the field. However, a number of laboratories that rely on commercial sources of FK866 have manifested difficulty in obtaining reliable products (personal communications to A.A.G.). Last, given the clonal nature of cell lines, it is possible that nominally identical cell lines around the world behave differently.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. NAMPT inhibitors: replacement or chemical modification of the pyridine ring (I).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although not yet registered in the PDB database, the crystal structure of the pyrrole analogue with NAMPT has been described (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>a),<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and the PDB data were made available to us from the authors (personal communication to A.M.). The compound shares a similar binding pose compared to FK866. The nitrogen atom of the pyrrole is still sandwiched between Phe193 and Tyr18â². The authors suggest that Asp219 could contribute with additional ionic interactions with the pyrrole nitrogen atom. Nonetheless, this interaction would appear unlikely given the impossibility of the pyrrole to be protonated at physiological pH.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Details of other crystal structures of NAMPT in complex with <b>6</b> or <b>8</b>. FK866 is shown in green, and NMN is shown in yellow. (a) Binding mode of <b>6</b> (PDB code not available; obtained from the authors). Carbon atoms of <b>6</b> are shown in light yellow. (b) Binding mode of <b>8</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3G8E">3G8E</a>). Carbon atoms of <b>8</b> are shown in purple. (c) Overlay of <b>8</b> and NMN in the NMN binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Previously, the same authors prepared an analogue (<b>7</b>) with a ribose ring attached at the nitrogen atom of the pyridine of FK866 (named ISO001) with the aim to exploit the same hydrogen bond interactions of the ribose of NMN.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> This analogue was crystallized with NAMPT and showed the same orientation and binding mode of FK866 (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>b,c). Notwithstanding that, the binding affinity was greatly decreased (<i>K</i><sub>d</sub> of 45 Î¼M vs FK866 nanomolar for <b>1</b>). A possible explanation for this loss of activity may be the difficulty of the charged ISO001 to pass through the hydrophobic tunnel. Recently, a <i>C</i>-iminofuranoside analogue of FK866 has also been prepared (<b>8</b>). No pharmacological activity has been reported yet for this compound, but it is likely that the lack of the pyridine ring makes this compound inactive or poorly active.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><div class="NLM_p">In two recent patents<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> the pyridine moiety has been replaced with heterocycles in which the nitrogen atom of the pyridine is still present. From a medicinal chemistry point of view these compounds can be considered rigid analogues of the 3-vinylpyridine moiety. In particular, the heterocycles reported in Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a> have been used. Although the company did not disclose their lead candidates yet, we report two of the most active compounds (<b>9</b> and <b>10</b>) as NAMPT inhibitors illustrated in the patent (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>).</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Synoptic scheme of the heterocycles used as cap groups replacing the pyridine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. NAMPT inhibitors: replacement or chemical modification of the pyridine ring (II).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, a series of substituted pyridines, as well as pyridazine and pyrimidine analogues, have been shown to retain anti-NAMPT activity (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a>Surprisingly, some of them, while potent enzyme inhibitors, fail to elicit cytotoxic effects. A similar effect has been observed by the same authors in a different series of compounds.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> At present it is unclear which factors may contribute to this phenomenon, although the authors make different hypotheses (cell permeability, protein binding, ability to form the phosphoribosylated adduct, ability to compete with nicotinamide).</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. NAMPT inhibitors: replacement or chemical modification of the pyridine ring (III).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">An important conclusion is that so far all molecules able to interact with NAMPT at nanomolar levels have to contain a meta or para substituted pyridine, a heterocycle containing a pyridine moiety, a pyridazine, or a pyrimidine. Aromaticity is important to give Ï offset stacking interactions with Tyr18â² and Phe193, while the role of the nitrogen atom is still puzzling. It is improbable that it forms a hydrogen bond with the phenyl group of Phe193, as the two moieties are on different planes.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> On the other hand, it could contribute to fine-tune the offset Ï stacking interaction and to mimic nicotinamide to give the drugâphosphoriboside adduct that stabilizes the enzymeâinhibitor complex.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> (b) Replacement of the Vinylogous Amide Group</h4><div class="NLM_p">Recently, a novel inhibitor of NAMPT, exploiting the concept of click chemistry, has been reported (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The rationale for the identification of this novel inhibitor was that the replacement of the amide bond of FK866 with a triazole might have yielded a nonclassic bioisosteric substitution.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> A previous isosteric replacement of the amide of FK866 with a sulfonamide was attempted, but the compound was totally inactive.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> When the 1,4-disubstituted triazole (<b>11</b>) replaced the vinylogous amide FK866, the compound was shown to be cytotoxic (in a neuroblastoma cancer cell line) with an IC<sub>50</sub> of 3.0 Î¼M, i.e., 3000 times less active than FK866. On the other hand, the molecule (<b>12</b>) with a pyridine ring directly attached to the triazole was shown to be active at 90 nM. The activity of these compounds on cytotoxicity was superimposable to their activity on NAD levels and on NAMPT activity assays, supporting a correlation between these three phenomena.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> It is interesting that compounds with the amide directly attached to the pyridine ring (e.g., <b>13</b>) turned out to be inactive.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. NAMPT inhibitors: replacement of the amide group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These results strengthen the idea that a hydrogen bond acceptor should be at a distance of roughly three carbon atoms from the pyridine. The identification of a compound with nanomolar potency suggested to the authors that the pyridinyltriazole moiety was tolerated in the binding site of NAMPT, maintaining key bonds for the interactions, and a follow-up campaign was immediately started.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> A total of 181 different pyridinyltriazoles were synthesized by click chemistry, resulting in the identification of <b>14</b> as a potent nanomolar NAMPT inhibitor. SAR studies were also performed. Again, the replacement of the pyridine ring with a phenyl or other heterocycles yielded inactive compounds. It is important to stress that, also in this case, the length of the alkyl linker chain was fundamental to allow for a perfect accommodation of both the cap and the tail group. In this work with <i>n</i> = 6 the IC<sub>50</sub> was 56 nM, while with <i>n</i> = 7 and <i>n</i> = 8 the IC<sub>50</sub> values were 3.8 and 14.6 nM, respectively. The tail group displayed a dramatic shift in the activity, stressing its fundamental role for imparting biological activity with the phenyl analogue being poorly active and the 2 substituted 1,1â²-biphenyl group very potent.</div><div class="NLM_p">Very recently, putative NAMPT inhibitors containing a pyridinylurea or thiourea were synthesized and were shown to have a strong cytotoxic activity against the A2780 ovarian carcinoma cell line exemplified by compound <b>15</b> with an IC<sub>50</sub> of 0.89 nM. A schematic SAR is provided in Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. SAR of putative NAMPT inhibitors (I).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In another patent, rigid analogues of the pyridinylurea have been shown to be NAMPT and/or ROCK inhibitors.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Because of the huge number of active products reported, we show a general formula (<b>16</b>) of these compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>). In another patent a 3,4-diaminocyclobut-3-ene-1,2-dione was used as a hydrogen bond acceptor unit (Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Compound <b>17</b> had an IC<sub>50</sub> for cytotoxicity of 30 pM on the A2780 ovarian carcinoma cell line. Compound <b>17</b> is only an example of a selection of potent compounds described in this patent. For this class of molecules, a six-carbon linker appears to be important for the activity, while the tail group can be modified. Even in this case all the compounds must be considered putative inhibitors of NAMPT, as no direct proof of their mechanism of action was directly reported in the patent. It is likewise difficult to extrapolate a SAR from the patent.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. General formula for NAMPT and ROCK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. SAR of putative NAMPT inhibitors (II).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The connecting units between the pyridine and the alkyl chain that have been demonstrated to be accepted by the enzyme are represented in Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a>. In summary, a hydrogen bond donor or acceptor motif appears to be essential for activity. Furthermore, depending on the groups introduced in this region, the optimal chain length may differ. This might be an area in which the medicinal chemist may explore further structures.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Synoptic scheme of the connecting units accepted by NAMPT.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> (c) Replacement of the Tail Group</h4><div class="NLM_p">A recent patent disclosed analogues of FK866 with different tail groups instead of the benzoylpiperidine moiety. A series of nanomolar cytotoxic compounds active on the A2789 ovarian carcinoma cell line were presented (Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a>). Compound <b>18</b> showed a cytotoxic activity of 0.16 nM. Once again, no formal proof of their inhibitory activity on NAMPT was reported, and these compounds, although at first sight sharing key features with NAMPT inhibitors, at the moment must be considered putative NAMPT inhibitors. Caution is indeed required before enzymatic inhibition studies are performed, as in our laboratory we have found extremely cytotoxic compounds sharing key features with NAMPT inhibitors but devoid of inhibitory activity on the enzyme.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. NAMPT inhibitors: tail group modification (I).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Analogues of <b>2</b>, modified at the tail group have also been reported (Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>). In particular, compound <b>19</b> (TP201565) appears to be 85 times more cytotoxic than its related compound with a potency in the picomolar range, but other potent analogues with different tail groups have been reported in the same patent (small-cell lung cancer NYH cell line: FK866 1.5 nM, <b>2</b> 1.7 nM, <b>19</b> 0.02 nM).<a onclick="showRef(event, 'ref52 ref70'); return false;" href="javascript:void(0);" class="ref ref52 ref70">(52, 70)</a> This study supports the notion that the modification of the tail group is a good strategy to identify more potent analogues compared with the parent compound.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. NAMPT inhibitors: tail group modification (II).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Serendipitously, NAMPT inhibitors have also been developed starting from thymidylate synthase (TS) inhibitor scaffolds (Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a>). In this instance, a discrepancy between cytotoxicity and TS inhibition brought further detailed work that led to the finding that CB-30865 (<b>20</b>) was a novel inhibitor of NAMPT. Its water-soluble analogue (<b>21</b>, MPI-0486348) has also been synthesized (cytotoxicity in the human lymphoblastoid cell line: W1L2 EC<sub>50</sub> of 0.49 nM; NAMPT enzyme inhibition of 0.23 nM).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> An extensive SAR study was undertaken on <b>20</b>.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> In particular, the 3-substituted pyridine was intolerant to any modifications, whereby the propargilic group can also be replaced with other lipophilic moieties. The best tail groups were a quinazolin-4-one or a 1,2,3-benzotriazin-4-one. Although the authors did not explicitly highlight their lead compounds, the most interesting analogues appear to be compounds <b>22</b> and <b>23</b>.</div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. NAMPT inhibitors: tail group modification (III).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The replacement of the long alkyl chain with a benzene ring (Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a>) has been exploited in a patent<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> and recently published.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Briefly, a virtual screening based on a pharmacophoric model designed by the authors unraveled a compound (<b>24</b>) with nanomolar anti-NAMPT activity. From this lead compound, an impressive number of analogues displaying high cytotoxic activity have been reported in the patent (for example, <b>25</b> and <b>26</b>). A lead candidate (<b>25</b>) has been disclosed in the subsequent article,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> which showed in vivo antitumor activity when dosed orally in an ovarian tumor xenograft model. The same group has recently raised the issue that the pyridine in this series of NAMPT inhibitors may be a structural determinant for CYP2C9 inhibition. Different pyridine substituted analogues have been synthesized and tested, leading to the discovery of compound <b>27</b> which maintains NAMPT inhibitory activity and antitumoral activity in xenografts without displaying inhibition of CYP2C9.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> It is interesting that, also in this case, many of substituted pyridines retain NAMPT-inhibitory properties but fail to be cytotoxic.</div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. NAMPT inhibitors: tail group modification (IV).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The same company described a diphenylsulfone tail group (<b>28</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a>), which was also present in most of the structures described above, that bears as a cap group the pyridinylcyanoguanidine of <b>2</b>.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Finally, in a recent patent,<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> the authors disclosed a chimeric compound formed by joining the 3-pyridinylacrylamide of FK866 with the phenylsulfone tail group. Also in this case, we report only one example of this class of compounds (<b>29</b>).</div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. NAMPT inhibitors: tail group modification (V).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The benzoylpiperidine moiety of FK866 has also been replaced with adamantyl or carborane groups (Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a>).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The adamantyl derivative was 50 times less potent than FK866 as a cytotoxic agent on a lung cancer cell line (A549), while the carborane derivatives were more active than FK866. In particular, compound <b>30</b> showed an IC<sub>50</sub> of 0.41 nM for cytotoxicity (A549) and exhibited an approximately 100-fold higher inhibitory activity compared with FK866.</div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Structure of a carborane derivative of FK866.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The first virtual screening work appeared in 2011.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> The authors used the crystal structure information of FK866 and NMN bound to NAMPT and performed a docking simulation of compounds contained in a chemical library. This procedure yielded six compounds, which were experimentally tested. Two of these compounds (<b>31</b> and <b>32</b>) displayed cytotoxicity on U87 cancer cell line (human glioblastoma) comparable to that of FK866, and one of them (<b>32</b>) was shown to be a NAMPT inhibitor (Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a>). Nonetheless, this activity appears to be at least 1000-fold lower for FK866 than that reported by most authors.</div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structures of compounds selected by virtual screening.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In conclusion, the tail group modifications have yielded a great diversity of very active compounds, and other modifications are most likely possible and should be attempted. Yet it remains to be established whether these will impinge only on the pharmacodynamic profile of the drug or whether pharmacokinetic improvements will also be possible.</div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Pharmacological Considerations, Future Directions, and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13457" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13457" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">According to the structures identified to date as potent inhibitors of NAMPT, it is possible to sketch a pharmacophoric working model in order to help the people involved in this field, or newcomers, design novel/innovative NAMPT inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a>). In brief, it would appear that a NAMPT inhibitor is linear in shape, with a pyridine (substituted or not) or a heterocycle containing a pyridine moiety as a cap group, with the presence of a connecting unit at the 3 or 4 position of pyridine and with a hydrogen bond acceptor at a distance between 5.6 and 7.5 Ã from the nitrogen atom of the pyridine and an alkyl chain linker with a minimum length of 7.6 Ã, which corresponds approximately to five CâC bonds, in order for a hydrophobic group to protrude outward to be able to interact with the hydrophobic amino acids of the rim of the enzyme. Nonetheless, it has not escaped our attention that a similar model has been proposed for other enzymes. For example, histone deacetylase (HDAC) inhibitors possess a hydroxamic acid or other zinc-chelating warhead in the active site of the enzyme, a linker in the long and narrow tunnel, and a hydrophobic cap group that protrudes outside. A potential strategy therefore could be to capitalize on the numerous HDAC libraries present and to substitute the zinc-chelating warhead with a pyridine to evaluate their activity.</div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Roadmap to the synthesis of novel NAMPT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In conclusion, there are ample data suggesting that NAMPT inhibitors may have an important therapeutic role in cancer, and this target enzyme appears to display some features that would make it attractive. It is overexpressed in target issues. An antidote exists (nicotinic acid or nicotinamide). Proof-of-principle experiments in rodents have ascertained its potential, and lead compounds with sufficient potency have been described. Less is known about its potential in inflammatory diseases.</div><div class="NLM_p">Yet novel compounds are urgently warranted to allow for the field to proceed speedily. Compounds should be able to display distinct pharmacokinetic properties compared to the most established compounds, as this seems to be an area that requires improvement, should be able to inhibit those mutated enzymes which have been described, and should be characterized for selectivity. Indeed, while most of the compounds described above discriminate between NAMPT and NaPRT, very little is known regarding their overall specificity, for example, with respect to other enzymes that use NAD. Last and most important, new compounds able to discriminate between iNAMPT and eNAMPT are urgently warranted both because they might have a different usefulness in the clinic and because they will be able to allow us to understand the role of these two forms.</div><div class="NLM_p">Apart from medicinal chemistry, much remains to be done on these compounds. In the laboratory, it will be fundamental to understand more thoroughly the involvement of NAMPT in health and disease. For example, it has been suggested by others that cancer, inflammation, and metabolism have strong ties, and NAMPT might be an important link.<a onclick="showRef(event, 'cit2b'); return false;" href="javascript:void(0);" class="ref cit2b">(2b)</a> In translational research, furthermore, it will be important to understand which combinations of drugs that include NAMPT inhibitors are more likely to work in the clinic, both regarding cancer and inflammation. Last, NAMPT inhibition brings up a number of practical issues that will need to be resolved for therapy to be effective. For example, what impact will the diet have on therapy (as a source of NAD precursors) or what impact will the time of day in which therapy is administered have?</div><div class="NLM_p last">Notwithstanding all the areas of research that still present uncertainties in the NAMPT field, it has been suggested that basic metabolism may be an important strategy in combating cancer,<a onclick="showRef(event, 'cit2a'); return false;" href="javascript:void(0);" class="ref cit2a">(2a)</a> and NAMPT still appears to be one of the most promising targets. The potential in inflammatory diseases remains instead to be ascertained.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm4001049" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02562" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02562" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gian Cesare Tron</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze del
Farmaco, UniversitÃ  degli Studi del Piemonte Orientale
âA. Avogadroâ, Largo Donegani 2, 28100
Novara, Italy</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2256504d4c62524a43504f0c574c4b524f4c0c4b56"><span class="__cf_email__" data-cfemail="077375686947776f66756a2972696e776a69296e73">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ubaldina Galli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze del
Farmaco, UniversitÃ  degli Studi del Piemonte Orientale
âA. Avogadroâ, Largo Donegani 2, 28100
Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Travelli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze del
Farmaco, UniversitÃ  degli Studi del Piemonte Orientale
âA. Avogadroâ, Largo Donegani 2, 28100
Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alberto Massarotti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze del
Farmaco, UniversitÃ  degli Studi del Piemonte Orientale
âA. Avogadroâ, Largo Donegani 2, 28100
Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gohar Fakhfouri</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Research Center, Shahid Beheshti University of Medical
Sciences, Tehran,
Iran</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reza Rahimian</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology,
School
of Medicine, Tehran University of Medical Sciences, Tehran, Iran</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Armando A. Genazzani</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze del
Farmaco, UniversitÃ  degli Studi del Piemonte Orientale
âA. Avogadroâ, Largo Donegani 2, 28100
Novara, Italy</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Dr. Galli and Dr. Travelli contributed equally to the work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04632" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04632" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Ubaldina Galli</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=BIO-d605e1629-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ubaldina Galli</b> received her degree in Pharmacy in 1992 and her Ph.D. in Medicinal Chemistry in 1995 from the UniversitÃ  di Torino (Italy). At present she is an Assistant Professor in Medicinal Chemistry at the UniversitÃ  del Piemonte Orientale (Novara, Italy). Her research focus at present is on the development of new nicotinamide phosphoribosyltransferase inhibitors.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Cristina Travelli</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=BIO-d605e1634-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Cristina Travelli</b> received her degree in Medical and Pharmaceutical Biotechnology in 2009 and her Ph.D. in Food and Pharmaceutical Biotechnology in 2013 from the UniversitÃ  del Piemonte Orientale (Novara, Italy). At present she is a postdoc in pharmacology in Novara. Her main research interests concern the role of NAD metabolism in cancer biology.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Alberto Massarotti</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=BIO-d605e1639-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Alberto Massarotti</b> received his degree in Medical and Pharmaceutical Biotechnology in 2006 and his Ph.D. in Medicinal Chemistry in 2009 at the UniversitÃ  del Piemonte Orientale (Novara, Italy). Since 2012, he is Assistant Professor in Medicinal Chemistry at the UniversitÃ  del Piemonte Orientale. His main research interests concern development and application of novel computational methodologies to discovery new lead compounds.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Gohar Fakhfouri</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=BIO-d605e1644-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Gohar Fakhfouri</b> received her PharmD (Doctorate in Pharmacy) in 2007 from Shiraz Beheshti University of Medical Sciences (Tehran, Iran) and her Ph.D. in Pharmacology from Shahid Beheshti University of Medical Sciences (Tehran, Iran). In 2011, a scholarship by the Health Ministry of Iran supported her stay in A.A.G.âs laboratory, where she worked on NAMPT inhibitors and inflammation.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Reza Rahimian</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=BIO-d605e1649-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Reza Rahimian</b> received his PharmD (Doctorate in Pharmacy) in 2006 from Shiraz University of Medical Sciences (Tehran, Iran) and his Ph.D in Pharmacology in 2012. In 2011 a scholarship by the Health Ministry of Iran supported his stay in A.A.G.âs laboratory, where he worked on NAMPT inhibitors and inflammation.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Gian Cesare Tron</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=BIO-d605e1654-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Gian Cesare Tron</b> received his degree in Pharmaceutical Chemistry and Technology in 1994 and his Ph.D. in Organic Chemistry in 2000 at the UniversitÃ  di Torino (Italy). At present, he is an Associate Professor of Medicinal Chemistry at the UniversitÃ  del Piemonte Orientale (Novara, Italy). In 2007 he was awarded the Farmindustria Prize for his achievements in medicinal chemistry. His research interests focus on the discovery of novel multicomponent reactions and their applications to medicinal chemistry, especially in the realm of anticancer agents.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Armando A. Genazzani</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=BIO-d605e1659-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Armando A. Genazzani</b> received his medical degree from the UniversitÃ  di Catania (Italy) and obtained his D.Phil. in Pharmacology from the University of Oxford (U.K.). Subsequently he obtained independent positions at the University of Cambridge (U.K.) first as a Pharmacology Fellow and then as a BBSRC David Phillips Fellow and as a University Lecturer. He was also a Clare Hall Official Fellow. At present, he is a Full Professor of Pharmacology at the UniversitÃ  del Piemonte Orientale (Novara, Italy). His main research interests concern cell signaling and the mechanisms of action of old and new biologically active compounds.</p></figure></div><div class="ack" id="ACK-d605e1669-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support from M.I.U.R. PRIN 2010-2011 (Grant 2010W7YRLZ_002), Italy, from the Italian Foundation for Cancer Research AIRC (Grant IG 10509), and from the Compagnia San Paolo is gratefully acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i25" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i25"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i26" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i26"> Abbreviations Used</h2><tr><td class="NLM_term">1-MT</td><td class="NLM_def"><p class="first last">1-methyltryptophan</p></td></tr><tr><td class="NLM_term">ADPR</td><td class="NLM_def"><p class="first last">ADP-ribose</p></td></tr><tr><td class="NLM_term">AMP</td><td class="NLM_def"><p class="first last">adenosine monophosphate</p></td></tr><tr><td class="NLM_term">ART</td><td class="NLM_def"><p class="first last">mono (ADP-ribose) transferase</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmatic reticulum</p></td></tr><tr><td class="NLM_term">IDO</td><td class="NLM_def"><p class="first last">indoleamine 2,3-dioxygenase</p></td></tr><tr><td class="NLM_term">MMS</td><td class="NLM_def"><p class="first last">methyl methanesulfonate</p></td></tr><tr><td class="NLM_term">MNNG</td><td class="NLM_def"><p class="first last">methylnitronitrosoguanidine</p></td></tr><tr><td class="NLM_term">MX</td><td class="NLM_def"><p class="first last">methoxyamine</p></td></tr><tr><td class="NLM_term">NA</td><td class="NLM_def"><p class="first last">nicotinic acid</p></td></tr><tr><td class="NLM_term">NAAD</td><td class="NLM_def"><p class="first last">nicotinic acid adenine dinucleotide</p></td></tr><tr><td class="NLM_term">NADS</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide synthetase</p></td></tr><tr><td class="NLM_term">Nam</td><td class="NLM_def"><p class="first last">nicotinamide</p></td></tr><tr><td class="NLM_term">NAMN</td><td class="NLM_def"><p class="first last">nicotinic acid mononucleotide</p></td></tr><tr><td class="NLM_term">NAMPT</td><td class="NLM_def"><p class="first last">nicotinamide phosphoribosyltransferase</p></td></tr><tr><td class="NLM_term">NaPRT</td><td class="NLM_def"><p class="first last">nicotinic acid phosphoribosyltransferase</p></td></tr><tr><td class="NLM_term">NMN</td><td class="NLM_def"><p class="first last">nicotinamide mononucleotide</p></td></tr><tr><td class="NLM_term">NMNAT</td><td class="NLM_def"><p class="first last">nicotinamide mononucleotide adenylyltransferase</p></td></tr><tr><td class="NLM_term">NMNAT</td><td class="NLM_def"><p class="first last">nicotinamide mononucleotide adenylyltransferase</p></td></tr><tr><td class="NLM_term">NR</td><td class="NLM_def"><p class="first last">nicotinamide riboside</p></td></tr><tr><td class="NLM_term">NRK</td><td class="NLM_def"><p class="first last">nicotinamide riboside kinase</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly (ADP-ribose) polymerase</p></td></tr><tr><td class="NLM_term">PMNC</td><td class="NLM_def"><p class="first last">polymorphonucleate cell</p></td></tr><tr><td class="NLM_term">PPi</td><td class="NLM_def"><p class="first last">pyrophosphate</p></td></tr><tr><td class="NLM_term">PRPP</td><td class="NLM_def"><p class="first last">phosphoribosyl pyrophosphate</p></td></tr><tr><td class="NLM_term">QA</td><td class="NLM_def"><p class="first last">quinolinic acid</p></td></tr><tr><td class="NLM_term">QAPRT</td><td class="NLM_def"><p class="first last">quinolinic acid phosphoribosyltransferase</p></td></tr><tr><td class="NLM_term">SCF</td><td class="NLM_def"><p class="first last">stem cell factor</p></td></tr><tr><td class="NLM_term">TCA</td><td class="NLM_def"><p class="first last">tricarboxylic acid</p></td></tr><tr><td class="NLM_term">TDO</td><td class="NLM_def"><p class="first last">tryptophan 2,3-dioxygenase</p></td></tr><tr><td class="NLM_term">TRAIL</td><td class="NLM_def"><p class="first last">tumor necrosis factor related apoptosis inducing ligand</p></td></tr><tr><td class="NLM_term">TS</td><td class="NLM_def"><p class="first last">thymidylate synthase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75711" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75711" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 99 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Vander Heiden, M. G.</span><span> </span><span class="NLM_article-title">Targeting cancer metabolism: a therapeutic window opens</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">â</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1038%2Fnrd3504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=21878982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSltb3J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=671-684&author=M.+G.+Vander+Heiden&title=Targeting+cancer+metabolism%3A+a+therapeutic+window+opens"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer metabolism: a therapeutic window opens</span></div><div class="casAuthors">Vander Heiden, Matthew G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">671-684</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genetic events in cancer activate signalling pathways that alter cell metab.  Clin. evidence has linked cell metab. with cancer outcomes.  Together, these observations have raised interest in targeting metabolic enzymes for cancer therapy, but they have also raised concerns that these therapies would have unacceptable effects on normal cells.  However, some of the first cancer therapies that were developed target the specific metabolic needs of cancer cells and remain effective agents in the clinic today.  Research into how changes in cell metab. promote tumor growth has accelerated in recent years.  This has refocused efforts to target metabolic dependencies of cancer cells as a selective anticancer strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdwef_xmbtRrVg90H21EOLACvtfcHk0lh2uMmid3SRtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSltb3J&md5=5051a52f70ba7dd0cd99cf6ffce7f4c6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3504%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26atitle%3DTargeting%2520cancer%2520metabolism%253A%2520a%2520therapeutic%2520window%2520opens%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D671%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span> </span><span class="NLM_article-title">Nampt: linking NAD biology, metabolism and cancer</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">â</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.tem.2008.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=19109034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFanu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=130-138&author=A.+Gartenauthor=S.+Petzoldauthor=A.+Kornerauthor=S.+Imaiauthor=W.+Kiess&title=Nampt%3A+linking+NAD+biology%2C+metabolism+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Nampt: linking NAD biology, metabolism and cancer</span></div><div class="casAuthors">Garten, Antje; Petzold, Stefanie; Koerner, Antje; Imai, Shin-ichiro; Kiess, Wieland</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">130-138</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nicotinamide phosphoribosyltransferase (Nampt) converts nicotinamide to NMN, a key NAD intermediate.  Previously identified as a cytokine pre-B-cell colony-enhancing factor and controversially claimed as an insulin-mimetic hormone visfatin, Nampt has recently drawn much attention in several fields, including NAD biol., metab. and inflammation.  As a NAD biosynthetic enzyme, Nampt regulates the activity of NAD-consuming enzymes such as sirtuins and influences a variety of metabolic and stress responses.  Nampt also plays an important part in regulating insulin secretion in pancreatic Î²-cells.  Nampt seems to have another function as an immunomodulatory cytokine and, therefore, has a role in inflammation.  This review summarizes these various functional aspects of Nampt and discusses its potential roles in diseases, including type 2 diabetes and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMtmRWd15knbVg90H21EOLACvtfcHk0lh2uMmid3SRtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFanu7o%253D&md5=2e6fc10db431e1963b0b827747466c53</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2008.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2008.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DPetzold%26aufirst%3DS.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DKiess%26aufirst%3DW.%26atitle%3DNampt%253A%2520linking%2520NAD%2520biology%252C%2520metabolism%2520and%2520cancer%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2009%26volume%3D20%26spage%3D130%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Galli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rongvaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, O.</span><span> </span><span class="NLM_article-title">The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">â</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=8-11&author=M.+Galliauthor=F.+Van+Goolauthor=A.+Rongvauxauthor=F.+Andrisauthor=O.+Leo&title=The+nicotinamide+phosphoribosyltransferase%3A+a+molecular+link+between+metabolism%2C+inflammation%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DM.%26aulast%3DVan%2BGool%26aufirst%3DF.%26aulast%3DRongvaux%26aufirst%3DA.%26aulast%3DAndris%26aufirst%3DF.%26aulast%3DLeo%26aufirst%3DO.%26atitle%3DThe%2520nicotinamide%2520phosphoribosyltransferase%253A%2520a%2520molecular%2520link%2520between%2520metabolism%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D8%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gholson, R. K.</span><span> </span><span class="NLM_article-title">The pyridine nucleotide cycle</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">â</span> <span class="NLM_lpage">935</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=1966&pages=933-935&author=R.+K.+Gholson&title=The+pyridine+nucleotide+cycle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGholson%26aufirst%3DR.%2BK.%26atitle%3DThe%2520pyridine%2520nucleotide%2520cycle%26jtitle%3DNature%26date%3D1966%26volume%3D212%26spage%3D933%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rechsteiner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catanzarite, V.</span><span> </span><span class="NLM_article-title">The biosynthesis and turnover of nicotinamide adenine dinucleotide in enucleated culture cells</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">â</span> <span class="NLM_lpage">422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1002%2Fjcp.1040840309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADyaE2MXmvFamtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1974&pages=409-422&author=M.+Rechsteinerauthor=V.+Catanzarite&title=The+biosynthesis+and+turnover+of+nicotinamide+adenine+dinucleotide+in+enucleated+culture+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Biosynthesis and turnover of nicotinamide adenine dinucleotide in enucleated culture cells</span></div><div class="casAuthors">Rechsteiner, Martin; Catanzarite, Valerian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-21</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    </div><div class="casAbstract">Nicotinic acid mononucleotide (NaMN) and NMN were proposed as intermediates in the biosynthesis of NAD from nicotinic acid and nicotinamide, resp.  Although NaMN and NMN were not detected in acid exts. from whole D98/AH2 cells following pulses with nicotinic-3H acid and nicotinamide-3H, they were obsd. following pulses of enucleated cells.  Several expts. indicated that enucleated cells were incapable of synthesizing NAD and that biosynthesis stopped with mononucleotide formation.  These results provide support for the idea, based upon fractionation studies, that NAD pyrophosphorylase (which catalyzes the reaction NMN or NaMN + ATP â NAD or desamido-NAD) is localized exclusively in the nucleus.  Acid extn. and chromatog. were also used to compare the stability of NAD-3H in enucleated and whole cells.  In the presence of the glutamine analog, azaserine, the intracellular concn. of NAD-3H decreased exponentially with a half-life of 4 hr in whole cells.  In enucleated cells the intracellular concn. of NAD-3H decreased with a half-life of >14 hr.  The increased stability of NAD in enucleated cells was confirmed by autoradiog.  These results demonstrate the key role of the nucleus in both the biosynthesis and turnover of NAD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRcdeaOaoq_7Vg90H21EOLACvtfcHk0lgVBvcbY3o6TQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXmvFamtQ%253D%253D&md5=e2b14ff4b8a1fec9b0614c629192a351</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1002%2Fjcp.1040840309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.1040840309%26sid%3Dliteratum%253Aachs%26aulast%3DRechsteiner%26aufirst%3DM.%26aulast%3DCatanzarite%26aufirst%3DV.%26atitle%3DThe%2520biosynthesis%2520and%2520turnover%2520of%2520nicotinamide%2520adenine%2520dinucleotide%2520in%2520enucleated%2520culture%2520cells%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D1974%26volume%3D84%26spage%3D409%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span> </span><span class="NLM_article-title">Comparative genomics of NAD(P) biosynthesis and novel antibiotic drug targets</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">â</span> <span class="NLM_lpage">340</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1002%2Fjcp.22419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fgt1CksQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2011&pages=331-340&author=J.+Biauthor=H.+Wangauthor=J.+Xie&title=Comparative+genomics+of+NAD%28P%29+biosynthesis+and+novel+antibiotic+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative genomics of NAD(P) biosynthesis and novel antibiotic drug targets</span></div><div class="casAuthors">Bi Jicai; Wang Honghai; Xie Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">331-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NAD(P) is an indispensable cofactor for all organisms and its biosynthetic pathways are proposed as promising novel antibiotics targets against pathogens such as Mycobacterium tuberculosis.  Six NAD(P) biosynthetic pathways were reconstructed by comparative genomics: de novo pathway (Asp), de novo pathway (Try), NmR pathway I (RNK-dependent), NmR pathway II (RNK-independent), Niacin salvage, and Niacin recycling.  Three enzymes pivotal to the key reactions of NAD(P) biosynthesis are shared by almost all organisms, that is, NMN/NaMN adenylyltransferase (NMN/NaMNAT), NAD synthetase (NADS), and NAD kinase (NADK).  They might serve as ideal broad spectrum antibiotic targets.  Studies in M. tuberculosis have in part tested such hypothesis.  Three regulatory factors NadR, NiaR, and NrtR, which regulate NAD biosynthesis, have been identified.  M. tuberculosis NAD(P) metabolism and regulation thereof, potential drug targets and drug development are summarized in this paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlqlWDxtx3xr0AGQpJZWpJfW6udTcc2ebo8970en--Erntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fgt1CksQ%253D%253D&md5=9d698872c856c0bbf925ddde4c619e86</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fjcp.22419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.22419%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DJ.%26atitle%3DComparative%2520genomics%2520of%2520NAD%2528P%2529%2520biosynthesis%2520and%2520novel%2520antibiotic%2520drug%2520targets%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2011%26volume%3D226%26spage%3D331%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bieganowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, C.</span><span> </span><span class="NLM_article-title">Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a PreissâHandler independent route to NAD+ in fungi and humans</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">â</span> <span class="NLM_lpage">502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2004&pages=495-502&author=P.+Bieganowskiauthor=C.+Brenner&title=Discoveries+of+nicotinamide+riboside+as+a+nutrient+and+conserved+NRK+genes+establish+a+Preiss%E2%80%93Handler+independent+route+to+NAD%2B+in+fungi+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBieganowski%26aufirst%3DP.%26aulast%3DBrenner%26aufirst%3DC.%26atitle%3DDiscoveries%2520of%2520nicotinamide%2520riboside%2520as%2520a%2520nutrient%2520and%2520conserved%2520NRK%2520genes%2520establish%2520a%2520Preiss%25E2%2580%2593Handler%2520independent%2520route%2520to%2520NAD%252B%2520in%2520fungi%2520and%2520humans%26jtitle%3DCell%26date%3D2004%26volume%3D117%26spage%3D495%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chiarugi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegler, M.</span><span> </span><span class="NLM_article-title">The NAD metabolomeâa key determinant of cancer cell biology</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">â</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1038%2Fnrc3340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=23018234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWnurvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=741-752&author=A.+Chiarugiauthor=C.+Dolleauthor=R.+Feliciauthor=M.+Ziegler&title=The+NAD+metabolome%E2%80%94a+key+determinant+of+cancer+cell+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The NAD metabolome - a key determinant of cancer cell biology</span></div><div class="casAuthors">Chiarugi, Alberto; Doelle, Christian; Felici, Roberta; Ziegler, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">741-752</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  NAD is a vital mol. in all organisms.  It is a key component of both energy and signal transduction - processes that undergo crucial changes in cancer cells.  NAD+-dependent signalling pathways are many and varied, and they regulate fundamental events such as transcription, DNA repair, cell cycle progression, apoptosis and metab.  Many of these processes have been linked to cancer development.  Given that NAD+-dependent signalling reactions involve the degrdn. of the mol., permanent nucleotide resynthesis through different biosynthetic pathways is crucial for incessant cancer cell proliferation.  This necessity supports the targeting of NAD metab. as a new therapeutic concept for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopGSV9JpM_CLVg90H21EOLACvtfcHk0lgVBvcbY3o6TQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWnurvP&md5=5111918068b9362f6932cff3b3ebd824</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2Fnrc3340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3340%26sid%3Dliteratum%253Aachs%26aulast%3DChiarugi%26aufirst%3DA.%26aulast%3DDolle%26aufirst%3DC.%26aulast%3DFelici%26aufirst%3DR.%26aulast%3DZiegler%26aufirst%3DM.%26atitle%3DThe%2520NAD%2520metabolome%25E2%2580%2594a%2520key%2520determinant%2520of%2520cancer%2520cell%2520biology%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D741%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Magni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsomando, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffelli, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggieri, S.</span><span> </span><span class="NLM_article-title">Enzymology of mammalian NAD metabolism in health and disease</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">6135</span><span class="NLM_x">â</span> <span class="NLM_lpage">6154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.2741%2F3143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOisb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=6135-6154&author=G.+Magniauthor=G.+Orsomandoauthor=N.+Raffelliauthor=S.+Ruggieri&title=Enzymology+of+mammalian+NAD+metabolism+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymology of mammalian NAD metabolism in health and disease</span></div><div class="casAuthors">Magni, Giulio; Orsomando, Giuseppe; Raffelli, Nadia; Ruggieri, Silverio</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6135-6154</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Mounting evidence attests to the paramount importance of the non-redox NAD functions.  Indeed, NAD homeostasis is related to the free radicals-mediated prodn. of reactive oxygen species responsible for irreversible cellular damage in infectious disease, diabetes, inflammatory syndromes, neurodegeneration and cancer.  Because the cellular redox status depends on both the abs. concn. of pyridine dinucleotides and their resp. ratios of oxidized and reduced forms (i.e., NAD/NADH and NADP/NADPH), it is conceivable that an altered regulation of the synthesis and degrdn. of NAD impairs the cell redox state and likely contributes to the mechanisms underlying the pathogenesis of the above mentioned diseases.  Taking into account the recent appearance in the literature of comprehensive reviews covering different aspects of the significance of NAD metab., with particular attention to the enzymes involved in NAD cleavage, this monograph includes the most recent results on NAD biosynthesis in mammals and humans.  Due to recent findings on nicotinamide riboside as a nutrient, its inclusion under "niacins" is proposed.  Here, the enzymes involved in the de novo and reutilization pathways are overviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvX2dsB8dbbrVg90H21EOLACvtfcHk0ljpr5febUNrDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOisb0%253D&md5=aa02e7cb092b9e7449b5bce49e97fa82</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.2741%2F3143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3143%26sid%3Dliteratum%253Aachs%26aulast%3DMagni%26aufirst%3DG.%26aulast%3DOrsomando%26aufirst%3DG.%26aulast%3DRaffelli%26aufirst%3DN.%26aulast%3DRuggieri%26aufirst%3DS.%26atitle%3DEnzymology%2520of%2520mammalian%2520NAD%2520metabolism%2520in%2520health%2520and%2520disease%26jtitle%3DFront.%2520Biosci.%26date%3D2008%26volume%3D13%26spage%3D6135%26epage%3D6154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Di Pucchio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danese, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cristofaro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutella, S.</span><span> </span><span class="NLM_article-title">Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">â</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1517%2F13543770903512974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=229-250&author=T.+Di+Pucchioauthor=S.+Daneseauthor=R.+De+Cristofaroauthor=S.+Rutella&title=Inhibitors+of+indoleamine+2%2C3-dioxygenase%3A+a+review+of+novel+patented+lead+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds</span></div><div class="casAuthors">Di Pucchio, Tiziana; Danese, Silvio; De Cristofaro, Raimondo; Rutella, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-250</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The enzyme indoleamine 2,3-dioxygenase (IDO) regulates immune responses through the capacity to degrade the essential amino-acid tryptophan into kynurenine and other downstream metabolites that suppress effector T-cell function and favor the differentiation of regulatory T cells.  The current exptl. evidence indicates that IDO can be expressed by a variety of cell types, including dendritic cells, tumor cells and stromal cells.  Recently, IDO has been implicated in B-cell stimulation and autoantibody prodn. in exptl. models of autoimmune diseases.  Areas covered in this review: Advances in the biochem. of IDO and our understanding of the biol. relevance of IDO-mediated tryptophan consumption to the establishment of immune tolerance are summarised and discussed.  A selection of recent patents in the field are also reviewed and analyzed.  What the reader will gain: Readers will gain an overview of the patented compds. with IDO inhibitory activity from an immunologist's perspective.  They will also learn about the companies that are main players in the field.  Take home message: Current evidence points to IDO as a mol. target for therapeutic intervention in order to restrain unwanted inflammatory/autoimmune responses and/or to boost antitumor immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjqWfk1x37f7Vg90H21EOLACvtfcHk0ljpr5febUNrDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktLc%253D&md5=0ced49cf3450de90c238a862e0d73e94</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F13543770903512974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903512974%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPucchio%26aufirst%3DT.%26aulast%3DDanese%26aufirst%3DS.%26aulast%3DDe%2BCristofaro%26aufirst%3DR.%26aulast%3DRutella%26aufirst%3DS.%26atitle%3DInhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%253A%2520a%2520review%2520of%2520novel%2520patented%2520lead%2520compounds%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D229%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Preiss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handler, P.</span><span> </span><span class="NLM_article-title">Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">â</span> <span class="NLM_lpage">492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1958&pages=488-492&author=J.+Preissauthor=P.+Handler&title=Biosynthesis+of+diphosphopyridine+nucleotide.+I.+Identification+of+intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPreiss%26aufirst%3DJ.%26aulast%3DHandler%26aufirst%3DP.%26atitle%3DBiosynthesis%2520of%2520diphosphopyridine%2520nucleotide.%2520I.%2520Identification%2520of%2520intermediates%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1958%26volume%3D233%26spage%3D488%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bheda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revollo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolberger, C.</span><span> </span><span class="NLM_article-title">Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">â</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1038%2Fnsmb1114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=16783373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1eltLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=661-662&author=T.+Wangauthor=X.+Zhangauthor=P.+Bhedaauthor=J.+R.+Revolloauthor=S.+Imaiauthor=C.+Wolberger&title=Structure+of+Nampt%2FPBEF%2Fvisfatin%2C+a+mammalian+NAD%2B+biosynthetic+enzyme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme</span></div><div class="casAuthors">Wang, Tao; Zhang, Xiangbin; Bheda, Poonam; Revollo, Javier R.; Imai, Shin-ichiro; Wolberger, Cynthia</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">661-662</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (Nampt) synthesizes NMN from nicotinamide in a mammalian NAD+ biosynthetic pathway and is required for SirT1 activity in vivo.  Nampt has also been presumed to be a cytokine (PBEF) or a hormone (visfatin).  The crystal structure of Nampt in the presence and absence of NMN shows that Nampt is a dimeric type II phosphoribosyltransferase and provides insights into the enzymic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZDB0vef67YbVg90H21EOLACvtfcHk0ljpr5febUNrDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1eltLg%253D&md5=ad2fd7f5cf0085896a157d1f1831f8c6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1114%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DBheda%26aufirst%3DP.%26aulast%3DRevollo%26aufirst%3DJ.%2BR.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DWolberger%26aufirst%3DC.%26atitle%3DStructure%2520of%2520Nampt%252FPBEF%252Fvisfatin%252C%2520a%2520mammalian%2520NAD%252B%2520biosynthetic%2520enzyme%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D661%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Revollo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolberger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milbrandt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span> </span><span class="NLM_article-title">Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">â</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.cmet.2007.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlemsr%252FJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=363-375&author=J.+R.+Revolloauthor=A.+Kornerauthor=K.+F.+Millsauthor=A.+Satohauthor=T.+Wangauthor=A.+Gartenauthor=B.+Dasguptaauthor=Y.+Sasakiauthor=C.+Wolbergerauthor=R.+R.+Townsendauthor=J.+Milbrandtauthor=W.+Kiessauthor=S.+Imai&title=Nampt%2FPBEF%2Fvisfatin+regulates+insulin+secretion+in+beta+cells+as+a+systemic+NAD+biosynthetic+enzyme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nampt/PBEF/visfatin regulates insulin secretion in Î² cells as a systemic NAD biosynthetic enzyme</span></div><div class="casAuthors">Revollo, Javier R.; Korner, Antje; Mills, Kathryn F.; Satoh, Akiko; Wang, Tao; Garten, Antje; Dasgupta, Biplab; Sasaki, Yo; Wolberger, Cynthia; Townsend, R. Reid; Milbrandt, Jeffrey; Kiess, Wieland; Imai, Shin-ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">363-375</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Intracellular nicotinamide phosphoribosyltransferase (iNampt) is an essential enzyme in the NAD biosynthetic pathway.  An extracellular form of this protein (eNampt) has been reported to act as a cytokine named PBEF or an insulin-mimetic hormone named visfatin, but its physiol. relevance remains controversial.  The eNampt does not exert insulin-mimetic effects in vitro or in vivo but rather exhibits robust NAD biosynthetic activity.  Haplodeficiency and chem. inhibition of Nampt cause defects in NAD biosynthesis and glucose-stimulated insulin secretion in pancreatic islets in vivo and in vitro.  These defects are cor. by administration of NMN, a product of the Nampt reaction.  A high concn. of NMN is present in mouse plasma, and plasma eNampt and NMN levels are reduced in Nampt heterozygous females.  The authors' results demonstrate that Nampt-mediated systemic NAD biosynthesis is crit. for Î²-cell function, suggesting a vital framework for the regulation of glucose homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp80WTQ18g5f7Vg90H21EOLACvtfcHk0lg91sn3P0bXUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlemsr%252FJ&md5=14cf43c42e565a6e9b81856173b0806c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DRevollo%26aufirst%3DJ.%2BR.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DMills%26aufirst%3DK.%2BF.%26aulast%3DSatoh%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DDasgupta%26aufirst%3DB.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DWolberger%26aufirst%3DC.%26aulast%3DTownsend%26aufirst%3DR.%2BR.%26aulast%3DMilbrandt%26aufirst%3DJ.%26aulast%3DKiess%26aufirst%3DW.%26aulast%3DImai%26aufirst%3DS.%26atitle%3DNampt%252FPBEF%252Fvisfatin%2520regulates%2520insulin%2520secretion%2520in%2520beta%2520cells%2520as%2520a%2520systemic%2520NAD%2520biosynthetic%2520enzyme%26jtitle%3DCell%2520Metab.%26date%3D2007%26volume%3D6%26spage%3D363%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Zhang, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heruth, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, S. Q.</span><span> </span><span class="NLM_article-title">Nicotinamide phosphoribosyltransferase in human diseases</span> <span class="citation_source-journal">J. Bioanal. Biomed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">â</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.4172%2F1948-593X.1000038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=22140607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFagur%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=13-25&author=L.+Q.+Zhangauthor=D.+P.+Heruthauthor=S.+Q.+Ye&title=Nicotinamide+phosphoribosyltransferase+in+human+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide phosphoribosyltransferase in human diseases</span></div><div class="casAuthors">Zhang, Li Qin; Heruth, Daniel P.; Ye, Shui Qing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bioanalysis & Biomedicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">013-025</span>CODEN:
                <span class="NLM_cas:coden">JBBOHQ</span>;
        ISSN:<span class="NLM_cas:issn">1948-593X</span>.
    
            (<span class="NLM_cas:orgname">OMICS Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nicotinamide phosphoribosyltransferase (NAMPT) was first reported as a pre-B-cell colony enhancing factor in 1994 with little notice, but it has received increasing attention in recent years due to accumulating evidence indicating that NAMPT is a pleiotropic protein such as a growth factor, a cytokine, an enzyme and a visfatin.  Now, NAMPT has been accepted as an official name of this protein.  Because of NAMPT's multiple functions in a variety of physiol. processes, their dysregulations have been implicated in the pathogenesis of a no. of human diseases or conditions such as acute lung injury, aging, atherosclerosis, cancer, diabetes, rheumatoid arthritis and sepsis.  This review will cover the current understanding of NAMPT's structure and functions with an emphasis on recent progress of nicotinamide phosphoribosyltransferase's pathol. roles in various human diseases and conditions.  Future directions on exploring its Terra incognita will be offered in the end.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZKBmweBE-KLVg90H21EOLACvtfcHk0lg91sn3P0bXUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFagur%252FL&md5=b072620549d511fdeeab5dec6e3fb7d7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4172%2F1948-593X.1000038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F1948-593X.1000038%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%2BQ.%26aulast%3DHeruth%26aufirst%3DD.%2BP.%26aulast%3DYe%26aufirst%3DS.%2BQ.%26atitle%3DNicotinamide%2520phosphoribosyltransferase%2520in%2520human%2520diseases%26jtitle%3DJ.%2520Bioanal.%2520Biomed.%26date%3D2011%26volume%3D3%26spage%3D13%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Burgos, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">11086</span><span class="NLM_x">â</span> <span class="NLM_lpage">11096</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi801198m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=11086-11096&author=E.+S.+Burgosauthor=V.+L.+Schramm&title=Weak+coupling+of+ATP+hydrolysis+to+the+chemical+equilibrium+of+human+nicotinamide+phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi801198m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801198m%26sid%3Dliteratum%253Aachs%26aulast%3DBurgos%26aufirst%3DE.%2BS.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DWeak%2520coupling%2520of%2520ATP%2520hydrolysis%2520to%2520the%2520chemical%2520equilibrium%2520of%2520human%2520nicotinamide%2520phosphoribosyltransferase%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D11086%26epage%3D11096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Pittelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formentini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapizzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cialdai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moneti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiarugi, A.</span><span> </span><span class="NLM_article-title">Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">34106</span><span class="NLM_x">â</span> <span class="NLM_lpage">34114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1074%2Fjbc.M110.136739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=20724478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWktrbM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=34106-34114&author=M.+Pittelliauthor=L.+Formentiniauthor=G.+Faracoauthor=A.+Lapucciauthor=E.+Rapizziauthor=F.+Cialdaiauthor=G.+Romanoauthor=G.+Monetiauthor=F.+Moroniauthor=A.+Chiarugi&title=Inhibition+of+nicotinamide+phosphoribosyltransferase%3A+cellular+bioenergetics+reveals+a+mitochondrial+insensitive+NAD+pool"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Nicotinamide Phosphoribosyltransferase: Cellular bioenergetics reveals a mitochondrial insensitive NAD pool</span></div><div class="casAuthors">Pittelli, Maria; Formentini, Laura; Faraco, Giuseppe; Lapucci, Andrea; Rapizzi, Elena; Cialdai, Francesca; Romano, Giovanni; Moneti, Gloriano; Moroni, Flavio; Chiarugi, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">34106-34114</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The NAD rescue pathway consists of two enzymic steps operated by nicotinamide phosphoribosyltransferase (Nampt) and NMN adenylyltransferases.  Recently, the potent Nampt inhibitor FK866 has been identified and evaluated in clin. trials against cancer.  Yet, how Nampt inhibition affects NAD contents and bioenergetics is in part obscure.  It is also unknown whether NAD rescue takes place in mitochondria, and FK866 alters NAD homeostasis within the organelle.  Here, we show that FK866-dependent redn. of the NAD contents is paralleled by a concomitant increase of ATP in various cell types, in keeping with ATP utilization for NAD resynthesis.  We also show that poly- and mono(ADP-ribose) transferases rather than Sirt-1 are responsible for NAD depletion in HeLa cells exposed to FK866.  Mass spectrometry reveals that the drug distributes in the cytosolic and mitochondrial compartment.  However, the cytoplasmic but not the mitochondrial NAD pool is reduced upon acute or chronic exposure to the drug.  Accordingly, Nampt does not localize within the organelles and their bioenergetics is not affected by the drug.  In the mouse, FK866-dependent redn. of NAD contents in various organs is prevented by inhibitors of poly(ADP-ribose) polymerases or the NAD precursor kynurenine.  For the first time, our data indicate that mitochondria lack the canonical NAD rescue pathway, broadening current understanding of cellular bioenergetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGospj_13whivrVg90H21EOLACvtfcHk0lg91sn3P0bXUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWktrbM&md5=ee8de3045040ba421dfd6dcf7f05b322</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.136739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.136739%26sid%3Dliteratum%253Aachs%26aulast%3DPittelli%26aufirst%3DM.%26aulast%3DFormentini%26aufirst%3DL.%26aulast%3DFaraco%26aufirst%3DG.%26aulast%3DLapucci%26aufirst%3DA.%26aulast%3DRapizzi%26aufirst%3DE.%26aulast%3DCialdai%26aufirst%3DF.%26aulast%3DRomano%26aufirst%3DG.%26aulast%3DMoneti%26aufirst%3DG.%26aulast%3DMoroni%26aufirst%3DF.%26aulast%3DChiarugi%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%253A%2520cellular%2520bioenergetics%2520reveals%2520a%2520mitochondrial%2520insensitive%2520NAD%2520pool%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D34106%26epage%3D34114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baur, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmona, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamming, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza-Pinto, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohr, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Cabo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauve, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, D. A.</span><span> </span><span class="NLM_article-title">Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1095</span><span class="NLM_x">â</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2007&pages=1095-1107&author=H.+Yangauthor=T.+Yangauthor=J.+A.+Baurauthor=E.+Perezauthor=T.+Matsuiauthor=J.+J.+Carmonaauthor=D.+W.+Lammingauthor=N.+C.+Souza-Pintoauthor=V.+A.+Bohrauthor=A.+Rosenzweigauthor=R.+de+Caboauthor=A.+A.+Sauveauthor=D.+A.+Sinclair&title=Nutrient-sensitive+mitochondrial+NAD%2B+levels+dictate+cell+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DBaur%26aufirst%3DJ.%2BA.%26aulast%3DPerez%26aufirst%3DE.%26aulast%3DMatsui%26aufirst%3DT.%26aulast%3DCarmona%26aufirst%3DJ.%2BJ.%26aulast%3DLamming%26aufirst%3DD.%2BW.%26aulast%3DSouza-Pinto%26aufirst%3DN.%2BC.%26aulast%3DBohr%26aufirst%3DV.%2BA.%26aulast%3DRosenzweig%26aufirst%3DA.%26aulast%3Dde%2BCabo%26aufirst%3DR.%26aulast%3DSauve%26aufirst%3DA.%2BA.%26aulast%3DSinclair%26aufirst%3DD.%2BA.%26atitle%3DNutrient-sensitive%2520mitochondrial%2520NAD%252B%2520levels%2520dictate%2520cell%2520survival%26jtitle%3DCell%26date%3D2007%26volume%3D130%26spage%3D1095%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Samal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suggs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNiece, I.</span><span> </span><span class="NLM_article-title">Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1431</span><span class="NLM_x">â</span> <span class="NLM_lpage">1437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1128%2FMCB.14.2.1431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=8289818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADyaK2cXhvV2gsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=1431-1437&author=B.+Samalauthor=Y.+Sunauthor=G.+Stearnsauthor=C.+Xieauthor=S.+Suggsauthor=I.+McNiece&title=Cloning+and+characterization+of+the+cDNA+encoding+a+novel+human+pre-B-cell+colony-enhancing+factor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor</span></div><div class="casAuthors">Samal, Babru; Sun, Yinghao; Stearns, George; Xie, Chunshan; Suggs, Sidney; McNiece, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1431-7</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">A novel gene coding for the pre-B-cell colony-enhancing factor (PBEF) was isolated from a human peripheral blood lymphocyte cDNA library.  The expression of this gene is induced by pokeweed mitogen and superinduced by cycloheximide.  It is also induced in the T-lymphoblastoid cell line HUT 78 after phorbol ester (phorbol myristate acetate) treatment.  The predominant mRNA for PBEF is â¼2.4 kb long and codes for a 52-kDa secreted protein.  The 3'-untranslated region of the mRNA has multiple TATT motifs, usually found in cytokine and oncogene messages.  The PBEF gene is mainly transcribed in human bone marrow, liver tissue, and muscle.  PBEF was expressed in COS 7 and PA317 cells and the biol. activities were tested in the conditioned medium as well as the antibody-purified protein in different in vitro assays.  PBEF itself had no activity but synergized the pre-B-cell colony formation activity of stem cell factor and interleukin 7.  In the presence of PBEF, the no. of pre-B-cell colonies was increased by â¥70% above the amt. stimulated by stem cell factor plus interleukin 7.  No effect of PBEF was found with cells of myeloid or erythroid lineages.  These data define PBEF as a novel cytokine which acts on early B-lineage precursor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7obiHXnOZbLVg90H21EOLACvtfcHk0lgFWOKwIdvL1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhvV2gsbw%253D&md5=9b112face0e7a285e04689a99e9eed56</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1128%2FMCB.14.2.1431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.14.2.1431%26sid%3Dliteratum%253Aachs%26aulast%3DSamal%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DStearns%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DSuggs%26aufirst%3DS.%26aulast%3DMcNiece%26aufirst%3DI.%26atitle%3DCloning%2520and%2520characterization%2520of%2520the%2520cDNA%2520encoding%2520a%2520novel%2520human%2520pre-B-cell%2520colony-enhancing%2520factor%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1994%26volume%3D14%26spage%3D1431%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dahl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aukrust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halvorsen, B.</span><span> </span><span class="NLM_article-title">Visfatin/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology</span> <span class="citation_source-journal">Annu. Rev. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">â</span> <span class="NLM_lpage">243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=229-243&author=T.+B.+Dahlauthor=S.+Holmauthor=P.+Aukrustauthor=B.+Halvorsen&title=Visfatin%2FNAMPT%3A+a+multifaceted+molecule+with+diverse+roles+in+physiology+and+pathophysiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDahl%26aufirst%3DT.%2BB.%26aulast%3DHolm%26aufirst%3DS.%26aulast%3DAukrust%26aufirst%3DP.%26aulast%3DHalvorsen%26aufirst%3DB.%26atitle%3DVisfatin%252FNAMPT%253A%2520a%2520multifaceted%2520molecule%2520with%2520diverse%2520roles%2520in%2520physiology%2520and%2520pathophysiology%26jtitle%3DAnnu.%2520Rev.%2520Nutr.%26date%3D2012%26volume%3D32%26spage%3D229%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yammani, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeser, R. F.</span><span> </span><span class="NLM_article-title">Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">R23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=R23&author=R.+R.+Yammaniauthor=R.+F.+Loeser&title=Extracellular+nicotinamide+phosphoribosyltransferase+%28NAMPT%2Fvisfatin%29+inhibits+insulin-like+growth+factor-1+signaling+and+proteoglycan+synthesis+in+human+articular+chondrocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYammani%26aufirst%3DR.%2BR.%26aulast%3DLoeser%26aufirst%3DR.%2BF.%26atitle%3DExtracellular%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%252Fvisfatin%2529%2520inhibits%2520insulin-like%2520growth%2520factor-1%2520signaling%2520and%2520proteoglycan%2520synthesis%2520in%2520human%2520articular%2520chondrocytes%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2012%26volume%3D14%26spage%3DR23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kang, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, S. K.</span><span> </span><span class="NLM_article-title">Visfatin induces neurite outgrowth in PC12 cells via ERK1/2 signaling pathway</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">504</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">â</span> <span class="NLM_lpage">126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2011&pages=121-126&author=Y.+S.+Kangauthor=M.+K.+Baeauthor=J.+Y.+Kimauthor=J.+W.+Jeongauthor=I.+Yunauthor=H.+O.+Jangauthor=S.+K.+Bae&title=Visfatin+induces+neurite+outgrowth+in+PC12+cells+via+ERK1%2F2+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DY.%2BS.%26aulast%3DBae%26aufirst%3DM.%2BK.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DJeong%26aufirst%3DJ.%2BW.%26aulast%3DYun%26aufirst%3DI.%26aulast%3DJang%26aufirst%3DH.%2BO.%26aulast%3DBae%26aufirst%3DS.%2BK.%26atitle%3DVisfatin%2520induces%2520neurite%2520outgrowth%2520in%2520PC12%2520cells%2520via%2520ERK1%252F2%2520signaling%2520pathway%26jtitle%3DNeurosci.%2520Lett.%26date%3D2011%26volume%3D504%26spage%3D121%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuhara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komuro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimomura, I.</span><span> </span><span class="NLM_article-title">Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">â</span> <span class="NLM_lpage">201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2007&pages=194-201&author=M.+Tanakaauthor=M.+Nozakiauthor=A.+Fukuharaauthor=K.+Segawaauthor=N.+Aokiauthor=M.+Matsudaauthor=R.+Komuroauthor=I.+Shimomura&title=Visfatin+is+released+from+3T3-L1+adipocytes+via+a+non-classical+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNozaki%26aufirst%3DM.%26aulast%3DFukuhara%26aufirst%3DA.%26aulast%3DSegawa%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DN.%26aulast%3DMatsuda%26aufirst%3DM.%26aulast%3DKomuro%26aufirst%3DR.%26aulast%3DShimomura%26aufirst%3DI.%26atitle%3DVisfatin%2520is%2520released%2520from%25203T3-L1%2520adipocytes%2520via%2520a%2520non-classical%2520pathway%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2007%26volume%3D359%26spage%3D194%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnikol-Oettler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thasler, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratzsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhardt, R.</span><span> </span><span class="NLM_article-title">Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">â</span> <span class="NLM_lpage">381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2010&pages=376-381&author=A.+Gartenauthor=S.+Petzoldauthor=A.+Barnikol-Oettlerauthor=A.+Kornerauthor=W.+E.+Thaslerauthor=J.+Kratzschauthor=W.+Kiessauthor=R.+Gebhardt&title=Nicotinamide+phosphoribosyltransferase+%28NAMPT%2FPBEF%2Fvisfatin%29+is+constitutively+released+from+human+hepatocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DPetzold%26aufirst%3DS.%26aulast%3DBarnikol-Oettler%26aufirst%3DA.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DThasler%26aufirst%3DW.%2BE.%26aulast%3DKratzsch%26aufirst%3DJ.%26aulast%3DKiess%26aufirst%3DW.%26aulast%3DGebhardt%26aufirst%3DR.%26atitle%3DNicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%252FPBEF%252Fvisfatin%2529%2520is%2520constitutively%2520released%2520from%2520human%2520hepatocytes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2010%26volume%3D391%26spage%3D376%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schilling, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauschildt, S.</span><span> </span><span class="NLM_article-title">Extracellular ATP induces P2X7-dependent nicotinamide phosphoribosyltransferase release in LPS-activated human monocytes</span> <span class="citation_source-journal">Innate Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">â</span> <span class="NLM_lpage">744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1177%2F1753425912439614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVKku7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=738-744&author=E.+Schillingauthor=S.+Hauschildt&title=Extracellular+ATP+induces+P2X7-dependent+nicotinamide+phosphoribosyltransferase+release+in+LPS-activated+human+monocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular ATP induces P2X7-dependent nicotinamide phosphoribosyltransferase release in LPS-activated human monocytes</span></div><div class="casAuthors">Schilling, Erik; Hauschildt, Sunna</div><div class="citationInfo"><span class="NLM_cas:title">Innate Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">738-744, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">IINMCB</span>;
        ISSN:<span class="NLM_cas:issn">1753-4259</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NAMPT), an enzyme involved in NAD biosynthesis, has recently been identified as a novel mediator of innate immunity.  In the present study, we report that treatment of LPS-primed monocytes with ATP greatly enhanced the secretion of NAMPT in a time- and concn.-dependent manner without displaying any cytotoxic effect.  NAMPT release was suppressed by pretreatment with the P2X7 receptor (P2X7R) inhibitors oxidized ATP (oxATP) and KN-62, indicating the engagement of P2X7Rs.  Furthermore, P2X7R was found to be involved in mediating cell permeability caused by the addn. of ATP.  To define a role of endogenous ATP in NAMPT secretion, LPS-primed monocytes were incubated in the presence of oxATP and KN-62, as well as the ATP-hydrolyzing enzymes apyrase and hexokinase.  With the exception of oxATP, neither substance led to a decrease in NAMPT release, suggesting that autocrine/paracrine ATP is unlikely to be responsible for the LPS-induced release of NAMPT.  In conclusion, the enhanced release of NAMPT by extracellular ATP described here indicates the requirement of a second stimulus for the efficient secretion of NAMPT.  This mode of secretion, which also applies to IL-1Î², might represent a general mechanism for the release of leaderless secretory proteins at locally restricted sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK9-0M43_k7LVg90H21EOLACvtfcHk0lg5SfL-vnKYCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVKku7g%253D&md5=52b1e116c3644c571c219a25c8b523ef</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1177%2F1753425912439614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1753425912439614%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DE.%26aulast%3DHauschildt%26aufirst%3DS.%26atitle%3DExtracellular%2520ATP%2520induces%2520P2X7-dependent%2520nicotinamide%2520phosphoribosyltransferase%2520release%2520in%2520LPS-activated%2520human%2520monocytes%26jtitle%3DInnate%2520Immun.%26date%3D2012%26volume%3D18%26spage%3D738%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pillai, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaresan, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Vinasco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, M.</span><span> </span><span class="NLM_article-title">Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling</span> <span class="citation_source-journal">Am. J. Physiol.: Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">H415</span><span class="NLM_x">â</span> <span class="NLM_lpage">H426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2013&pages=H415-H426&author=V.+B.+Pillaiauthor=N.+R.+Sundaresanauthor=G.+H.+Kimauthor=S.+Samantauthor=L.+Moreno-Vinascoauthor=J.+G.+Garciaauthor=M.+Gupta&title=Nampt+secreted+from+cardiomyocytes+promotes+development+of+cardiac+hypertrophy+and+adverse+ventricular+remodeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPillai%26aufirst%3DV.%2BB.%26aulast%3DSundaresan%26aufirst%3DN.%2BR.%26aulast%3DKim%26aufirst%3DG.%2BH.%26aulast%3DSamant%26aufirst%3DS.%26aulast%3DMoreno-Vinasco%26aufirst%3DL.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%26aulast%3DGupta%26aufirst%3DM.%26atitle%3DNampt%2520secreted%2520from%2520cardiomyocytes%2520promotes%2520development%2520of%2520cardiac%2520hypertrophy%2520and%2520adverse%2520ventricular%2520remodeling%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Heart%2520Circ.%2520Physiol.%26date%3D2013%26volume%3D304%26spage%3DH415%26epage%3DH426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">van der Veer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâNeil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cregan, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, J. G.</span><span> </span><span class="NLM_article-title">Extension of human cell lifespan by nicotinamide phosphoribosyltransferase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">10841</span><span class="NLM_x">â</span> <span class="NLM_lpage">10845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=10841-10845&author=E.+van+der+Veerauthor=C.+Hoauthor=C.+O%E2%80%99Neilauthor=N.+Barbosaauthor=R.+Scottauthor=S.+P.+Creganauthor=J.+G.+Pickering&title=Extension+of+human+cell+lifespan+by+nicotinamide+phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BVeer%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DC.%26aulast%3DBarbosa%26aufirst%3DN.%26aulast%3DScott%26aufirst%3DR.%26aulast%3DCregan%26aufirst%3DS.%2BP.%26aulast%3DPickering%26aufirst%3DJ.%2BG.%26atitle%3DExtension%2520of%2520human%2520cell%2520lifespan%2520by%2520nicotinamide%2520phosphoribosyltransferase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D10841%26epage%3D10845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Nakahata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astarita, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaluzova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassone-Corsi, P.</span><span> </span><span class="NLM_article-title">Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span><span class="NLM_x">â</span> <span class="NLM_lpage">657</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=654-657&author=Y.+Nakahataauthor=S.+Saharauthor=G.+Astaritaauthor=M.+Kaluzovaauthor=P.+Sassone-Corsi&title=Circadian+control+of+the+NAD%2B+salvage+pathway+by+CLOCK-SIRT1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakahata%26aufirst%3DY.%26aulast%3DSahar%26aufirst%3DS.%26aulast%3DAstarita%26aufirst%3DG.%26aulast%3DKaluzova%26aufirst%3DM.%26aulast%3DSassone-Corsi%26aufirst%3DP.%26atitle%3DCircadian%2520control%2520of%2520the%2520NAD%252B%2520salvage%2520pathway%2520by%2520CLOCK-SIRT1%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D654%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Ramsey, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brace, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrassart, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcheva, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhr, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, J.</span><span> </span><span class="NLM_article-title">Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">â</span> <span class="NLM_lpage">654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=651-654&author=K.+M.+Ramseyauthor=J.+Yoshinoauthor=C.+S.+Braceauthor=D.+Abrassartauthor=Y.+Kobayashiauthor=B.+Marchevaauthor=H.+K.+Hongauthor=J.+L.+Chongauthor=E.+D.+Buhrauthor=C.+Leeauthor=J.+S.+Takahashiauthor=S.+Imaiauthor=J.+Bass&title=Circadian+clock+feedback+cycle+through+NAMPT-mediated+NAD%2B+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamsey%26aufirst%3DK.%2BM.%26aulast%3DYoshino%26aufirst%3DJ.%26aulast%3DBrace%26aufirst%3DC.%2BS.%26aulast%3DAbrassart%26aufirst%3DD.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DMarcheva%26aufirst%3DB.%26aulast%3DHong%26aufirst%3DH.%2BK.%26aulast%3DChong%26aufirst%3DJ.%2BL.%26aulast%3DBuhr%26aufirst%3DE.%2BD.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DTakahashi%26aufirst%3DJ.%2BS.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DBass%26aufirst%3DJ.%26atitle%3DCircadian%2520clock%2520feedback%2520cycle%2520through%2520NAMPT-mediated%2520NAD%252B%2520biosynthesis%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D651%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, C. Y.</span><span> </span><span class="NLM_article-title">Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">â</span> <span class="NLM_lpage">380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2009&pages=370-380&author=P.+Wangauthor=T.+Y.+Xuauthor=Y.+F.+Guanauthor=D.+F.+Suauthor=G.+R.+Fanauthor=C.+Y.+Miao&title=Perivascular+adipose+tissue-derived+visfatin+is+a+vascular+smooth+muscle+cell+growth+factor%3A+role+of+nicotinamide+mononucleotide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DT.%2BY.%26aulast%3DGuan%26aufirst%3DY.%2BF.%26aulast%3DSu%26aufirst%3DD.%2BF.%26aulast%3DFan%26aufirst%3DG.%2BR.%26aulast%3DMiao%26aufirst%3DC.%2BY.%26atitle%3DPerivascular%2520adipose%2520tissue-derived%2520visfatin%2520is%2520a%2520vascular%2520smooth%2520muscle%2520cell%2520growth%2520factor%253A%2520role%2520of%2520nicotinamide%2520mononucleotide%26jtitle%3DCardiovasc.%2520Res.%26date%3D2009%26volume%3D81%26spage%3D370%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yoshino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span> </span><span class="NLM_article-title">Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">â</span> <span class="NLM_lpage">536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.cmet.2011.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=21982712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12rtLvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=528-536&author=J.+Yoshinoauthor=K.+F.+Millsauthor=M.+J.+Yoonauthor=S.+Imai&title=Nicotinamide+mononucleotide%2C+a+key+NAD%28%2B%29+intermediate%2C+treats+the+pathophysiology+of+diet-+and+age-induced+diabetes+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice</span></div><div class="casAuthors">Yoshino, Jun; Mills, Kathryn F.; Yoon, Myeong Jin; Imai, Shin-ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">528-536</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Type 2 diabetes (T2D) has become epidemic in our modern lifestyle, likely due to calorie-rich diets overwhelming our adaptive metabolic pathways.  One such pathway is mediated by nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in mammalian NAD+ biosynthesis, and the NAD+-dependent protein deacetylase SIRT1.  Here, we show that NAMPT-mediated NAD+ biosynthesis is severely compromised in metabolic organs by high-fat diet (HFD).  Strikingly, NMN (NMN), a product of the NAMPT reaction and a key NAD+ intermediate, ameliorates glucose intolerance by restoring NAD+ levels in HFD-induced T2D mice.  NMN also enhances hepatic insulin sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian rhythm, partly through SIRT1 activation.  Furthermore, NAD+ and NAMPT levels show significant decreases in multiple organs during aging, and NMN improves glucose intolerance and lipid profiles in age-induced T2D mice.  These findings provide crit. insights into a potential nutriceutical intervention against diet- and age-induced T2D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo62Q7piy8bR7Vg90H21EOLACvtfcHk0li3Xq3d17XEvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12rtLvK&md5=a33f288cd823d4f85fd7201623e842d4</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DYoshino%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DK.%2BF.%26aulast%3DYoon%26aufirst%3DM.%2BJ.%26aulast%3DImai%26aufirst%3DS.%26atitle%3DNicotinamide%2520mononucleotide%252C%2520a%2520key%2520NAD%2528%252B%2529%2520intermediate%252C%2520treats%2520the%2520pathophysiology%2520of%2520diet-%2520and%2520age-induced%2520diabetes%2520in%2520mice%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D14%26spage%3D528%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span> </span><span class="NLM_article-title">Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-kappaB signaling pathway</span> <span class="citation_source-journal">Int. J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">â</span> <span class="NLM_lpage">615</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.3892%2Fijmm.2011.611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslOisb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2011&pages=607-615&author=Y.+Fanauthor=S.+Mengauthor=Y.+Wangauthor=J.+Caoauthor=C.+Wang&title=Visfatin%2FPBEF%2FNampt+induces+EMMPRIN+and+MMP-9+production+in+macrophages+via+the+NAMPT-MAPK+%28p38%2C+ERK1%2F2%29-NF-kappaB+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Visfatin/PBEF/nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-ÎºB signaling pathway</span></div><div class="casAuthors">Fan, Yuqi; Meng, Shu; Wang, Yue; Cao, Jiatian; Wang, Changqian</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">607-615</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">The adipocytokine visfatin is closely assocd. with metabolic disorders.  This study explored the effects of visfatin on macrophage-induced inflammation in atheroma.  The ability of visfatin to enhance extracellular matrix metalloproteinase inducer (EMMPRIN) expression, matrix metalloproteinase-9 (MMP-9) prodn. and enzymic activity in THP-1 derived macrophages as well as the mechanisms involved were investigated.  EMMPRIN and MMP-9 mRNA levels were investigated by RT-PCR.  EMMPRIN and MMP-9 protein levels, nuclear factor (NF)-ÎºB -p65 protein levels, peroxisome proliferator-activated receptor Î³ (PPARÎ³) protein levels, and mitogen-activated protein kinase (MAPK) phosphorylation were detd. by Western blotting.  MMP-9 enzymic activity was assayed by gelatin zymog.  Visfatin (50-400 ng/mL) induced EMMPRIN and MMP-9 depending on the dosage used.  Visfatin elicited the activation of NF-ÎºB and MAPK (p38, ERK1/2).  Exogenous NMN (NMN), the product of nicotinamide phosphoribosyltransferase (NAMPT) activity, mimicked the effects of visfatin on MAPK (p38, ERK1/2)-NF-ÎºB activation and EMMPRIN/MMP-9 induction.  Using the p38 inhibitor, SB203580, the ERK1/2 inhibitor PD98059, the NF-ÎºB inhibitor, pyrrolidine dithiocarbamate and the NAMPT inhibitor FK866, we demonstrated that the visfatin pro-inflammatory action was through the NAMPT-MAPK (p38, ERK1/2)-NF-ÎºB pathway.  Furthermore, the visfatin pro-inflammatory action was not prevented by insulin receptor blockade or by a PPARÎ³ agonist.  Visfatin did not modulate PPARÎ³ expression.  Retinoid X receptor (RXR) agonist suppressed the effects of visfatin on EMMPRIN/MMP-9, NF-ÎºB, but not on MAPK activation.  In conclusion, we have demonstrated that visfatin enhances atheroma inflammation through the NAMPT-MAPK (p38, ERK1/2)-NF-ÎºB-EMMPRIN/MMP-9 pathway, a key feature of atherosclerotic diseases linked to metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozf42EMGPB_bVg90H21EOLACvtfcHk0li3Xq3d17XEvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslOisb0%253D&md5=322f2127e9641d7d2206f737b0c5dafe</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2011.611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2011.611%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DVisfatin%252FPBEF%252FNampt%2520induces%2520EMMPRIN%2520and%2520MMP-9%2520production%2520in%2520macrophages%2520via%2520the%2520NAMPT-MAPK%2520%2528p38%252C%2520ERK1%252F2%2529-NF-kappaB%2520signaling%2520pathway%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2011%26volume%3D27%26spage%3D607%26epage%3D615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Moschen, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enrich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosheimer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theurl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niederegger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilg, H.</span><span> </span><span class="NLM_article-title">Visfatin, an adipocytokine with proinflammatory and immunomodulating properties</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">1748</span><span class="NLM_x">â</span> <span class="NLM_lpage">1758</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=1748-1758&author=A.+R.+Moschenauthor=A.+Kaserauthor=B.+Enrichauthor=B.+Mosheimerauthor=M.+Theurlauthor=H.+Niedereggerauthor=H.+Tilg&title=Visfatin%2C+an+adipocytokine+with+proinflammatory+and+immunomodulating+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoschen%26aufirst%3DA.%2BR.%26aulast%3DKaser%26aufirst%3DA.%26aulast%3DEnrich%26aufirst%3DB.%26aulast%3DMosheimer%26aufirst%3DB.%26aulast%3DTheurl%26aufirst%3DM.%26aulast%3DNiederegger%26aufirst%3DH.%26aulast%3DTilg%26aufirst%3DH.%26atitle%3DVisfatin%252C%2520an%2520adipocytokine%2520with%2520proinflammatory%2520and%2520immunomodulating%2520properties%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D178%26spage%3D1748%26epage%3D1758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Skokowa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakur, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cario, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brechlin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schambach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinrichsen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanulla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welte, K.</span><span> </span><span class="NLM_article-title">NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">â</span> <span class="NLM_lpage">158</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1038%2Fnm.1913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ehu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=151-158&author=J.+Skokowaauthor=D.+Lanauthor=B.+K.+Thakurauthor=F.+Wangauthor=K.+Guptaauthor=G.+Carioauthor=A.+M.+Brechlinauthor=A.+Schambachauthor=L.+Hinrichsenauthor=G.+Meyerauthor=M.+Gaestelauthor=M.+Stanullaauthor=Q.+Tongauthor=K.+Welte&title=NAMPT+is+essential+for+the+G-CSF-induced+myeloid+differentiation+via+a+NAD%28%2B%29-sirtuin-1-dependent+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD+-sirtuin-1-dependent pathway</span></div><div class="casAuthors">Skokowa, Julia; Lan, Dan; Thakur, Basant Kumar; Wang, Fei; Gupta, Kshama; Cario, Gunnar; Brechlin, Annette Mueller; Schambach, Axel; Hinrichsen, Lars; Meyer, Gustav; Gaestel, Matthias; Stanulla, Martin; Tong, Qiang; Welte, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-158</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We identified nicotinamide phosphoribosyltransferase (NAMPT), also known as pre-B cell colony enhancing factor (PBEF), as an essential enzyme mediating granulocyte colony-stimulating factor (G-CSF)-triggered granulopoiesis in healthy individuals and in individuals with severe congenital neutropenia.  Intracellular NAMPT and NAD+ amts. in myeloid cells, as well as plasma NAMPT and NAD+ levels, were increased by G-CSF treatment of both healthy volunteers and individuals with congenital neutropenia.  NAMPT administered both extracellularly and intracellularly induced granulocytic differentiation of CD34+ hematopoietic progenitor cells and of the promyelocytic leukemia cell line HL-60.  Treatment of healthy individuals with high doses of vitamin B3 (nicotinamide), a substrate of NAMPT, induced neutrophilic granulocyte differentiation.  The mol. events triggered by NAMPT include NAD+-dependent sirtuin-1 activation, subsequent induction of CCAAT/enhancer binding protein-Î± and CCAAT/enhancer binding protein-Î², and, ultimately, upregulation of G-CSF synthesis and G-CSF receptor expression.  G-CSF, in turn, further increases NAMPT levels.  These results reveal a decisive role of the NAD+ metabolic pathway in G-CSF-triggered myelopoiesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlJgBC7Y8HNbVg90H21EOLACvtfcHk0li7PZHBeUPdNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ehu7s%253D&md5=4aef2263e94dec4da4ea4d2acf204165</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnm.1913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1913%26sid%3Dliteratum%253Aachs%26aulast%3DSkokowa%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DD.%26aulast%3DThakur%26aufirst%3DB.%2BK.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DGupta%26aufirst%3DK.%26aulast%3DCario%26aufirst%3DG.%26aulast%3DBrechlin%26aufirst%3DA.%2BM.%26aulast%3DSchambach%26aufirst%3DA.%26aulast%3DHinrichsen%26aufirst%3DL.%26aulast%3DMeyer%26aufirst%3DG.%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DStanulla%26aufirst%3DM.%26aulast%3DTong%26aufirst%3DQ.%26aulast%3DWelte%26aufirst%3DK.%26atitle%3DNAMPT%2520is%2520essential%2520for%2520the%2520G-CSF-induced%2520myeloid%2520differentiation%2520via%2520a%2520NAD%2528%252B%2529-sirtuin-1-dependent%2520pathway%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D151%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Fukuhara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishizawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichisaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyoshi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makishima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimomura, I.</span><span> </span><span class="NLM_article-title">Retraction</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=565&author=A.+Fukuharaauthor=M.+Matsudaauthor=M.+Nishizawaauthor=K.+Segawaauthor=M.+Tanakaauthor=K.+Kishimotoauthor=Y.+Matsukiauthor=M.+Murakamiauthor=T.+Ichisakaauthor=H.+Murakamiauthor=E.+Watanabeauthor=T.+Takagiauthor=M.+Akiyoshiauthor=T.+Ohtsuboauthor=S.+Kiharaauthor=S.+Yamashitaauthor=M.+Makishimaauthor=T.+Funahashiauthor=S.+Yamanakaauthor=R.+Hiramatsuauthor=Y.+Matsuzawaauthor=I.+Shimomura&title=Retraction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukuhara%26aufirst%3DA.%26aulast%3DMatsuda%26aufirst%3DM.%26aulast%3DNishizawa%26aufirst%3DM.%26aulast%3DSegawa%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DKishimoto%26aufirst%3DK.%26aulast%3DMatsuki%26aufirst%3DY.%26aulast%3DMurakami%26aufirst%3DM.%26aulast%3DIchisaka%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DE.%26aulast%3DTakagi%26aufirst%3DT.%26aulast%3DAkiyoshi%26aufirst%3DM.%26aulast%3DOhtsubo%26aufirst%3DT.%26aulast%3DKihara%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DS.%26aulast%3DMakishima%26aufirst%3DM.%26aulast%3DFunahashi%26aufirst%3DT.%26aulast%3DYamanaka%26aufirst%3DS.%26aulast%3DHiramatsu%26aufirst%3DR.%26aulast%3DMatsuzawa%26aufirst%3DY.%26aulast%3DShimomura%26aufirst%3DI.%26atitle%3DRetraction%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Romacho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azcutia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez-Bella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cercas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevado, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carraro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Manas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Ferrer, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiro, C.</span><span> </span><span class="NLM_article-title">Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2455</span><span class="NLM_x">â</span> <span class="NLM_lpage">2463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2455-2463&author=T.+Romachoauthor=V.+Azcutiaauthor=M.+Vazquez-Bellaauthor=N.+Matesanzauthor=E.+Cercasauthor=J.+Nevadoauthor=R.+Carraroauthor=L.+Rodriguez-Manasauthor=C.+F.+Sanchez-Ferrerauthor=C.+Peiro&title=Extracellular+PBEF%2FNAMPT%2Fvisfatin+activates+pro-inflammatory+signalling+in+human+vascular+smooth+muscle+cells+through+nicotinamide+phosphoribosyltransferase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomacho%26aufirst%3DT.%26aulast%3DAzcutia%26aufirst%3DV.%26aulast%3DVazquez-Bella%26aufirst%3DM.%26aulast%3DMatesanz%26aufirst%3DN.%26aulast%3DCercas%26aufirst%3DE.%26aulast%3DNevado%26aufirst%3DJ.%26aulast%3DCarraro%26aufirst%3DR.%26aulast%3DRodriguez-Manas%26aufirst%3DL.%26aulast%3DSanchez-Ferrer%26aufirst%3DC.%2BF.%26aulast%3DPeiro%26aufirst%3DC.%26atitle%3DExtracellular%2520PBEF%252FNAMPT%252Fvisfatin%2520activates%2520pro-inflammatory%2520signalling%2520in%2520human%2520vascular%2520smooth%2520muscle%2520cells%2520through%2520nicotinamide%2520phosphoribosyltransferase%2520activity%26jtitle%3DDiabetologia%26date%3D2009%26volume%3D52%26spage%3D2455%26epage%3D2463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osago, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, M.</span><span> </span><span class="NLM_article-title">Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e22781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e22781&author=N.+Haraauthor=K.+Yamadaauthor=T.+Shibataauthor=H.+Osagoauthor=M.+Tsuchiya&title=Nicotinamide+phosphoribosyltransferase%2Fvisfatin+does+not+catalyze+nicotinamide+mononucleotide+formation+in+blood+plasma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DN.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DOsago%26aufirst%3DH.%26aulast%3DTsuchiya%26aufirst%3DM.%26atitle%3DNicotinamide%2520phosphoribosyltransferase%252Fvisfatin%2520does%2520not%2520catalyze%2520nicotinamide%2520mononucleotide%2520formation%2520in%2520blood%2520plasma%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De22781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Warburg, O.</span><span> </span><span class="NLM_article-title">On the origin of cancer cells</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1956</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">â</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1126%2Fscience.123.3191.309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=13298683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1956&pages=309-314&author=O.+Warburg&title=On+the+origin+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">On the origin of cancer cells</span></div><div class="casAuthors">WARBURG O</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3191</span>),
    <span class="NLM_cas:pages">309-14</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDsp1coYpQW669lAbTj9rGfW6udTcc2eYkwTfS32dO-Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D&md5=860d5ce9456831968fcc897b37d6d9c2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.123.3191.309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.123.3191.309%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3DOn%2520the%2520origin%2520of%2520cancer%2520cells%26jtitle%3DScience%26date%3D1956%26volume%3D123%26spage%3D309%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Dalamaga, M.</span><span> </span><span class="NLM_article-title">Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges</span> <span class="citation_source-journal">Med. Hypotheses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">â</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.mehy.2012.07.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSlsrbN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=617-621&author=M.+Dalamaga&title=Nicotinamide+phosphoribosyl-transferase%2Fvisfatin%3A+a+missing+link+between+overweight%2Fobesity+and+postmenopausal+breast+cancer%3F+Potential+preventive+and+therapeutic+perspectives+and+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide phosphoribosyl-transferase/visfatin: A missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges</span></div><div class="casAuthors">Dalamaga, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Medical Hypotheses</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">617-621</span>CODEN:
                <span class="NLM_cas:coden">MEHYDY</span>;
        ISSN:<span class="NLM_cas:issn">0306-9877</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Worldwide breast cancer (BC) constitutes a significant public health concern.  Excess body wt. is assocd. with postmenopausal BC (PBC) risk.  Recent studies have shown that the constellation of obesity, insulin resistance and serum adipokine levels are assocd. with the risk and prognosis of PBC.  Nicotinamide phosphoribosyl-transferase (Nampt), also known as visfatin and pre-B-cell-colony-enhancing factor, found in the visceral fat, represents a novel pleiotropic adipokine acting as a cytokine, a growth factor and an enzyme.  It plays an important role in a variety of metabolic and stress responses as well as in the cellular energy metab., particularly NAD biosynthesis.  Nampt exhibits proliferative, anti-apoptotic, pro-inflammatory and pro-angiogenic properties.  Nampt's insulin-mimetic function remains a controversial issue.  Circulating Nampt levels are increased in obese women.  Also, Nampt levels are significantly elevated in women suffering from PBC than in healthy controls independently from known risk factors of BC, anthropometric and metabolic parameters as well as serum concns. of well known adipokines.  High expression of Nampt in BC tissues was reported to be assocd. with more malignant cancer behavior as well as adverse prognosis.  Taking into account the mitogenicity of Nampt as well as its proliferative, anti-apoptotic and pro-angiogenic properties, a novel hypothesis is proposed whereas Nampt may be involved in the etiopathogenesis of PBC and may represent a missing link between overweight/obesity and PBC.  Nampt could exert its effects on the normal and neoplastic mammary tissue by endocrine and paracrine mechanisms; Nampt could also be secreted by tumor epithelial cells in an autocrine manner.  It could stimulate mammary epithelial cell proliferation, invasion, metastasis, and angiogenesis, which is essential for BC development and progression.  Serum Nampt might be a novel risk factor as well as a potential diagnostic and prognostic biomarker in PBC.  In addn., pharmacol. agents that neutralize biochem. Nampt or medications that decrease Nampt levels or downregulate signaling pathways downstream of Nampt may prove to be useful anti-cancer agents.  The potential harmful effect on PBC risk due to vitamin B3 (nicotinic acid, a natural NAD precursor in the biosynthetic route leading to NAD) intake is speculated for the first time.  In this hypothesis, the role of Nampt in BC carcinogenesis and progression is explored as well as the pathophysiol. mechanisms that underlie the assocn. between Nampt and PBC in the context of a dysfunctional adipose tissue in obesity.  Understanding of these mechanisms may be important for the development of preventive and therapeutic strategies against PBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMynKj7qHDj7Vg90H21EOLACvtfcHk0lgHp-YpTE_H9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSlsrbN&md5=af34dc3f2602053d9fd97d40956364c5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.mehy.2012.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mehy.2012.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DDalamaga%26aufirst%3DM.%26atitle%3DNicotinamide%2520phosphoribosyl-transferase%252Fvisfatin%253A%2520a%2520missing%2520link%2520between%2520overweight%252Fobesity%2520and%2520postmenopausal%2520breast%2520cancer%253F%2520Potential%2520preventive%2520and%2520therapeutic%2520perspectives%2520and%2520challenges%26jtitle%3DMed.%2520Hypotheses%26date%3D2012%26volume%3D79%26spage%3D617%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. J.</span><span> </span><span class="NLM_article-title">Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review</span> <span class="citation_source-journal">Diabetes Metab. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">â</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1002%2Fdmrr.1201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1CjsLfP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2011&pages=515-527&author=Y.+H.+Changauthor=D.+M.+Changauthor=K.+C.+Linauthor=S.+J.+Shinauthor=Y.+J.+Lee&title=Visfatin+in+overweight%2Fobesity%2C+type+2+diabetes+mellitus%2C+insulin+resistance%2C+metabolic+syndrome+and+cardiovascular+diseases%3A+a+meta-analysis+and+systemic+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review</span></div><div class="casAuthors">Chang, Yu-Hung; Chang, Dao-Ming; Lin, Kun-Cheng; Shin, Shyi-Jang; Lee, Yau-Jiunn</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes/Metabolism Research and Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">515-527</span>CODEN:
                <span class="NLM_cas:coden">DMRRFM</span>;
        ISSN:<span class="NLM_cas:issn">1520-7552</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">There are controversies regarding the assocn. of visfatin with overweight/obesity, type 2 diabetes mellitus, insulin resistance (IR), metabolic syndrome and cardiovascular disease in published articles.  A meta-anal. was performed to identify the significance of visfatin in these diseases.  We searched for relevant articles in Pubmed, Scopus and SCIE.  A total of 1035 articles were surveyed and 46 articles were identified, with 14 reports reporting more than one of our investigated diseases.  A total of 13 (n = 644), 19 (n = 2405), 20 (n = 2249), 5 (n = 527) and 5 (n = 851) articles/(participants) were included in each meta-anal. regarding the assocn. of visfatin and overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases, resp.  Plasma visfatin concns. were increased in participants diagnosed with overweight/obesity, type 2 diabetes mellitus, metabolic syndrome and cardiovascular diseases, with pooled log odds ratios of 1.164 [95% confidence interval (CI): 0.348 to 1.981, p = 0.005], 1.981 (95% CI: 1.377 to 2.584, p < 0.001), 1.094 (95% CI: 0.678 to 1.511, p < 0.001), and 2.902 (95% CI: 0.924 to 4.879, p < 0.005), resp.  The circulating visfatin level was pos. assocd. with insulin resistance, with a Fisher's z of 0.089 (95% CI: 0.013 to 0.165, p = 0.022).  No single study was found to affect the overall result of each anal. by sensitivity testing.  No publication bias was found by the Egger test.  Our study suggests that the use of visfatin may be promising for predicting obesity, diabetes status, insulin resistance, metabolic syndrome and cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEgzSUZLltlbVg90H21EOLACvtfcHk0lgHp-YpTE_H9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1CjsLfP&md5=5bc501a85d9d0dbca647dc11e9c28ca7</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1002%2Fdmrr.1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdmrr.1201%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DY.%2BH.%26aulast%3DChang%26aufirst%3DD.%2BM.%26aulast%3DLin%26aufirst%3DK.%2BC.%26aulast%3DShin%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DY.%2BJ.%26atitle%3DVisfatin%2520in%2520overweight%252Fobesity%252C%2520type%25202%2520diabetes%2520mellitus%252C%2520insulin%2520resistance%252C%2520metabolic%2520syndrome%2520and%2520cardiovascular%2520diseases%253A%2520a%2520meta-analysis%2520and%2520systemic%2520review%26jtitle%3DDiabetes%2520Metab.%2520Res.%2520Rev.%26date%3D2011%26volume%3D27%26spage%3D515%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratzsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span> </span><span class="NLM_article-title">Nampt and its potential role in inflammation and type 2 diabetes</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">â</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1007%2F978-3-642-17214-4_7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvVahtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=147-164&author=A.+Gartenauthor=S.+Petzoldauthor=S.+Schusterauthor=A.+Kornerauthor=J.+Kratzschauthor=W.+Kiess&title=Nampt+and+its+potential+role+in+inflammation+and+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Nampt and its potential role in inflammation and type 2 diabetes</span></div><div class="casAuthors">Garten, Antje; Petzold, Stefanie; Schuster, Susanne; Koerner, Antje; Kratzsch, Juergen; Kiess, Wieland</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">Diabetes: Perspectives in Drug Therapy</span>),
    <span class="NLM_cas:pages">147-164</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Nicotinamide phosphoribosyltransferase (Nampt) is a key NAD (NAD) biosynthetic enzyme in mammals, converting nicotinamide into NMN (NMN), an NAD intermediate.  First identified in humans as a cytokine pre-B-cell colony enhancing factor (PBEF) and subsequently described as an insulin-mimetic hormone visfatin, Nampt has recently excited the scientific interest of researchers from diverse fields, including NAD biol., metabolic regulation, and inflammation.  As an NAD biosynthetic enzyme, Nampt regulates the activity of NAD-consuming enzymes such as sirtuins and influences a variety of metabolic and stress responses.  Nampt plays an important role in the regulation of insulin secretion in pancreatic Î²-cells.  Nampt also functions as an immunomodulatory cytokine and is involved in the regulation of inflammatory responses.  This chapter summarizes the various functional aspects of Nampt and discusses its potential roles in diseases, with special focus on type 2 diabetes mellitus (T2DM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq14UyLXNKAlrVg90H21EOLACvtfcHk0lgHvFmnty0bJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvVahtL4%253D&md5=9a5fc4b963255b312ec488a8d1ff34be</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-17214-4_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-17214-4_7%26sid%3Dliteratum%253Aachs%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DPetzold%26aufirst%3DS.%26aulast%3DSchuster%26aufirst%3DS.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DKratzsch%26aufirst%3DJ.%26aulast%3DKiess%26aufirst%3DW.%26atitle%3DNampt%2520and%2520its%2520potential%2520role%2520in%2520inflammation%2520and%2520type%25202%2520diabetes%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2011%26spage%3D147%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Barth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horbach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rascher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knerr, I.</span><span> </span><span class="NLM_article-title">Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: relation to endocrine and clinical parameters</span> <span class="citation_source-journal">Obes. Facts</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">â</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1159%2F000319508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWqt73I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=245-251&author=S.+Barthauthor=P.+Kleinauthor=T.+Horbachauthor=J.+Dotschauthor=M.+Rauhauthor=W.+Rascherauthor=I.+Knerr&title=Expression+of+neuropeptide+Y%2C+omentin+and+visfatin+in+visceral+and+subcutaneous+adipose+tissues+in+humans%3A+relation+to+endocrine+and+clinical+parameters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Neuropeptide Y, Omentin and Visfatin in Visceral and Subcutaneous Adipose Tissues in Humans: Relation to Endocrine and Clinical Parameters</span></div><div class="casAuthors">Barth, Stephanie; Klein, Peter; Horbach, Thomas; Doetsch, Joerg; Rauh, Manfred; Rascher, Wolfgang; Knerr, Ina</div><div class="citationInfo"><span class="NLM_cas:title">Obesity Facts</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">245-251</span>CODEN:
                <span class="NLM_cas:coden">OFBABR</span>;
        ISSN:<span class="NLM_cas:issn">1662-4025</span>.
    
            (<span class="NLM_cas:orgname">S. Karger Verlag fuer Medizin und Naturwissenschaften GmbH</span>)
        </div><div class="casAbstract">Objective: The authors aimed at exploring the expression of neuropeptide Y (NPY), omentin and visfatin in adipose tissues of adults along with clin. parameters and hormones.  Methods: the authors included 168 adult patients (31 surgical obese patients and 31 surgical controls, 76 non-surgical obese patients, 30 non-surgical controls).  The authors measured plasma NPY (by RIA), cortisol (with an electrochemiluminescence immunoassay) and urinary cortisol metabolites (by gas chromatog./mass spectrometry).  Expression of NPY, omentin and visfatin in s.c. and visceral adipose tissue specimens of the surgical patients was quantified using real-time PCR.  Results: NPY was detectable in adipose tissue specimens and, like plasma NPY concns., comparable between groups.  Omentin gene expression was higher in visceral than in s.c. adipose tissues (p < 0.0001).  Visfatin expression was lower in the s.c. tissue of obese patients compared with controls (p < 0.05).  Cortisol was lower in obese adults compared with controls (136.5Â±74.1 vs. 162.2Â±56.1 ng/mL; p < 0.05), cortisol metabolites were comparable between groups.  Conclusion: In the authors' obese adults, plasma NPY levels and the glucocorticoid measures were not elevated.  Even though the expression of NPY, omentin and visfatin was comparable between obese individuals and controls, the authors have to consider differences in the total prodn. rate of adipose tissue-derived factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6IIS8I_8zVbVg90H21EOLACvtfcHk0lgHvFmnty0bJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWqt73I&md5=f2895a8f8fe838e70ed471b1a5c5aa99</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1159%2F000319508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000319508%26sid%3Dliteratum%253Aachs%26aulast%3DBarth%26aufirst%3DS.%26aulast%3DKlein%26aufirst%3DP.%26aulast%3DHorbach%26aufirst%3DT.%26aulast%3DDotsch%26aufirst%3DJ.%26aulast%3DRauh%26aufirst%3DM.%26aulast%3DRascher%26aufirst%3DW.%26aulast%3DKnerr%26aufirst%3DI.%26atitle%3DExpression%2520of%2520neuropeptide%2520Y%252C%2520omentin%2520and%2520visfatin%2520in%2520visceral%2520and%2520subcutaneous%2520adipose%2520tissues%2520in%2520humans%253A%2520relation%2520to%2520endocrine%2520and%2520clinical%2520parameters%26jtitle%3DObes.%2520Facts%26date%3D2010%26volume%3D3%26spage%3D245%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhoutte, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, C. Y.</span><span> </span><span class="NLM_article-title">Visfatin and cardio-cerebro-vascular disease</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2012&pages=1-9&author=P.+Wangauthor=P.+M.+Vanhoutteauthor=C.+Y.+Miao&title=Visfatin+and+cardio-cerebro-vascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DVanhoutte%26aufirst%3DP.%2BM.%26aulast%3DMiao%26aufirst%3DC.%2BY.%26atitle%3DVisfatin%2520and%2520cardio-cerebro-vascular%2520disease%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2012%26volume%3D59%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Benedict, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shostak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schioth, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Born, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oster, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallschmid, M.</span><span> </span><span class="NLM_article-title">Diurnal rhythm of circulating nicotinamide phosphoribosyltransferase (Nampt/visfatin/PBEF): impact of sleep loss and relation to glucose metabolism</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">E218</span><span class="NLM_x">â</span> <span class="NLM_lpage">E222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2012&pages=E218-E222&author=C.+Benedictauthor=A.+Shostakauthor=T.+Langeauthor=S.+J.+Brooksauthor=H.+B.+Schiothauthor=B.+Schultesauthor=J.+Bornauthor=H.+Osterauthor=M.+Hallschmid&title=Diurnal+rhythm+of+circulating+nicotinamide+phosphoribosyltransferase+%28Nampt%2Fvisfatin%2FPBEF%29%3A+impact+of+sleep+loss+and+relation+to+glucose+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenedict%26aufirst%3DC.%26aulast%3DShostak%26aufirst%3DA.%26aulast%3DLange%26aufirst%3DT.%26aulast%3DBrooks%26aufirst%3DS.%2BJ.%26aulast%3DSchioth%26aufirst%3DH.%2BB.%26aulast%3DSchultes%26aufirst%3DB.%26aulast%3DBorn%26aufirst%3DJ.%26aulast%3DOster%26aufirst%3DH.%26aulast%3DHallschmid%26aufirst%3DM.%26atitle%3DDiurnal%2520rhythm%2520of%2520circulating%2520nicotinamide%2520phosphoribosyltransferase%2520%2528Nampt%252Fvisfatin%252FPBEF%2529%253A%2520impact%2520of%2520sleep%2520loss%2520and%2520relation%2520to%2520glucose%2520metabolism%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D97%26spage%3DE218%26epage%3DE222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bluher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratzsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span> </span><span class="NLM_article-title">Molecular characteristics of serum visfatin and differential detection by immunoassays</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">4783</span><span class="NLM_x">â</span> <span class="NLM_lpage">4791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1210%2Fjc.2007-1304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BD2sjhs1Oluw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2007&pages=4783-4791&author=A.+Kornerauthor=A.+Gartenauthor=M.+Bluherauthor=R.+Tauscherauthor=J.+Kratzschauthor=W.+Kiess&title=Molecular+characteristics+of+serum+visfatin+and+differential+detection+by+immunoassays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characteristics of serum visfatin and differential detection by immunoassays</span></div><div class="casAuthors">Korner Antje; Garten Antje; Bluher Matthias; Tauscher Roy; Kratzsch Jurgen; Kiess Wieland</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical endocrinology and metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4783-91</span>
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">CONTEXT:  There are controversial results concerning the association of visfatin with obesity and diabetes.  We aimed to characterize molecular features of visfatin, to assess visfatin detection by different immunoassays, and evaluate the association with human obesity and glucose metabolism.  RESULTS:  Distinct preparations of human visfatin (recombinant, endogenously expressed from human adipocytes, and overexpressed in COS-7 cells) were readily identified by three currently available immunoassays.  However, direct comparison of native human serum samples did reveal great discrepancies between these assays and complete lack of correlation.  To specify putative molecular isoforms of visfatin, we fractionated iodine-125-labeled recombinant visfatin spiked into human serum and supernatants of visfatin-overexpressing COS-7 cells by size exclusion chromatography.  We obtained a distinct peak at approximately 100 kDa that was confirmed by subsequent Western blotting of the fractions and is equivalent to the molecular mass of the dimer.  Only one of the immunoassays detected a similar peak in native human size exclusion chromatography serum fractions, whereas the others detected a peak at more than 500 kDa or did not show any distinct peak.  We did not observe any differences in visfatin serum levels between lean or obese patients.  In addition, there was no correlation between visfatin serum levels with visfatin mRNA expression in sc or visceral fat and with parameters of glucose metabolism.  CONCLUSION:  Differences in the qualitative and quantitative detection of visfatin by immunoassays need to be considered in clinical association studies and may explain the conflicting observations with respect to a putative relation of circulating visfatin to human obesity or insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRooV4qMaINh8ERNNga7KD-fW6udTcc2ebET0J-CHXO3Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjhs1Oluw%253D%253D&md5=04c17b4ef3880892122c7570d130d11d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1210%2Fjc.2007-1304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2007-1304%26sid%3Dliteratum%253Aachs%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DBluher%26aufirst%3DM.%26aulast%3DTauscher%26aufirst%3DR.%26aulast%3DKratzsch%26aufirst%3DJ.%26aulast%3DKiess%26aufirst%3DW.%26atitle%3DMolecular%2520characteristics%2520of%2520serum%2520visfatin%2520and%2520differential%2520detection%2520by%2520immunoassays%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2007%26volume%3D92%26spage%3D4783%26epage%3D4791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Busso, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karababa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobile, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Smedt, T.</span><span> </span><span class="NLM_article-title">Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e2267&author=N.+Bussoauthor=M.+Karababaauthor=M.+Nobileauthor=A.+Rolazauthor=F.+Van+Goolauthor=M.+Galliauthor=O.+Leoauthor=A.+Soauthor=T.+De+Smedt&title=Pharmacological+inhibition+of+nicotinamide+phosphoribosyltransferase%2Fvisfatin+enzymatic+activity+identifies+a+new+inflammatory+pathway+linked+to+NAD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBusso%26aufirst%3DN.%26aulast%3DKarababa%26aufirst%3DM.%26aulast%3DNobile%26aufirst%3DM.%26aulast%3DRolaz%26aufirst%3DA.%26aulast%3DVan%2BGool%26aufirst%3DF.%26aulast%3DGalli%26aufirst%3DM.%26aulast%3DLeo%26aufirst%3DO.%26aulast%3DSo%26aufirst%3DA.%26aulast%3DDe%2BSmedt%26aufirst%3DT.%26atitle%3DPharmacological%2520inhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%252Fvisfatin%2520enzymatic%2520activity%2520identifies%2520a%2520new%2520inflammatory%2520pathway%2520linked%2520to%2520NAD%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De2267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tilg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschen, A. R.</span><span> </span><span class="NLM_article-title">Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases</span> <span class="citation_source-journal">Clin. Sci. (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">â</span> <span class="NLM_lpage">288</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1042%2FCS20070196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=18194136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FktVGqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2008&pages=275-288&author=H.+Tilgauthor=A.+R.+Moschen&title=Role+of+adiponectin+and+PBEF%2Fvisfatin+as+regulators+of+inflammation%3A+involvement+in+obesity-associated+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases</span></div><div class="casAuthors">Tilg Herbert; Moschen Alexander R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical science (London, England : 1979)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">275-88</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Obesity and obesity-related disorders play an important role in clinical medicine.  Adipose tissue, with its soluble mediators called adipocytokines, has emerged as a major endocrine organ.  These adipocytokines comprise many mediators such as adiponectin, PBEF (pre-B-cell-enhancing factor)/visfatin, leptin, resistin, retinol-binding protein-4 and others.  They play major roles in key aspects of metabolism, such as insulin resistance, fatty acid oxidation, inflammation and immunity.  Adiponectin, a prototypic adipocytokine, is of importance in the regulation of insulin resistance, as circulating levels are decreased in obesity and diseases associated with insulin resistance.  Besides its major role in regulation of insulin sensitivity, recent evidence suggests potent anti-inflammatory functions for adiponectin.  These effects are paralleled by other immune-regulatory properties, such as regulation of endothelial cell function.  The in vitro effects of adiponectin have been corroborated by several studies demonstrating potent in vivo anti-inflammatory effects.  Many other adipocytokines, such as PBEF/visfatin, leptin, resistin or retinol binding protein-4, are involved in the physiology and pathophysiology of adipocytes, adipose tissue and related diseases.  PBEF/visfatin, another recently characterized adipocytokine, has been linked to several inflammatory disease states beyond insulin resistance, such as acute lung injury or inflammatory bowel diseases.  It has been recognized for many decades that obesity is accompanied by an increase in cancer and potentially some immune-mediated diseases.  Understanding this new exciting world of adipocytokines will be of importance in the development of novel therapies for obesity-associated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQngrZcsoE2LO98rul4nhSdfW6udTcc2ebACa7-AwNQ1bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FktVGqsg%253D%253D&md5=0d07f03ad5807e291377295aaa6f0405</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1042%2FCS20070196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20070196%26sid%3Dliteratum%253Aachs%26aulast%3DTilg%26aufirst%3DH.%26aulast%3DMoschen%26aufirst%3DA.%2BR.%26atitle%3DRole%2520of%2520adiponectin%2520and%2520PBEF%252Fvisfatin%2520as%2520regulators%2520of%2520inflammation%253A%2520involvement%2520in%2520obesity-associated%2520diseases%26jtitle%3DClin.%2520Sci.%2520%2528London%2529%26date%3D2008%26volume%3D114%26spage%3D275%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Huang, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, W. L.</span><span> </span><span class="NLM_article-title">Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection</span> <span class="citation_source-journal">J. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">â</span> <span class="NLM_lpage">535</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1111%2Fj.1440-1746.2010.06438.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1amu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=530-535&author=J.+F.+Huangauthor=C.+F.+Huangauthor=M.+L.+Yuauthor=C.+Y.+Daiauthor=C.+I.+Huangauthor=M.+L.+Yehauthor=M.+H.+Hsiehauthor=J.+F.+Yangauthor=M.+Y.+Hsiehauthor=Z.+Y.+Linauthor=S.+C.+Chenauthor=W.+L.+Chuang&title=Serum+visfatin+is+correlated+with+disease+severity+and+metabolic+syndrome+in+chronic+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection</span></div><div class="casAuthors">Huang, Jee-Fu; Huang, Chung-Feng; Yu, Ming-Lung; Dai, Chia-Yen; Huang, Ching-I.; Yeh, Ming-Lun; Hsieh, Meng-Hsuan; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Chern; Chuang, Wan-Long</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">530-535</span>CODEN:
                <span class="NLM_cas:coden">JGHEEO</span>;
        ISSN:<span class="NLM_cas:issn">0815-9319</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Aim: Cytokines activation is a common feature in chronic hepatitis C (CHC) infection.  Visfatin, as a recently-recognized adipocytokine, may correlate with metabolic abnormalities.  We aimed to elucidate the characteristics of visfatin in CHC patients.  Methods: This retrospective study included 102 treatment-naive CHC patients and 97 sex-/age-matched healthy adults.  Serum visfatin levels were examd. by an enzyme linked immunosorbent assay test.  The correlation between visfatin and hepatitis C virus (HCV) infection in terms of virol., metabolic, and histopathol. profiles was analyzed.  The impact of visfatin on the treatment response to pegylated interferon plus ribavirin (PEGIFN/RBV) therapy was also assessed.  Results: The visfatin level was correlated significantly with fibrosis scores (r = 0.23, P = 0.02) in CHC patients.  A significant higher visfatin level was obsd. in CHC patients with histol. activity index scores of mild and more (p = 0.01) and advanced fibrosis (P = 0.04).  The mean visfatin level (0.81 Â± 0.28 log ng/mL) of 26 CHC patients with metabolic syndrome was significantly lower than their counterparts (0.95 Â± 0.30 log ng/mL) (P = 0.03).  There was no significant correlation between visfatin and HCV genotypes, viral load, and treatment response to PEGIFN/RBV therapy.  Multiple logistic regression analyses demonstrated that metabolic syndrome was the leading neg. variable (odds ratio = 0.09, 95% confidence interval = 0.02-0.46, P = 0.004) assocd. with high visfatin level, followed by advanced fibrosis (odds ratio = 2.88, 95% confidence interval = 1.06-6.78, P = 0.03).  Conclusions: Serum visfatin was correlated with disease severity and metabolic syndrome in CHC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppTFj9qzKSo7Vg90H21EOLACvtfcHk0li1UDlwrdbFWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1amu7Y%253D&md5=29ccdcc62aeef7eac215140fe9e6be1c</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1746.2010.06438.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1746.2010.06438.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%2BF.%26aulast%3DHuang%26aufirst%3DC.%2BF.%26aulast%3DYu%26aufirst%3DM.%2BL.%26aulast%3DDai%26aufirst%3DC.%2BY.%26aulast%3DHuang%26aufirst%3DC.%2BI.%26aulast%3DYeh%26aufirst%3DM.%2BL.%26aulast%3DHsieh%26aufirst%3DM.%2BH.%26aulast%3DYang%26aufirst%3DJ.%2BF.%26aulast%3DHsieh%26aufirst%3DM.%2BY.%26aulast%3DLin%26aufirst%3DZ.%2BY.%26aulast%3DChen%26aufirst%3DS.%2BC.%26aulast%3DChuang%26aufirst%3DW.%2BL.%26atitle%3DSerum%2520visfatin%2520is%2520correlated%2520with%2520disease%2520severity%2520and%2520metabolic%2520syndrome%2520in%2520chronic%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Gastroenterol.%2520Hepatol.%26date%3D2011%26volume%3D26%26spage%3D530%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Malam, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waheed, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szaszi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, J. C.</span><span> </span><span class="NLM_article-title">Pre-B cell colony-enhancing factor (PBEF/Nampt/visfatin) primes neutrophils for augmented respiratory burst activity through partial assembly of the NADPH oxidase</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">6474</span><span class="NLM_x">â</span> <span class="NLM_lpage">6484</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=6474-6484&author=Z.+Malamauthor=J.+Parodoauthor=F.+Waheedauthor=K.+Szasziauthor=A.+Kapusauthor=J.+C.+Marshall&title=Pre-B+cell+colony-enhancing+factor+%28PBEF%2FNampt%2Fvisfatin%29+primes+neutrophils+for+augmented+respiratory+burst+activity+through+partial+assembly+of+the+NADPH+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalam%26aufirst%3DZ.%26aulast%3DParodo%26aufirst%3DJ.%26aulast%3DWaheed%26aufirst%3DF.%26aulast%3DSzaszi%26aufirst%3DK.%26aulast%3DKapus%26aufirst%3DA.%26aulast%3DMarshall%26aufirst%3DJ.%2BC.%26atitle%3DPre-B%2520cell%2520colony-enhancing%2520factor%2520%2528PBEF%252FNampt%252Fvisfatin%2529%2520primes%2520neutrophils%2520for%2520augmented%2520respiratory%2520burst%2520activity%2520through%2520partial%2520assembly%2520of%2520the%2520NADPH%2520oxidase%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D6474%26epage%3D6484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Dietrich, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muniz, O.</span><span> </span><span class="NLM_article-title">Inhibition of nicotinamide phosphoribosyltransferase by pyridine nucleotides</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1691</span><span class="NLM_x">â</span> <span class="NLM_lpage">1695</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00759a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1972&pages=1691-1695&author=L.+S.+Dietrichauthor=O.+Muniz&title=Inhibition+of+nicotinamide+phosphoribosyltransferase+by+pyridine+nucleotides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi00759a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00759a025%26sid%3Dliteratum%253Aachs%26aulast%3DDietrich%26aufirst%3DL.%2BS.%26aulast%3DMuniz%26aufirst%3DO.%26atitle%3DInhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520by%2520pyridine%2520nucleotides%26jtitle%3DBiochemistry%26date%3D1972%26volume%3D11%26spage%3D1691%26epage%3D1695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Biedermann, E.; Hasmann, M.; Loser, R.; Rattel, B.; Reiter, F.; Schein, B.; Seibel, K.; Vogt, K.</span><span> </span><span class="NLM_article-title">Preparation and Formulation of Pyridine Derivatives as Antitumor Agents and Immunosuppressants</span>. WO9748397A1,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=E.+Biedermann&author=M.+Hasmann&author=R.+Loser&author=B.+Rattel&author=F.+Reiter&author=B.+Schein&author=K.+Seibel&author=K.+Vogt&title=Preparation+and+Formulation+of+Pyridine+Derivatives+as+Antitumor+Agents+and+Immunosuppressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiedermann%26aufirst%3DE.%26atitle%3DPreparation%2520and%2520Formulation%2520of%2520Pyridine%2520Derivatives%2520as%2520Antitumor%2520Agents%2520and%2520Immunosuppressants%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wosikowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemainda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loser, R.</span><span> </span><span class="NLM_article-title">WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">â</span> <span class="NLM_lpage">1062</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=1057-1062&author=K.+Wosikowskiauthor=K.+Matternauthor=I.+Schemaindaauthor=M.+Hasmannauthor=B.+Rattelauthor=R.+Loser&title=WK175%2C+a+novel+antitumor+agent%2C+decreases+the+intracellular+nicotinamide+adenine+dinucleotide+concentration+and+induces+the+apoptotic+cascade+in+human+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWosikowski%26aufirst%3DK.%26aulast%3DMattern%26aufirst%3DK.%26aulast%3DSchemainda%26aufirst%3DI.%26aulast%3DHasmann%26aufirst%3DM.%26aulast%3DRattel%26aufirst%3DB.%26aulast%3DLoser%26aufirst%3DR.%26atitle%3DWK175%252C%2520a%2520novel%2520antitumor%2520agent%252C%2520decreases%2520the%2520intracellular%2520nicotinamide%2520adenine%2520dinucleotide%2520concentration%2520and%2520induces%2520the%2520apoptotic%2520cascade%2520in%2520human%2520leukemia%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D1057%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hasmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemainda, I.</span><span> </span><span class="NLM_article-title">FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7436</span><span class="NLM_x">â</span> <span class="NLM_lpage">7442</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=14612543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVGltb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7436-7442&author=M.+Hasmannauthor=I.+Schemainda&title=FK866%2C+a+highly+specific+noncompetitive+inhibitor+of+nicotinamide+phosphoribosyltransferase%2C+represents+a+novel+mechanism+for+induction+of+tumor+cell+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36cR"><div class="casContent"><span class="casTitleNuber">36c</span><div class="casTitle"><span class="NLM_cas:atitle">FK866, a Highly Specific Noncompetitive Inhibitor of Nicotinamide Phosphoribosyltransferase, Represents a Novel Mechanism for Induction of Tumor Cell Apoptosis</span></div><div class="casAuthors">Hasmann, Max; Schemainda, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7436-7442</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Deregulation of apoptosis, the physiol. form of cell death, is closely assocd. with immunol. diseases and cancer.  Apoptosis is activated either by death receptor-driven or mitochondrial pathways, both of which may provide potential targets for novel anticancer drugs.  Although several ligands stimulating death receptors have been described, the actual mol. events triggering the mitochondrial pathway are largely unknown.  Here, we show initiation of apoptosis by gradual depletion of the intracellular coenzyme NAD+.  We identified the first low mol. wt. compd., designated FK866, which induces apoptosis by highly specific, noncompetitive inhibition of nicotinamide phosphoribosyltransferase (NAPRT), a key enzyme in the regulation of NAD+ biosynthesis from the natural precursor nicotinamide.  Interference with this enzyme does not primarily intoxicate cells because the mitochondrial respiratory activity and the NAD+-dependent redox reactions involved remain unaffected as long as NAD+ is not effectively depleted by catabolic reactions.  Certain tissues, however, have a high turnover of NAD+ through its cleavage by enzymes like poly(ADP-ribose) polymerase.  Such cells often rely on the more readily available nicotinamide pathway for NAD+ synthesis and undergo apoptosis after inhibition of NAPRT, whereas cells effectively using the nicotinic acid pathway for NAD+ synthesis remain unaffected.  In support of this concept, FK866 effectively induced delayed cell death by apoptosis in HepG2 human liver carcinoma cells with an IC50 of â¼1 nM, did not directly inhibit mitochondrial respiratory activity, but caused gradual NAD+ depletion through specific inhibition of NAPRT.  This enzyme, when partially purified from K562 human leukemia cells, was noncompetitively inhibited by FK866, and the inhibitor consts. were calcd. to be 0.4 nM for the enzyme/substrate complex (Ki) and 0.3 nM for the free enzyme (Ki'), resp.  Nicotinic acid and nicotinamide were both found to have antidote potential for the cellular effects of FK866.  FK866 may be used for treatment of diseases implicating deregulated apoptosis such as cancer for immunosuppression or as a sensitizer for genotoxic agents.  Furthermore, it may provide an important tool for investigation of the mol. triggers of the mitochondrial pathway leading to apoptosis through enabling temporal sepn. of NAD+ decrease from ATP breakdown and apoptosis by several days.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAOS3LOADp6LVg90H21EOLACvtfcHk0liKtjkgS2Qu8A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVGltb4%253D&md5=c67fd08fdfc233ba86478967b13d19a2</span></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHasmann%26aufirst%3DM.%26aulast%3DSchemainda%26aufirst%3DI.%26atitle%3DFK866%252C%2520a%2520highly%2520specific%2520noncompetitive%2520inhibitor%2520of%2520nicotinamide%2520phosphoribosyltransferase%252C%2520represents%2520a%2520novel%2520mechanism%2520for%2520induction%2520of%2520tumor%2520cell%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7436%26epage%3D7442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Khan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span> </span><span class="NLM_article-title">Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">582</span><span class="NLM_x">â</span> <span class="NLM_lpage">588</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1038%2Fnsmb1105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=16783377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1elt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=582-588&author=J.+A.+Khanauthor=X.+Taoauthor=L.+Tong&title=Molecular+basis+for+the+inhibition+of+human+NMPRTase%2C+a+novel+target+for+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents</span></div><div class="casAuthors">Khan, Javed A.; Tao, Xiao; Tong, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">582-588</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NMPRTase) has a crucial role in the salvage pathway of NAD+ biosynthesis, and a potent inhibitor of NMPRTase, FK866, can reduce cellular NAD+ levels and induce apoptosis in tumors.  The authors have detd. the crystal structures at up to 2.1-Ã resoln. of human and murine NMPRTase, alone and in complex with the reaction product NMN or the inhibitor FK866.  The structures suggest that Asp219 is a determinant of substrate specificity of NMPRTase, which is confirmed by our mutagenesis studies.  FK866 is bound in a tunnel at the interface of the NMPRTase dimer, and mutations in this binding site can abolish the inhibition by FK866.  Contrary to current knowledge, the structures show that FK866 should compete directly with the nicotinamide substrate.  Our structural and biochem. studies provide a starting point for the development of new anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1s-XY1uB70LVg90H21EOLACvtfcHk0liKtjkgS2Qu8A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1elt7k%253D&md5=debef567dbcf629422472ef1b63dc396</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1105%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DTong%26aufirst%3DL.%26atitle%3DMolecular%2520basis%2520for%2520the%2520inhibition%2520of%2520human%2520NMPRTase%252C%2520a%2520novel%2520target%2520for%2520anticancer%2520agents%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D582%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Olesen, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaattela, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, S. J.</span><span> </span><span class="NLM_article-title">Anticancer agent CHS-828 inhibits cellular synthesis of NAD</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">â</span> <span class="NLM_lpage">804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2008&pages=799-804&author=U.+H.+Olesenauthor=M.+K.+Christensenauthor=F.+Bjorklingauthor=M.+Jaattelaauthor=P.+B.+Jensenauthor=M.+Sehestedauthor=S.+J.+Nielsen&title=Anticancer+agent+CHS-828+inhibits+cellular+synthesis+of+NAD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DU.%2BH.%26aulast%3DChristensen%26aufirst%3DM.%2BK.%26aulast%3DBjorkling%26aufirst%3DF.%26aulast%3DJaattela%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DSehested%26aufirst%3DM.%26aulast%3DNielsen%26aufirst%3DS.%2BJ.%26atitle%3DAnticancer%2520agent%2520CHS-828%2520inhibits%2520cellular%2520synthesis%2520of%2520NAD%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D367%26spage%3D799%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Burgos, E. S.</span><span> </span><span class="NLM_article-title">NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1947</span><span class="NLM_x">â</span> <span class="NLM_lpage">1961</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.2174%2F092986711795590101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=21517777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFehurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1947-1961&author=E.+S.+Burgos&title=NAMPT+in+regulated+NAD+biosynthesis+and+its+pivotal+role+in+human+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism</span></div><div class="casAuthors">Burgos, E. S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1947-1961</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the first reversible step in NAD biosynthesis and nicotinamide (NAM) salvage.  The enzyme is designed for efficient capture of nicotinamide by coupling of ATP hydrolysis to assist in extraordinary NAM binding affinity and formation of NMN (NMN).  NAMPT provides the mechanism to replenish the NAD pool in human metab.  In addn. to its role in redox biochem., NAD fuels the sirtuins (SIRTs) to regulate transcription factors involved in pathways linked to inflammation, diabetes and lifespan.  NAMPT-mediated lifespan expansion has caused a focus on the catalytic mechanism, regulation and inhibition of NAMPT.  Structural, mechanistic and inhibitor design all contribute to a developing but yet incomplete story of NAMPT function.  Although the first generation of NAMPT inhibitors has entered clin. trials, disappointing outcomes suggest more powerful and specific inhibitors will be needed.  Understanding the ATP-linked mechanism of NAMPT and the catalytic site machinery may permit the design of improved NAMPT inhibitors as more efficient drugs against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9tpSE0yYDVbVg90H21EOLACvtfcHk0li9rCSzI4HY5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFehurs%253D&md5=cfbd0c1d081468ef98d43c667714e91d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F092986711795590101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795590101%26sid%3Dliteratum%253Aachs%26aulast%3DBurgos%26aufirst%3DE.%2BS.%26atitle%3DNAMPT%2520in%2520regulated%2520NAD%2520biosynthesis%2520and%2520its%2520pivotal%2520role%2520in%2520human%2520metabolism%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1947%26epage%3D1961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Watson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belec, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billot, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratton, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khadir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavoie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawless, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcotte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauparlant, P.</span><span> </span><span class="NLM_article-title">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5872</span><span class="NLM_x">â</span> <span class="NLM_lpage">5888</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1128%2FMCB.00112-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=19703994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=5872-5888&author=M.+Watsonauthor=A.+Roulstonauthor=L.+Belecauthor=X.+Billotauthor=R.+Marcellusauthor=D.+Bedardauthor=C.+Bernierauthor=S.+Branchaudauthor=H.+Chanauthor=K.+Dairiauthor=K.+Gilbertauthor=D.+Gouletauthor=M.+O.+Grattonauthor=H.+Isakauauthor=A.+Jangauthor=A.+Khadirauthor=E.+Kochauthor=M.+Lavoieauthor=M.+Lawlessauthor=M.+Nguyenauthor=D.+Paquetteauthor=E.+Turcotteauthor=A.+Bergerauthor=M.+Mitchellauthor=G.+C.+Shoreauthor=P.+Beauparlant&title=The+small+molecule+GMX1778+is+a+potent+inhibitor+of+NAD%2B+biosynthesis%3A+strategy+for+enhanced+therapy+in+nicotinic+acid+phosphoribosyltransferase+1-deficient+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span></div><div class="casAuthors">Watson, Mark; Roulston, Anne; Belec, Laurent; Billot, Xavier; Marcellus, Richard; Bedard, Dominique; Bernier, Cynthia; Branchaud, Stephane; Chan, Helen; Dairi, Kenza; Gilbert, Karine; Goulet, Daniel; Gratton, Michel-Olivier; Isakau, Henady; Jang, Anne; Khadir, Abdelkrim; Koch, Elizabeth; Lavoie, Manon; Lawless, Michael; Nguyen, Mai; Paquette, Denis; Turcotte, Emilie; Berger, Alvin; Mitchell, Matthew; Shore, Gordon C.; Beauparlant, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5872-5888</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">GMX1777 is a prodrug of the small mol. GMX1778, currently in phase I clin. trials for the treatment of cancer.  We describe findings indicating that GMX1778 is a potent and specific inhibitor of the NAD+ biosynthesis enzyme nicotinamide phosphoribosyltransferase (NAMPT).  Cancer cells have a very high rate of NAD+ turnover, which makes NAD+ modulation an attractive target for anticancer therapy.  Selective inhibition by GMX1778 of NAMPT blocks the prodn. of NAD+ and results in tumor cell death.  Furthermore, GMX1778 is phosphoribosylated by NAMPT, which increases its cellular retention.  The cytotoxicity of GMX1778 can be bypassed with exogenous nicotinic acid (NA), which permits NAD+ repletion via NA phosphoribosyltransferase 1 (NAPRT1).  The cytotoxicity of GMX1778 in cells with NAPRT1 deficiency, however, cannot be rescued by NA.  Analyses of NAPRT1 mRNA and protein levels in cell lines and primary tumor tissue indicate that high frequencies of glioblastomas, neuroblastomas, and sarcomas are deficient in NAPRT1 and not susceptible to rescue with NA.  As a result, the therapeutic index of GMX1777 can be widended in the treatment animals bearing NAPRT1-deficient tumors by coadministration with NA.  This provides the rationale for a novel therapeutic approach for the use of GMX1777 in the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT7TUeIRTTIrVg90H21EOLACvtfcHk0li9rCSzI4HY5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE&md5=a6157117d7e67368954ff5ae11986879</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FMCB.00112-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00112-09%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DM.%26aulast%3DRoulston%26aufirst%3DA.%26aulast%3DBelec%26aufirst%3DL.%26aulast%3DBillot%26aufirst%3DX.%26aulast%3DMarcellus%26aufirst%3DR.%26aulast%3DBedard%26aufirst%3DD.%26aulast%3DBernier%26aufirst%3DC.%26aulast%3DBranchaud%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DDairi%26aufirst%3DK.%26aulast%3DGilbert%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DD.%26aulast%3DGratton%26aufirst%3DM.%2BO.%26aulast%3DIsakau%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DA.%26aulast%3DKhadir%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DE.%26aulast%3DLavoie%26aufirst%3DM.%26aulast%3DLawless%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DPaquette%26aufirst%3DD.%26aulast%3DTurcotte%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DMitchell%26aufirst%3DM.%26aulast%3DShore%26aufirst%3DG.%2BC.%26aulast%3DBeauparlant%26aufirst%3DP.%26atitle%3DThe%2520small%2520molecule%2520GMX1778%2520is%2520a%2520potent%2520inhibitor%2520of%2520NAD%252B%2520biosynthesis%253A%2520strategy%2520for%2520enhanced%2520therapy%2520in%2520nicotinic%2520acid%2520phosphoribosyltransferase%25201-deficient%2520tumors%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D5872%26epage%3D5888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Cea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnetta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulciniti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roccaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calimeri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubikova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">3519</span><span class="NLM_x">â</span> <span class="NLM_lpage">3529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=3519-3529&author=M.+Ceaauthor=A.+Cagnettaauthor=M.+Fulcinitiauthor=Y.+T.+Taiauthor=T.+Hideshimaauthor=D.+Chauhanauthor=A.+Roccaroauthor=A.+Saccoauthor=T.+Calimeriauthor=F.+Cottiniauthor=J.+Jakubikovaauthor=S.+Y.+Kongauthor=F.+Patroneauthor=A.+Nencioniauthor=M.+Gobbiauthor=P.+Richardsonauthor=N.+Munshiauthor=K.+C.+Anderson&title=Targeting+NAD%2B+salvage+pathway+induces+autophagy+in+multiple+myeloma+cells+via+mTORC1+and+extracellular+signal-regulated+kinase+%28ERK1%2F2%29+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCea%26aufirst%3DM.%26aulast%3DCagnetta%26aufirst%3DA.%26aulast%3DFulciniti%26aufirst%3DM.%26aulast%3DTai%26aufirst%3DY.%2BT.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DRoccaro%26aufirst%3DA.%26aulast%3DSacco%26aufirst%3DA.%26aulast%3DCalimeri%26aufirst%3DT.%26aulast%3DCottini%26aufirst%3DF.%26aulast%3DJakubikova%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DS.%2BY.%26aulast%3DPatrone%26aufirst%3DF.%26aulast%3DNencioni%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DTargeting%2520NAD%252B%2520salvage%2520pathway%2520induces%2520autophagy%2520in%2520multiple%2520myeloma%2520cells%2520via%2520mTORC1%2520and%2520extracellular%2520signal-regulated%2520kinase%2520%2528ERK1%252F2%2529%2520inhibition%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D3519%26epage%3D3529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Billington, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condorelli, F.</span><span> </span><span class="NLM_article-title">NAD depletion by FK866 induces autophagy</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">â</span> <span class="NLM_lpage">387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=385-387&author=R.+A.+Billingtonauthor=A.+A.+Genazzaniauthor=C.+Travelliauthor=F.+Condorelli&title=NAD+depletion+by+FK866+induces+autophagy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBillington%26aufirst%3DR.%2BA.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DTravelli%26aufirst%3DC.%26aulast%3DCondorelli%26aufirst%3DF.%26atitle%3DNAD%2520depletion%2520by%2520FK866%2520induces%2520autophagy%26jtitle%3DAutophagy%26date%3D2008%26volume%3D4%26spage%3D385%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnetta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Intracellular NAD (+) depletion induces autophagic death in multiple myeloma cells</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">3</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=1-3&author=M.+Ceaauthor=A.+Cagnettaauthor=F.+Patroneauthor=A.+Nencioniauthor=M.+Gobbiauthor=K.+C.+Anderson&title=Intracellular+NAD+%28%2B%29+depletion+induces+autophagic+death+in+multiple+myeloma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCea%26aufirst%3DM.%26aulast%3DCagnetta%26aufirst%3DA.%26aulast%3DPatrone%26aufirst%3DF.%26aulast%3DNencioni%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DIntracellular%2520NAD%2520%2528%252B%2529%2520depletion%2520induces%2520autophagic%2520death%2520in%2520multiple%2520myeloma%2520cells%26jtitle%3DAutophagy%26date%3D2013%26volume%3D9%26spage%3D1%26epage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bruzzone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruscione, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morando, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garuti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DâUrso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selmo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benvenuto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoppoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballestrero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sordat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mostoslavsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uccelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencioni, A.</span><span> </span><span class="NLM_article-title">Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e7897</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7897&author=S.+Bruzzoneauthor=F.+Fruscioneauthor=S.+Morandoauthor=T.+Ferrandoauthor=A.+Poggiauthor=A.+Garutiauthor=A.+D%E2%80%99Ursoauthor=M.+Selmoauthor=F.+Benvenutoauthor=M.+Ceaauthor=G.+Zoppoliauthor=E.+Moranauthor=D.+Sonciniauthor=A.+Ballestreroauthor=B.+Sordatauthor=F.+Patroneauthor=R.+Mostoslavskyauthor=A.+Uccelliauthor=A.+Nencioni&title=Catastrophic+NAD%2B+depletion+in+activated+T+lymphocytes+through+Nampt+inhibition+reduces+demyelination+and+disability+in+EAE"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBruzzone%26aufirst%3DS.%26aulast%3DFruscione%26aufirst%3DF.%26aulast%3DMorando%26aufirst%3DS.%26aulast%3DFerrando%26aufirst%3DT.%26aulast%3DPoggi%26aufirst%3DA.%26aulast%3DGaruti%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Urso%26aufirst%3DA.%26aulast%3DSelmo%26aufirst%3DM.%26aulast%3DBenvenuto%26aufirst%3DF.%26aulast%3DCea%26aufirst%3DM.%26aulast%3DZoppoli%26aufirst%3DG.%26aulast%3DMoran%26aufirst%3DE.%26aulast%3DSoncini%26aufirst%3DD.%26aulast%3DBallestrero%26aufirst%3DA.%26aulast%3DSordat%26aufirst%3DB.%26aulast%3DPatrone%26aufirst%3DF.%26aulast%3DMostoslavsky%26aufirst%3DR.%26aulast%3DUccelli%26aufirst%3DA.%26aulast%3DNencioni%26aufirst%3DA.%26atitle%3DCatastrophic%2520NAD%252B%2520depletion%2520in%2520activated%2520T%2520lymphocytes%2520through%2520Nampt%2520inhibition%2520reduces%2520demyelination%2520and%2520disability%2520in%2520EAE%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De7897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit43b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Travelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drago, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaludercic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldorini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Lisa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonico, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span> </span><span class="NLM_article-title">Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">â</span> <span class="NLM_lpage">840</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1124%2Fjpet.111.184630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaktLjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=829-840&author=C.+Travelliauthor=V.+Dragoauthor=E.+Maldiauthor=N.+Kaludercicauthor=U.+Galliauthor=R.+Boldoriniauthor=F.+Di+Lisaauthor=G.+C.+Tronauthor=P.+L.+Canonicoauthor=A.+A.+Genazzani&title=Reciprocal+potentiation+of+the+antitumoral+activities+of+FK866%2C+an+inhibitor+of+nicotinamide+phosphoribosyltransferase%2C+and+etoposide+or+cisplatin+in+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43bR"><div class="casContent"><span class="casTitleNuber">43b</span><div class="casTitle"><span class="NLM_cas:atitle">Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells</span></div><div class="casAuthors">Travelli, Cristina; Drago, Valentina; Maldi, Elena; Kaludercic, Nina; Galli, Ubaldina; Boldorini, Renzo; Di Lisa, Fabio; Tron, Gian Cesare; Canonico, Pier Luigi; Genazzani, Armando A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">829-840</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">NAD is an essential coenzyme involved in numerous metabolic pathways.  Its principal role is in redox reactions, and as such it is not heavily "consumed" by cells.  Yet a no. of signaling pathways that bring about its consumption have recently emerged.  This has brought about the hypothesis that the enzymes that lead to its biosynthesis may be targets for anticancer therapy.  In particular, inhibition of the enzyme nicotinamide phosphoribosyl transferase has been shown to be an effective treatment in a no. of preclin. studies, and two lead mols. [N-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2E-propenamide (FK866) and (E)-1-[6-(4-chlorophenoxy)hexyl]-2-cyano-3-(pyridin-4-yl)guanidine (CHS 828)] have now entered preclin. trials.  Yet, the full potential of these drugs is still unclear.  In the present study we have investigated the role of FK866 in neuroblastoma cell lines.  We now confirm that FK866 alone in neuroblastoma cells induces autophagy, and its effects are potentiated by chloroquine and antagonized by 3-methyladenine or by down-regulating autophagy-related protein 7.  Autophagy, in this model, seems to be crucial for FK866-induced cell death.  On the other hand, a striking potentiation of the effects of cisplatin and etoposide is given by cotreatment of cells with ineffective concns. of FK866 (1 nM).  The effect of etoposide on DNA damage is potentiated by FK866 treatment, whereas the effect of FK866 on cytosolic NAD depletion is potentiated by etoposide.  Even more strikingly, cotreatment with etoposide/cisplatin and FK866 unmasks an effect on mitochondrial NAD depletion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo66wjnRQYbE7Vg90H21EOLACvtfcHk0lhSkPPFAAWC0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaktLjI&md5=62a97a2e2fa748dba251128b93723a81</span></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.184630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.184630%26sid%3Dliteratum%253Aachs%26aulast%3DTravelli%26aufirst%3DC.%26aulast%3DDrago%26aufirst%3DV.%26aulast%3DMaldi%26aufirst%3DE.%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DGalli%26aufirst%3DU.%26aulast%3DBoldorini%26aufirst%3DR.%26aulast%3DDi%2BLisa%26aufirst%3DF.%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26atitle%3DReciprocal%2520potentiation%2520of%2520the%2520antitumoral%2520activities%2520of%2520FK866%252C%2520an%2520inhibitor%2520of%2520nicotinamide%2520phosphoribosyltransferase%252C%2520and%2520etoposide%2520or%2520cisplatin%2520in%2520neuroblastoma%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D338%26spage%3D829%26epage%3D840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. D.</span><span> </span><span class="NLM_article-title">A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity</span> <span class="citation_source-journal">Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">â</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1258%2Febm.2010.010001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslSnt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=2010&pages=869-876&author=H.+J.+Yangauthor=M.+C.+Yenauthor=C.+C.+Linauthor=C.+M.+Linauthor=Y.+L.+Chenauthor=T.+Y.+Wengauthor=T.+T.+Huangauthor=C.+L.+Wuauthor=M.+D.+Lai&title=A+combination+of+the+metabolic+enzyme+inhibitor+APO866+and+the+immune+adjuvant+L-1-methyl+tryptophan+induces+additive+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44aR"><div class="casContent"><span class="casTitleNuber">44a</span><div class="casTitle"><span class="NLM_cas:atitle">A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity</span></div><div class="casAuthors">Yang, Huei-Jiun; Yen, Meng-Chi; Lin, Chi-Chen; Lin, Chiu-Mei; Chen, Yi-Ling; Weng, Tzu-Yang; Huang, Tzu-Ting; Wu, Chao-Liang; Lai, Ming-Derg</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">869-876</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Medicine Press Ltd.</span>)
        </div><div class="casAbstract">Many types of malignant cells have a higher NAD (NAD) turnover rate than normal cells, as well as the ability to escape immune responses.  Indoleamine 2,3-dioxygenase (IDO) is reported to be a neg. immune regulator.  Overexpression of IDO in dendritic cells is obsd. in tumor-draining lymph nodes.  IDO-expressing dendritic cells suppress T-cell activation and promote immune tolerance.  The nicotinamide phosphoribosyl transferase (NAMPT) inhibitor APO866 (also called FK866 or WK175) selectively inhibits tumor growth through intracellular NAD depletion.  The IDO-specific inhibitor L-1-methyl-tryptophan (L-1MT) activates immune responses and reduces tumor vol. in murine tumor models.  We combined L-1MT and APO866 treatments and tested their antitumor effects in the murine gastric and bladder tumor models.  In immune-competent mice, a combination of APO866 and L-1MT had a better therapeutic effect than did either L-1MT or APO866 alone.  The intracellular level of NAD was suppressed by APO866 but not L-1MT.  However, an additive inhibitory effect on tumor growth was not obsd. in tumor-bearing immune-deficient mice.  The new strategy of combining a metabolic inhibitor and an immune adjuvant induced a potent therapeutic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZFPY0uzNVZrVg90H21EOLACvtfcHk0lhSkPPFAAWC0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslSnt7o%253D&md5=0b1e98f3c5af5014574fe9a1a3569bd6</span></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=10.1258%2Febm.2010.010001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252Febm.2010.010001%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%2BJ.%26aulast%3DYen%26aufirst%3DM.%2BC.%26aulast%3DLin%26aufirst%3DC.%2BC.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DWeng%26aufirst%3DT.%2BY.%26aulast%3DHuang%26aufirst%3DT.%2BT.%26aulast%3DWu%26aufirst%3DC.%2BL.%26aulast%3DLai%26aufirst%3DM.%2BD.%26atitle%3DA%2520combination%2520of%2520the%2520metabolic%2520enzyme%2520inhibitor%2520APO866%2520and%2520the%2520immune%2520adjuvant%2520L-1-methyl%2520tryptophan%2520induces%2520additive%2520antitumor%2520activity%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D2010%26volume%3D235%26spage%3D869%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit44b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bajrami, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kigozi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Weverwijk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1087</span><span class="NLM_x">â</span> <span class="NLM_lpage">1096</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1002%2Femmm.201201250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44b&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=22933245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVeiur7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1087-1096&author=I.+Bajramiauthor=A.+Kigoziauthor=A.+Van+Weverwijkauthor=R.+Broughauthor=J.+Frankumauthor=C.+J.+Lordauthor=A.+Ashworth&title=Synthetic+lethality+of+PARP+and+NAMPT+inhibition+in+triple-negative+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44bR"><div class="casContent"><span class="casTitleNuber">44b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells</span></div><div class="casAuthors">Bajrami, Ilirjana; Kigozi, Asha; Van Weverwijk, Antoinette; Brough, Rachel; Frankum, Jessica; Lord, Christopher J.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1087-1096</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">PARP inhibitors have been proposed as a potential targeted therapy for patients with triple-neg. (ER-, PR-, HER2-neg.) breast cancers.  However, it is as yet unclear as to whether single agent or combination therapy using PARP inhibitors would be most beneficial.  To better understand the mechanisms that det. the response to PARP inhibitors, we investigated whether enzymes involved in metab. of the PARP substrate, Î²-NAD+, might alter the response to a clin. PARP inhibitor.  Using an olaparib sensitization screen in a triple-neg. (TN) breast cancer model, we identified nicotinamide phosphoribosyltransferase (NAMPT) as a non-redundant modifier of olaparib response.  NAMPT is a rate-limiting enzyme involved in the generation of the PARP substrate Î²-NAD+ and the suppression of Î²-NAD+ levels by NAMPT inhibition most likely explains these observations.  Importantly, the combination of a NAMPT small mol. inhibitor, FK866, with olaparib inhibited TN breast tumor growth in vivo to a greater extent than either single agent alone suggesting that assessing NAMPT/PARP inhibitor combinations for the treatment of TN breast cancer may be warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDlMhMk2Q7WbVg90H21EOLACvtfcHk0liaMCYTz7u3sg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVeiur7M&md5=c97061b1a3505cce8230352f5bb9f07e</span></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=10.1002%2Femmm.201201250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201201250%26sid%3Dliteratum%253Aachs%26aulast%3DBajrami%26aufirst%3DI.%26aulast%3DKigozi%26aufirst%3DA.%26aulast%3DVan%2BWeverwijk%26aufirst%3DA.%26aulast%3DBrough%26aufirst%3DR.%26aulast%3DFrankum%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DSynthetic%2520lethality%2520of%2520PARP%2520and%2520NAMPT%2520inhibition%2520in%2520triple-negative%2520breast%2520cancer%2520cells%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D1087%26epage%3D1096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit44c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Okumura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsaki, Y.</span><span> </span><span class="NLM_article-title">Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation</span> <span class="citation_source-journal">J. Thorac. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44c&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1097%2FJTO.0b013e318233d686" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44c&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFGqu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=49-56&author=S.+Okumuraauthor=T.+Sasakiauthor=Y.+Minamiauthor=Y.+Ohsaki&title=Nicotinamide+phosphoribosyltransferase%3A+a+potent+therapeutic+target+in+non-small+cell+lung+cancer+with+epidermal+growth+factor+receptor-gene+mutation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44cR"><div class="casContent"><span class="casTitleNuber">44c</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation</span></div><div class="casAuthors">Okumura, Shunsuke; Sasaki, Takaaki; Minami, Yoshinori; Ohsaki, Yoshinobu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thoracic Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">JTOOB7</span>;
        ISSN:<span class="NLM_cas:issn">1556-0864</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background: Non-small cell lung cancer (NSCLC) often has an epidermal growth factor receptor (EGFR) gene mutation.  Growth of EGFR-gene-mutated NSCLC depends predominantly on EGFR signaling and requires a large amt. of intracellular ATP to activate EGFR signal transduction.  Nicotinamide phosphoribosyltransferase (NAMPT) is a rate-limiting enzyme in NAD biosynthesis, and it regulates intracellular ATP levels in mammalian cells.  The effect of NAMPT inhibition on NSCLC has not been completely understood.  Methods: We aimed to clarify the hypothesis that NAMPT inhibition suppresses growth of EGFR-gene-mutated NSCLC through redn. of intracellular ATP levels, using NAMPT-siRNA transfection and NAMPT inhibitor FK866.  We used four lung adenocarcinoma cell lines, including H358 (Wild type EGFR), LC2 (EGFRL858R), PC9 (EGFRDel E746-A750), and H1975 (EGFRL858R+T790M), and evaluated the effect of FK866 on these cells and its mechanisms, using cell proliferation, Western blot, ATP, and apoptosis assay.  Results: We found that (1) H358, LC2, and H1975 cell lines highly expressed NAMPT-mRNA; (2) NAMPT-specific siRNA and FK866 suppressed proliferation of these NSCLCs; (3) FK866 reduced intracellular ATP levels in H1975 cells; (4) FK866 dephosphorylated EGFR signal proteins, including EGFR, Akt, Map kinase kinase 1/2, and extracellular signal-regulated kinase 1/2 (ERK 1/2); (5) FK866 induced apoptosis of H1975 cells; and (6) FK866 suppressed growth of H1975 xenograft tumors and attenuated expression of phospho-ERK 1/2 in the tumors in a tumor-bearing mouse model.  Conclusion: These findings indicate that NAMPT is a potent therapeutic target in the treatment of EGFR-gene-mutated NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXgZLJx_HCaLVg90H21EOLACvtfcHk0liaMCYTz7u3sg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFGqu7s%253D&md5=8c8388659fb8d06aeb0420b3dc4cc775</span></div><a href="/servlet/linkout?suffix=cit44c&amp;dbid=16384&amp;doi=10.1097%2FJTO.0b013e318233d686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJTO.0b013e318233d686%26sid%3Dliteratum%253Aachs%26aulast%3DOkumura%26aufirst%3DS.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DMinami%26aufirst%3DY.%26aulast%3DOhsaki%26aufirst%3DY.%26atitle%3DNicotinamide%2520phosphoribosyltransferase%253A%2520a%2520potent%2520therapeutic%2520target%2520in%2520non-small%2520cell%2520lung%2520cancer%2520with%2520epidermal%2520growth%2520factor%2520receptor-gene%2520mutation%26jtitle%3DJ.%2520Thorac.%2520Oncol.%26date%3D2012%26volume%3D7%26spage%3D49%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit44d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Munk Jensen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnbeck, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzorek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hojgaard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kjaer, A.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]FLT and [<sup>18</sup>F]FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenografts</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e53410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e53410&author=M.+Munk+Jensenauthor=K.+D.+Erichsenauthor=C.+B.+Johnbeckauthor=F.+Bjorklingauthor=J.+Madsenauthor=M.+Bzorekauthor=P.+B.+Jensenauthor=L.+Hojgaardauthor=M.+Sehestedauthor=A.+Kjaer&title=%5B18F%5DFLT+and+%5B18F%5DFDG+PET+for+non-invasive+treatment+monitoring+of+the+nicotinamide+phosphoribosyltransferase+inhibitor+APO866+in+human+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMunk%2BJensen%26aufirst%3DM.%26aulast%3DErichsen%26aufirst%3DK.%2BD.%26aulast%3DJohnbeck%26aufirst%3DC.%2BB.%26aulast%3DBjorkling%26aufirst%3DF.%26aulast%3DMadsen%26aufirst%3DJ.%26aulast%3DBzorek%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DHojgaard%26aufirst%3DL.%26aulast%3DSehested%26aufirst%3DM.%26aulast%3DKjaer%26aufirst%3DA.%26atitle%3D%255B18F%255DFLT%2520and%2520%255B18F%255DFDG%2520PET%2520for%2520non-invasive%2520treatment%2520monitoring%2520of%2520the%2520nicotinamide%2520phosphoribosyltransferase%2520inhibitor%2520APO866%2520in%2520human%2520xenografts%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De53410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lee, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, M. N.</span><span> </span><span class="NLM_article-title">Pre-B-cell colony-enhancing factor and its clinical correlates with acute lung injury and sepsis</span> <span class="citation_source-journal">Chest</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">â</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2011&pages=382-390&author=K.+A.+Leeauthor=M.+N.+Gong&title=Pre-B-cell+colony-enhancing+factor+and+its+clinical+correlates+with+acute+lung+injury+and+sepsis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BA.%26aulast%3DGong%26aufirst%3DM.%2BN.%26atitle%3DPre-B-cell%2520colony-enhancing%2520factor%2520and%2520its%2520clinical%2520correlates%2520with%2520acute%2520lung%2520injury%2520and%2520sepsis%26jtitle%3DChest%26date%3D2011%26volume%3D140%26spage%3D382%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit45b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Esposito, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Impellizzeri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fakhfouri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzocrea, S.</span><span> </span><span class="NLM_article-title">The NAMPT inhibitor FK866 reverts the damage in spinal cord injury</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1186%2F1742-2094-9-66" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=22490786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlWjtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=66&author=E.+Espositoauthor=D.+Impellizzeriauthor=E.+Mazzonauthor=G.+Fakhfouriauthor=R.+Rahimianauthor=C.+Travelliauthor=G.+C.+Tronauthor=A.+A.+Genazzaniauthor=S.+Cuzzocrea&title=The+NAMPT+inhibitor+FK866+reverts+the+damage+in+spinal+cord+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45bR"><div class="casContent"><span class="casTitleNuber">45b</span><div class="casTitle"><span class="NLM_cas:atitle">The NAMPT inhibitor FK866 reverts the damage in spinal cord injury</span></div><div class="casAuthors">Esposito, Emanuela; Impellizzeri, Daniela; Mazzon, Emanuela; Fakhfouri, Gohar; Rahimian, Reza; Travelli, Cristina; Tron, Gian Cesare; Genazzani, Armando A.; Cuzzocrea, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Emerging data implicate nicotinamide phosphoribosyl transferase (NAMPT) in the pathogenesis of cancer and inflammation.  NAMPT inhibitors have proven beneficial in inflammatory animal models of arthritis and endotoxic shock as well as in autoimmune encephalitis.  Given the role of inflammatory responses in spinal cord injury (SCI), the effect of NAMPT inhibitors was examd. in this setting.  Methods: We investigated the effects of the NAMPT inhibitor FK866 in an exptl. compression model of SCI.  Results: Twenty-four hr following induction of SCI, a significant functional deficit accompanied widespread edema, demyelination, neuron loss and a substantial increase in TNF-Î±, IL-1Î², PAR, NAMPT, Bax, MPO activity, NF-ÎºB activation, astrogliosis and microglial activation was obsd.  Meanwhile, the expression of neurotrophins BDNF, GDNF, NT3 and anti-apoptotic Bcl-2 decreased significantly.  Treatment with FK866 (10 mg/kg), the best known and characterized NAMPT inhibitor, at 1 h and 6 h after SCI rescued motor function, preserved perilesional gray and white matter, restored anti-apoptotic and neurotrophic factors, prevented the activation of neutrophils, microglia and astrocytes and inhibited the elevation of NAMPT, PAR, TNF-Î±, IL-1Î², Bax expression and NF-ÎºB activity.  We show for the first time that FK866, a specific inhibitor of NAMPT, administered after SCI, is capable of reducing the secondary inflammatory injury and partly reduce permanent damage.  We also show that NAMPT protein levels are increased upon SCI in the perilesional area which can be cor. by administration of FK866.  Conclusions: Our findings suggest that the inflammatory component assocd. to SCI is the primary target of these inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh5Ird8GZC07Vg90H21EOLACvtfcHk0lh1gGmb7T96Uw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlWjtrk%253D&md5=5f87d4adfae52844d3510da4bdfcb608</span></div><a href="/servlet/linkout?suffix=cit45b&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-9-66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-9-66%26sid%3Dliteratum%253Aachs%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DImpellizzeri%26aufirst%3DD.%26aulast%3DMazzon%26aufirst%3DE.%26aulast%3DFakhfouri%26aufirst%3DG.%26aulast%3DRahimian%26aufirst%3DR.%26aulast%3DTravelli%26aufirst%3DC.%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DCuzzocrea%26aufirst%3DS.%26atitle%3DThe%2520NAMPT%2520inhibitor%2520FK866%2520reverts%2520the%2520damage%2520in%2520spinal%2520cord%2520injury%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2012%26volume%3D9%26spage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Schou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottosen, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BjÃ¶rkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjarnaa, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binderup, L.</span><span> </span><span class="NLM_article-title">Novel cyanoguanidines with potent oral antitumour activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3095</span><span class="NLM_x">â</span> <span class="NLM_lpage">3100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=3095-3100&author=C.+Schouauthor=E.+R.+Ottosenauthor=H.+J.+Petersenauthor=F.+Bj%C3%B6rklingauthor=S.+Latiniauthor=P.+V.+Hjarnaaauthor=E.+Brammauthor=L.+Binderup&title=Novel+cyanoguanidines+with+potent+oral+antitumour+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchou%26aufirst%3DC.%26aulast%3DOttosen%26aufirst%3DE.%2BR.%26aulast%3DPetersen%26aufirst%3DH.%2BJ.%26aulast%3DBj%25C3%25B6rkling%26aufirst%3DF.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DHjarnaa%26aufirst%3DP.%2BV.%26aulast%3DBramm%26aufirst%3DE.%26aulast%3DBinderup%26aufirst%3DL.%26atitle%3DNovel%2520cyanoguanidines%2520with%2520potent%2520oral%2520antitumour%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D3095%26epage%3D3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Hjarnaa, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skov, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binderup, L.</span><span> </span><span class="NLM_article-title">CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5751</span><span class="NLM_x">â</span> <span class="NLM_lpage">5757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5751-5757&author=P.+J.+Hjarnaaauthor=E.+Jonssonauthor=S.+Latiniauthor=S.+Dharauthor=R.+Larssonauthor=E.+Brammauthor=T.+Skovauthor=L.+Binderup&title=CHS+828%2C+a+novel+pyridyl+cyanoguanidine+with+potent+antitumor+activity+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHjarnaa%26aufirst%3DP.%2BJ.%26aulast%3DJonsson%26aufirst%3DE.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DBramm%26aufirst%3DE.%26aulast%3DSkov%26aufirst%3DT.%26aulast%3DBinderup%26aufirst%3DL.%26atitle%3DCHS%2520828%252C%2520a%2520novel%2520pyridyl%2520cyanoguanidine%2520with%2520potent%2520antitumor%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D5751%26epage%3D5757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Lovborg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullbo, J.</span><span> </span><span class="NLM_article-title">Structureâactivity relationship analysis of cytotoxic cyanoguanidines: selection of CHS 828 as candidate drug</span> <span class="citation_source-journal">BMC Res. Notes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1186%2F1756-0500-2-114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BD1MvotFersw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=114&author=H.+Lovborgauthor=R.+Burmanauthor=J.+Gullbo&title=Structure%E2%80%93activity+relationship+analysis+of+cytotoxic+cyanoguanidines%3A+selection+of+CHS+828+as+candidate+drug"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship analysis of cytotoxic cyanoguanidines: selection of CHS 828 as candidate drug</span></div><div class="casAuthors">Lovborg Henrik; Burman Robert; Gullbo Joachim</div><div class="citationInfo"><span class="NLM_cas:title">BMC research notes</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  N-(6-(4-chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridyl guanidine) (CHS 828) is the first candidate drug from a novel group of anti-tumour agents - the pyridyl cyanoguanidines, shown to be potent compounds interfering with cellular metabolism (inhibition of nicotinamide phosphoribosyl transferase) and NF-kappaB signalling.  Substituted cyanoguanidines are also found in anti-hypertensive agents such as the potassium channel opener pinacidil (N-cyano-N'-(4-pyridyl)-N''-(1,2,2-trimethylpropyl)guanidine) and histamine-II receptor antagonists (e.g. cimetidine, N-cyano-N'-methyl-N''-[2-[[(5-methylimidazol-4-yl]methyl]thio]ethyl)guanidine).  In animal studies, CHS 828 has shown very promising activity, and phase I and II studies resulted in further development of a with a water soluble prodrug.  FINDINGS:  To study the structural requirements for cyanoguanidine cytotoxicity a set of 19 analogues were synthesized.  The cytotoxic effects were then studied in ten cell lines selected for different origins and mechanisms of resistance, using the fluorometric microculture cytotoxicity assay (FMCA).  The compounds showed varying cytotoxic activity even though the dose-response curves for some analogues were very shallow.  Pinacidil and cimetidine were found to be non-toxic in all ten cell lines.  Starting with cyanoguanidine as the crucial core it was shown that 4-pyridyl substitution was more efficient than was 3-pyridyl substitution.  The 4-pyridyl cyanoguanidine moiety should be linked by an alkyl chain, optimally a hexyl, heptyl or octyl chain, to a bulky end group.  The exact composition of this end group did not seem to be of crucial importance; when the end group was a mono-substituted phenyl ring it was shown that the preferred position was 4-substitution, followed by 3- and, finally, 2-substitution as the least active.  Whether the substituent was a chloro, nitro or methoxy substituent seemed to be of minor importance.  Finally, the activity patterns in the ten cell lines were compared.  Substances with similar structures correlated well, whilst substances with large differences in molecular structure demonstrated lower correlation coefficients.  CONCLUSION:  According to this structure-activity relationship (SAR) study, CHS 828 meets the requirements for optimal cytotoxic activity for this class of compounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRO7KHacRtCzzC850By6mxpfW6udTcc2eYA6aP42pAtHLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvotFersw%253D%253D&md5=a6fbe2d2b3ad093afd3bf0c8dc4668b9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2F1756-0500-2-114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-0500-2-114%26sid%3Dliteratum%253Aachs%26aulast%3DLovborg%26aufirst%3DH.%26aulast%3DBurman%26aufirst%3DR.%26aulast%3DGullbo%26aufirst%3DJ.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520analysis%2520of%2520cytotoxic%2520cyanoguanidines%253A%2520selection%2520of%2520CHS%2520828%2520as%2520candidate%2520drug%26jtitle%3DBMC%2520Res.%2520Notes%26date%3D2009%26volume%3D2%26spage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Chern, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, H. Y.</span><span> </span><span class="NLM_article-title">Synthesis and in vitro cytotoxicity of 5-substituted 2-cyanoimino-4-imidazodinone and 2-cyanoimino-4-pyrimidinone derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1169</span><span class="NLM_x">â</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1169-1172&author=J.+H.+Chernauthor=K.+S.+Shiaauthor=C.+M.+Changauthor=C.+C.+Leeauthor=Y.+C.+Leeauthor=C.+L.+Taiauthor=Y.+T.+Linauthor=C.+S.+Changauthor=H.+Y.+Tseng&title=Synthesis+and+in+vitro+cytotoxicity+of+5-substituted+2-cyanoimino-4-imidazodinone+and+2-cyanoimino-4-pyrimidinone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChern%26aufirst%3DJ.%2BH.%26aulast%3DShia%26aufirst%3DK.%2BS.%26aulast%3DChang%26aufirst%3DC.%2BM.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DTai%26aufirst%3DC.%2BL.%26aulast%3DLin%26aufirst%3DY.%2BT.%26aulast%3DChang%26aufirst%3DC.%2BS.%26aulast%3DTseng%26aufirst%3DH.%2BY.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520cytotoxicity%2520of%25205-substituted%25202-cyanoimino-4-imidazodinone%2520and%25202-cyanoimino-4-pyrimidinone%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1169%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Beauparlant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratton, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavoie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcotte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, M.</span><span> </span><span class="NLM_article-title">Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">â</span> <span class="NLM_lpage">354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=346-354&author=P.+Beauparlantauthor=D.+Bedardauthor=C.+Bernierauthor=H.+Chanauthor=K.+Gilbertauthor=D.+Gouletauthor=M.+O.+Grattonauthor=M.+Lavoieauthor=A.+Roulstonauthor=E.+Turcotteauthor=M.+Watson&title=Preclinical+development+of+the+nicotinamide+phosphoribosyl+transferase+inhibitor+prodrug+GMX1777"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeauparlant%26aufirst%3DP.%26aulast%3DBedard%26aufirst%3DD.%26aulast%3DBernier%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DGilbert%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DD.%26aulast%3DGratton%26aufirst%3DM.%2BO.%26aulast%3DLavoie%26aufirst%3DM.%26aulast%3DRoulston%26aufirst%3DA.%26aulast%3DTurcotte%26aufirst%3DE.%26aulast%3DWatson%26aufirst%3DM.%26atitle%3DPreclinical%2520development%2520of%2520the%2520nicotinamide%2520phosphoribosyl%2520transferase%2520inhibitor%2520prodrug%2520GMX1777%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2009%26volume%3D20%26spage%3D346%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Binderup, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjarnaa, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltzer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binderup, L.</span><span> </span><span class="NLM_article-title">EB1627: a soluble prodrug of the potent anticancer cyanoguanidine CHS828</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2491</span><span class="NLM_x">â</span> <span class="NLM_lpage">2494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2491-2494&author=E.+Binderupauthor=F.+Bjorklingauthor=P.+V.+Hjarnaaauthor=S.+Latiniauthor=B.+Baltzerauthor=M.+Carlsenauthor=L.+Binderup&title=EB1627%3A+a+soluble+prodrug+of+the+potent+anticancer+cyanoguanidine+CHS828"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBinderup%26aufirst%3DE.%26aulast%3DBjorkling%26aufirst%3DF.%26aulast%3DHjarnaa%26aufirst%3DP.%2BV.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DBaltzer%26aufirst%3DB.%26aulast%3DCarlsen%26aufirst%3DM.%26aulast%3DBinderup%26aufirst%3DL.%26atitle%3DEB1627%253A%2520a%2520soluble%2520prodrug%2520of%2520the%2520potent%2520anticancer%2520cyanoguanidine%2520CHS828%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2491%26epage%3D2494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Olesen, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fristrup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thougaard, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span> </span><span class="NLM_article-title">Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=677&author=U.+H.+Olesenauthor=J.+G.+Petersenauthor=A.+Gartenauthor=W.+Kiessauthor=J.+Yoshinoauthor=S.+Imaiauthor=M.+K.+Christensenauthor=P.+Fristrupauthor=A.+V.+Thougaardauthor=F.+Bjorklingauthor=P.+B.+Jensenauthor=S.+J.+Nielsenauthor=M.+Sehested&title=Target+enzyme+mutations+are+the+molecular+basis+for+resistance+towards+pharmacological+inhibition+of+nicotinamide+phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DU.%2BH.%26aulast%3DPetersen%26aufirst%3DJ.%2BG.%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DKiess%26aufirst%3DW.%26aulast%3DYoshino%26aufirst%3DJ.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DChristensen%26aufirst%3DM.%2BK.%26aulast%3DFristrup%26aufirst%3DP.%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DBjorkling%26aufirst%3DF.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DNielsen%26aufirst%3DS.%2BJ.%26aulast%3DSehested%26aufirst%3DM.%26atitle%3DTarget%2520enzyme%2520mutations%2520are%2520the%2520molecular%2520basis%2520for%2520resistance%2520towards%2520pharmacological%2520inhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%26jtitle%3DBMC%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">von Heideman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nygren, P.</span><span> </span><span class="NLM_article-title">Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1165</span><span class="NLM_x">â</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1007%2Fs00280-009-1125-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=19789873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BC3c7ot1ehsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2010&pages=1165-1172&author=A.+von+Heidemanauthor=A.+Berglundauthor=R.+Larssonauthor=P.+Nygren&title=Safety+and+efficacy+of+NAD+depleting+cancer+drugs%3A+results+of+a+phase+I+clinical+trial+of+CHS+828+and+overview+of+published+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data</span></div><div class="casAuthors">von Heideman Anne; Berglund Ake; Larsson Rolf; Nygren Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cancer chemotherapy and pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1165-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Depletion of cellular nicotinamide adenine dinucleotide (NAD) by inhibition of its synthesis is a new pharmacological principle for cancer treatment currently in early phases of clinical development.  We present new and previously published data on the safety and efficacy of these drugs based on early clinical trials.  METHODS:  A phase I clinical trial of CHS 828 in patients with advanced solid tumours was performed.  Published clinical trials on NAD depleting drugs for cancer treatment were summarised for safety and efficacy.  RESULTS:  Seven patients with previously treated solid tumours received oral administration of CHS 828 in the dose range 20-80 mg once weekly for 3 weeks in 4 weeks cycles.  Toxicity was dominated by gastrointestinal symptoms including nausea, vomiting, diarrhoea, constipation, subileus and gastric ulcer.  One patient had thrombocytopenia grade 2.  There were two cases each of grade 3-4 hyperuricemia and hypokalemia.  Safety and efficacy of the NAD depleting drugs CHS 828 and FK866 have been reported from four phase I clinical trials, including a total of 97 patients with previously treated solid tumours.  Outstanding toxicity reported was thrombocytopenia and various gastrointestinal symptoms.  No objective tumour remission has been observed in the total of 104 patients treated in the above early trials.  CONCLUSIONS:  Critical toxicity from NAD depleting cancer drugs to consider in future trials seems to be thrombocytopenia and various gastrointestinal symptoms.  Efficacy of NAD depleting drugs when used alone is expected to be low.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSg0_xmYRnTuDAEfvC7EH1LfW6udTcc2eagHt9qmJOdDLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7ot1ehsA%253D%253D&md5=a6520fe98a1a59f2686a949f919943e5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs00280-009-1125-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-009-1125-3%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BHeideman%26aufirst%3DA.%26aulast%3DBerglund%26aufirst%3DA.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DNygren%26aufirst%3DP.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520NAD%2520depleting%2520cancer%2520drugs%253A%2520results%2520of%2520a%2520phase%2520I%2520clinical%2520trial%2520of%2520CHS%2520828%2520and%2520overview%2520of%2520published%2520data%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2010%26volume%3D65%26spage%3D1165%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Maldi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agazzone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cintura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scatolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miglino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiorino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldorini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span> </span><span class="NLM_article-title">Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions</span> <span class="citation_source-journal">Pigm. Cell Melanoma Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">â</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1111%2Fpcmr.12037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislygsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=144-146&author=E.+Maldiauthor=C.+Travelliauthor=A.+Caldarelliauthor=N.+Agazzoneauthor=S.+Cinturaauthor=U.+Galliauthor=M.+Scatoliniauthor=P.+Ostanoauthor=B.+Miglinoauthor=G.+Chiorinoauthor=R.+Boldoriniauthor=A.+A.+Genazzani&title=Nicotinamide+phosphoribosyltransferase+%28NAMPT%29+is+over-expressed+in+melanoma+lesions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions</span></div><div class="casAuthors">Maldi, Elena; Travelli, Cristina; Caldarelli, Antonio; Agazzone, Nicolo; Cintura, Sara; Galli, Ubaldina; Scatolini, Maria; Ostano, Paola; Miglino, Benedetta; Chiorino, Giovanna; Boldorini, Renzo; Genazzani, Armando A.</div><div class="citationInfo"><span class="NLM_cas:title">Pigment Cell & Melanoma Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">144-146</span>CODEN:
                <span class="NLM_cas:coden">PCMRCM</span>;
        ISSN:<span class="NLM_cas:issn">1755-1471</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaw-bW4I2sr7Vg90H21EOLACvtfcHk0lg9P4o_c5txRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislygsLc%253D&md5=bfb1fd9746b119d2c13287cf10144365</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fpcmr.12037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpcmr.12037%26sid%3Dliteratum%253Aachs%26aulast%3DMaldi%26aufirst%3DE.%26aulast%3DTravelli%26aufirst%3DC.%26aulast%3DCaldarelli%26aufirst%3DA.%26aulast%3DAgazzone%26aufirst%3DN.%26aulast%3DCintura%26aufirst%3DS.%26aulast%3DGalli%26aufirst%3DU.%26aulast%3DScatolini%26aufirst%3DM.%26aulast%3DOstano%26aufirst%3DP.%26aulast%3DMiglino%26aufirst%3DB.%26aulast%3DChiorino%26aufirst%3DG.%26aulast%3DBoldorini%26aufirst%3DR.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26atitle%3DNicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520is%2520over-expressed%2520in%2520melanoma%2520lesions%26jtitle%3DPigm.%2520Cell%2520Melanoma%2520Res.%26date%3D2013%26volume%3D26%26spage%3D144%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Holen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollywood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanauske, A. R.</span><span> </span><span class="NLM_article-title">The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">â</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=45-51&author=K.+Holenauthor=L.+B.+Saltzauthor=E.+Hollywoodauthor=K.+Burkauthor=A.+R.+Hanauske&title=The+pharmacokinetics%2C+toxicities%2C+and+biologic+effects+of+FK866%2C+a+nicotinamide+adenine+dinucleotide+biosynthesis+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolen%26aufirst%3DK.%26aulast%3DSaltz%26aufirst%3DL.%2BB.%26aulast%3DHollywood%26aufirst%3DE.%26aulast%3DBurk%26aufirst%3DK.%26aulast%3DHanauske%26aufirst%3DA.%2BR.%26atitle%3DThe%2520pharmacokinetics%252C%2520toxicities%252C%2520and%2520biologic%2520effects%2520of%2520FK866%252C%2520a%2520nicotinamide%2520adenine%2520dinucleotide%2520biosynthesis%2520inhibitor%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2008%26volume%3D26%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Ravaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerny, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Droz, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumoleau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twelves, C.</span><span> </span><span class="NLM_article-title">Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">â</span> <span class="NLM_lpage">707</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=702-707&author=A.+Ravaudauthor=T.+Cernyauthor=C.+Terretauthor=J.+Wandersauthor=B.+N.+Buiauthor=D.+Hessauthor=J.+P.+Drozauthor=P.+Fumoleauauthor=C.+Twelves&title=Phase+I+study+and+pharmacokinetic+of+CHS-828%2C+a+guanidino-containing+compound%2C+administered+orally+as+a+single+dose+every+3+weeks+in+solid+tumours%3A+an+ECSG%2FEORTC+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavaud%26aufirst%3DA.%26aulast%3DCerny%26aufirst%3DT.%26aulast%3DTerret%26aufirst%3DC.%26aulast%3DWanders%26aufirst%3DJ.%26aulast%3DBui%26aufirst%3DB.%2BN.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DDroz%26aufirst%3DJ.%2BP.%26aulast%3DFumoleau%26aufirst%3DP.%26aulast%3DTwelves%26aufirst%3DC.%26atitle%3DPhase%2520I%2520study%2520and%2520pharmacokinetic%2520of%2520CHS-828%252C%2520a%2520guanidino-containing%2520compound%252C%2520administered%2520orally%2520as%2520a%2520single%2520dose%2520every%25203%2520weeks%2520in%2520solid%2520tumours%253A%2520an%2520ECSG%252FEORTC%2520study%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2005%26volume%3D41%26spage%3D702%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">You, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eom, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span> </span><span class="NLM_article-title">Design, synthesis and X-ray crystallographic study of NAmPRTase inhibitors as anti-cancer agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1153</span><span class="NLM_x">â</span> <span class="NLM_lpage">1164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=1153-1164&author=H.+Youauthor=H.+S.+Younauthor=I.+Imauthor=M.+H.+Baeauthor=S.+K.+Leeauthor=H.+Koauthor=S.+H.+Eomauthor=Y.+C.+Kim&title=Design%2C+synthesis+and+X-ray+crystallographic+study+of+NAmPRTase+inhibitors+as+anti-cancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYou%26aufirst%3DH.%26aulast%3DYoun%26aufirst%3DH.%2BS.%26aulast%3DIm%26aufirst%3DI.%26aulast%3DBae%26aufirst%3DM.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DKo%26aufirst%3DH.%26aulast%3DEom%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DY.%2BC.%26atitle%3DDesign%252C%2520synthesis%2520and%2520X-ray%2520crystallographic%2520study%2520of%2520NAmPRTase%2520inhibitors%2520as%2520anti-cancer%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D1153%26epage%3D1164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Nahimana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greaney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ireson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thougaard, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjornelund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duchosal, M. A.</span><span> </span><span class="NLM_article-title">The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">3276</span><span class="NLM_x">â</span> <span class="NLM_lpage">3286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=3276-3286&author=A.+Nahimanaauthor=A.+Attingerauthor=D.+Aubryauthor=P.+Greaneyauthor=C.+Iresonauthor=A.+V.+Thougaardauthor=J.+Tjornelundauthor=K.+M.+Dawsonauthor=M.+Dupuisauthor=M.+A.+Duchosal&title=The+NAD+biosynthesis+inhibitor+APO866+has+potent+antitumor+activity+against+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNahimana%26aufirst%3DA.%26aulast%3DAttinger%26aufirst%3DA.%26aulast%3DAubry%26aufirst%3DD.%26aulast%3DGreaney%26aufirst%3DP.%26aulast%3DIreson%26aufirst%3DC.%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DTjornelund%26aufirst%3DJ.%26aulast%3DDawson%26aufirst%3DK.%2BM.%26aulast%3DDupuis%26aufirst%3DM.%26aulast%3DDuchosal%26aufirst%3DM.%2BA.%26atitle%3DThe%2520NAD%2520biosynthesis%2520inhibitor%2520APO866%2520has%2520potent%2520antitumor%2520activity%2520against%2520hematologic%2520malignancies%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D3276%26epage%3D3286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Kang, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eom, S. H.</span><span> </span><span class="NLM_article-title">Crystal structure of <i>Rattus norvegicus</i> visfatin/PBEF/Nampt in complex with an FK866-based inhibitor</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">â</span> <span class="NLM_lpage">671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=667-671&author=G.+B.+Kangauthor=M.+H.+Baeauthor=M.+K.+Kimauthor=I.+Imauthor=Y.+C.+Kimauthor=S.+H.+Eom&title=Crystal+structure+of+Rattus+norvegicus+visfatin%2FPBEF%2FNampt+in+complex+with+an+FK866-based+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DG.%2BB.%26aulast%3DBae%26aufirst%3DM.%2BH.%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DIm%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DEom%26aufirst%3DS.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520Rattus%2520norvegicus%2520visfatin%252FPBEF%252FNampt%2520in%2520complex%2520with%2520an%2520FK866-based%2520inhibitor%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D27%26spage%3D667%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Gillig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majjigapu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sordat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, P.</span><span> </span><span class="NLM_article-title">Synthesis of a <i>C</i>-iminoribofuranoside analog of the nicotinamide phosphoribosyltransferase (NAMPT) inhibitor FK866</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">â</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2012&pages=34-42&author=A.+Gilligauthor=S.+R.+Majjigapuauthor=B.+Sordatauthor=P.+Vogel&title=Synthesis+of+a+C-iminoribofuranoside+analog+of+the+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+inhibitor+FK866"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGillig%26aufirst%3DA.%26aulast%3DMajjigapu%26aufirst%3DS.%2BR.%26aulast%3DSordat%26aufirst%3DB.%26aulast%3DVogel%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520a%2520C-iminoribofuranoside%2520analog%2520of%2520the%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520inhibitor%2520FK866%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2012%26volume%3D95%26spage%3D34%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bair, K. W.; Baumeister, T.; Buckmelter, A. J.; Clodfelter, K. H.; Dragovich, P.; Gosselin, F.; Han, B.; Lin, J.; Reynolds, D. J.; Roth, B.; Smith, C. C.; Wang, Z.; Yuen, P.-W.; Zheng, X.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Sulfonylbenzyl)heteroarylcarboxamide Derivatives as Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors and Their Preparation and Use for the Treatment of Diseases</span>. WO2012031197A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+W.+Bair&author=T.+Baumeister&author=A.+J.+Buckmelter&author=K.+H.+Clodfelter&author=P.+Dragovich&author=F.+Gosselin&author=B.+Han&author=J.+Lin&author=D.+J.+Reynolds&author=B.+Roth&author=C.+C.+Smith&author=Z.+Wang&author=P.-W.+Yuen&author=X.+Zheng&title=N-%28Sulfonylbenzyl%29heteroarylcarboxamide+Derivatives+as+Nicotinamide+Phosphoribosyltransferase+%28NAMPT%29+Inhibitors+and+Their+Preparation+and+Use+for+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DN-%2528Sulfonylbenzyl%2529heteroarylcarboxamide%2520Derivatives%2520as%2520Nicotinamide%2520Phosphoribosyltransferase%2520%2528NAMPT%2529%2520Inhibitors%2520and%2520Their%2520Preparation%2520and%2520Use%2520for%2520the%2520Treatment%2520of%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit61b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bair, K. W.; Baumeister, T.; Buckmelter, A. J.; Clodfelter, K. H.; Han, B.; Kuntz, J. D.; Lin, J.; Reynolds, D. J.; Smith, C. C.; Wang, Z.; Zheng, X.</span><span> </span><span class="NLM_article-title">Piperidine Derivatives and Compositions for the Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT) and Their Preparation</span>. WO2012154194A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+W.+Bair&author=T.+Baumeister&author=A.+J.+Buckmelter&author=K.+H.+Clodfelter&author=B.+Han&author=J.+D.+Kuntz&author=J.+Lin&author=D.+J.+Reynolds&author=C.+C.+Smith&author=Z.+Wang&author=X.+Zheng&title=Piperidine+Derivatives+and+Compositions+for+the+Inhibition+of+Nicotinamide+Phosphoribosyltransferase+%28NAMPT%29+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DPiperidine%2520Derivatives%2520and%2520Compositions%2520for%2520the%2520Inhibition%2520of%2520Nicotinamide%2520Phosphoribosyltransferase%2520%2528NAMPT%2529%2520and%2520Their%2520Preparation%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckmelter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clodfelter, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kley, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liederer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukadam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâBrien, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodhi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, P.-w.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bair, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span> </span><span class="NLM_article-title">Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3531</span><span class="NLM_x">â</span> <span class="NLM_lpage">3538</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3531-3538&author=J.+Gunzner-Tosteauthor=G.+Zhaoauthor=P.+Bauerauthor=T.+Baumeisterauthor=A.+J.+Buckmelterauthor=M.+Caligiuriauthor=K.+H.+Clodfelterauthor=B.+Fuauthor=B.+Hanauthor=Y.-C.+Hoauthor=N.+Kleyauthor=X.+Liangauthor=B.+M.+Liedererauthor=J.+Linauthor=S.+Mukadamauthor=T.+O%E2%80%99Brienauthor=A.+Ohauthor=D.+J.+Reynoldsauthor=G.+Sharmaauthor=N.+Skeltonauthor=C.+C.+Smithauthor=J.+Sodhiauthor=W.+Wangauthor=Z.+Wangauthor=Y.+Xiaoauthor=P.-w.+Yuenauthor=M.+Zakauthor=L.+Zhangauthor=X.+Zhengauthor=K.+W.+Bairauthor=P.+S.+Dragovich&title=Discovery+of+potent+and+efficacious+urea-containing+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+inhibitors+with+reduced+CYP2C9+inhibition+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DBauer%26aufirst%3DP.%26aulast%3DBaumeister%26aufirst%3DT.%26aulast%3DBuckmelter%26aufirst%3DA.%2BJ.%26aulast%3DCaligiuri%26aufirst%3DM.%26aulast%3DClodfelter%26aufirst%3DK.%2BH.%26aulast%3DFu%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DHo%26aufirst%3DY.-C.%26aulast%3DKley%26aufirst%3DN.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DReynolds%26aufirst%3DD.%2BJ.%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DSkelton%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DC.%2BC.%26aulast%3DSodhi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYuen%26aufirst%3DP.-w.%26aulast%3DZak%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520efficacious%2520urea-containing%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520inhibitors%2520with%2520reduced%2520CYP2C9%2520inhibition%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3531%26epage%3D3538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Zheng, X.; Bauer, P.; Baumeister, T.; Buckmelter, A. J.; Caligiuri, M.; Clodfelter, K. H.; Han, B.; Ho, Y. C.; Kley, N.; Lin, J.; Reynolds, D. J.; Sharma, G.; Smith, C. C.; Wang, Z.; Dragovich, P. S.; Oh, A.; Wang, W.; Zak, M.; Gunzner-Toste, J.; Zhao, G.; Yuen, P. W.; Bair, K. W.</span><span> </span><span class="NLM_article-title">Structure-based identification of novel nicotinamide phosphoribosyltransferase (Nampt) Inhibitors</span>.  <span class="citation_source-journal">J. Med. Chem.</span> [Online early access]. DOI: <span class="refDoi">Â DOI: 10.1021/jm400186h</span> . Published Online: Apr 25,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm400186h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=X.+Zheng&author=P.+Bauer&author=T.+Baumeister&author=A.+J.+Buckmelter&author=M.+Caligiuri&author=K.+H.+Clodfelter&author=B.+Han&author=Y.+C.+Ho&author=N.+Kley&author=J.+Lin&author=D.+J.+Reynolds&author=G.+Sharma&author=C.+C.+Smith&author=Z.+Wang&author=P.+S.+Dragovich&author=A.+Oh&author=W.+Wang&author=M.+Zak&author=J.+Gunzner-Toste&author=G.+Zhao&author=P.+W.+Yuen&author=K.+W.+Bair&title=Structure-based+identification+of+novel+nicotinamide+phosphoribosyltransferase+%28Nampt%29+Inhibitors&doi=10.1021%2Fjm400186h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm400186h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400186h%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26atitle%3DStructure-based%2520identification%2520of%2520novel%2520nicotinamide%2520phosphoribosyltransferase%2520%2528Nampt%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm400186h%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">A medicinal chemistâs guide to molecular interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">â</span> <span class="NLM_lpage">5084</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Colombano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonico, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifulco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span> </span><span class="NLM_article-title">A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">â</span> <span class="NLM_lpage">623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9010669" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWhsLzL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=616-623&author=G.+Colombanoauthor=C.+Travelliauthor=U.+Galliauthor=A.+Caldarelliauthor=M.+G.+Chiniauthor=P.+L.+Canonicoauthor=G.+Sorbaauthor=G.+Bifulcoauthor=G.+C.+Tronauthor=A.+A.+Genazzani&title=A+novel+potent+nicotinamide+phosphoribosyltransferase+inhibitor+synthesized+via+click+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Potent Nicotinamide Phosphoribosyltransferase Inhibitor Synthesized via Click Chemistry</span></div><div class="casAuthors">Colombano, Giampiero; Travelli, Cristina; Galli, Ubaldina; Caldarelli, Antonio; Chini, Maria Giovanna; Canonico, Pier Luigi; Sorba, Giovanni; Bifulco, Giuseppe; Tron, Gian Cesare; Genazzani, Armando A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">616-623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of NAD synthesis or salvage pathways has been proposed as a novel target for antitumor drugs.  In the search for mols. with this mechanism of action, the copper-catalyzed [3 + 2] cycloaddn. reaction between azides and alkynes (click chem.) was exploited to synthesize 185 novel analogs.  The most promising compd. I displays an IC50 for cytotoxicity in vitro of 3.8 Â± 0.3 nM and an IC50 for NAD depletion of 3.0 Â± 0.4 nM.  Also, the previous data suggesting that this class of compds. induces autophagic cell death were confirmed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8ImgtuD64qbVg90H21EOLACvtfcHk0lgNNQYmm5Uh5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWhsLzL&md5=1fed5cfce463e08cdcbd91328c2842bf</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm9010669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9010669%26sid%3Dliteratum%253Aachs%26aulast%3DColombano%26aufirst%3DG.%26aulast%3DTravelli%26aufirst%3DC.%26aulast%3DGalli%26aufirst%3DU.%26aulast%3DCaldarelli%26aufirst%3DA.%26aulast%3DChini%26aufirst%3DM.%2BG.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DBifulco%26aufirst%3DG.%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26atitle%3DA%2520novel%2520potent%2520nicotinamide%2520phosphoribosyltransferase%2520inhibitor%2520synthesized%2520via%2520click%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D616%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirali, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billington, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonico, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span> </span><span class="NLM_article-title">Click chemistry reactions in medicinal chemistry: applications of the 1,3-dipolar cycloaddition between azides and alkynes</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">â</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1002%2Fmed.20107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=17763363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsVerurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=278-308&author=G.+C.+Tronauthor=T.+Piraliauthor=R.+A.+Billingtonauthor=P.+L.+Canonicoauthor=G.+Sorbaauthor=A.+A.+Genazzani&title=Click+chemistry+reactions+in+medicinal+chemistry%3A+applications+of+the+1%2C3-dipolar+cycloaddition+between+azides+and+alkynes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry reactions in medicinal chemistry: applications of the 1,3-dipolar cycloaddition between azides and alkynes</span></div><div class="casAuthors">Tron, Gian Cesare; Pirali, Tracey; Billington, Richard A.; Canonico, Pier Luigi; Sorba, Giovanni; Genazzani, Armando A.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">278-308</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  In recent years, there has been an ever-increasing need for rapid reactions that meet the three main criteria of an ideal synthesis: efficiency, versatility, and selectivity.  Such reactions would allow medicinal chem. to keep pace with the multitude of information derived from modern biol. screening techniques.  The present review describes one of these reactions, the 1,3-dipolar cycloaddn. ("click-reaction") between azides and alkynes catalyzed by copper (I) salts.  The simplicity of this reaction and the ease of purifn. of the resulting products have opened new opportunities in generating vast arrays of compds. with biol. potential.  The present review will outline the accomplishments of this strategy achieved so far and outline some of medicinal chem. applications in which click-chem. might be relevant in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbqDBrdkhYXrVg90H21EOLACvtfcHk0lgNNQYmm5Uh5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsVerurg%253D&md5=ef565fc46c50047a6181e85711cb5c37</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fmed.20107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20107%26sid%3Dliteratum%253Aachs%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DPirali%26aufirst%3DT.%26aulast%3DBillington%26aufirst%3DR.%2BA.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26atitle%3DClick%2520chemistry%2520reactions%2520in%2520medicinal%2520chemistry%253A%2520applications%2520of%2520the%25201%252C3-dipolar%2520cycloaddition%2520between%2520azides%2520and%2520alkynes%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D278%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Galli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercolano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carraro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasi Roman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonico, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billington, R. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">â</span> <span class="NLM_lpage">779</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=771-779&author=U.+Galliauthor=E.+Ercolanoauthor=L.+Carraroauthor=C.+R.+Blasi+Romanauthor=G.+Sorbaauthor=P.+L.+Canonicoauthor=A.+A.+Genazzaniauthor=G.+C.+Tronauthor=R.+A.+Billington&title=Synthesis+and+biological+evaluation+of+isosteric+analogues+of+FK866%2C+an+inhibitor+of+NAD+salvage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DU.%26aulast%3DErcolano%26aufirst%3DE.%26aulast%3DCarraro%26aufirst%3DL.%26aulast%3DBlasi%2BRoman%26aufirst%3DC.%2BR.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DBillington%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520isosteric%2520analogues%2520of%2520FK866%252C%2520an%2520inhibitor%2520of%2520NAD%2520salvage%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D771%26epage%3D779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Curtin, M. L.; Sorensen, B. K.; Heyman, H. R.; Clark, R. F.; Woller, K. R.; Shah, O. J.; Michaelides, M.; Tse, C.; Vasudevan, A.; Mack, H.; Hansen, T. M.; Sweis, R.; Pliushchev, M. A.</span><span> </span><span class="NLM_article-title">Dihydroisoindolecarboxamide Derivatives as NAMPT and ROCK Inhibitors and Their Preparation</span>. US20120122842A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+L.+Curtin&author=B.+K.+Sorensen&author=H.+R.+Heyman&author=R.+F.+Clark&author=K.+R.+Woller&author=O.+J.+Shah&author=M.+Michaelides&author=C.+Tse&author=A.+Vasudevan&author=H.+Mack&author=T.+M.+Hansen&author=R.+Sweis&author=M.+A.+Pliushchev&title=Dihydroisoindolecarboxamide+Derivatives+as+NAMPT+and+ROCK+Inhibitors+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCurtin%26aufirst%3DM.%2BL.%26atitle%3DDihydroisoindolecarboxamide%2520Derivatives%2520as%2520NAMPT%2520and%2520ROCK%2520Inhibitors%2520and%2520Their%2520Preparation%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Christensen, M. K.; Bjoerkling, F.</span><span> </span><span class="NLM_article-title">Preparation of Squaric Acid Derivatives for Treating Diseases Caused by an Elevated Level of Nicotinamide Phosphoribosyltransferase (NAMPRT)</span>. WO2009156421A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+K.+Christensen&author=F.+Bjoerkling&title=Preparation+of+Squaric+Acid+Derivatives+for+Treating+Diseases+Caused+by+an+Elevated+Level+of+Nicotinamide+Phosphoribosyltransferase+%28NAMPRT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DM.%2BK.%26atitle%3DPreparation%2520of%2520Squaric%2520Acid%2520Derivatives%2520for%2520Treating%2520Diseases%2520Caused%2520by%2520an%2520Elevated%2520Level%2520of%2520Nicotinamide%2520Phosphoribosyltransferase%2520%2528NAMPRT%2529%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Bjoerkling, F.; Christensen, M. K.</span><span> </span><span class="NLM_article-title">Preparation of Cyanoguanidines for Treating Diseases Caused by an Elevated Level of Nicotinamide Phosphoribosyltransferase</span>. WO2009086835A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=F.+Bjoerkling&author=M.+K.+Christensen&title=Preparation+of+Cyanoguanidines+for+Treating+Diseases+Caused+by+an+Elevated+Level+of+Nicotinamide+Phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBjoerkling%26aufirst%3DF.%26atitle%3DPreparation%2520of%2520Cyanoguanidines%2520for%2520Treating%2520Diseases%2520Caused%2520by%2520an%2520Elevated%2520Level%2520of%2520Nicotinamide%2520Phosphoribosyltransferase%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Fleischer, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry-Lorenzo, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostanin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boniface, J. J.</span><span> </span><span class="NLM_article-title">Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">â</span> <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.chembiol.2010.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=20609415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVWqsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=659-664&author=T.+C.+Fleischerauthor=B.+R.+Murphyauthor=J.+S.+Flickauthor=R.+T.+Terry-Lorenzoauthor=Z.+H.+Gaoauthor=T.+Davisauthor=R.+McKinnonauthor=K.+Ostaninauthor=J.+A.+Willardsenauthor=J.+J.+Boniface&title=Chemical+proteomics+identifies+Nampt+as+the+target+of+CB30865%2C+an+orphan+cytotoxic+compound"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Proteomics Identifies Nampt as the Target of CB30865, An Orphan Cytotoxic Compound</span></div><div class="casAuthors">Fleischer, Tracey C.; Murphy, Brett R.; Flick, Jeffrey S.; Terry-Lorenzo, Ryan T.; Gao, Zhong-Hua; Davis, Thaylon; McKinnon, Rena; Ostanin, Kirill; Willardsen, J. Adam; Boniface, J. Jay</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">659-664</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Drug discovery based on cellular phenotypes is impeded by the challenge of identifying the mol. target.  To alleviate this problem, we developed a chem. proteomic process to identify cellular proteins that bind to small mols.  CB30865 is a potent (subnanomolar) and selective cytotoxic compd. of previously unknown mechanism of action.  By combining chem. proteomics with biochem. and cellular pharmacol. we have detd. that CB30865 cytotoxicity is due to subnanomolar inhibition of nicotinamide phosphoribosyltransferase (Nampt), an enzyme present in the NAD biosynthetic pathway.  Cancer cells develop dependence on Nampt due to increased energy requirements and the elevated activity of NAD consuming enzymes such as sirtuins and mono and poly(ADP-ribose) polymerases (PARPs).  These findings suggest new chem. starting points for Nampt inhibitors and further implicate this enzyme as a target in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLnL_Bki8MfLVg90H21EOLACvtfcHk0lj1GWmLde8NoA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVWqsL4%253D&md5=cb496f614b057ec84e67e4fa940662cc</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DFleischer%26aufirst%3DT.%2BC.%26aulast%3DMurphy%26aufirst%3DB.%2BR.%26aulast%3DFlick%26aufirst%3DJ.%2BS.%26aulast%3DTerry-Lorenzo%26aufirst%3DR.%2BT.%26aulast%3DGao%26aufirst%3DZ.%2BH.%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DBoniface%26aufirst%3DJ.%2BJ.%26atitle%3DChemical%2520proteomics%2520identifies%2520Nampt%2520as%2520the%2520target%2520of%2520CB30865%252C%2520an%2520orphan%2520cytotoxic%2520compound%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D659%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Lockman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zigar, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slattum, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostanin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry-Lorenzo, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleischer, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boniface, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenderovich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span> </span><span class="NLM_article-title">Analogues of 4-[(7-bromo-2-methyl-4-oxo-3<i>H</i>-quinazolin-6-yl)methylprop-2-ynylamino]-<i>N</i>-(3-pyridy lmethyl)benzamide (CB-30865) as potent inhibitors of nicotinamide phosphoribosyltransferase (Nampt)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8734</span><span class="NLM_x">â</span> <span class="NLM_lpage">8746</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101145b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8734-8746&author=J.+W.+Lockmanauthor=B.+R.+Murphyauthor=D.+F.+Zigarauthor=W.+R.+Juddauthor=P.+M.+Slattumauthor=Z.+H.+Gaoauthor=K.+Ostaninauthor=J.+Greenauthor=R.+McKinnonauthor=R.+T.+Terry-Lorenzoauthor=T.+C.+Fleischerauthor=J.+J.+Bonifaceauthor=M.+Shenderovichauthor=J.+A.+Willardsen&title=Analogues+of+4-%5B%287-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl%29methylprop-2-ynylamino%5D-N-%283-pyridy+lmethyl%29benzamide+%28CB-30865%29+as+potent+inhibitors+of+nicotinamide+phosphoribosyltransferase+%28Nampt%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm101145b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101145b%26sid%3Dliteratum%253Aachs%26aulast%3DLockman%26aufirst%3DJ.%2BW.%26aulast%3DMurphy%26aufirst%3DB.%2BR.%26aulast%3DZigar%26aufirst%3DD.%2BF.%26aulast%3DJudd%26aufirst%3DW.%2BR.%26aulast%3DSlattum%26aufirst%3DP.%2BM.%26aulast%3DGao%26aufirst%3DZ.%2BH.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DTerry-Lorenzo%26aufirst%3DR.%2BT.%26aulast%3DFleischer%26aufirst%3DT.%2BC.%26aulast%3DBoniface%26aufirst%3DJ.%2BJ.%26aulast%3DShenderovich%26aufirst%3DM.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26atitle%3DAnalogues%2520of%25204-%255B%25287-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl%2529methylprop-2-ynylamino%255D-N-%25283-pyridy%2520lmethyl%2529benzamide%2520%2528CB-30865%2529%2520as%2520potent%2520inhibitors%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520%2528Nampt%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8734%26epage%3D8746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Bair, K. W.; Baumeister, T. B.; Buckmelter, A. J.; Clodfelter, K. H.; Han, B.; Lin, J.; Reynolds, D. J.; Smith, C. C.; Wang, Z.; Zheng, X.; Yuen, P.-W.</span><span> </span><span class="NLM_article-title">Preparation of 4-[[(Pyridin-3-ylmethyl)aminocarbonyl]amino]benzenesulfone Derivatives as NAMPT Inhibitors for Therapy of Diseases Such as Cancer</span>. WO2012031196A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+W.+Bair&author=T.+B.+Baumeister&author=A.+J.+Buckmelter&author=K.+H.+Clodfelter&author=B.+Han&author=J.+Lin&author=D.+J.+Reynolds&author=C.+C.+Smith&author=Z.+Wang&author=X.+Zheng&author=P.-W.+Yuen&title=Preparation+of+4-%5B%5B%28Pyridin-3-ylmethyl%29aminocarbonyl%5Damino%5Dbenzenesulfone+Derivatives+as+NAMPT+Inhibitors+for+Therapy+of+Diseases+Such+as+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DPreparation%2520of%25204-%255B%255B%2528Pyridin-3-ylmethyl%2529aminocarbonyl%255Damino%255Dbenzenesulfone%2520Derivatives%2520as%2520NAMPT%2520Inhibitors%2520for%2520Therapy%2520of%2520Diseases%2520Such%2520as%2520Cancer%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Bair, K. W.; Buckmelter, A. J.; Han, B.; Lin, J.; Reynolds, D. J.; Smith, C. C.; Wang, Z.; Zheng, X.</span><span> </span><span class="NLM_article-title">Guanidine Compounds and Compositions for the Inhibition of NAMPT and Their Preparation</span>. WO2012031199A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+W.+Bair&author=A.+J.+Buckmelter&author=B.+Han&author=J.+Lin&author=D.+J.+Reynolds&author=C.+C.+Smith&author=Z.+Wang&author=X.+Zheng&title=Guanidine+Compounds+and+Compositions+for+the+Inhibition+of+NAMPT+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DGuanidine%2520Compounds%2520and%2520Compositions%2520for%2520the%2520Inhibition%2520of%2520NAMPT%2520and%2520Their%2520Preparation%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Bair, K. W.; Baumeister, T.; Buckmelter, A. J.; Clodfelter, K. H.; Han, B.; Lin, J.; Reynolds, D. J.; Smith, C. C.; Wang, Z.; Zheng, X.</span><span> </span><span class="NLM_article-title">Preparation of Pyridinylprop-2-enamide Compounds as NAMPT Inhibitors</span>. WO2012150952A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+W.+Bair&author=T.+Baumeister&author=A.+J.+Buckmelter&author=K.+H.+Clodfelter&author=B.+Han&author=J.+Lin&author=D.+J.+Reynolds&author=C.+C.+Smith&author=Z.+Wang&author=X.+Zheng&title=Preparation+of+Pyridinylprop-2-enamide+Compounds+as+NAMPT+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DPreparation%2520of%2520Pyridinylprop-2-enamide%2520Compounds%2520as%2520NAMPT%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Lee, M. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevryugina, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, S. Q.</span><span> </span><span class="NLM_article-title">Carboranes increase the potency of small molecule inhibitors of nicotinamide phosphoribosyltranferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7290</span><span class="NLM_x">â</span> <span class="NLM_lpage">7294</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300740t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7290-7294&author=M.+W.+Leeauthor=Y.+V.+Sevryuginaauthor=A.+Khanauthor=S.+Q.+Ye&title=Carboranes+increase+the+potency+of+small+molecule+inhibitors+of+nicotinamide+phosphoribosyltranferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm300740t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300740t%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BW.%26aulast%3DSevryugina%26aufirst%3DY.%2BV.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DS.%2BQ.%26atitle%3DCarboranes%2520increase%2520the%2520potency%2520of%2520small%2520molecule%2520inhibitors%2520of%2520nicotinamide%2520phosphoribosyltranferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7290%26epage%3D7294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Chandra, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagavat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreekanthreddy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somasundaram, K.</span><span> </span><span class="NLM_article-title">Virtual screening, identification and experimental testing of novel inhibitors of PBEF1/visfatin/NMPRTase for glioma therapy</span> <span class="citation_source-journal">J. Clin. Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1186%2F2043-9113-1-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFShur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=5&author=N.+Chandraauthor=R.+Bhagavatauthor=E.+Sharmaauthor=P.+Sreekanthreddyauthor=K.+Somasundaram&title=Virtual+screening%2C+identification+and+experimental+testing+of+novel+inhibitors+of+PBEF1%2Fvisfatin%2FNMPRTase+for+glioma+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual screening, identification and experimental testing of novel inhibitors of PBEF1/visfatin/NMPRTase for glioma therapy</span></div><div class="casAuthors">Chandra, Nagasuma; Bhagavat, Raghu; Sharma, Eshita; Sreekanthreddy, P.; Somasundaram, Kumaravel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Bioinformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5</span>CODEN:
                <span class="NLM_cas:coden">JCBOBR</span>;
        ISSN:<span class="NLM_cas:issn">2043-9113</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Pre-B-cell colony enhancing factor 1 gene (PBEF1) encodes nicotinamide phosphoribosyltransferase (NMPRTase), which catalyzes the rate limiting step in the salvage pathway of NAD+ metab. in mammalian cells.  PBEF1 transcript and protein levels have been shown to be elevated in glioblastoma and a chem. inhibitor of NMPRTase has been shown to specifically inhibit cancer cells.  Methods: Virtual screening using docking was used to screen a library of more than 13,000 chem. compds.  A shortlisted set of compds. were tested for their inhibition activity in vitro by an NMPRTase enzyme assay.  Further, the ability of the compds. to inhibit glioma cell proliferation was carried out.  Results: Virtual screening resulted in short listing of 34 possible ligands, of which six were tested exptl., using the NMPRTase enzyme inhibition assay and further with the glioma cell viability assays.  Of these, two compds. were found to be significantly efficacious in inhibiting the conversion of nicotinamide to NAD+, and out of which, one compd., 3-amino-2-benzyl-7-nitro-4-(2-quinolyl-)-1,2-dihydroisoquinolin-1-one, was found to inhibit the growth of a PBEF1 over expressing glioma derived cell line U87 as well.  Conclusions: Thus, a novel inhibitor has been identified through a structure based drug discovery approach and is further supported by exptl. evidence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpJpygBbJb1LVg90H21EOLACvtfcHk0ljfBGNX2iwu0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFShur4%253D&md5=b39873fb098f5ffcf1c31d9a44ed35f7</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1186%2F2043-9113-1-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2043-9113-1-5%26sid%3Dliteratum%253Aachs%26aulast%3DChandra%26aufirst%3DN.%26aulast%3DBhagavat%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DE.%26aulast%3DSreekanthreddy%26aufirst%3DP.%26aulast%3DSomasundaram%26aufirst%3DK.%26atitle%3DVirtual%2520screening%252C%2520identification%2520and%2520experimental%2520testing%2520of%2520novel%2520inhibitors%2520of%2520PBEF1%252Fvisfatin%252FNMPRTase%2520for%2520glioma%2520therapy%26jtitle%3DJ.%2520Clin.%2520Bioinf.%26date%3D2011%26volume%3D1%26spage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Lee, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S. S.</span><span> </span><span class="NLM_article-title">High visfatin expression in breast cancer tissue is associated with poor survival</span> <span class="citation_source-journal">Cancer Epidemiol., Biomarkers Prev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1892</span><span class="NLM_x">â</span> <span class="NLM_lpage">1901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1892-1901&author=Y.+C.+Leeauthor=Y.+H.+Yangauthor=J.+H.+Suauthor=H.+L.+Changauthor=M.+F.+Houauthor=S.+S.+Yuan&title=High+visfatin+expression+in+breast+cancer+tissue+is+associated+with+poor+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DYang%26aufirst%3DY.%2BH.%26aulast%3DSu%26aufirst%3DJ.%2BH.%26aulast%3DChang%26aufirst%3DH.%2BL.%26aulast%3DHou%26aufirst%3DM.%2BF.%26aulast%3DYuan%26aufirst%3DS.%2BS.%26atitle%3DHigh%2520visfatin%2520expression%2520in%2520breast%2520cancer%2520tissue%2520is%2520associated%2520with%2520poor%2520survival%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D2011%26volume%3D20%26spage%3D1892%26epage%3D1901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Dalamaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karmaniolas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadavid, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelekanos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotiropoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lekka, A.</span><span> </span><span class="NLM_article-title">Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters</span> <span class="citation_source-journal">Menopause</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1198</span><span class="NLM_x">â</span> <span class="NLM_lpage">1204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1097%2Fgme.0b013e31821e21f5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FksVaqtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1198-1204&author=M.+Dalamagaauthor=K.+Karmaniolasauthor=E.+Papadavidauthor=N.+Pelekanosauthor=G.+Sotiropoulosauthor=A.+Lekka&title=Elevated+serum+visfatin%2Fnicotinamide+phosphoribosyl-transferase+levels+are+associated+with+risk+of+postmenopausal+breast+cancer+independently+from+adiponectin%2C+leptin%2C+and+anthropometric+and+metabolic+parameters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters</span></div><div class="casAuthors">Dalamaga Maria; Karmaniolas Konstantinos; Papadavid Evangelia; Pelekanos Nicolaos; Sotiropoulos George; Lekka Antigoni</div><div class="citationInfo"><span class="NLM_cas:title">Menopause (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1198-204</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Obesity has been implicated in the etiology of postmenopausal breast cancer (PBC).  We hypothesized that altered secretion of visfatin may underlie this association.  We thus investigated the association of serum visfatin with PBC risk, taking into account known risk factors including adipokines and anthropometric and metabolic parameters.  METHODS:  In a case-control study, we studied 102 postmenopausal women with pathologically confirmed, incident invasive breast cancer and 102 control women matched on age and time of diagnosis between 2003 and 2010 at Army Share Fund Hospital, Veterans' Hospital (NIMTS).  Levels of serum visfatin, adiponectin, leptin, metabolic parameters, carcinoembryonic antigen, and CA 15-3 were determined.  RESULTS:  The mean serum visfatin level was significantly higher in case than in control participants (P < 0.001).  Women in the highest quartile of visfatin concentration presented significantly higher odds for PBC, adjusting for age, date of diagnosis, education, body mass index, waist circumference, years with menstruation, parity/age at first full-term pregnancy, breast-feeding, family history of cancer, use of exogenous hormones, alcohol consumption, smoking status, homeostasis model assessment score, and serum leptin and adiponectin concentrations (odds ratio, 7.93; 95% CI, 2.52-24.9).  In case participants, the visfatin level correlated significantly with the tumor marker CA 15-3 (P = 0.03) but not with metabolic and anthropometric variables (P > 0.05).  CONCLUSIONS:  Further prospective studies are needed to determine whether an elevated serum visfatin level is implicated in the etiopathogenesis of PBC or reflects changes during PBC progression and could therefore be used as a biomarker for PBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9GcvvCbsuQN0Q2ypr7jHkfW6udTcc2eYyz2tO_cUKmbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FksVaqtA%253D%253D&md5=384f754022ff1793452f7a6411e510e5</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1097%2Fgme.0b013e31821e21f5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fgme.0b013e31821e21f5%26sid%3Dliteratum%253Aachs%26aulast%3DDalamaga%26aufirst%3DM.%26aulast%3DKarmaniolas%26aufirst%3DK.%26aulast%3DPapadavid%26aufirst%3DE.%26aulast%3DPelekanos%26aufirst%3DN.%26aulast%3DSotiropoulos%26aufirst%3DG.%26aulast%3DLekka%26aufirst%3DA.%26atitle%3DElevated%2520serum%2520visfatin%252Fnicotinamide%2520phosphoribosyl-transferase%2520levels%2520are%2520associated%2520with%2520risk%2520of%2520postmenopausal%2520breast%2520cancer%2520independently%2520from%2520adiponectin%252C%2520leptin%252C%2520and%2520anthropometric%2520and%2520metabolic%2520parameters%26jtitle%3DMenopause%26date%3D2011%26volume%3D18%26spage%3D1198%26epage%3D1204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Bi, T. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span> </span><span class="NLM_article-title">Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">â</span> <span class="NLM_lpage">1257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtleku7zK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=1251-1257&author=T.+Q.+Biauthor=X.+M.+Cheauthor=X.+H.+Liaoauthor=D.+J.+Zhangauthor=H.+L.+Longauthor=H.+J.+Liauthor=W.+Zhao&title=Overexpression+of+Nampt+in+gastric+cancer+and+chemopotentiating+effects+of+the+Nampt+inhibitor+FK866+in+combination+with+fluorouracil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil</span></div><div class="casAuthors">Bi, Tie-Qiang; Che, Xiang-Ming; Liao, Xin-Hua; Zhang, Dan-Jie; Long, Hou-Long; Li, Hai-Jun; Zhao, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1251-1257</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (Nampt), an enzyme involved in the NAD+ salvage pathway, is overexpressed and important in the carcinogenesis in several types of cancers.  The expression of Nampt and its role in gastric cancer remain largely unknown.  In this study, using real-time PCR and Western blotting we found that Nampt was overexpressed at the mRNA and protein levels, resp., in established gastric cancer cells and human gastric cancer tissues.  The specific Nampt inhibitor FK866 repressed gastric cancer cell proliferation, as assessed by MTT assay.  Using transwell and soft agar clonogenic assays, we also found that FK866 suppressed gastric cancer cell migration and anchorage-independent growth, resp.  These inhibitory effects of FK866 were accompanied by significantly decreased expression of VEGF, MMP2, MMP9 and NF-ÎºB.  As detd. by MTT assay and flow cytometry, FK866 also increased the chemosensitivity of gastric cancer cells to fluorouracil by greater inhibition of cell proliferation and the induction of apoptosis.  Our findings indicate that Nampt may be a new therapeutic target for gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDdcXVj4ZRwLVg90H21EOLACvtfcHk0lg1o75JGw0vxg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtleku7zK&md5=753c14ed24ee84c8415560b9c87efcf1</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DT.%2BQ.%26aulast%3DChe%26aufirst%3DX.%2BM.%26aulast%3DLiao%26aufirst%3DX.%2BH.%26aulast%3DZhang%26aufirst%3DD.%2BJ.%26aulast%3DLong%26aufirst%3DH.%2BL.%26aulast%3DLi%26aufirst%3DH.%2BJ.%26aulast%3DZhao%26aufirst%3DW.%26atitle%3DOverexpression%2520of%2520Nampt%2520in%2520gastric%2520cancer%2520and%2520chemopotentiating%2520effects%2520of%2520the%2520Nampt%2520inhibitor%2520FK866%2520in%2520combination%2520with%2520fluorouracil%26jtitle%3DOncol.%2520Rep.%26date%3D2011%26volume%3D26%26spage%3D1251%26epage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Nakajima, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span> </span><span class="NLM_article-title">Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer</span> <span class="citation_source-journal">J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">â</span> <span class="NLM_lpage">690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1007%2Fs00535-009-0063-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotlehtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=685-690&author=T.+E.+Nakajimaauthor=Y.+Yamadaauthor=T.+Hamanoauthor=K.+Furutaauthor=T.+Gotodaauthor=H.+Kataiauthor=K.+Katoauthor=T.+Hamaguchiauthor=Y.+Shimada&title=Adipocytokine+levels+in+gastric+cancer+patients%3A+resistin+and+visfatin+as+biomarkers+of+gastric+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer</span></div><div class="casAuthors">Nakajima, Takako Eguchi; Yamada, Yasuhide; Hamano, Tetsutaro; Furuta, Koh; Gotoda, Takuji; Katai, Hitoshi; Kato, Ken; Hamaguchi, Tetsuya; Shimada, Yasuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">685-690</span>CODEN:
                <span class="NLM_cas:coden">JOGAET</span>;
        ISSN:<span class="NLM_cas:issn">0944-1174</span>.
    
            (<span class="NLM_cas:orgname">Springer Japan</span>)
        </div><div class="casAbstract">Purpose: Adipocytokines are adipocyte-secreted hormones assocd. with some malignancies.  We investigated the assocn. of adipocytokines with gastric cancer.  Methods: The levels of body mass index (BMI) and adiponectin, leptin, resistin, visfatin, and C-peptide in blood at diagnosis were measured in 156 gastric cancer patients and 156 age- and sex-matched controls.  Logistic regression models were used to est. odds ratio, and one-way anal. of variance was performed to examine the prevalence of each variable between 2 or more groups.  Results: Adiponectin, C-peptide and BMI levels were significantly lower, and resistin and visfatin levels were significantly higher in the patients on multivariate anal. (P = 0.0004, 0.0006, 0.0051, 0.0006 and 0.0013, resp.).  In the controls, the inverse correlation between BMI and adiponectin was comparatively strong, but was weak in the patients.  The correlation between BMI and leptin was strong in both the controls and the patients.  The correlation between BMI and resistin or visfatin was not clear in either the patients or the controls.  The correlation between BMI and C-peptide was not clear in the controls, but might be weak in the patients.  Leptin, C-peptide and BMI levels gradually decreased with stage progression, and resistin and visfatin levels gradually increased with stage progression (P < 0.0001 for all).  Comparison between 38 patients with Stage I gastric cancer and the controls showed that adiponectin level tended to decrease in the patients (P = 0.0582), and BMI level was not different between two groups (P = 0.2480).  Conclusions: Resistin and visfatin may be good biomarkers of gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolOu4PrQRgILVg90H21EOLACvtfcHk0lg1o75JGw0vxg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotlehtrk%253D&md5=1bb21b8661c1bb716bd5ae3f0c0e9384</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1007%2Fs00535-009-0063-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00535-009-0063-5%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DT.%2BE.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DHamano%26aufirst%3DT.%26aulast%3DFuruta%26aufirst%3DK.%26aulast%3DGotoda%26aufirst%3DT.%26aulast%3DKatai%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DHamaguchi%26aufirst%3DT.%26aulast%3DShimada%26aufirst%3DY.%26atitle%3DAdipocytokine%2520levels%2520in%2520gastric%2520cancer%2520patients%253A%2520resistin%2520and%2520visfatin%2520as%2520biomarkers%2520of%2520gastric%2520cancer%26jtitle%3DJ.%2520Gastroenterol.%26date%3D2009%26volume%3D44%26spage%3D685%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Long, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, T. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D. W.</span><span> </span><span class="NLM_article-title">The expression of nicotinamide phosphoribosyl transferase and vascular endothelial growth factor-A in gastric carcinoma and their clinical significance</span> <span class="citation_source-journal">Zhonghua Waike Zazhi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">â</span> <span class="NLM_lpage">842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2012&pages=839-842&author=H.+L.+Longauthor=X.+M.+Cheauthor=T.+Q.+Biauthor=H.+J.+Liauthor=J.+S.+Liuauthor=D.+W.+Li&title=The+expression+of+nicotinamide+phosphoribosyl+transferase+and+vascular+endothelial+growth+factor-A+in+gastric+carcinoma+and+their+clinical+significance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DH.%2BL.%26aulast%3DChe%26aufirst%3DX.%2BM.%26aulast%3DBi%26aufirst%3DT.%2BQ.%26aulast%3DLi%26aufirst%3DH.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%2BS.%26aulast%3DLi%26aufirst%3DD.%2BW.%26atitle%3DThe%2520expression%2520of%2520nicotinamide%2520phosphoribosyl%2520transferase%2520and%2520vascular%2520endothelial%2520growth%2520factor-A%2520in%2520gastric%2520carcinoma%2520and%2520their%2520clinical%2520significance%26jtitle%3DZhonghua%2520Waike%2520Zazhi%26date%3D2012%26volume%3D50%26spage%3D839%26epage%3D842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Olesen, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastrup, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span> </span><span class="NLM_article-title">Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas</span> <span class="citation_source-journal">APMIS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">â</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1111%2Fj.1600-0463.2011.02733.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVegt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2011&pages=296-303&author=U.+H.+Olesenauthor=N.+Hastrupauthor=M.+Sehested&title=Expression+patterns+of+nicotinamide+phosphoribosyltransferase+and+nicotinic+acid+phosphoribosyltransferase+in+human+malignant+lymphomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas</span></div><div class="casAuthors">Olesen, Uffe Hoegh; Hastrup, Nina; Sehested, Maxwell</div><div class="citationInfo"><span class="NLM_cas:title">APMIS</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">296-303</span>CODEN:
                <span class="NLM_cas:coden">APMSEL</span>;
        ISSN:<span class="NLM_cas:issn">0903-4641</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The purpose of the study was to det. in human malignant lymphomas the expression patterns of nicotinamide phosphoribosyltransferase (NAMPT) and nicotinic acid phosphoribosyltransferase (NAPRT), the primary, rate-limiting enzymes in the synthesis of NAD+.  NAMPT is a potential biomarker for sensitivity to NAMPT inhibitors and NAPRT is a biomarker for the use of nicotinic acid as a chemoprotectant in treatment with NAMPT inhibitors.  The NAMPT inhibitor, APO866, is currently in clin. phase II trials in lymphomas.  The expression of NAMPT and NAPRT was investigated in 53 samples of malignant lymphomas (diffuse large B-cell lymphoma, follicular B-cell lymphoma, Hodgkin's lymphoma and peripheral T-cell lymphoma).  The expression of NAMPT was generally high in the more aggressive malignant lymphomas, with >80% strong expression, whereas the expression in the more indolent follicular lymphoma (FL) was significantly lower (>75% moderate or low expression, p = 0.0002).  NAMPT was very highly expressed in Hodgkin Reed-Sternberg cells in Hodgkin's lymphoma.  NAPRT expression was more varied (p > 0.0001) with 30-50% low expression except for Hodgkin's lymphoma where 85% displayed low expression (p = 0.0024).  In conclusion, FL are a promising target for NAMPT inhibitors whereas substantial subsets of malignant lymphomas esp. in Hodgkin lymphoma may be suitable for a combination treatment with nicotinic acid and NAMPT inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoba8znTBOxiLVg90H21EOLACvtfcHk0lgP30daGT1Q0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVegt7o%253D&md5=eda747b3441bfa67095e71a64e1b6a16</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0463.2011.02733.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0463.2011.02733.x%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DU.%2BH.%26aulast%3DHastrup%26aufirst%3DN.%26aulast%3DSehested%26aufirst%3DM.%26atitle%3DExpression%2520patterns%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520and%2520nicotinic%2520acid%2520phosphoribosyltransferase%2520in%2520human%2520malignant%2520lymphomas%26jtitle%3DAPMIS%26date%3D2011%26volume%3D119%26spage%3D296%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Patel, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digby, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randeva, H. S.</span><span> </span><span class="NLM_article-title">A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">â</span> <span class="NLM_lpage">57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=51-57&author=S.+T.+Patelauthor=T.+Mistryauthor=J.+E.+Brownauthor=J.+E.+Digbyauthor=R.+Adyaauthor=K.+M.+Desaiauthor=H.+S.+Randeva&title=A+novel+role+for+the+adipokine+visfatin%2Fpre-B+cell+colony-enhancing+factor+1+in+prostate+carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%2BT.%26aulast%3DMistry%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DJ.%2BE.%26aulast%3DDigby%26aufirst%3DJ.%2BE.%26aulast%3DAdya%26aufirst%3DR.%26aulast%3DDesai%26aufirst%3DK.%2BM.%26aulast%3DRandeva%26aufirst%3DH.%2BS.%26atitle%3DA%2520novel%2520role%2520for%2520the%2520adipokine%2520visfatin%252Fpre-B%2520cell%2520colony-enhancing%2520factor%25201%2520in%2520prostate%2520carcinogenesis%26jtitle%3DPeptides%26date%3D2010%26volume%3D31%26spage%3D51%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Shackelford, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakam, A.</span><span> </span><span class="NLM_article-title">Over-expression of nicotinamide phosphoribosyltransferase in ovarian cancers</span> <span class="citation_source-journal">Int. J. Clin. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">â</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVyrtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=522-527&author=R.+E.+Shackelfordauthor=M.+M.+Buiauthor=D.+Coppolaauthor=A.+Hakam&title=Over-expression+of+nicotinamide+phosphoribosyltransferase+in+ovarian+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Over-expression of niotinamide phosphoribosyltransferase in ovarian cancers</span></div><div class="casAuthors">Shackelford, Rodney E.; Bui, Marilyn M.; Coppola, Domenico; Hakam, Ardeshir</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">522-527</span>CODEN:
                <span class="NLM_cas:coden">IJCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1936-2625</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (Nampt) catalyzes the rate-limiting step of NAD (NAD+) synthesis and is required for cell growth, survival, DNA replication and repair, and angiogenesis.  Nampt expression increases gene expression which promotes cell survival and increases SirT1 activity, promoting angiogenesis, and it is increased in several human malignancies.  Recently, others have shown that ovarian serous adenocarcinomas (OSAs) express high levels of activated Stat3.  Since Nampt expression is increased by Stat3, we hypothesized that Nampt protein might be highly expressed in OSAs.  Using tissue microarray (TMA) and the avidinbiotin complex immunohistochem. technique we examd. Nampt expression in 47 samples of benign ovarian tissue and 49 samples of ovarian serous adenoacarcinomas.  Our data show that Nampt protein expression is significantly increased in OSAs as compared to benign ovarian tissue (0.49+/-0.12 benign vs. 4.78+/-0.46 malignant; +/- std. error of the mean).  This is the first report demonstrating Nampt overexpression in OSA, which may shed light on the pathogenesis of OSA.  Further studies of the role of Nampt overexpresion in OSA may shed light on the prognosis and clin. course of OSA.  Last, since an effective pharmacol. Nampt inhibitor is currently in clin. use, further studies of Nampt overexpression in OSA may be used in selecting patients for Nampt inhibitor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxJ45cA4F99rVg90H21EOLACvtfcHk0lgP30daGT1Q0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVyrtLk%253D&md5=84616aa3a69e58bd876351a00e55f881</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShackelford%26aufirst%3DR.%2BE.%26aulast%3DBui%26aufirst%3DM.%2BM.%26aulast%3DCoppola%26aufirst%3DD.%26aulast%3DHakam%26aufirst%3DA.%26atitle%3DOver-expression%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520in%2520ovarian%2520cancers%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2010%26volume%3D3%26spage%3D522%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Nakajima, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span> </span><span class="NLM_article-title">Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1286</span><span class="NLM_x">â</span> <span class="NLM_lpage">1291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1111%2Fj.1349-7006.2010.01518.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsF2qu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2010&pages=1286-1291&author=T.+E.+Nakajimaauthor=Y.+Yamadaauthor=T.+Hamanoauthor=K.+Furutaauthor=T.+Matsudaauthor=S.+Fujitaauthor=K.+Katoauthor=T.+Hamaguchiauthor=Y.+Shimada&title=Adipocytokines+as+new+promising+markers+of+colorectal+tumors%3A+adiponectin+for+colorectal+adenoma%2C+and+resistin+and+visfatin+for+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer</span></div><div class="casAuthors">Nakajima, Takako Eguchi; Yamada, Yasuhide; Hamano, Tetsutaro; Furuta, Koh; Matsuda, Takahisa; Fujita, Shin; Kato, Ken; Hamaguchi, Tetsuya; Shimada, Yasuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1286-1291</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Adipocytokines are adipocyte-secreted hormones assocd. with some malignancies such as colorectal, breast, and prostate cancer.  We hypothesized that changes in the levels of adipocytokines may indicate the carcinogenesis and progression of colorectal cancer and adenoma, and investigated the assocn. of the blood levels of several adipocytokines through a case-control study.  Blood levels of adiponectin, leptin, resistin, visfatin, and C-peptide at diagnosis were measured in 115 colorectal cancer patients and 115 age-, sex-, and body mass index-matched controls.  The same anal. was performed in 72 colorectal adenoma patients and 72 controls.  Logistic regression models were used for estg. odds ratios and 95% confidence intervals, and one-way ANOVA was performed to det. the prevalence of each variable between two or more groups.  Resistin and visfatin levels in cancer patients were significantly higher than those of controls on multivariate anal. (P = 0.03 and P < 0.01, resp.).  Stage progression significantly correlated with resistin and visfatin levels (P < 0.01 for both).  The adiponectin level in adenoma patients was significantly lower than that of controls on multivariate anal. (P = 0.04).  Its level was inversely correlated with the no. of adenoma (P = 0.02), but not correlated with the size of adenoma.  Resistin and visfatin may be good biomarkers of colorectal malignant potential and stage progression.  Adiponectin level may be a good biomarker of colorectal adenoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0esinIQPQabVg90H21EOLACvtfcHk0lgP30daGT1Q0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsF2qu78%253D&md5=b46592da1f736341215d4f5e7a223b9c</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2010.01518.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2010.01518.x%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DT.%2BE.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DHamano%26aufirst%3DT.%26aulast%3DFuruta%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DHamaguchi%26aufirst%3DT.%26aulast%3DShimada%26aufirst%3DY.%26atitle%3DAdipocytokines%2520as%2520new%2520promising%2520markers%2520of%2520colorectal%2520tumors%253A%2520adiponectin%2520for%2520colorectal%2520adenoma%252C%2520and%2520resistin%2520and%2520visfatin%2520for%2520colorectal%2520cancer%26jtitle%3DCancer%2520Sci.%26date%3D2010%26volume%3D101%26spage%3D1286%26epage%3D1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Reddy, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thota, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramaniam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandramouli, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santosh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondaiah, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somasundaram, K.</span><span> </span><span class="NLM_article-title">PBEF1/NAmPRTase/visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">â</span> <span class="NLM_lpage">668</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.4161%2Fcbt.7.5.5663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVeisLjN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=663-668&author=P.+S.+Reddyauthor=S.+Umeshauthor=B.+Thotaauthor=A.+Tandonauthor=P.+Pandeyauthor=A.+S.+Hegdeauthor=A.+Balasubramaniamauthor=B.+A.+Chandramouliauthor=V.+Santoshauthor=M.+R.+Raoauthor=P.+Kondaiahauthor=K.+Somasundaram&title=PBEF1%2FNAmPRTase%2Fvisfatin%3A+a+potential+malignant+astrocytoma%2Fglioblastoma+serum+marker+with+prognostic+value"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">PBEF1/NAmPRTase/visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value</span></div><div class="casAuthors">Reddy, P. Sreekanth; Umesh, Srikantha; Thota, Balaram; Tandon, Ashwani; Pandey, Paritosh; Hegde, A. S.; Balasubramaniam, Anandh; Chandramouli, B. A.; Santosh, Vani; Rao, M. R. S.; Kondaiah, Paturu; Somasundaram, Kumaravel</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">663-668</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Malignant astrocytomas comprise anaplastic astrocytoma (AA; grade III) and Glioblastoma (GBM; grade IV).  GBM is the most malignant with a median survival of 10-12 mo in patients.  Using cDNA microarray based expression profiling of different grades of astrocytomas, we identified several fold increased levels of PBEF1 transcripts in GBM samples.  Pre-B-cell colony enhancing factor 1 gene (PBEF1) encodes Nicotinamide phosphoribosyl-transferase (NAmPRTase), which catalyzes the rate limiting step in the salvage pathway of NAD metab. in mammalian cells.  Further validation using real time RT-qPCR on an independent set of tumor samples (n = 91) and normal brain samples (n = 9), GBM specific higher expression of PBEF1 was confirmed.  Immunohistochem. staining for PBEF1 on a subset of the above samples largely reinforced our finding.  We carried out ELISA anal. on serum samples of astrocytoma patients to det. whether this protein levels would correlate with the presence of tumor and tumor grade.  PBEF1 serum levels were substantially elevated in many of the AA and GBM patients.  Statistical anal. of these data indicates that in patients with astrocytoma, serum PBEF1 levels correlate with tumor grade and is highest in GBM.  Immunohistochem. anal. of an independent set of 51 retrospective GBM cases with known survival data revealed that PBEF1 expression in the tumor tissue along with its co-expression with p53 was assocd. with poor survival.  Thus, we have identified PBEF1 as a potential malignant astrocytoma serum marker and prognostic indicator among GBMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-kqvIx3lhFLVg90H21EOLACvtfcHk0liw1Qw4pkOg5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVeisLjN&md5=367bab489808e3ac18bb8d278a5d8922</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.4161%2Fcbt.7.5.5663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.7.5.5663%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BS.%26aulast%3DUmesh%26aufirst%3DS.%26aulast%3DThota%26aufirst%3DB.%26aulast%3DTandon%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DP.%26aulast%3DHegde%26aufirst%3DA.%2BS.%26aulast%3DBalasubramaniam%26aufirst%3DA.%26aulast%3DChandramouli%26aufirst%3DB.%2BA.%26aulast%3DSantosh%26aufirst%3DV.%26aulast%3DRao%26aufirst%3DM.%2BR.%26aulast%3DKondaiah%26aufirst%3DP.%26aulast%3DSomasundaram%26aufirst%3DK.%26atitle%3DPBEF1%252FNAmPRTase%252Fvisfatin%253A%2520a%2520potential%2520malignant%2520astrocytoma%252Fglioblastoma%2520serum%2520marker%2520with%2520prognostic%2520value%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D663%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsubokura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, G.</span><span> </span><span class="NLM_article-title">Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study</span> <span class="citation_source-journal">J. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1186%2F1479-5876-8-103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BC3cbmsVGisg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=103&author=S.+Takahashiauthor=N.+Miuraauthor=T.+Haradaauthor=Z.+Wangauthor=X.+Wangauthor=H.+Tsubokuraauthor=Y.+Oshimaauthor=J.+Hasegawaauthor=Y.+Inagakiauthor=G.+Shiota&title=Prognostic+impact+of+clinical+course-specific+mRNA+expression+profiles+in+the+serum+of+perioperative+patients+with+esophageal+cancer+in+the+ICU%3A+a+case+control+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study</span></div><div class="casAuthors">Takahashi Shunsaku; Miura Norimasa; Harada Tomomi; Wang ZhongZhi; Wang Xinhui; Tsubokura Hideyuki; Oshima Yoshiaki; Hasegawa Junichi; Inagaki Yoshimi; Shiota Goshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  We previously reported that measuring circulating serum mRNAs using quantitative one-step real-time RT-PCR was clinically useful for detecting malignancies and determining prognosis.  The aim of our study was to find crucial serum mRNA biomarkers in esophageal cancer that would provide prognostic information for post-esophagectomy patients in the critical care setting.  METHODS:  We measured serum mRNA levels of 11 inflammatory-related genes in 27 post-esophagectomy patients admitted to the intensive care unit (ICU).  We tracked these levels chronologically, perioperatively and postoperatively, until the two-week mark, investigating their clinical and prognostic significance as compared with clinical parameters.  Furthermore, we investigated whether gene expression can accurately predict clinical outcome and prognosis.  RESULTS:  Circulating mRNAs in postoperative esophagectomy patients had gene-specific expression profiles that varied with the clinical phase of their treatment.  Multivariate regression analysis showed that upregulation of IL-6, VWF and TGF-Î²1 mRNA in the intraoperative phase (p = 0.016, 0.0021 and 0.009) and NAMPT and MUC1 mRNA on postoperative day 3 (p < 0.01) were independent factors of mortality in the first year of follow-up.  Duration of ventilator dependence (DVD) and ICU stay were independent factors of poor prognosis (p < 0.05).  Therapeutic use of Sivelestat (ElaspolÂ®, Ono Pharmaceutical Co., Ltd.) significantly correlated with MUC1 and NAMPT mRNA expression (p = 0.048 and 0.045).  IL-6 mRNA correlated with hypercytokinemia and recovery from hypercytokinemia (sensitivity 80.9%) and was a significant biomarker in predicting the onset of severe inflammatory diseases.  CONCLUSION:  Chronological tracking of postoperative mRNA levels of inflammatory-related genes in esophageal cancer patients may facilitate early institution of pharamacologic therapy, prediction of treatment response, and prognostication during ICU management in the perioperative period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3kysQSgJNz1vAgqb2vdc5fW6udTcc2ea0SylUfy0gTbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbmsVGisg%253D%253D&md5=8ac179e10d1ccbe5a4009af5765baf2b</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-8-103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-8-103%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DMiura%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTsubokura%26aufirst%3DH.%26aulast%3DOshima%26aufirst%3DY.%26aulast%3DHasegawa%26aufirst%3DJ.%26aulast%3DInagaki%26aufirst%3DY.%26aulast%3DShiota%26aufirst%3DG.%26atitle%3DPrognostic%2520impact%2520of%2520clinical%2520course-specific%2520mRNA%2520expression%2520profiles%2520in%2520the%2520serum%2520of%2520perioperative%2520patients%2520with%2520esophageal%2520cancer%2520in%2520the%2520ICU%253A%2520a%2520case%2520control%2520study%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2010%26volume%3D8%26spage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Thakur, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittrich, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehnau, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klusmann, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welte, K.</span><span> </span><span class="NLM_article-title">Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">â</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1002%2Fijc.27726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOmtLbP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=766-774&author=B.+K.+Thakurauthor=T.+Dittrichauthor=P.+Chandraauthor=A.+Beckerauthor=W.+Kuehnauauthor=J.+H.+Klusmannauthor=D.+Reinhardtauthor=K.+Welte&title=Involvement+of+p53+in+the+cytotoxic+activity+of+the+NAMPT+inhibitor+FK866+in+myeloid+leukemic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells</span></div><div class="casAuthors">Thakur, Basant Kumar; Dittrich, Tino; Chandra, Prakash; Becker, Annette; Kuehnau, Wolfgang; Klusmann, Jan-Henning; Reinhardt, Dirk; Welte, Karl</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">766-774</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">FK866 is a specific inhibitor of NAMPT and induces apoptosis of leukemic cells by depletion of intracellular NAD+.  Since up-regulation of NAMPT is assocd. with several cases of cancers, including leukemias, we asked whether in leukemic cells inhibition of NAMPT involves p53 pathway.  We obsd. that FK866 induced apoptosis and reduced cell proliferation in NB-4, OCI-AML3 and MOLM-13 cell lines.  In contrast, the leukemia cell lines, K-562 and Kasumi, contg. nonfunctional p53 were relatively unaffected by FK866 treatment.  Importantly, direct inhibition of sirtuins significantly reduced the viability of NB-4, OCI-AML3 and MOLM-13 cell lines.  Activation of p53 by FK866 involved increased acetylation of p53 at lysine 382 with subsequent increase in the expression of p21 and BAX.  Further, knockdown of p53 attenuated the effects of FK866 on apoptosis and cell cycle arrest, which was partly assocd. with decreased expression of p21 and BAX.  Our results suggest the role of p53 acetylation pathway in the anti-leukemic effect of FK866.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0ex_g8bdch7Vg90H21EOLACvtfcHk0liw1Qw4pkOg5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOmtLbP&md5=68c9e5ac20ef921ca71fd59883e3d4ae</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1002%2Fijc.27726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27726%26sid%3Dliteratum%253Aachs%26aulast%3DThakur%26aufirst%3DB.%2BK.%26aulast%3DDittrich%26aufirst%3DT.%26aulast%3DChandra%26aufirst%3DP.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DKuehnau%26aufirst%3DW.%26aulast%3DKlusmann%26aufirst%3DJ.%2BH.%26aulast%3DReinhardt%26aufirst%3DD.%26aulast%3DWelte%26aufirst%3DK.%26atitle%3DInvolvement%2520of%2520p53%2520in%2520the%2520cytotoxic%2520activity%2520of%2520the%2520NAMPT%2520inhibitor%2520FK866%2520in%2520myeloid%2520leukemic%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2013%26volume%3D132%26spage%3D766%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Pogrebniak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemainda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelka-Fleischer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasmann, M.</span><span> </span><span class="NLM_article-title">Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents</span> <span class="citation_source-journal">Eur. J. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">â</span> <span class="NLM_lpage">321</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Wms7rL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=313-321&author=A.+Pogrebniakauthor=I.+Schemaindaauthor=K.+Azzamauthor=R.+Pelka-Fleischerauthor=V.+Nusslerauthor=M.+Hasmann&title=Chemopotentiating+effects+of+a+novel+NAD+biosynthesis+inhibitor%2C+FK866%2C+in+combination+with+antineoplastic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents</span></div><div class="casAuthors">Pogrebniak, A.; Schemainda, I.; Azzam, K.; Pelka-Fleischer, R.; Nuessler, V.; Hasmann, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">EJMRFL</span>;
        ISSN:<span class="NLM_cas:issn">0949-2321</span>.
    
            (<span class="NLM_cas:orgname">I. Holzapfel Verlag GmbH</span>)
        </div><div class="casAbstract">FK866 is a novel anticancer agent that was previously shown to interfere with NAD+ biosynthesis by inhibition of nicotinamide phosphoribosyltransferase and to initiate apoptosis in cancer cells.  As NAD+ is involved in cellular DNA repair processes, the present in vitro study on THP-1 and K562 leukemia cells was conducted to investigate the cytotoxicity of FK866 combination treatment with various cytotoxic agents: the antimetabolite Ara-C, the DNA-intercalating agent daunorubicin and the alkylating compds. 1-methyl-3-nitro-1-nitrosoguanidinium (MNNG) and melphalan.  Cell viability after drug exposure was assessed by propidium iodide (PI) staining.  Non-cytotoxic concns. of FK866 (10-9M or less), applied simultaneously or 24 h before adding cytotoxic agents, caused a depletion in the intracellular NAD+ and - to a lesser extent - NADH levels in THP-1 cells.  After 48 and 72 h treatment with daunorubicin and Ara-C, resp., increased cell death was obsd. in THP-1 cells that were pretreated with FK866, as compared to cells exposed to antineoplastic drugs alone.  However, this effect was transient, and there was no difference in cell survival after 72 h incubation with daunorubicin or 96 h with Ara-C.  Non-toxic concns. of FK866 added 8, 16, or 24 h before starting treatment with the PARP-activating agent MNNG synergistically decreased intracellular NAD+ contents, and increased MNNG-induced cytotoxicity both in THP-1 and K562 cells for at least 72 h.  This effect was less pronounced when FK866 was used in combination with another alkylating agent, melphalan.  The PARP inhibitor 3-aminobenzamide delayed MNNG-induced cytotoxicity by 24 h both in cells that were pretreated with FK866 and in non-pretreated cells.  48 H later, the protective effect of 3-aminobenzamide could no longer be obsd., but FK866-pretreated cells retained increased sensitivity to MNNG.  In conclusion, the chemosensitizing effect of FK866 on cell death induced by antineoplastic drugs was particularly obvious in combination with substances like MNNG that cause NAD+ depletion per se.  It was less pronounced and only transiently measurable in combination with daunorubicin, Ara-C, and melphalan, resp.  These results may indicate different levels of DNA damage implicated in the action of the cytotoxic agents used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeOtVq11EFxrVg90H21EOLACvtfcHk0ljvlRQcYlT9mQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Wms7rL&md5=6dba2ba494a33d5ab3146ed3407db74c</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPogrebniak%26aufirst%3DA.%26aulast%3DSchemainda%26aufirst%3DI.%26aulast%3DAzzam%26aufirst%3DK.%26aulast%3DPelka-Fleischer%26aufirst%3DR.%26aulast%3DNussler%26aufirst%3DV.%26aulast%3DHasmann%26aufirst%3DM.%26atitle%3DChemopotentiating%2520effects%2520of%2520a%2520novel%2520NAD%2520biosynthesis%2520inhibitor%252C%2520FK866%252C%2520in%2520combination%2520with%2520antineoplastic%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Res.%26date%3D2006%26volume%3D11%26spage%3D313%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Cea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruscione, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffaghello, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garuti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emionite, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoppoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reverberi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnetta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamaschi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casciaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierri, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damonte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansaldi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistoia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballestrero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencioni, A.</span><span> </span><span class="NLM_article-title">Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e22739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e22739&author=M.+Ceaauthor=D.+Sonciniauthor=F.+Fruscioneauthor=L.+Raffaghelloauthor=A.+Garutiauthor=L.+Emioniteauthor=E.+Moranauthor=M.+Magnoneauthor=G.+Zoppoliauthor=D.+Reverberiauthor=I.+Caffaauthor=A.+Salisauthor=A.+Cagnettaauthor=M.+Bergamaschiauthor=S.+Casciaroauthor=I.+Pierriauthor=G.+Damonteauthor=F.+Ansaldiauthor=M.+Gobbiauthor=V.+Pistoiaauthor=A.+Ballestreroauthor=F.+Patroneauthor=S.+Bruzzoneauthor=A.+Nencioni&title=Synergistic+interactions+between+HDAC+and+sirtuin+inhibitors+in+human+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCea%26aufirst%3DM.%26aulast%3DSoncini%26aufirst%3DD.%26aulast%3DFruscione%26aufirst%3DF.%26aulast%3DRaffaghello%26aufirst%3DL.%26aulast%3DGaruti%26aufirst%3DA.%26aulast%3DEmionite%26aufirst%3DL.%26aulast%3DMoran%26aufirst%3DE.%26aulast%3DMagnone%26aufirst%3DM.%26aulast%3DZoppoli%26aufirst%3DG.%26aulast%3DReverberi%26aufirst%3DD.%26aulast%3DCaffa%26aufirst%3DI.%26aulast%3DSalis%26aufirst%3DA.%26aulast%3DCagnetta%26aufirst%3DA.%26aulast%3DBergamaschi%26aufirst%3DM.%26aulast%3DCasciaro%26aufirst%3DS.%26aulast%3DPierri%26aufirst%3DI.%26aulast%3DDamonte%26aufirst%3DG.%26aulast%3DAnsaldi%26aufirst%3DF.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DPistoia%26aufirst%3DV.%26aulast%3DBallestrero%26aufirst%3DA.%26aulast%3DPatrone%26aufirst%3DF.%26aulast%3DBruzzone%26aufirst%3DS.%26aulast%3DNencioni%26aufirst%3DA.%26atitle%3DSynergistic%2520interactions%2520between%2520HDAC%2520and%2520sirtuin%2520inhibitors%2520in%2520human%2520leukemia%2520cells%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De22739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Zoppoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruscione, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedognetti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrando, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballestrero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencioni, A.</span><span> </span><span class="NLM_article-title">Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells</span> <span class="citation_source-journal">Exp. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">â</span> <span class="NLM_lpage">988</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.exphem.2010.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCgs7%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=979-988&author=G.+Zoppoliauthor=M.+Ceaauthor=D.+Sonciniauthor=F.+Fruscioneauthor=J.+Rudnerauthor=E.+Moranauthor=I.+Caffaauthor=D.+Bedognettiauthor=G.+Mottaauthor=R.+Ghioauthor=F.+Ferrandoauthor=A.+Ballestreroauthor=S.+Parodiauthor=C.+Belkaauthor=F.+Patroneauthor=S.+Bruzzoneauthor=A.+Nencioni&title=Potent+synergistic+interaction+between+the+Nampt+inhibitor+APO866+and+the+apoptosis+activator+TRAIL+in+human+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells</span></div><div class="casAuthors">Zoppoli, Gabriele; Cea, Michele; Soncini, Debora; Fruscione, Floriana; Rudner, Justine; Moran, Eva; Caffa, Irene; Bedognetti, Davide; Motta, Giulia; Ghio, Riccardo; Ferrando, Fabio; Ballestrero, Alberto; Parodi, Silvio; Belka, Claus; Patrone, Franco; Bruzzone, Santina; Nencioni, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Hematology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">979-988</span>CODEN:
                <span class="NLM_cas:coden">EXHMA6</span>;
        ISSN:<span class="NLM_cas:issn">0301-472X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The nicotinamide phosphoribosyltransferase (Nampt) inhibitor APO866 depletes intracellular NAD (NAD+) and shows promising anticancer activity in preclin. studies.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) binds to plasma membrane receptors DR4 and DR5 and induces apoptosis via caspase-8 and -10.  Here we have explored the interaction between APO866 and TRAIL in leukemia cell lines and in primary B-cell chronic lymphocytic leukemia cells.  Cells were treated with APO866, TRAIL, or their combination.  Viability and mitochondrial transmembrane potential (ÎÎ¨m) were detd. by cell staining with propidium iodide and tetramethylrhodamine Et ester, resp., and flow cytometry.  Nampt and Î³-tubulin levels, as well as caspase-3 cleavage were detected by immunoblotting.  DR4 and DR5 expression were assessed by immunostaining and flow cytometry.  Caspases were inhibited with zVAD-FMK and zDEVD-FMK; autophagy with 3-methyladenine, LY294002, and wortmannin.  Intracellular NAD+ and ATP were measured by cycling assays and high-performance liq. chromatog. (HPLC), resp.  Results: APO866 induced NAD+ depletion, ÎÎ¨m dissipation, and ATP shortage in leukemia cells, thereby leading to autophagic cell death.  TRAIL induced caspase-dependent apoptosis.  TRAIL addn. to APO866 synergistically increased its activity in leukemia cells by enhancing NAD+ depletion, ÎÎ¨m dissipation, and ATP shortage.  No DR5 upregulation at the cell surface in response to APO866 was obsd.  Remarkably, in healthy leukocytes APO866 and TRAIL were poorly active and failed to show any cooperation.  Activation of the extrinsic apoptotic cascade with TRAIL selectively amplifies the sequelae of Nampt inhibition in leukemia cells, and appears as a promising strategy to enhance APO866 activity in hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Zj_ImaCce7Vg90H21EOLACvtfcHk0ljvlRQcYlT9mQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCgs7%252FF&md5=de5c9d8134a8e1c0ccbd50e8e2da15e8</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.exphem.2010.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exphem.2010.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DZoppoli%26aufirst%3DG.%26aulast%3DCea%26aufirst%3DM.%26aulast%3DSoncini%26aufirst%3DD.%26aulast%3DFruscione%26aufirst%3DF.%26aulast%3DRudner%26aufirst%3DJ.%26aulast%3DMoran%26aufirst%3DE.%26aulast%3DCaffa%26aufirst%3DI.%26aulast%3DBedognetti%26aufirst%3DD.%26aulast%3DMotta%26aufirst%3DG.%26aulast%3DGhio%26aufirst%3DR.%26aulast%3DFerrando%26aufirst%3DF.%26aulast%3DBallestrero%26aufirst%3DA.%26aulast%3DParodi%26aufirst%3DS.%26aulast%3DBelka%26aufirst%3DC.%26aulast%3DPatrone%26aufirst%3DF.%26aulast%3DBruzzone%26aufirst%3DS.%26aulast%3DNencioni%26aufirst%3DA.%26atitle%3DPotent%2520synergistic%2520interaction%2520between%2520the%2520Nampt%2520inhibitor%2520APO866%2520and%2520the%2520apoptosis%2520activator%2520TRAIL%2520in%2520human%2520leukemia%2520cells%26jtitle%3DExp.%2520Hematol.%26date%3D2010%26volume%3D38%26spage%3D979%26epage%3D988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Muruganandham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfieri, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukenick, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemainda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koutcher, J. A.</span><span> </span><span class="NLM_article-title">Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by <sup>1</sup>H-decoupledâ<sup>31</sup>P magnetic resonance spectroscopy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3503</span><span class="NLM_x">â</span> <span class="NLM_lpage">3513</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1158%2F1078-0432.CCR-04-1399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslOqtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=3503-3513&author=M.+Muruganandhamauthor=A.+A.+Alfieriauthor=C.+Mateiauthor=Y.+Chenauthor=G.+Sukenickauthor=I.+Schemaindaauthor=M.+Hasmannauthor=L.+B.+Saltzauthor=J.+A.+Koutcher&title=Metabolic+signatures+associated+with+a+NAD+synthesis+inhibitor-induced+tumor+apoptosis+identified+by+1H-decoupled%E2%80%9331P+magnetic+resonance+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Signatures Associated with a NAD Synthesis Inhibitor-Induced Tumor Apoptosis Identified by 1H-Decoupled-31P Magnetic Resonance Spectroscopy</span></div><div class="casAuthors">Muruganandham, Manickam; Alfieri, Alan A.; Matei, Cornelia; Chen, Yuchun; Sukenick, George; Schemainda, Isabel; Hasmann, Max; Saltz, Leonard B.; Koutcher, Jason A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3503-3513</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Attempts to selectively initiate tumor cell death through inducible apoptotic pathways are increasingly being exploited as a potential anticancer strategy.  Inhibition of NAD+ synthesis by a novel agent FK866 has been recently reported to induce apoptosis in human leukemia, hepatocarcinoma cells in vitro, and various types of tumor xenografts in vivo.  In the present study, we used 1H-decoupled phosphorus (31P) magnetic resonance spectroscopy (MRS) to examine the metabolic changes assocd. with FK866 induced tumor cell death in a mouse mammary carcinoma.  Exptl. Design: Induction of apoptosis in FK866-treated tumors was confirmed by histol. and cytofluorometric anal.  FK866-induced changes in mammary carcinoma tumor metab. in vivo were investigated using 1H-decoupled 31P MRS.  To discern further the changes in metabolic profiles of tumors obsd. in vivo, high-resoln. in vitro 1H-decoupled 31P MRS studies were carried out with perchloric acid exts. of mammary carcinoma tumors excised after similar treatments.  In addn., the effects of FK866 on mammary carcinoma tumor growth and radiation sensitivity were studied.  RESULTS: Treatment with FK866 induced a tumor growth delay and enhanced radiation sensitivity in mammary carcinoma tumors that was assocd. with significant increases in the 31P MR signal in the phosphomonoester region and a decrease in NAD+ levels, pH, and bioenergetic status.  The 31P MRS of perchloric acid exts. of treated tumors identified the large unresolved signal in the phosphomonoester region as the resultant of resonances originating from intermediates of tumor glycolysis and guanylate synthesis in addn. to alterations in pyridine nucleotide pools and phospholipid metab.  CONCLUSION: The present results suggest that FK866 interferes with multiple biochem. pathways that contribute to the increased cell death (apoptosis) and subsequent radiation sensitivity obsd. in the mammary carcinoma that could be serially monitored by 31P MRS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsKhDQoeDkGrVg90H21EOLACvtfcHk0lhyHWAozcBIiw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslOqtLg%253D&md5=b942df22d36ef74cb7f948b2e3cb5dc3</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1399%26sid%3Dliteratum%253Aachs%26aulast%3DMuruganandham%26aufirst%3DM.%26aulast%3DAlfieri%26aufirst%3DA.%2BA.%26aulast%3DMatei%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSukenick%26aufirst%3DG.%26aulast%3DSchemainda%26aufirst%3DI.%26aulast%3DHasmann%26aufirst%3DM.%26aulast%3DSaltz%26aufirst%3DL.%2BB.%26aulast%3DKoutcher%26aufirst%3DJ.%2BA.%26atitle%3DMetabolic%2520signatures%2520associated%2520with%2520a%2520NAD%2520synthesis%2520inhibitor-induced%2520tumor%2520apoptosis%2520identified%2520by%25201H-decoupled%25E2%2580%259331P%2520magnetic%2520resonance%2520spectroscopy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D3503%26epage%3D3513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Drevs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esser, N.</span><span> </span><span class="NLM_article-title">Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">â</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvVGnsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=4853-4858&author=J.+Drevsauthor=R.+Loserauthor=B.+Rattelauthor=N.+Esser&title=Antiangiogenic+potency+of+FK866%2FK22.175%2C+a+new+inhibitor+of+intracellular+NAD+biosynthesis%2C+in+murine+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma</span></div><div class="casAuthors">Drevs, Joachim; Loeser, Roland; Rattel, Benno; Esser, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6C</span>),
    <span class="NLM_cas:pages">4853-4858</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">FK 866/ K 22.175 (FK-866), developed as an anticancer agent, interferes with the NAD+ biosynthesis and therefore might have characteristics distinct from conventional chemotherapeutic agents.  We investigated FK-866 in a murine renal cell carcinoma model (RENCA) to assess its antitumor, antimetastatic and antiangiogenic potency.  FK-866 was administered twice daily on days 10 to 15 after intrarenal inoculation of RENCA cells in syngenic Balb/c mice at oral doses of 6, 10, 14 and 18 mg/kg to define the optimal dose related to toxicity.  For efficacy studies, FK-866 was administered orally twice daily at doses of 6 and 10 mg/kg or twice daily at doses of 3 and 5 mg/kg on days 14 to 19 after tumor cell inoculation.  Animals in the pos. control group received 30 mg/kg TNP 470 s.c. on every other day beginning on day 1.  On day 17, all animals were examd. for blood flow in the left renal artery by color Doppler imaging (CDI).  The animals were sacrificed on day 21 and analyzed for primary tumor wt. and vol., no. of metastases to the lung and abdominal lymph nodes and vessel d. in tumor tissues.  Doses of up to 6 mg/kg FK-866 were less toxic than treatment with TNP-470.  Significant antitumor efficacy was obsd. for doses of â¥10 mg/kg FK-866 only.  In contrast, a significant decrease of vessel d. in tumor tissues by up to 70% could be detected for all dose groups.  Changes in blood flow in the tumor feeding renal artery could not be detected because of the profound strong tumor redn.  FK-866 has antitumoral and antimetastatic activity in RENCA mice.  Furthermore, this is the first report to describe a strong antiangiogenic potency of FK-866.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX_hbEmmix1LVg90H21EOLACvtfcHk0lhyHWAozcBIiw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvVGnsbs%253D&md5=b1e66d6be66a4a37b0fe7991c158ba13</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrevs%26aufirst%3DJ.%26aulast%3DLoser%26aufirst%3DR.%26aulast%3DRattel%26aufirst%3DB.%26aulast%3DEsser%26aufirst%3DN.%26atitle%3DAntiangiogenic%2520potency%2520of%2520FK866%252FK22.175%252C%2520a%2520new%2520inhibitor%2520of%2520intracellular%2520NAD%2520biosynthesis%252C%2520in%2520murine%2520renal%2520cell%2520carcinoma%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Zhang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qie, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. P.</span><span> </span><span class="NLM_article-title">Anti-proliferation effect of APO866 on C6 glioblastoma cells by inhibiting nicotinamide phosphoribosyltransferase</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">674</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">â</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.ejphar.2011.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1Gqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=674&publication_year=2012&pages=163-170&author=L.+Y.+Zhangauthor=L.+Y.+Liuauthor=L.+L.+Qieauthor=K.+N.+Lingauthor=L.+H.+Xuauthor=F.+Wangauthor=S.+H.+Fangauthor=Y.+B.+Luauthor=H.+Huauthor=E.+Q.+Weiauthor=W.+P.+Zhang&title=Anti-proliferation+effect+of+APO866+on+C6+glioblastoma+cells+by+inhibiting+nicotinamide+phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-proliferation effect of APO866 on C6 glioblastoma cells by inhibiting nicotinamide phosphoribosyltransferase</span></div><div class="casAuthors">Zhang, Li-Yuan; Liu, Li-Ying; Qie, Ling-Ling; Ling, Ka-Na; Xu, Li-Hua; Wang, Feng; Fang, San-Hua; Lu, Yun-Bi; Hu, Hua; Wei, Er-Qing; Zhang, Wei-Ping</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">674</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">163-170</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NAMPT) is a key enzyme in the salvaging pathway for the synthesis of NAD that is involved in cell metab. and proliferation.  NAMPT is normally absent in astrocyte but highly expressed in glioblastoma, suggesting that it may promote cell survival through synthesizing more NAD.  In this report, we evaluated the effect of APO866, a potent inhibitor of NAMPT against C6 glioblastoma.  We found that APO866 inhibited the growth of C6 glioblastoma cells with IC50 in nano-molar range.  APO866 depleted intracellular NAD, caused marked inhibition of ERK activation and induced G2/M cell-cycle arrest.  The effects by APO866 were abrogated by NMN, the direct product of NAMPT.  Administration of U0126, an ERK1/2 inhibitor, inhibited cell growth but displayed no synergistic effect with APO866.  Taken together, our results indicated that APO866 is a potent growth inhibitor against glioblastoma through targeting NAMPT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2SOUIUHqm_7Vg90H21EOLACvtfcHk0lhyHWAozcBIiw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1Gqsg%253D%253D&md5=dcb583b7f14776812cd02e45520b268e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%2BY.%26aulast%3DLiu%26aufirst%3DL.%2BY.%26aulast%3DQie%26aufirst%3DL.%2BL.%26aulast%3DLing%26aufirst%3DK.%2BN.%26aulast%3DXu%26aufirst%3DL.%2BH.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DFang%26aufirst%3DS.%2BH.%26aulast%3DLu%26aufirst%3DY.%2BB.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DE.%2BQ.%26aulast%3DZhang%26aufirst%3DW.%2BP.%26atitle%3DAnti-proliferation%2520effect%2520of%2520APO866%2520on%2520C6%2520glioblastoma%2520cells%2520by%2520inhibiting%2520nicotinamide%2520phosphoribosyltransferase%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D674%26spage%3D163%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Goellner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimme, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugrue, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobol, R. W.</span><span> </span><span class="NLM_article-title">Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">2308</span><span class="NLM_x">â</span> <span class="NLM_lpage">2317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=2308-2317&author=E.+M.+Goellnerauthor=B.+Grimmeauthor=A.+R.+Brownauthor=Y.+C.+Linauthor=X.+H.+Wangauthor=K.+F.+Sugrueauthor=L.+Mitchellauthor=R.+N.+Trivediauthor=J.+B.+Tangauthor=R.+W.+Sobol&title=Overcoming+temozolomide+resistance+in+glioblastoma+via+dual+inhibition+of+NAD%2B+biosynthesis+and+base+excision+repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoellner%26aufirst%3DE.%2BM.%26aulast%3DGrimme%26aufirst%3DB.%26aulast%3DBrown%26aufirst%3DA.%2BR.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DX.%2BH.%26aulast%3DSugrue%26aufirst%3DK.%2BF.%26aulast%3DMitchell%26aufirst%3DL.%26aulast%3DTrivedi%26aufirst%3DR.%2BN.%26aulast%3DTang%26aufirst%3DJ.%2BB.%26aulast%3DSobol%26aufirst%3DR.%2BW.%26atitle%3DOvercoming%2520temozolomide%2520resistance%2520in%2520glioblastoma%2520via%2520dual%2520inhibition%2520of%2520NAD%252B%2520biosynthesis%2520and%2520base%2520excision%2520repair%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D2308%26epage%3D2317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Le, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouw, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinavahi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deck, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royer, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vander Jagt, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenza, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">2037</span><span class="NLM_x">â</span> <span class="NLM_lpage">2042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1073%2Fpnas.0914433107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=20133848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFCit7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=2037-2042&author=A.+Leauthor=C.+R.+Cooperauthor=A.+M.+Gouwauthor=R.+Dinavahiauthor=A.+Maitraauthor=L.+M.+Deckauthor=R.+E.+Royerauthor=D.+L.+Vander+Jagtauthor=G.+L.+Semenzaauthor=C.+V.+Dang&title=Inhibition+of+lactate+dehydrogenase+A+induces+oxidative+stress+and+inhibits+tumor+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression</span></div><div class="casAuthors">Le, Anne; Cooper, Charles R.; Gouw, Arvin M.; Dinavahi, Ramani; Maitra, Anirban; Deck, Lorraine M.; Royer, Robert E.; Vander Jagt, David L.; Semenza, Gregg L.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2037-2042, S2037/1-S2037/12</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">As the result of genetic alterations and tumor hypoxia, many cancer cells avidly take up glucose and generate lactate through lactate dehydrogenase A (LDHA), which is encoded by a target gene of c-Myc and hypoxia-inducible factor (HIF-1).  Previous studies with redn. of LDHA expression indicate that LDHA is involved in tumor initiation, but its role in tumor maintenance and progression has not been established.  Furthermore, how redn. of LDHA expression by interference or antisense RNA inhibits tumorigenesis is not well understood.  Here, we report that redn. of LDHA by siRNA or its inhibition by a small-mol. inhibitor (FX11 [3-dihydroxy-6-methyl-7-(phenylmethyl)-4-propylnaphthalene-1-carboxylic acid]) reduced ATP levels and induced significant oxidative stress and cell death that could be partially reversed by the antioxidant N-acetylcysteine (NAC).  Furthermore, we document that FX11 inhibited the progression of sizable human lymphoma and pancreatic cancer xenografts.  When used in combination with the NAD+ synthesis inhibitor FK866, FX11 induced lymphoma regression.  Hence, inhibition of LDHA with FX11 is an achievable and tolerable treatment for LDHA-dependent tumors.  Our studies document a therapeutical approach to the Warburg effect and demonstrate that oxidative stress and metabolic phenotyping of cancers are crit. aspects of cancer biol. to consider for the therapeutical targeting of cancer energy metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1h1YikQKAn7Vg90H21EOLACvtfcHk0lhm_eDurmhZfw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFCit7g%253D&md5=714af2ec2bc79ffcba57d6987c52a87a</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0914433107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0914433107%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DA.%26aulast%3DCooper%26aufirst%3DC.%2BR.%26aulast%3DGouw%26aufirst%3DA.%2BM.%26aulast%3DDinavahi%26aufirst%3DR.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DDeck%26aufirst%3DL.%2BM.%26aulast%3DRoyer%26aufirst%3DR.%2BE.%26aulast%3DVander%2BJagt%26aufirst%3DD.%2BL.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DInhibition%2520of%2520lactate%2520dehydrogenase%2520A%2520induces%2520oxidative%2520stress%2520and%2520inhibits%2520tumor%2520progression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D2037%26epage%3D2042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Olesen, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thougaard, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span> </span><span class="NLM_article-title">A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1609</span><span class="NLM_x">â</span> <span class="NLM_lpage">1617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1158%2F1535-7163.MCT-09-1130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=20515945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFGgsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1609-1617&author=U.+H.+Olesenauthor=A.+V.+Thougaardauthor=P.+B.+Jensenauthor=M.+Sehested&title=A+preclinical+study+on+the+rescue+of+normal+tissue+by+nicotinic+acid+in+high-dose+treatment+with+APO866%2C+a+specific+nicotinamide+phosphoribosyltransferase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">A Preclinical Study on the Rescue of Normal Tissue by Nicotinic Acid in High-Dose Treatment with APO866, a Specific Nicotinamide Phosphoribosyltransferase Inhibitor</span></div><div class="casAuthors">Olesen, Uffe Hogh; Thougaard, Annemette V.; Jensen, Peter Buhl; Sehested, Maxwell</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1609-1617</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibitor of nicotinamide phosphoribosyltransferase APO866 is a promising cancer drug currently in phase II clin. trials in oncol.  Here, we present a strategy for increasing the therapeutic potential of APO866 through the rescue of normal tissues by coadministration of nicotinic acid (Vitamin B3).  We examd. the toxicity profile of APO866 in B6D2F1 mice and the effect of oral administration of nicotinic acid on tissue toxicity.  Nicotinic acid (50 mg/kg) protects mice from death and severe toxicity from an APO866 dose (60 mg/kg) four times the monotherapy max. tolerated dose (15 mg/kg).  In a panel of six cancer cell lines, we find that three (including ML-2 cells) are protected by nicotinic acid in vitro, whereas the cytotoxicity of APO866 remains unaffected in the remaining three (including A2780 cells).  A selective biomarker for the protection by nicotinic acid was subsequently identified by quant. RT-PCR.  The expression of nicotinic acid phosphoribosyltransferase is low in the cell lines not rescued from APO866 by nicotinic acid compared with protected cell lines.  The findings in cell lines translated into xenograft models in which the combination of 50 mg/kg nicotinic acid and 50 mg/kg APO866 in mouse xenografts of A2780 cells increased life span by >3-fold compared with std. treatment of 15 mg/kg, and the effect of APO866 was clearly decreased when using the same treatment paradigm in ML-2 xenografts.  In conclusion, the combination of high doses of APO866 with rescue by nicotinic acid may significantly increase the therapeutic potential in a subset of cancers with low expression of nicotinic acid phosphoribosyltransferase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEEVf5ZtCvXrVg90H21EOLACvtfcHk0lhm_eDurmhZfw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFGgsbg%253D&md5=353e954d2fd5308992a0ce8039ef081c</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1130%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DU.%2BH.%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DSehested%26aufirst%3DM.%26atitle%3DA%2520preclinical%2520study%2520on%2520the%2520rescue%2520of%2520normal%2520tissue%2520by%2520nicotinic%2520acid%2520in%2520high-dose%2520treatment%2520with%2520APO866%252C%2520a%2520specific%2520nicotinamide%2520phosphoribosyltransferase%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1609%26epage%3D1617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Tan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parthasarathy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkholder, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geeganage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span> </span><span class="NLM_article-title">Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">3500</span><span class="NLM_x">â</span> <span class="NLM_lpage">3511</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=3500-3511&author=B.+Tanauthor=D.+A.+Youngauthor=Z.+H.+Luauthor=T.+Wangauthor=T.+I.+Meierauthor=R.+L.+Shepardauthor=K.+Rothauthor=Y.+Zhaiauthor=K.+Hussauthor=M.+S.+Kuoauthor=J.+Gilligauthor=S.+Parthasarathyauthor=T.+P.+Burkholderauthor=M.+C.+Smithauthor=S.+Geeganageauthor=G.+Zhao&title=Pharmacological+inhibition+of+nicotinamide+phosphoribosyltransferase+%28NAMPT%29%2C+an+enzyme+essential+for+NAD%2B+biosynthesis%2C+in+human+cancer+cells%3A+metabolic+basis+and+potential+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DB.%26aulast%3DYoung%26aufirst%3DD.%2BA.%26aulast%3DLu%26aufirst%3DZ.%2BH.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DMeier%26aufirst%3DT.%2BI.%26aulast%3DShepard%26aufirst%3DR.%2BL.%26aulast%3DRoth%26aufirst%3DK.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DHuss%26aufirst%3DK.%26aulast%3DKuo%26aufirst%3DM.%2BS.%26aulast%3DGillig%26aufirst%3DJ.%26aulast%3DParthasarathy%26aufirst%3DS.%26aulast%3DBurkholder%26aufirst%3DT.%2BP.%26aulast%3DSmith%26aufirst%3DM.%2BC.%26aulast%3DGeeganage%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DG.%26atitle%3DPharmacological%2520inhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%252C%2520an%2520enzyme%2520essential%2520for%2520NAD%252B%2520biosynthesis%252C%2520in%2520human%2520cancer%2520cells%253A%2520metabolic%2520basis%2520and%2520potential%2520clinical%2520implications%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D3500%26epage%3D3511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':['cit15a','cit15b'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29a','cit29b'],'ref30':['cit30a','cit30b'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33a','cit33b','cit33c'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36a','cit36b','cit36c'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42a','cit42b'],'ref43':['cit43a','cit43b'],'ref44':['cit44a','cit44b','cit44c','cit44d'],'ref45':['cit45a','cit45b'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61a','cit61b'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 88 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Daniel S. Palacios, Erik L. Meredith, Toshio Kawanami, Christopher M. Adams, Xin Chen, Veronique Darsigny, Mark Palermo, Daniel Baird, Elizabeth L. George, Chantale Guy, Jeffrey Hewett, Laryssa Tierney, Sachin Thigale, Louis Wang, <span class="NLM_string-name hlFld-ContribAuthor">Wilhelm A. Weihofen</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold Morphing Identifies 3-Pyridyl Azetidine Ureas as Inhibitors of Nicotinamide Phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (11)
                                     , 1524-1529. <a href="https://doi.org/10.1021/acsmedchemlett.9b00325" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00325%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DScaffold%252BMorphing%252BIdentifies%252B3-Pyridyl%252BAzetidine%252BUreas%252Bas%252BInhibitors%252Bof%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DPalacios%26aufirst%3DDaniel%2BS.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19072019%26date%3D10102019%26date%3D17102019%26date%3D10102019%26volume%3D10%26issue%3D11%26spage%3D1524%26epage%3D1529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Ying  Wu</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chaoyu  Miao</span>, and <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     , 34-38. <a href="https://doi.org/10.1021/acsmedchemlett.7b00414" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00414%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDual%252BNAMPT%25252FHDAC%252BInhibitors%252Bas%252Ba%252BNew%252BStrategy%252Bfor%252BMultitargeting%252BAntitumor%252BDrug%252BDiscovery%26aulast%3DChen%26aufirst%3DWei%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10102017%26date%3D14122017%26date%3D19122017%26date%3D11012018%26date%3D14122017%26volume%3D9%26issue%3D1%26spage%3D34%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Xinglin  Yang</span>, <span class="hlFld-ContribAuthor ">Tianying  Xu</span>, <span class="hlFld-ContribAuthor ">Pei  Wang</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Rao</span>, <span class="hlFld-ContribAuthor ">Chaoyu  Miao</span>, and <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (19)
                                     , 7965-7983. <a href="https://doi.org/10.1021/acs.jmedchem.7b00467" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00467</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00467%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BInhibitors%252BSimultaneously%252BTargeting%252BCancer%252BMetabolism%252Band%252BEpigenetics%25253A%252BDiscovery%252Bof%252BNovel%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%252Band%252BHistone%252BDeacetylase%252B%252528HDAC%252529%252BDual%252BInhibitors%26aulast%3DDong%26aufirst%3DGuoqiang%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D27032017%26date%3D21092017%26date%3D12102017%26date%3D08092017%26volume%3D60%26issue%3D19%26spage%3D7965%26epage%3D7983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Travelli</span>, <span class="hlFld-ContribAuthor ">Silvio  Aprile</span>, <span class="hlFld-ContribAuthor ">Reza  Rahimian</span>, <span class="hlFld-ContribAuthor ">Ambra A.  Grolla</span>, <span class="hlFld-ContribAuthor ">Federica  Rogati</span>, <span class="hlFld-ContribAuthor ">Mattia  Bertolotti</span>, <span class="hlFld-ContribAuthor ">Floriana  Malagnino</span>, <span class="hlFld-ContribAuthor ">Rosanna  di Paola</span>, <span class="hlFld-ContribAuthor ">Daniela  Impellizzeri</span>, <span class="hlFld-ContribAuthor ">Roberta  Fusco</span>, <span class="hlFld-ContribAuthor ">Valentina  Mercalli</span>, <span class="hlFld-ContribAuthor ">Alberto  Massarotti</span>, <span class="hlFld-ContribAuthor ">Giorgio  Stortini</span>, <span class="hlFld-ContribAuthor ">Salvatore  Terrazzino</span>, <span class="hlFld-ContribAuthor ">Erika  Del Grosso</span>, <span class="hlFld-ContribAuthor ">Gohar  Fakhfouri</span>, <span class="hlFld-ContribAuthor ">Maria Pia  Troiani</span>, <span class="hlFld-ContribAuthor ">Maria Alessandra  Alisi</span>, <span class="hlFld-ContribAuthor ">Giorgio  Grosa</span>, <span class="hlFld-ContribAuthor ">Giovanni  Sorba</span>, <span class="hlFld-ContribAuthor ">Pier Luigi  Canonico</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Orsomando</span>, <span class="hlFld-ContribAuthor ">Salvatore  Cuzzocrea</span>, <span class="hlFld-ContribAuthor ">Armando A.  Genazzani</span>, <span class="hlFld-ContribAuthor ">Ubaldina  Galli</span>, and <span class="hlFld-ContribAuthor ">Gian Cesare  Tron</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 1768-1792. <a href="https://doi.org/10.1021/acs.jmedchem.6b01392" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01392%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BNovel%252BTriazole-Based%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%252BInhibitors%252BEndowed%252Bwith%252BAntiproliferative%252Band%252BAntiinflammatory%252BActivity%26aulast%3DTravelli%26aufirst%3DCristina%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D22092016%26date%3D22022017%26date%3D09032017%26date%3D06022017%26volume%3D60%26issue%3D5%26spage%3D1768%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Xiongcai  Liu</span>, <span class="hlFld-ContribAuthor ">Snahel  Patel</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Thomas  OâBrien</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Nicholas  Skelton</span>, <span class="hlFld-ContribAuthor ">Rongbao  Hua</span>, <span class="hlFld-ContribAuthor ">Jasleen  Sodhi</span>, <span class="hlFld-ContribAuthor ">Yunli  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, and <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8345-8368. <a href="https://doi.org/10.1021/acs.jmedchem.6b00697" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00697%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMinimizing%252BCYP2C9%252BInhibition%252Bof%252BExposed-Pyridine%252BNAMPT%252B%252528Nicotinamide%252BPhosphoribosyltransferase%252529%252BInhibitors%26aulast%3DZak%26aufirst%3DMark%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D06052016%26date%3D30082016%26date%3D22092016%26date%3D19082016%26volume%3D59%26issue%3D18%26spage%3D8345%26epage%3D8368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinhong  Bai</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>, <span class="hlFld-ContribAuthor ">Yanghan  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaochu  Qin</span>, <span class="hlFld-ContribAuthor ">Jiaxuan  Chen</span>, <span class="hlFld-ContribAuthor ">Yatao  Qiu</span>, <span class="hlFld-ContribAuthor ">Dongguang  Qin</span>, <span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Zheng-Chao  Tu</span>, and <span class="hlFld-ContribAuthor ">Sheng  Jiang</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Potent Nicotinamide Phosphoribosyltransferase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (12)
                                     , 5766-5779. <a href="https://doi.org/10.1021/acs.jmedchem.6b00324" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00324</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00324%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BPotent%252BNicotinamide%252BPhosphoribosyltransferase%252BInhibitors%252Bwith%252BPromising%252Bin%252BVitro%252Band%252Bin%252BVivo%252BAntitumor%252BActivities%26aulast%3DBai%26aufirst%3DJinhong%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29022016%26date%3D13062016%26date%3D23062016%26date%3D25052016%26volume%3D59%26issue%3D12%26spage%3D5766%26epage%3D5779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony M.  Giannetti</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Skelton</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Brandon J.  Bravo</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Eric  Cheng</span>, <span class="hlFld-ContribAuthor ">Lisa  Crocker</span>, <span class="hlFld-ContribAuthor ">Yezhen  Feng</span>, <span class="hlFld-ContribAuthor ">Janet  Gunzner-Toste</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Rongbao  Hua</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Yongbo  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Ma</span>, <span class="hlFld-ContribAuthor ">Thomas  OâBrien</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Youming  Shen</span>, <span class="hlFld-ContribAuthor ">Chengcheng  Wang</span>, <span class="hlFld-ContribAuthor ">Leslie  Wang</span>, <span class="hlFld-ContribAuthor ">Hongxing  Wu</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>, and <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Identification of Amides Derived from trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 770-792. <a href="https://doi.org/10.1021/jm4015108" title="DOI URL">https://doi.org/10.1021/jm4015108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4015108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4015108%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BIdentification%252Bof%252BAmides%252BDerived%252Bfrom%252Btrans-2-%252528Pyridin-3-yl%252529cyclopropanecarboxylic%252BAcid%252Bas%252BPotent%252BInhibitors%252Bof%252BHuman%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DGiannetti%26aufirst%3DAnthony%2BM.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D27092013%26date%3D22012014%26date%3D13022014%26date%3D09012014%26volume%3D57%26issue%3D3%26spage%3D770%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jordan L.  Meier</span>  . </span><span class="cited-content_cbyCitation_article-title">Metabolic Mechanisms of Epigenetic Regulation. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (12)
                                     , 2607-2621. <a href="https://doi.org/10.1021/cb400689r" title="DOI URL">https://doi.org/10.1021/cb400689r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb400689r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb400689r%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DMetabolic%252BMechanisms%252Bof%252BEpigenetic%252BRegulation%26aulast%3DMeier%26aufirst%3DJordan%2BL.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D07092013%26date%3D16102013%26date%3D14112013%26date%3D20122013%26volume%3D8%26issue%3D12%26spage%3D2607%26epage%3D2621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mette K.  Christensen</span>, <span class="hlFld-ContribAuthor ">Kamille D.  Erichsen</span>, <span class="hlFld-ContribAuthor ">Uffe H.  Olesen</span>, <span class="hlFld-ContribAuthor ">Jette  TjÃ¸rnelund</span>, <span class="hlFld-ContribAuthor ">Peter  Fristrup</span>, <span class="hlFld-ContribAuthor ">Annemette  Thougaard</span>, <span class="hlFld-ContribAuthor ">SÃ¸ren Jensby  Nielsen</span>, <span class="hlFld-ContribAuthor ">Maxwell  Sehested</span>, <span class="hlFld-ContribAuthor ">Peter B.  Jensen</span>, <span class="hlFld-ContribAuthor ">Einars  Loza</span>, <span class="hlFld-ContribAuthor ">Ivars  Kalvinsh</span>, <span class="hlFld-ContribAuthor ">Antje  Garten</span>, <span class="hlFld-ContribAuthor ">Wieland  Kiess</span>, and <span class="hlFld-ContribAuthor ">Fredrik  BjÃ¶rkling</span>  . </span><span class="cited-content_cbyCitation_article-title">Nicotinamide Phosphoribosyltransferase Inhibitors, Design, Preparation, and StructureâActivity Relationship. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (22)
                                     , 9071-9088. <a href="https://doi.org/10.1021/jm4009949" title="DOI URL">https://doi.org/10.1021/jm4009949</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4009949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4009949%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNicotinamide%252BPhosphoribosyltransferase%252BInhibitors%25252C%252BDesign%25252C%252BPreparation%25252C%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%26aulast%3DChristensen%26aufirst%3DMette%2BK.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D02072013%26date%3D13112013%26date%3D27112013%26date%3D28102013%26volume%3D56%26issue%3D22%26spage%3D9071%26epage%3D9088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Paul  Bauer</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Alexandre J.  Buckmelter</span>, <span class="hlFld-ContribAuthor ">Maureen  Caligiuri</span>, <span class="hlFld-ContribAuthor ">Karl H.  Clodfelter</span>, <span class="hlFld-ContribAuthor ">Bingsong  Han</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Nikolai  Kley</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Dominic J.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Geeta  Sharma</span>, <span class="hlFld-ContribAuthor ">Chase C.  Smith</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Wang</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Janet  Gunzner-Toste</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Thomas  OâBrien</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Leslie  Wang</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, and <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (16)
                                     , 6413-6433. <a href="https://doi.org/10.1021/jm4008664" title="DOI URL">https://doi.org/10.1021/jm4008664</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4008664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4008664%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDiscovery%252Bof%252BNovel%252BAmide-Containing%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528Nampt%252529%252BInhibitors%26aulast%3DZheng%26aufirst%3DXiaozhang%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D28042013%26date%3D31072013%26date%3D22082013%26date%3D16072013%26volume%3D56%26issue%3D16%26spage%3D6413%26epage%3D6433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Strauss</span>, <span class="hlFld-ContribAuthor ">Valentina  Guarneri</span>, <span class="hlFld-ContribAuthor ">Alessandra  Gennari</span>, <span class="hlFld-ContribAuthor ">Antonio  Sica</span>. </span><span class="cited-content_cbyCitation_article-title">Implications of metabolism-driven myeloid dysfunctions in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Cellular & Molecular Immunology</span><span> <strong>2021,</strong> <em>18 </em>
                                    (4)
                                     , 829-841. <a href="https://doi.org/10.1038/s41423-020-00556-w" title="DOI URL">https://doi.org/10.1038/s41423-020-00556-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41423-020-00556-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41423-020-00556-w%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520%2526%2520Molecular%2520Immunology%26atitle%3DImplications%252Bof%252Bmetabolism-driven%252Bmyeloid%252Bdysfunctions%252Bin%252Bcancer%252Btherapy%26aulast%3DStrauss%26aufirst%3DLaura%26date%3D2021%26date%3D2020%26volume%3D18%26issue%3D4%26spage%3D829%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wanheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Kuojun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yiwu  Yao</span>, <span class="hlFld-ContribAuthor ">Yunyao  Liu</span>, <span class="hlFld-ContribAuthor ">Yong  Ni</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Yatao  Qiu</span>, <span class="hlFld-ContribAuthor ">Dexiang  Wang</span>, <span class="hlFld-ContribAuthor ">Dong  Chen</span>, <span class="hlFld-ContribAuthor ">Lei  Qiang</span>, <span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Sheng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Dual nicotinamide phosphoribosyltransferase and epidermal growth factor receptor inhibitors for the treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113022. <a href="https://doi.org/10.1016/j.ejmech.2020.113022" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252Bnicotinamide%252Bphosphoribosyltransferase%252Band%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%26aulast%3DZhang%26aufirst%3DWanheng%26date%3D2021%26volume%3D211%26spage%3D113022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongwei  Lv</span>, <span class="hlFld-ContribAuthor ">Guishuai  Lv</span>, <span class="hlFld-ContribAuthor ">Cian  Chen</span>, <span class="hlFld-ContribAuthor ">Qianni  Zong</span>, <span class="hlFld-ContribAuthor ">Guoqing  Jiang</span>, <span class="hlFld-ContribAuthor ">Dan  Ye</span>, <span class="hlFld-ContribAuthor ">Xiuliang  Cui</span>, <span class="hlFld-ContribAuthor ">Yufei  He</span>, <span class="hlFld-ContribAuthor ">Wei  Xiang</span>, <span class="hlFld-ContribAuthor ">Qin  Han</span>, <span class="hlFld-ContribAuthor ">Liang  Tang</span>, <span class="hlFld-ContribAuthor ">Wen  Yang</span>, <span class="hlFld-ContribAuthor ">Hongyang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion. </span><span class="cited-content_cbyCitation_journal-name">Cell Metabolism</span><span> <strong>2021,</strong> <em>33 </em>
                                    (1)
                                     , 110-127.e5. <a href="https://doi.org/10.1016/j.cmet.2020.10.021" title="DOI URL">https://doi.org/10.1016/j.cmet.2020.10.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cmet.2020.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cmet.2020.10.021%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Metabolism%26atitle%3DNAD%25252B%252BMetabolism%252BMaintains%252BInducible%252BPD-L1%252BExpression%252Bto%252BDrive%252BTumor%252BImmune%252BEvasion%26aulast%3DLv%26aufirst%3DHongwei%26date%3D2021%26volume%3D33%26issue%3D1%26spage%3D110%26epage%3D127.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gargi Nikhil  Vaidya</span>, <span class="hlFld-ContribAuthor ">Pooja  Rana</span>, <span class="hlFld-ContribAuthor ">Ashwini  Venkatesh</span>, <span class="hlFld-ContribAuthor ">Deep Rohan  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Darshan  Contractor</span>, <span class="hlFld-ContribAuthor ">Dinesh Parshuram  Satpute</span>, <span class="hlFld-ContribAuthor ">Mithilesh  Nagpure</span>, <span class="hlFld-ContribAuthor ">Alok  Jain</span>, <span class="hlFld-ContribAuthor ">Dinesh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Paradigm shift of âclassicalâ HDAC inhibitors to âhybridâ HDAC inhibitors in therapeutic interventions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112844. <a href="https://doi.org/10.1016/j.ejmech.2020.112844" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112844%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DParadigm%252Bshift%252Bof%252B%2525E2%252580%25259Cclassical%2525E2%252580%25259D%252BHDAC%252Binhibitors%252Bto%252B%2525E2%252580%25259Chybrid%2525E2%252580%25259D%252BHDAC%252Binhibitors%252Bin%252Btherapeutic%252Binterventions%26aulast%3DVaidya%26aufirst%3DGargi%2BNikhil%26date%3D2021%26volume%3D209%26spage%3D112844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shomoita  Sayed</span>. </span><span class="cited-content_cbyCitation_article-title">COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario. </span><span class="cited-content_cbyCitation_journal-name">Cancer Treatment and Research Communications</span><span> <strong>2021,</strong> <em>28 </em>, 100425. <a href="https://doi.org/10.1016/j.ctarc.2021.100425" title="DOI URL">https://doi.org/10.1016/j.ctarc.2021.100425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ctarc.2021.100425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ctarc.2021.100425%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Treatment%2520and%2520Research%2520Communications%26atitle%3DCOVID-19%252Band%252BMalignancy%25253A%252BExploration%252Bof%252Bthe%252Bpossible%252Bgenetic%252Band%252Bepigenetic%252Binterlinks%252Band%252Boverview%252Bof%252Bthe%252Bvaccination%252Bscenario%26aulast%3DSayed%26aufirst%3DShomoita%26date%3D2021%26volume%3D28%26spage%3D100425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Wilk</span>, <span class="hlFld-ContribAuthor ">Faisal  Hayat</span>, <span class="hlFld-ContribAuthor ">Richard  Cunningham</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Li</span>, <span class="hlFld-ContribAuthor ">Silvia  Garavaglia</span>, <span class="hlFld-ContribAuthor ">Leila  Zamani</span>, <span class="hlFld-ContribAuthor ">Davide M.  Ferraris</span>, <span class="hlFld-ContribAuthor ">Peter  Sykora</span>, <span class="hlFld-ContribAuthor ">Joel  Andrews</span>, <span class="hlFld-ContribAuthor ">Jennifer  Clark</span>, <span class="hlFld-ContribAuthor ">Amanda  Davis</span>, <span class="hlFld-ContribAuthor ">Laurent  Chaloin</span>, <span class="hlFld-ContribAuthor ">Menico  Rizzi</span>, <span class="hlFld-ContribAuthor ">Marie  Migaud</span>, <span class="hlFld-ContribAuthor ">Robert W.  Sobol</span>. </span><span class="cited-content_cbyCitation_article-title">Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-57506-9" title="DOI URL">https://doi.org/10.1038/s41598-020-57506-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-57506-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-57506-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DExtracellular%252BNAD%25252B%252Benhances%252BPARP-dependent%252BDNA%252Brepair%252Bcapacity%252Bindependently%252Bof%252BCD73%252Bactivity%26aulast%3DWilk%26aufirst%3DAnna%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhe  Wei</span>, <span class="hlFld-ContribAuthor ">Jessica  Greaney</span>, <span class="hlFld-ContribAuthor ">Wei-Guo Nicholas  Loh</span>, <span class="hlFld-ContribAuthor ">Hayden Anthony  Homer</span>. </span><span class="cited-content_cbyCitation_article-title">Nampt-mediated spindle sizing secures a post-anaphase increase in spindle speed required for extreme asymmetry. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-17088-6" title="DOI URL">https://doi.org/10.1038/s41467-020-17088-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-17088-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-17088-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DNampt-mediated%252Bspindle%252Bsizing%252Bsecures%252Ba%252Bpost-anaphase%252Bincrease%252Bin%252Bspindle%252Bspeed%252Brequired%252Bfor%252Bextreme%252Basymmetry%26aulast%3DWei%26aufirst%3DZhe%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Sica</span>, <span class="hlFld-ContribAuthor ">M. P.  Colombo</span>, <span class="hlFld-ContribAuthor ">A.  Trama</span>, <span class="hlFld-ContribAuthor ">L.  Horn</span>, <span class="hlFld-ContribAuthor ">M. C.  Garassino</span>, <span class="hlFld-ContribAuthor ">V.  Torri</span>. </span><span class="cited-content_cbyCitation_article-title">Immunometabolic Status of COVID-19 Cancer Patients. </span><span class="cited-content_cbyCitation_journal-name">Physiological Reviews</span><span> <strong>2020,</strong> <em>100 </em>
                                    (4)
                                     , 1839-1850. <a href="https://doi.org/10.1152/physrev.00018.2020" title="DOI URL">https://doi.org/10.1152/physrev.00018.2020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/physrev.00018.2020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fphysrev.00018.2020%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysiological%2520Reviews%26atitle%3DImmunometabolic%252BStatus%252Bof%252BCOVID-19%252BCancer%252BPatients%26aulast%3DSica%26aufirst%3DA.%26date%3D2020%26volume%3D100%26issue%3D4%26spage%3D1839%26epage%3D1850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Enkhjargal  Budbazar</span>, <span class="hlFld-ContribAuthor ">Francisca  Rodriguez</span>, <span class="hlFld-ContribAuthor ">JosÃ© M.  Sanchez</span>, <span class="hlFld-ContribAuthor ">Francesca  Seta</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Sirtuin-1 in the Vasculature: Focus on Aortic Aneurysm. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Physiology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphys.2020.01047" title="DOI URL">https://doi.org/10.3389/fphys.2020.01047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphys.2020.01047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphys.2020.01047%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Physiology%26atitle%3DThe%252BRole%252Bof%252BSirtuin-1%252Bin%252Bthe%252BVasculature%25253A%252BFocus%252Bon%252BAortic%252BAneurysm%26aulast%3DBudbazar%26aufirst%3DEnkhjargal%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sei-ichi  Tanuma</span>, <span class="hlFld-ContribAuthor ">Kiyotaka  Katsuragi</span>, <span class="hlFld-ContribAuthor ">Takahiro  Oyama</span>, <span class="hlFld-ContribAuthor ">Atsushi  Yoshimori</span>, <span class="hlFld-ContribAuthor ">Yuri  Shibasaki</span>, <span class="hlFld-ContribAuthor ">Yasunobu  Asawa</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Kosho  Makino</span>, <span class="hlFld-ContribAuthor ">Miwa  Okazawa</span>, <span class="hlFld-ContribAuthor ">Yoko  Ogino</span>, <span class="hlFld-ContribAuthor ">Yoshimi  Sakamoto</span>, <span class="hlFld-ContribAuthor ">Miyuki  Nomura</span>, <span class="hlFld-ContribAuthor ">Akira  Sato</span>, <span class="hlFld-ContribAuthor ">Hideaki  Abe</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Nakamura</span>, <span class="hlFld-ContribAuthor ">Hideyo  Takahashi</span>, <span class="hlFld-ContribAuthor ">Nobuhiro  Tanuma</span>, <span class="hlFld-ContribAuthor ">Fumiaki  Uchiumi</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (16)
                                     , 3633. <a href="https://doi.org/10.3390/molecules25163633" title="DOI URL">https://doi.org/10.3390/molecules25163633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25163633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25163633%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructural%252BBasis%252Bof%252BBeneficial%252BDesign%252Bfor%252BEffective%252BNicotinamide%252BPhosphoribosyltransferase%252BInhibitors%26aulast%3DTanuma%26aufirst%3DSei-ichi%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D16%26spage%3D3633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lioubov  Korotchkina</span>, <span class="hlFld-ContribAuthor ">Denis  Kazyulkin</span>, <span class="hlFld-ContribAuthor ">Pavel G.  Komarov</span>, <span class="hlFld-ContribAuthor ">Alex  Polinsky</span>, <span class="hlFld-ContribAuthor ">Ekaterina L.  Andrianova</span>, <span class="hlFld-ContribAuthor ">Sangeeta  Joshi</span>, <span class="hlFld-ContribAuthor ">Mahima  Gupta</span>, <span class="hlFld-ContribAuthor ">Slavoljub  Vujcic</span>, <span class="hlFld-ContribAuthor ">Eugene  Kononov</span>, <span class="hlFld-ContribAuthor ">Ilia  Toshkov</span>, <span class="hlFld-ContribAuthor ">Yuan  Tian</span>, <span class="hlFld-ContribAuthor ">Peter  Krasnov</span>, <span class="hlFld-ContribAuthor ">Mikhail V.  Chernov</span>, <span class="hlFld-ContribAuthor ">Jean  Veith</span>, <span class="hlFld-ContribAuthor ">Marina P.  Antoch</span>, <span class="hlFld-ContribAuthor ">Shiloh  Middlemiss</span>, <span class="hlFld-ContribAuthor ">Klaartje  Somers</span>, <span class="hlFld-ContribAuthor ">Richard B.  Lock</span>, <span class="hlFld-ContribAuthor ">Murray D.  Norris</span>, <span class="hlFld-ContribAuthor ">Michelle J.  Henderson</span>, <span class="hlFld-ContribAuthor ">Michelle  Haber</span>, <span class="hlFld-ContribAuthor ">Olga B.  Chernova</span>, <span class="hlFld-ContribAuthor ">Andrei V.  Gudkov</span>. </span><span class="cited-content_cbyCitation_article-title">OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2020,</strong> <em>34 </em>
                                    (7)
                                     , 1828-1839. <a href="https://doi.org/10.1038/s41375-019-0692-5" title="DOI URL">https://doi.org/10.1038/s41375-019-0692-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41375-019-0692-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41375-019-0692-5%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DOT-82%25252C%252Ba%252Bnovel%252Banticancer%252Bdrug%252Bcandidate%252Bthat%252Btargets%252Bthe%252Bstrong%252Bdependence%252Bof%252Bhematological%252Bmalignancies%252Bon%252BNAD%252Bbiosynthesis%26aulast%3DKorotchkina%26aufirst%3DLioubov%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D7%26spage%3D1828%26epage%3D1839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ubaldina  Galli</span>, <span class="hlFld-ContribAuthor ">Giorgia  Colombo</span>, <span class="hlFld-ContribAuthor ">Cristina  Travelli</span>, <span class="hlFld-ContribAuthor ">Gian Cesare  Tron</span>, <span class="hlFld-ContribAuthor ">Armando A.  Genazzani</span>, <span class="hlFld-ContribAuthor ">Ambra A.  Grolla</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00656" title="DOI URL">https://doi.org/10.3389/fphar.2020.00656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00656%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DRecent%252BAdvances%252Bin%252BNAMPT%252BInhibitors%25253A%252BA%252BNovel%252BImmunotherapic%252BStrategy%26aulast%3DGalli%26aufirst%3DUbaldina%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentina  Audrito</span>, <span class="hlFld-ContribAuthor ">Vincenzo Gianluca  Messana</span>, <span class="hlFld-ContribAuthor ">Silvia  Deaglio</span>. </span><span class="cited-content_cbyCitation_article-title">NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.00358" title="DOI URL">https://doi.org/10.3389/fonc.2020.00358</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.00358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.00358%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DNAMPT%252Band%252BNAPRT%25253A%252BTwo%252BMetabolic%252BEnzymes%252BWith%252BKey%252BRoles%252Bin%252BInflammation%26aulast%3DAudrito%26aufirst%3DValentina%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentina  Audrito</span>, <span class="hlFld-ContribAuthor ">Antonella  ManagÃ²</span>, <span class="hlFld-ContribAuthor ">Federica  Gaudino</span>, <span class="hlFld-ContribAuthor ">Silvia  Deaglio</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cell & Developmental Biology</span><span> <strong>2020,</strong> <em>98 </em>, 192-201. <a href="https://doi.org/10.1016/j.semcdb.2019.05.001" title="DOI URL">https://doi.org/10.1016/j.semcdb.2019.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcdb.2019.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcdb.2019.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cell%2520%2526%2520Developmental%2520Biology%26atitle%3DTargeting%252Bmetabolic%252Breprogramming%252Bin%252Bmetastatic%252Bmelanoma%25253A%252BThe%252Bkey%252Brole%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DAudrito%26aufirst%3DValentina%26date%3D2020%26volume%3D98%26spage%3D192%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Tomaselli</span>, <span class="hlFld-ContribAuthor ">Alessia  Lucidi</span>, <span class="hlFld-ContribAuthor ">Dante  Rotili</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetic polypharmacology: A new frontier for epiâdrug discovery. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (1)
                                     , 190-244. <a href="https://doi.org/10.1002/med.21600" title="DOI URL">https://doi.org/10.1002/med.21600</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21600%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DEpigenetic%252Bpolypharmacology%25253A%252BA%252Bnew%252Bfrontier%252Bfor%252Bepi%2525E2%252580%252590drug%252Bdiscovery%26aulast%3DTomaselli%26aufirst%3DDaniela%26date%3D2020%26date%3D2019%26volume%3D40%26issue%3D1%26spage%3D190%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoko  Ogino</span>, <span class="hlFld-ContribAuthor ">Akira  Sato</span>, <span class="hlFld-ContribAuthor ">Fumiaki  Uchiumi</span>, <span class="hlFld-ContribAuthor ">Sei-ichi  Tanuma</span>. </span><span class="cited-content_cbyCitation_article-title">Genomic and tumor biological aspects of the anticancer nicotinamide phosphoribosyltransferase inhibitor FK866 in resistant human colorectal cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Genomics</span><span> <strong>2019,</strong> <em>111 </em>
                                    (6)
                                     , 1889-1895. <a href="https://doi.org/10.1016/j.ygeno.2018.12.012" title="DOI URL">https://doi.org/10.1016/j.ygeno.2018.12.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ygeno.2018.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ygeno.2018.12.012%26sid%3Dliteratum%253Aachs%26jtitle%3DGenomics%26atitle%3DGenomic%252Band%252Btumor%252Bbiological%252Baspects%252Bof%252Bthe%252Banticancer%252Bnicotinamide%252Bphosphoribosyltransferase%252Binhibitor%252BFK866%252Bin%252Bresistant%252Bhuman%252Bcolorectal%252Bcancer%252Bcells%26aulast%3DOgino%26aufirst%3DYoko%26date%3D2019%26volume%3D111%26issue%3D6%26spage%3D1889%26epage%3D1895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Travelli</span>, <span class="hlFld-ContribAuthor ">Silvio  Aprile</span>, <span class="hlFld-ContribAuthor ">Daiana  Mattoteia</span>, <span class="hlFld-ContribAuthor ">Giorgia  Colombo</span>, <span class="hlFld-ContribAuthor ">Nausicaa  Clemente</span>, <span class="hlFld-ContribAuthor ">Eugenio  Scanziani</span>, <span class="hlFld-ContribAuthor ">Salvatore  Terrazzino</span>, <span class="hlFld-ContribAuthor ">Maria Alessandra  Alisi</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Polenzani</span>, <span class="hlFld-ContribAuthor ">Giorgio  Grosa</span>, <span class="hlFld-ContribAuthor ">Armando A.  Genazzani</span>, <span class="hlFld-ContribAuthor ">Gian Cesare  Tron</span>, <span class="hlFld-ContribAuthor ">Ubaldina  Galli</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>181 </em>, 111576. <a href="https://doi.org/10.1016/j.ejmech.2019.111576" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111576</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111576%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bpotent%252Btriazolylpyridine%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Binhibitors%252Bbearing%252Ba%252B1%25252C2%25252C3-triazole%252Btail%252Bgroup%26aulast%3DTravelli%26aufirst%3DCristina%26date%3D2019%26volume%3D181%26spage%3D111576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siqi  Chen</span>, <span class="hlFld-ContribAuthor ">Derek A  Wainwright</span>, <span class="hlFld-ContribAuthor ">Jennifer D  Wu</span>, <span class="hlFld-ContribAuthor ">Yong  Wan</span>, <span class="hlFld-ContribAuthor ">Daniela E  Matei</span>, <span class="hlFld-ContribAuthor ">Yi  Zhang</span>, <span class="hlFld-ContribAuthor ">Bin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">CD73: an emerging checkpoint for cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Immunotherapy</span><span> <strong>2019,</strong> <em>11 </em>
                                    (11)
                                     , 983-997. <a href="https://doi.org/10.2217/imt-2018-0200" title="DOI URL">https://doi.org/10.2217/imt-2018-0200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/imt-2018-0200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fimt-2018-0200%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunotherapy%26atitle%3DCD73%25253A%252Ban%252Bemerging%252Bcheckpoint%252Bfor%252Bcancer%252Bimmunotherapy%26aulast%3DChen%26aufirst%3DSiqi%26date%3D2019%26volume%3D11%26issue%3D11%26spage%3D983%26epage%3D997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentina  Audrito</span>, <span class="hlFld-ContribAuthor ">Antonella  ManagÃ²</span>, <span class="hlFld-ContribAuthor ">Federica  Gaudino</span>, <span class="hlFld-ContribAuthor ">Leonardo  Sorci</span>, <span class="hlFld-ContribAuthor ">Vincenzo Gianluca  Messana</span>, <span class="hlFld-ContribAuthor ">Nadia  Raffaelli</span>, <span class="hlFld-ContribAuthor ">Silvia  Deaglio</span>. </span><span class="cited-content_cbyCitation_article-title">NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fimmu.2019.01720" title="DOI URL">https://doi.org/10.3389/fimmu.2019.01720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2019.01720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2019.01720%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DNAD-Biosynthetic%252Band%252BConsuming%252BEnzymes%252Bas%252BCentral%252BPlayers%252Bof%252BMetabolic%252BRegulation%252Bof%252BInnate%252Band%252BAdaptive%252BImmune%252BResponses%252Bin%252BCancer%26aulast%3DAudrito%26aufirst%3DValentina%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasunobu  Asawa</span>, <span class="hlFld-ContribAuthor ">Kiyotaka  Katsuragi</span>, <span class="hlFld-ContribAuthor ">Akira  Sato</span>, <span class="hlFld-ContribAuthor ">Atsushi  Yoshimori</span>, <span class="hlFld-ContribAuthor ">Sei-ichi  Tanuma</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Nakamura</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based drug design of novel carborane-containing nicotinamide phosphoribosyltransferase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (13)
                                     , 2832-2844. <a href="https://doi.org/10.1016/j.bmc.2019.05.013" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.05.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.05.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdrug%252Bdesign%252Bof%252Bnovel%252Bcarborane-containing%252Bnicotinamide%252Bphosphoribosyltransferase%252Binhibitors%26aulast%3DAsawa%26aufirst%3DYasunobu%26date%3D2019%26volume%3D27%26issue%3D13%26spage%3D2832%26epage%3D2844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuojun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong  Ni</span>, <span class="hlFld-ContribAuthor ">Jiaxuan  Chen</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Xiaoxing  Wu</span>, <span class="hlFld-ContribAuthor ">Dong  Chen</span>, <span class="hlFld-ContribAuthor ">Hequan  Yao</span>, <span class="hlFld-ContribAuthor ">Sheng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of trans-3-(pyridin-3-yl)acrylamide-derived sulfamides as potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitors for the potential treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (12)
                                     , 1502-1506. <a href="https://doi.org/10.1016/j.bmcl.2019.04.013" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.04.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.04.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Btrans-3-%252528pyridin-3-yl%252529acrylamide-derived%252Bsulfamides%252Bas%252Bpotent%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Binhibitors%252Bfor%252Bthe%252Bpotential%252Btreatment%252Bof%252Bcancer%26aulast%3DZhang%26aufirst%3DKuojun%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D1502%26epage%3D1506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Travelli</span>, <span class="hlFld-ContribAuthor ">Francesca Maria  Consonni</span>, <span class="hlFld-ContribAuthor ">Sabina  Sangaletti</span>, <span class="hlFld-ContribAuthor ">Mariangela  Storto</span>, <span class="hlFld-ContribAuthor ">Sara  Morlacchi</span>, <span class="hlFld-ContribAuthor ">Ambra A.  Grolla</span>, <span class="hlFld-ContribAuthor ">Ubaldina  Galli</span>, <span class="hlFld-ContribAuthor ">Gian Cesare  Tron</span>, <span class="hlFld-ContribAuthor ">Paola  Portararo</span>, <span class="hlFld-ContribAuthor ">Lorenza  Rimassa</span>, <span class="hlFld-ContribAuthor ">Tiziana  Pressiani</span>, <span class="hlFld-ContribAuthor ">Massimiliano  Mazzone</span>, <span class="hlFld-ContribAuthor ">Rosalinda  Trovato</span>, <span class="hlFld-ContribAuthor ">Stefano  Ugel</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Bronte</span>, <span class="hlFld-ContribAuthor ">Claudio  Tripodo</span>, <span class="hlFld-ContribAuthor ">Mario P.  Colombo</span>, <span class="hlFld-ContribAuthor ">Armando A.  Genazzani</span>, <span class="hlFld-ContribAuthor ">Antonio  Sica</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2019,</strong> <em>79 </em>
                                    (8)
                                     , 1938-1951. <a href="https://doi.org/10.1158/0008-5472.CAN-18-1544" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-18-1544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-18-1544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-18-1544%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DNicotinamide%252BPhosphoribosyltransferase%252BActs%252Bas%252Ba%252BMetabolic%252BGate%252Bfor%252BMobilization%252Bof%252BMyeloid-Derived%252BSuppressor%252BCells%26aulast%3DTravelli%26aufirst%3DCristina%26date%3D2019%26date%3D2019%26volume%3D79%26issue%3D8%26spage%3D1938%26epage%3D1951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romana R  Gerner</span>, <span class="hlFld-ContribAuthor ">Victoria  Klepsch</span>, <span class="hlFld-ContribAuthor ">Sophie  Macheiner</span>, <span class="hlFld-ContribAuthor ">Kathrin  Arnhard</span>, <span class="hlFld-ContribAuthor ">Timon E  Adolph</span>, <span class="hlFld-ContribAuthor ">Christoph  Grander</span>, <span class="hlFld-ContribAuthor ">Verena  Wieser</span>, <span class="hlFld-ContribAuthor ">Alexandra  Pfister</span>, <span class="hlFld-ContribAuthor ">Patrizia  Moser</span>, <span class="hlFld-ContribAuthor ">Natascha  Hermann-Kleiter</span>, <span class="hlFld-ContribAuthor ">Gottfried  Baier</span>, <span class="hlFld-ContribAuthor ">Herbert  Oberacher</span>, <span class="hlFld-ContribAuthor ">Herbert  Tilg</span>, <span class="hlFld-ContribAuthor ">Alexander R  Moschen</span>. </span><span class="cited-content_cbyCitation_article-title">NAD metabolism fuels human and mouse intestinal inflammation. </span><span class="cited-content_cbyCitation_journal-name">Gut</span><span> <strong>2018,</strong> <em>67 </em>
                                    (10)
                                     , 1813-1823. <a href="https://doi.org/10.1136/gutjnl-2017-314241" title="DOI URL">https://doi.org/10.1136/gutjnl-2017-314241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1136/gutjnl-2017-314241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1136%2Fgutjnl-2017-314241%26sid%3Dliteratum%253Aachs%26jtitle%3DGut%26atitle%3DNAD%252Bmetabolism%252Bfuels%252Bhuman%252Band%252Bmouse%252Bintestinal%252Binflammation%26aulast%3DGerner%26aufirst%3DRomana%2BR%26date%3D2018%26date%3D2017%26volume%3D67%26issue%3D10%26spage%3D1813%26epage%3D1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Diguet</span>, <span class="hlFld-ContribAuthor ">Samuel A.J.  Trammell</span>, <span class="hlFld-ContribAuthor ">Cynthia  Tannous</span>, <span class="hlFld-ContribAuthor ">Robin  Deloux</span>, <span class="hlFld-ContribAuthor ">JÃ©rÃ´me  Piquereau</span>, <span class="hlFld-ContribAuthor ">Nathalie  Mougenot</span>, <span class="hlFld-ContribAuthor ">Anne  Gouge</span>, <span class="hlFld-ContribAuthor ">MÃ©lanie  Gressette</span>, <span class="hlFld-ContribAuthor ">Boris  Manoury</span>, <span class="hlFld-ContribAuthor ">Jocelyne  Blanc</span>, <span class="hlFld-ContribAuthor ">Marie  Breton</span>, <span class="hlFld-ContribAuthor ">Jean-FranÃ§ois  Decaux</span>, <span class="hlFld-ContribAuthor ">Gareth G.  Lavery</span>, <span class="hlFld-ContribAuthor ">IstvÃ¡n  BaczkÃ³</span>, <span class="hlFld-ContribAuthor ">Joffrey  Zoll</span>, <span class="hlFld-ContribAuthor ">Anne  Garnier</span>, <span class="hlFld-ContribAuthor ">Zhenlin  Li</span>, <span class="hlFld-ContribAuthor ">Charles  Brenner</span>, <span class="hlFld-ContribAuthor ">Mathias  Mericskay</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy. </span><span class="cited-content_cbyCitation_journal-name">Circulation</span><span> <strong>2018,</strong> <em>137 </em>
                                    (21)
                                     , 2256-2273. <a href="https://doi.org/10.1161/CIRCULATIONAHA.116.026099" title="DOI URL">https://doi.org/10.1161/CIRCULATIONAHA.116.026099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/CIRCULATIONAHA.116.026099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FCIRCULATIONAHA.116.026099%26sid%3Dliteratum%253Aachs%26jtitle%3DCirculation%26atitle%3DNicotinamide%252BRiboside%252BPreserves%252BCardiac%252BFunction%252Bin%252Ba%252BMouse%252BModel%252Bof%252BDilated%252BCardiomyopathy%26aulast%3DDiguet%26aufirst%3DNicolas%26date%3D2018%26volume%3D137%26issue%3D21%26spage%3D2256%26epage%3D2273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentina  Audrito</span>, <span class="hlFld-ContribAuthor ">Antonella  ManagÃ²</span>, <span class="hlFld-ContribAuthor ">Federica  Zamporlini</span>, <span class="hlFld-ContribAuthor ">Eliana  Rulli</span>, <span class="hlFld-ContribAuthor ">Federica  Gaudino</span>, <span class="hlFld-ContribAuthor ">Gabriele  Madonna</span>, <span class="hlFld-ContribAuthor ">Stefania  D'Atri</span>, <span class="hlFld-ContribAuthor ">Gian Carlo  Antonini Cappellini</span>, <span class="hlFld-ContribAuthor ">Paolo Antonio  Ascierto</span>, <span class="hlFld-ContribAuthor ">Daniela  Massi</span>, <span class="hlFld-ContribAuthor ">Nadia  Raffaelli</span>, <span class="hlFld-ContribAuthor ">Mario  MandalÃ </span>, <span class="hlFld-ContribAuthor ">Silvia  Deaglio</span>. </span><span class="cited-content_cbyCitation_article-title">Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (27)
                                     , 18997-19005. <a href="https://doi.org/10.18632/oncotarget.24871" title="DOI URL">https://doi.org/10.18632/oncotarget.24871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.24871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.24871%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DExtracellular%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528eNAMPT%252529%252Bis%252Ba%252Bnovel%252Bmarker%252Bfor%252Bpatients%252Bwith%252BBRAF-mutated%252Bmetastatic%252Bmelanoma%26aulast%3DAudrito%26aufirst%3DValentina%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D27%26spage%3D18997%26epage%3D19005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Buonvicino</span>, <span class="hlFld-ContribAuthor ">Francesca  Mazzola</span>, <span class="hlFld-ContribAuthor ">Federica  Zamporlini</span>, <span class="hlFld-ContribAuthor ">Francesco  Resta</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Ranieri</span>, <span class="hlFld-ContribAuthor ">Emidio  Camaioni</span>, <span class="hlFld-ContribAuthor ">Mirko  Muzzi</span>, <span class="hlFld-ContribAuthor ">Riccardo  Zecchi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Pieraccini</span>, <span class="hlFld-ContribAuthor ">Christian  DÃ¶lle</span>, <span class="hlFld-ContribAuthor ">Massimo  Calamante</span>, <span class="hlFld-ContribAuthor ">Gianluca  Bartolucci</span>, <span class="hlFld-ContribAuthor ">Mathias  Ziegler</span>, <span class="hlFld-ContribAuthor ">Barbara  Stecca</span>, <span class="hlFld-ContribAuthor ">Nadia  Raffaelli</span>, <span class="hlFld-ContribAuthor ">Alberto  Chiarugi</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2018,</strong> <em>25 </em>
                                    (4)
                                     , 471-482.e7. <a href="https://doi.org/10.1016/j.chembiol.2018.01.012" title="DOI URL">https://doi.org/10.1016/j.chembiol.2018.01.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2018.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2018.01.012%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DIdentification%252Bof%252Bthe%252BNicotinamide%252BSalvage%252BPathway%252Bas%252Ba%252BNew%252BToxification%252BRoute%252Bfor%252BAntimetabolites%26aulast%3DBuonvicino%26aufirst%3DDaniela%26date%3D2018%26volume%3D25%26issue%3D4%26spage%3D471%26epage%3D482.e7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoko  Ogino</span>, <span class="hlFld-ContribAuthor ">Akira  Sato</span>, <span class="hlFld-ContribAuthor ">Fumiaki  Uchiumi</span>, <span class="hlFld-ContribAuthor ">Sei-ichi  Tanuma</span>. </span><span class="cited-content_cbyCitation_article-title">Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (23)
                                     , 16451-16461. <a href="https://doi.org/10.18632/oncotarget.24731" title="DOI URL">https://doi.org/10.18632/oncotarget.24731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.24731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.24731%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DCross%252Bresistance%252Bto%252Bdiverse%252Banticancer%252Bnicotinamide%252Bphosphoribosyltransferase%252Binhibitors%252Binduced%252Bby%252BFK866%252Btreatment%26aulast%3DOgino%26aufirst%3DYoko%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D23%26spage%3D16451%26epage%3D16461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentina  Audrito</span>, <span class="hlFld-ContribAuthor ">Antonella  ManagÃ²</span>, <span class="hlFld-ContribAuthor ">Sofia  La Vecchia</span>, <span class="hlFld-ContribAuthor ">Federica  Zamporlini</span>, <span class="hlFld-ContribAuthor ">Nicoletta  Vitale</span>, <span class="hlFld-ContribAuthor ">Gianna  Baroni</span>, <span class="hlFld-ContribAuthor ">Simona  Cignetto</span>, <span class="hlFld-ContribAuthor ">Sara  Serra</span>, <span class="hlFld-ContribAuthor ">Cinzia  Bologna</span>, <span class="hlFld-ContribAuthor ">Aureliano  Stingi</span>, <span class="hlFld-ContribAuthor ">Francesca  Arruga</span>, <span class="hlFld-ContribAuthor ">Tiziana  Vaisitti</span>, <span class="hlFld-ContribAuthor ">Daniela  Massi</span>, <span class="hlFld-ContribAuthor ">Mario  MandalÃ </span>, <span class="hlFld-ContribAuthor ">Nadia  Raffaelli</span>, <span class="hlFld-ContribAuthor ">Silvia  Deaglio</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma. </span><span class="cited-content_cbyCitation_journal-name">JNCI: Journal of the National Cancer Institute</span><span> <strong>2018,</strong> <em>110 </em>
                                    (3)
                                     , 290-303. <a href="https://doi.org/10.1093/jnci/djx198" title="DOI URL">https://doi.org/10.1093/jnci/djx198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jnci/djx198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjnci%2Fdjx198%26sid%3Dliteratum%253Aachs%26jtitle%3DJNCI%253A%2520Journal%2520of%2520the%2520National%2520Cancer%2520Institute%26atitle%3DNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%252Bas%252Ba%252BTherapeutic%252BTarget%252Bin%252BBRAF-Mutated%252BMetastatic%252BMelanoma%26aulast%3DAudrito%26aufirst%3DValentina%26date%3D2018%26date%3D2017%26volume%3D110%26issue%3D3%26spage%3D290%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel S.  Palacios</span>, <span class="hlFld-ContribAuthor ">Erik  Meredith</span>, <span class="hlFld-ContribAuthor ">Toshio  Kawanami</span>, <span class="hlFld-ContribAuthor ">Christopher  Adams</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Veronique  Darsigny</span>, <span class="hlFld-ContribAuthor ">Erin  Geno</span>, <span class="hlFld-ContribAuthor ">Mark  Palermo</span>, <span class="hlFld-ContribAuthor ">Daniel  Baird</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Boynton</span>, <span class="hlFld-ContribAuthor ">Scott A.  Busby</span>, <span class="hlFld-ContribAuthor ">Elizabeth L.  George</span>, <span class="hlFld-ContribAuthor ">Chantale  Guy</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Hewett</span>, <span class="hlFld-ContribAuthor ">Laryssa  Tierney</span>, <span class="hlFld-ContribAuthor ">Sachin  Thigale</span>, <span class="hlFld-ContribAuthor ">Wilhelm  Weihofen</span>, <span class="hlFld-ContribAuthor ">Louis  Wang</span>, <span class="hlFld-ContribAuthor ">Nicole  White</span>, <span class="hlFld-ContribAuthor ">Ming  Yin</span>, <span class="hlFld-ContribAuthor ">Upendra A.  Argikar</span>. </span><span class="cited-content_cbyCitation_article-title">Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screen. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (3)
                                     , 365-370. <a href="https://doi.org/10.1016/j.bmcl.2017.12.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.12.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.12.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%252Bbased%252Bdesign%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Binhibitors%252Bfrom%252Ba%252Bphenotypic%252Bscreen%26aulast%3DPalacios%26aufirst%3DDaniel%2BS.%26date%3D2018%26volume%3D28%26issue%3D3%26spage%3D365%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai-long  Zhang</span>, <span class="hlFld-ContribAuthor ">Tian-ying  Xu</span>, <span class="hlFld-ContribAuthor ">Zhen-Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Shuo  Han</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Chao-yu  Miao</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure-based comparison of two NAMPT inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2018,</strong> <em>39 </em>
                                    (2)
                                     , 294-301. <a href="https://doi.org/10.1038/aps.2017.80" title="DOI URL">https://doi.org/10.1038/aps.2017.80</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2017.80&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2017.80%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DCrystal%252Bstructure-based%252Bcomparison%252Bof%252Btwo%252BNAMPT%252Binhibitors%26aulast%3DZhang%26aufirst%3DSai-long%26date%3D2018%26date%3D2017%26volume%3D39%26issue%3D2%26spage%3D294%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianmarco  Rinaldi</span>, <span class="hlFld-ContribAuthor ">Matteo  Rossi</span>, <span class="hlFld-ContribAuthor ">Sarah-Maria  Fendt</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic interactions in cancer: cellular metabolism at the interface between the microenvironment, the cancer cell phenotype and the epigenetic landscape. </span><span class="cited-content_cbyCitation_journal-name">Wiley Interdisciplinary Reviews: Systems Biology and Medicine</span><span> <strong>2018,</strong> <em>10 </em>
                                    (1)
                                     , e1397. <a href="https://doi.org/10.1002/wsbm.1397" title="DOI URL">https://doi.org/10.1002/wsbm.1397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wsbm.1397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwsbm.1397%26sid%3Dliteratum%253Aachs%26jtitle%3DWiley%2520Interdisciplinary%2520Reviews%253A%2520Systems%2520Biology%2520and%2520Medicine%26atitle%3DMetabolic%252Binteractions%252Bin%252Bcancer%25253A%252Bcellular%252Bmetabolism%252Bat%252Bthe%252Binterface%252Bbetween%252Bthe%252Bmicroenvironment%25252C%252Bthe%252Bcancer%252Bcell%252Bphenotype%252Band%252Bthe%252Bepigenetic%252Blandscape%26aulast%3DRinaldi%26aufirst%3DGianmarco%26date%3D2018%26date%3D2017%26volume%3D10%26issue%3D1%26spage%3De1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Geng-Chin  Wu</span>, <span class="hlFld-ContribAuthor ">Wen-I  Liao</span>, <span class="hlFld-ContribAuthor ">Shu-Yu  Wu</span>, <span class="hlFld-ContribAuthor ">Hsin-Ping  Pao</span>, <span class="hlFld-ContribAuthor ">Shih-En  Tang</span>, <span class="hlFld-ContribAuthor ">Min-Hui  Li</span>, <span class="hlFld-ContribAuthor ">Kun-Lun  Huang</span>, <span class="hlFld-ContribAuthor ">Shi-Jye  Chu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting of nicotinamide phosphoribosyltransferase enzymatic activity ameliorates lung damage induced by ischemia/reperfusion in rats. </span><span class="cited-content_cbyCitation_journal-name">Respiratory Research</span><span> <strong>2017,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12931-017-0557-2" title="DOI URL">https://doi.org/10.1186/s12931-017-0557-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12931-017-0557-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12931-017-0557-2%26sid%3Dliteratum%253Aachs%26jtitle%3DRespiratory%2520Research%26atitle%3DTargeting%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252Benzymatic%252Bactivity%252Bameliorates%252Blung%252Bdamage%252Binduced%252Bby%252Bischemia%25252Freperfusion%252Bin%252Brats%26aulast%3DWu%26aufirst%3DGeng-Chin%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jair Machado  Espindola-Netto</span>, <span class="hlFld-ContribAuthor ">Claudia C.S.  Chini</span>, <span class="hlFld-ContribAuthor ">Mariana  TarragÃ³</span>, <span class="hlFld-ContribAuthor ">Enfeng  Wang</span>, <span class="hlFld-ContribAuthor ">Shamit  Dutta</span>, <span class="hlFld-ContribAuthor ">Krishnendu  Pal</span>, <span class="hlFld-ContribAuthor ">Debabrata  Mukhopadhyay</span>, <span class="hlFld-ContribAuthor ">Mauro  Sola-Penna</span>, <span class="hlFld-ContribAuthor ">Eduardo N.  Chini</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (49)
                                     , 85054-85067. <a href="https://doi.org/10.18632/oncotarget.18841" title="DOI URL">https://doi.org/10.18632/oncotarget.18841</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.18841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.18841%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DPreclinical%252Befficacy%252Bof%252Bthe%252Bnovel%252Bcompetitive%252BNAMPT%252Binhibitor%252BSTF-118804%252Bin%252Bpancreatic%252Bcancer%26aulast%3DEspindola-Netto%26aufirst%3DJair%2BMachado%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D49%26spage%3D85054%26epage%3D85067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin Yue  Wang</span>, <span class="hlFld-ContribAuthor ">Jin Zhi  Wang</span>, <span class="hlFld-ContribAuthor ">Lu  Gao</span>, <span class="hlFld-ContribAuthor ">Fu Yin  Zhang</span>, <span class="hlFld-ContribAuthor ">Qi  Wang</span>, <span class="hlFld-ContribAuthor ">Ke Jian  Liu</span>, <span class="hlFld-ContribAuthor ">Bin  Xiang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Toxicology and Applied Pharmacology</span><span> <strong>2017,</strong> <em>331 </em>, 54-61. <a href="https://doi.org/10.1016/j.taap.2017.05.008" title="DOI URL">https://doi.org/10.1016/j.taap.2017.05.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.taap.2017.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.taap.2017.05.008%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520and%2520Applied%2520Pharmacology%26atitle%3DInhibition%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252Band%252Bdepletion%252Bof%252Bnicotinamide%252Badenine%252Bdinucleotide%252Bcontribute%252Bto%252Barsenic%252Btrioxide%252Bsuppression%252Bof%252Boral%252Bsquamous%252Bcell%252Bcarcinoma%26aulast%3DWang%26aufirst%3DXin%2BYue%26date%3D2017%26volume%3D331%26spage%3D54%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael L.  Curtin</span>, <span class="hlFld-ContribAuthor ">H. Robin  Heyman</span>, <span class="hlFld-ContribAuthor ">Richard F.  Clark</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Sorensen</span>, <span class="hlFld-ContribAuthor ">George A.  Doherty</span>, <span class="hlFld-ContribAuthor ">T. Matthew  Hansen</span>, <span class="hlFld-ContribAuthor ">Robin R.  Frey</span>, <span class="hlFld-ContribAuthor ">Kathy A.  Sarris</span>, <span class="hlFld-ContribAuthor ">Ana L.  Aguirre</span>, <span class="hlFld-ContribAuthor ">Anurupa  Shrestha</span>, <span class="hlFld-ContribAuthor ">Noah  Tu</span>, <span class="hlFld-ContribAuthor ">Kevin  Woller</span>, <span class="hlFld-ContribAuthor ">Marina A.  Pliushchev</span>, <span class="hlFld-ContribAuthor ">Ramzi F.  Sweis</span>, <span class="hlFld-ContribAuthor ">Min  Cheng</span>, <span class="hlFld-ContribAuthor ">Julie L.  Wilsbacher</span>, <span class="hlFld-ContribAuthor ">Peter J.  Kovar</span>, <span class="hlFld-ContribAuthor ">Jun  Guo</span>, <span class="hlFld-ContribAuthor ">Dong  Cheng</span>, <span class="hlFld-ContribAuthor ">Kenton L.  Longenecker</span>, <span class="hlFld-ContribAuthor ">Diana  Raich</span>, <span class="hlFld-ContribAuthor ">Alla V.  Korepanova</span>, <span class="hlFld-ContribAuthor ">Nirupama B.  Soni</span>, <span class="hlFld-ContribAuthor ">Mikkel A.  Algire</span>, <span class="hlFld-ContribAuthor ">Paul L.  Richardson</span>, <span class="hlFld-ContribAuthor ">Violeta L.  Marin</span>, <span class="hlFld-ContribAuthor ">Ilaria  Badagnani</span>, <span class="hlFld-ContribAuthor ">Anil  Vasudevan</span>, <span class="hlFld-ContribAuthor ">F. Greg  Buchanan</span>, <span class="hlFld-ContribAuthor ">David  Maag</span>, <span class="hlFld-ContribAuthor ">Gary G.  Chiang</span>, <span class="hlFld-ContribAuthor ">Chris  Tse</span>, <span class="hlFld-ContribAuthor ">Michael R.  Michaelides</span>. </span><span class="cited-content_cbyCitation_article-title">SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (15)
                                     , 3317-3325. <a href="https://doi.org/10.1016/j.bmcl.2017.06.018" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.06.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.06.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSAR%252Band%252Bcharacterization%252Bof%252Bnon-substrate%252Bisoindoline%252Burea%252Binhibitors%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DCurtin%26aufirst%3DMichael%2BL.%26date%3D2017%26volume%3D27%26issue%3D15%26spage%3D3317%26epage%3D3325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Piacente</span>, <span class="hlFld-ContribAuthor ">Irene  Caffa</span>, <span class="hlFld-ContribAuthor ">Silvia  Ravera</span>, <span class="hlFld-ContribAuthor ">Giovanna  Sociali</span>, <span class="hlFld-ContribAuthor ">Mario  Passalacqua</span>, <span class="hlFld-ContribAuthor ">Valerio G.  Vellone</span>, <span class="hlFld-ContribAuthor ">Pamela  Becherini</span>, <span class="hlFld-ContribAuthor ">Daniele  Reverberi</span>, <span class="hlFld-ContribAuthor ">Fiammetta  Monacelli</span>, <span class="hlFld-ContribAuthor ">Alberto  Ballestrero</span>, <span class="hlFld-ContribAuthor ">Patrizio  Odetti</span>, <span class="hlFld-ContribAuthor ">Antonia  Cagnetta</span>, <span class="hlFld-ContribAuthor ">Michele  Cea</span>, <span class="hlFld-ContribAuthor ">Aimable  Nahimana</span>, <span class="hlFld-ContribAuthor ">Michel  Duchosal</span>, <span class="hlFld-ContribAuthor ">Santina  Bruzzone</span>, <span class="hlFld-ContribAuthor ">Alessio  Nencioni</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2017,</strong> <em>77 </em>
                                    (14)
                                     , 3857-3869. <a href="https://doi.org/10.1158/0008-5472.CAN-16-3079" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-16-3079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-16-3079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-16-3079%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DNicotinic%252BAcid%252BPhosphoribosyltransferase%252BRegulates%252BCancer%252BCell%252BMetabolism%25252C%252BSusceptibility%252Bto%252BNAMPT%252BInhibitors%25252C%252Band%252BDNA%252BRepair%26aulast%3DPiacente%26aufirst%3DFrancesco%26date%3D2017%26date%3D2017%26volume%3D77%26issue%3D14%26spage%3D3857%26epage%3D3869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julie L.  Wilsbacher</span>, <span class="hlFld-ContribAuthor ">Min  Cheng</span>, <span class="hlFld-ContribAuthor ">Dong  Cheng</span>, <span class="hlFld-ContribAuthor ">Samuel A.J.  Trammell</span>, <span class="hlFld-ContribAuthor ">Yan  Shi</span>, <span class="hlFld-ContribAuthor ">Jun  Guo</span>, <span class="hlFld-ContribAuthor ">Stormy L.  Koeniger</span>, <span class="hlFld-ContribAuthor ">Peter J.  Kovar</span>, <span class="hlFld-ContribAuthor ">Yupeng  He</span>, <span class="hlFld-ContribAuthor ">Sujatha  Selvaraju</span>, <span class="hlFld-ContribAuthor ">H. Robin  Heyman</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Sorensen</span>, <span class="hlFld-ContribAuthor ">Richard F.  Clark</span>, <span class="hlFld-ContribAuthor ">T. Matthew  Hansen</span>, <span class="hlFld-ContribAuthor ">Kenton L.  Longenecker</span>, <span class="hlFld-ContribAuthor ">Diana  Raich</span>, <span class="hlFld-ContribAuthor ">Alla V.  Korepanova</span>, <span class="hlFld-ContribAuthor ">Steven  Cepa</span>, <span class="hlFld-ContribAuthor ">Danli L.  Towne</span>, <span class="hlFld-ContribAuthor ">Vivek C.  Abraham</span>, <span class="hlFld-ContribAuthor ">Hua  Tang</span>, <span class="hlFld-ContribAuthor ">Paul L.  Richardson</span>, <span class="hlFld-ContribAuthor ">Shaun M.  McLoughlin</span>, <span class="hlFld-ContribAuthor ">Ilaria  Badagnani</span>, <span class="hlFld-ContribAuthor ">Michael L.  Curtin</span>, <span class="hlFld-ContribAuthor ">Michael R.  Michaelides</span>, <span class="hlFld-ContribAuthor ">David  Maag</span>, <span class="hlFld-ContribAuthor ">F. Gregory  Buchanan</span>, <span class="hlFld-ContribAuthor ">Gary G.  Chiang</span>, <span class="hlFld-ContribAuthor ">Wenqing  Gao</span>, <span class="hlFld-ContribAuthor ">Saul H.  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Charles  Brenner</span>, <span class="hlFld-ContribAuthor ">Chris  Tse</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2017,</strong> <em>16 </em>
                                    (7)
                                     , 1236-1245. <a href="https://doi.org/10.1158/1535-7163.MCT-16-0819" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-16-0819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-16-0819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-16-0819%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252BNovel%252BNonsubstrate%252Band%252BSubstrate%252BNAMPT%252BInhibitors%26aulast%3DWilsbacher%26aufirst%3DJulie%2BL.%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D7%26spage%3D1236%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiziana  Tataranni</span>, <span class="hlFld-ContribAuthor ">Francesca  Agriesti</span>, <span class="hlFld-ContribAuthor ">Vitalba  Ruggieri</span>, <span class="hlFld-ContribAuthor ">Carmela  Mazzoccoli</span>, <span class="hlFld-ContribAuthor ">Vittorio  Simeon</span>, <span class="hlFld-ContribAuthor ">Ilaria  Laurenzana</span>, <span class="hlFld-ContribAuthor ">Rosella  Scrima</span>, <span class="hlFld-ContribAuthor ">Valerio  Pazienza</span>, <span class="hlFld-ContribAuthor ">Nazzareno  Capitanio</span>, <span class="hlFld-ContribAuthor ">Claudia  Piccoli</span>. </span><span class="cited-content_cbyCitation_article-title">Rewiring carbohydrate catabolism differentially affects survival of pancreatic cancer cell lines with diverse metabolic profiles. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (25)
                                     , 41265-41281. <a href="https://doi.org/10.18632/oncotarget.17172" title="DOI URL">https://doi.org/10.18632/oncotarget.17172</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.17172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.17172%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DRewiring%252Bcarbohydrate%252Bcatabolism%252Bdifferentially%252Baffects%252Bsurvival%252Bof%252Bpancreatic%252Bcancer%252Bcell%252Blines%252Bwith%252Bdiverse%252Bmetabolic%252Bprofiles%26aulast%3DTataranni%26aufirst%3DTiziana%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D25%26spage%3D41265%26epage%3D41281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adolfo  Amici</span>, <span class="hlFld-ContribAuthor ">Ambra A.  Grolla</span>, <span class="hlFld-ContribAuthor ">Erika  Del Grosso</span>, <span class="hlFld-ContribAuthor ">Roberta  Bellini</span>, <span class="hlFld-ContribAuthor ">Michele  Bianchi</span>, <span class="hlFld-ContribAuthor ">Cristina  Travelli</span>, <span class="hlFld-ContribAuthor ">Silvia  Garavaglia</span>, <span class="hlFld-ContribAuthor ">Leonardo  Sorci</span>, <span class="hlFld-ContribAuthor ">Nadia  Raffaelli</span>, <span class="hlFld-ContribAuthor ">Silverio  Ruggieri</span>, <span class="hlFld-ContribAuthor ">Armando A.  Genazzani</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Orsomando</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Degradation of Adenosine 5â²-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2017,</strong> <em>24 </em>
                                    (5)
                                     , 553-564.e4. <a href="https://doi.org/10.1016/j.chembiol.2017.03.010" title="DOI URL">https://doi.org/10.1016/j.chembiol.2017.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2017.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2017.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DSynthesis%252Band%252BDegradation%252Bof%252BAdenosine%252B5%2525E2%252580%2525B2-Tetraphosphate%252Bby%252BNicotinamide%252Band%252BNicotinate%252BPhosphoribosyltransferases%26aulast%3DAmici%26aufirst%3DAdolfo%26date%3D2017%26volume%3D24%26issue%3D5%26spage%3D553%26epage%3D564.e4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nina  Ilic</span>, <span class="hlFld-ContribAuthor ">KÄ±vanÃ§  Birsoy</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Aguirre</span>, <span class="hlFld-ContribAuthor ">Nora  Kory</span>, <span class="hlFld-ContribAuthor ">Michael E.  Pacold</span>, <span class="hlFld-ContribAuthor ">Shambhavi  Singh</span>, <span class="hlFld-ContribAuthor ">Susan E.  Moody</span>, <span class="hlFld-ContribAuthor ">Joseph D.  DeAngelo</span>, <span class="hlFld-ContribAuthor ">Nicole A.  Spardy</span>, <span class="hlFld-ContribAuthor ">Elizaveta  Freinkman</span>, <span class="hlFld-ContribAuthor ">Barbara A.  Weir</span>, <span class="hlFld-ContribAuthor ">Aviad  Tsherniak</span>, <span class="hlFld-ContribAuthor ">Glenn S.  Cowley</span>, <span class="hlFld-ContribAuthor ">David E.  Root</span>, <span class="hlFld-ContribAuthor ">John M.  Asara</span>, <span class="hlFld-ContribAuthor ">Francisca  Vazquez</span>, <span class="hlFld-ContribAuthor ">Hans R.  Widlund</span>, <span class="hlFld-ContribAuthor ">David M.  Sabatini</span>, <span class="hlFld-ContribAuthor ">William C.  Hahn</span>. </span><span class="cited-content_cbyCitation_article-title">PIK3CA
              mutant tumors depend on oxoglutarate dehydrogenase. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2017,</strong> <em>114 </em>
                                    (17)
                                     , E3434-E3443. <a href="https://doi.org/10.1073/pnas.1617922114" title="DOI URL">https://doi.org/10.1073/pnas.1617922114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1617922114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1617922114%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DPIK3CA%252Bmutant%252Btumors%252Bdepend%252Bon%252Boxoglutarate%252Bdehydrogenase%26aulast%3DIlic%26aufirst%3DNina%26date%3D2017%26date%3D2017%26volume%3D114%26issue%3D17%26spage%3DE3434%26epage%3DE3443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cornelia N.  Mutz</span>, <span class="hlFld-ContribAuthor ">Raphaela  Schwentner</span>, <span class="hlFld-ContribAuthor ">Dave N.T.  Aryee</span>, <span class="hlFld-ContribAuthor ">Eric D.J.  Bouchard</span>, <span class="hlFld-ContribAuthor ">Edgard M.  Mejia</span>, <span class="hlFld-ContribAuthor ">Grant M.  Hatch</span>, <span class="hlFld-ContribAuthor ">Maximilian O.  Kauer</span>, <span class="hlFld-ContribAuthor ">Anna M.  Katschnig</span>, <span class="hlFld-ContribAuthor ">Jozef  Ban</span>, <span class="hlFld-ContribAuthor ">Antje  Garten</span>, <span class="hlFld-ContribAuthor ">Javier  Alonso</span>, <span class="hlFld-ContribAuthor ">Versha  Banerji</span>, <span class="hlFld-ContribAuthor ">Heinrich  Kovar</span>. </span><span class="cited-content_cbyCitation_article-title">EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (15)
                                     , 24679-24693. <a href="https://doi.org/10.18632/oncotarget.14976" title="DOI URL">https://doi.org/10.18632/oncotarget.14976</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.14976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.14976%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DEWS-FLI1%252Bconfers%252Bexquisite%252Bsensitivity%252Bto%252BNAMPT%252Binhibition%252Bin%252BEwing%252Bsarcoma%252Bcells%26aulast%3DMutz%26aufirst%3DCornelia%2BN.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D15%26spage%3D24679%26epage%3D24693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Denise M.  Inman</span>, <span class="hlFld-ContribAuthor ">Mohammad  Harun-Or-Rashid</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Vulnerability in the Neurodegenerative Disease Glaucoma. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2017,</strong> <em>11 </em><a href="https://doi.org/10.3389/fnins.2017.00146" title="DOI URL">https://doi.org/10.3389/fnins.2017.00146</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2017.00146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2017.00146%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DMetabolic%252BVulnerability%252Bin%252Bthe%252BNeurodegenerative%252BDisease%252BGlaucoma%26aulast%3DInman%26aufirst%3DDenise%2BM.%26date%3D2017%26date%3D2017%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federico  Carbone</span>, <span class="hlFld-ContribAuthor ">Luca  Liberale</span>, <span class="hlFld-ContribAuthor ">Aldo  Bonaventura</span>, <span class="hlFld-ContribAuthor ">Alessandra  VecchiÃ¨</span>, <span class="hlFld-ContribAuthor ">Matteo  Casula</span>, <span class="hlFld-ContribAuthor ">Michele  Cea</span>, <span class="hlFld-ContribAuthor ">Fiammetta  Monacelli</span>, <span class="hlFld-ContribAuthor ">Irene  Caffa</span>, <span class="hlFld-ContribAuthor ">Santina  Bruzzone</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Montecucco</span>, <span class="hlFld-ContribAuthor ">Alessio  Nencioni</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 603-621. <a href="https://doi.org/10.1002/cphy.c160029" title="DOI URL">https://doi.org/10.1002/cphy.c160029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cphy.c160029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcphy.c160029%26sid%3Dliteratum%253Aachs%26atitle%3DRegulation%252Band%252BFunction%252Bof%252BExtracellular%252BNicotinamide%252BPhosphoribosyltransferase%25252FVisfatin%26aulast%3DCarbone%26aufirst%3DFederico%26date%3D2017%26date%3D2017%26spage%3D603%26epage%3D621%26pub%3DWiley%26atitle%3DComprehensive%252BPhysiology%26aulast%3DTerjung%26aufirst%3DRonald%26date%3D2011%26date%3D2011%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit D.  Gujar</span>, <span class="hlFld-ContribAuthor ">Son  Le</span>, <span class="hlFld-ContribAuthor ">Diane D.  Mao</span>, <span class="hlFld-ContribAuthor ">David Y. A.  Dadey</span>, <span class="hlFld-ContribAuthor ">Alice  Turski</span>, <span class="hlFld-ContribAuthor ">Yo  Sasaki</span>, <span class="hlFld-ContribAuthor ">Diane  Aum</span>, <span class="hlFld-ContribAuthor ">Jingqin  Luo</span>, <span class="hlFld-ContribAuthor ">Sonika  Dahiya</span>, <span class="hlFld-ContribAuthor ">Liya  Yuan</span>, <span class="hlFld-ContribAuthor ">Keith M.  Rich</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Milbrandt</span>, <span class="hlFld-ContribAuthor ">Dennis E.  Hallahan</span>, <span class="hlFld-ContribAuthor ">Hiroko  Yano</span>, <span class="hlFld-ContribAuthor ">David D.  Tran</span>, <span class="hlFld-ContribAuthor ">Albert H.  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">An NAD
              +
              -dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2016,</strong> <em>113 </em>
                                    (51)
                                     , E8247-E8256. <a href="https://doi.org/10.1073/pnas.1610921114" title="DOI URL">https://doi.org/10.1073/pnas.1610921114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1610921114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1610921114%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DAn%252BNAD%252B%25252B%252B-dependent%252Btranscriptional%252Bprogram%252Bgoverns%252Bself-renewal%252Band%252Bradiation%252Bresistance%252Bin%252Bglioblastoma%26aulast%3DGujar%26aufirst%3DAmit%2BD.%26date%3D2016%26date%3D2016%26volume%3D113%26issue%3D51%26spage%3DE8247%26epage%3DE8256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michele  Cea</span>, <span class="hlFld-ContribAuthor ">Antonia  Cagnetta</span>, <span class="hlFld-ContribAuthor ">Chirag  Acharya</span>, <span class="hlFld-ContribAuthor ">Prakrati  Acharya</span>, <span class="hlFld-ContribAuthor ">Yu-Tzu  Tai</span>, <span class="hlFld-ContribAuthor ">Cao  Yang</span>, <span class="hlFld-ContribAuthor ">Davide  Lovera</span>, <span class="hlFld-ContribAuthor ">Debora  Soncini</span>, <span class="hlFld-ContribAuthor ">Maurizio  Miglino</span>, <span class="hlFld-ContribAuthor ">Giulio  Fraternali-Orcioni</span>, <span class="hlFld-ContribAuthor ">Luca  Mastracci</span>, <span class="hlFld-ContribAuthor ">Alessio  Nencioni</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Montecucco</span>, <span class="hlFld-ContribAuthor ">Fiammetta  Monacelli</span>, <span class="hlFld-ContribAuthor ">Alberto  Ballestrero</span>, <span class="hlFld-ContribAuthor ">Teru  Hideshima</span>, <span class="hlFld-ContribAuthor ">Dharminder  Chauhan</span>, <span class="hlFld-ContribAuthor ">Marco  Gobbi</span>, <span class="hlFld-ContribAuthor ">Roberto M.  Lemoli</span>, <span class="hlFld-ContribAuthor ">Nikhil  Munshi</span>, <span class="hlFld-ContribAuthor ">Steven P.  Treon</span>, <span class="hlFld-ContribAuthor ">Kenneth C.  Anderson</span>. </span><span class="cited-content_cbyCitation_article-title">Dual NAMPT and BTK Targeting Leads to Synergistic Killing of WaldenstrÃ¶m Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation Status. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2016,</strong> <em>22 </em>
                                    (24)
                                     , 6099-6109. <a href="https://doi.org/10.1158/1078-0432.CCR-16-0630" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-16-0630</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-16-0630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-16-0630%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DDual%252BNAMPT%252Band%252BBTK%252BTargeting%252BLeads%252Bto%252BSynergistic%252BKilling%252Bof%252BWaldenstr%2525C3%2525B6m%252BMacroglobulinemia%252BCells%252BRegardless%252Bof%252BMYD88%252Band%252BCXCR4%252BSomatic%252BMutation%252BStatus%26aulast%3DCea%26aufirst%3DMichele%26date%3D2016%26date%3D2016%26volume%3D22%26issue%3D24%26spage%3D6099%26epage%3D6109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kensuke  Tateishi</span>, <span class="hlFld-ContribAuthor ">A. John  Iafrate</span>, <span class="hlFld-ContribAuthor ">Quan  Ho</span>, <span class="hlFld-ContribAuthor ">William T.  Curry</span>, <span class="hlFld-ContribAuthor ">Tracy T.  Batchelor</span>, <span class="hlFld-ContribAuthor ">Keith T.  Flaherty</span>, <span class="hlFld-ContribAuthor ">Maristela L.  Onozato</span>, <span class="hlFld-ContribAuthor ">Nina  Lelic</span>, <span class="hlFld-ContribAuthor ">Sudhandra  Sundaram</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Cahill</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Chi</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Wakimoto</span>. </span><span class="cited-content_cbyCitation_article-title">Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2016,</strong> <em>22 </em>
                                    (17)
                                     , 4452-4465. <a href="https://doi.org/10.1158/1078-0432.CCR-15-2274" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-15-2274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-15-2274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-15-2274%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DMyc-Driven%252BGlycolysis%252BIs%252Ba%252BTherapeutic%252BTarget%252Bin%252BGlioblastoma%26aulast%3DTateishi%26aufirst%3DKensuke%26date%3D2016%26date%3D2016%26volume%3D22%26issue%3D17%26spage%3D4452%26epage%3D4465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hang  Chen</span>, <span class="hlFld-ContribAuthor ">Shiyu  Wang</span>, <span class="hlFld-ContribAuthor ">Haiyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Edouard C.  Nice</span>, <span class="hlFld-ContribAuthor ">Canhua  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2016,</strong> <em>16 </em>
                                    (8)
                                     , 827-838. <a href="https://doi.org/10.1080/14737140.2016.1190649" title="DOI URL">https://doi.org/10.1080/14737140.2016.1190649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737140.2016.1190649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737140.2016.1190649%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DNicotinamide%252Bphosphoribosyltransferase%252B%252528Nampt%252529%252Bin%252Bcarcinogenesis%25253A%252Bnew%252Bclinical%252Bopportunities%26aulast%3DChen%26aufirst%3DHang%26date%3D2016%26date%3D2016%26volume%3D16%26issue%3D8%26spage%3D827%26epage%3D838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renate Hvidsten  Skoge</span>, <span class="hlFld-ContribAuthor ">Mathias  Ziegler</span>. </span><span class="cited-content_cbyCitation_article-title">SIRT2 inactivation reveals a subset of hyperacetylated perinuclear microtubules inaccessible to HDAC6. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cell Science</span><span> <strong>2016,</strong> <em>129 </em>
                                    (15)
                                     , 2972-2982. <a href="https://doi.org/10.1242/jcs.187518" title="DOI URL">https://doi.org/10.1242/jcs.187518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1242/jcs.187518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1242%2Fjcs.187518%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cell%2520Science%26atitle%3DSIRT2%252Binactivation%252Breveals%252Ba%252Bsubset%252Bof%252Bhyperacetylated%252Bperinuclear%252Bmicrotubules%252Binaccessible%252Bto%252BHDAC6%26aulast%3DSkoge%26aufirst%3DRenate%2BHvidsten%26date%3D2016%26volume%3D129%26issue%3D15%26spage%3D2972%26epage%3D2982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S M  Hong</span>, <span class="hlFld-ContribAuthor ">C W  Park</span>, <span class="hlFld-ContribAuthor ">S W  Kim</span>, <span class="hlFld-ContribAuthor ">Y J  Nam</span>, <span class="hlFld-ContribAuthor ">J H  Yu</span>, <span class="hlFld-ContribAuthor ">J H  Shin</span>, <span class="hlFld-ContribAuthor ">C H  Yun</span>, <span class="hlFld-ContribAuthor ">S-H  Im</span>, <span class="hlFld-ContribAuthor ">K-T  Kim</span>, <span class="hlFld-ContribAuthor ">Y C  Sung</span>, <span class="hlFld-ContribAuthor ">K Y  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">NAMPT suppresses glucose deprivation-induced oxidative stress by increasing NADPH levels in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2016,</strong> <em>35 </em>
                                    (27)
                                     , 3544-3554. <a href="https://doi.org/10.1038/onc.2015.415" title="DOI URL">https://doi.org/10.1038/onc.2015.415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/onc.2015.415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fonc.2015.415%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DNAMPT%252Bsuppresses%252Bglucose%252Bdeprivation-induced%252Boxidative%252Bstress%252Bby%252Bincreasing%252BNADPH%252Blevels%252Bin%252Bbreast%252Bcancer%26aulast%3DHong%26aufirst%3DS%2BM%26date%3D2016%26date%3D2015%26volume%3D35%26issue%3D27%26spage%3D3544%26epage%3D3554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vittorio  Rosti</span>, <span class="hlFld-ContribAuthor ">Rita  Campanelli</span>, <span class="hlFld-ContribAuthor ">Margherita  Massa</span>, <span class="hlFld-ContribAuthor ">Gianluca  Viarengo</span>, <span class="hlFld-ContribAuthor ">Laura  Villani</span>, <span class="hlFld-ContribAuthor ">Valentina  Poletto</span>, <span class="hlFld-ContribAuthor ">Elisa  Bonetti</span>, <span class="hlFld-ContribAuthor ">Paolo  Catarsi</span>, <span class="hlFld-ContribAuthor ">Umberto  Magrini</span>, <span class="hlFld-ContribAuthor ">Ambra A.  Grolla</span>, <span class="hlFld-ContribAuthor ">Cristina  Travelli</span>, <span class="hlFld-ContribAuthor ">Armando A.  Genazzani</span>, <span class="hlFld-ContribAuthor ">Giovanni  Barosi</span>. </span><span class="cited-content_cbyCitation_article-title">Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Hematology</span><span> <strong>2016,</strong> <em>91 </em>
                                    (7)
                                     , 709-713. <a href="https://doi.org/10.1002/ajh.24388" title="DOI URL">https://doi.org/10.1002/ajh.24388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajh.24388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajh.24388%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Hematology%26atitle%3DIncreased%252Bplasma%252Bnicotinamide%252Bphosphoribosyltransferase%252Bis%252Bassociated%252Bwith%252Ba%252Bhyperproliferative%252Bphenotype%252Band%252Brestrains%252Bdisease%252Bprogression%252Bin%252BMPN-associated%252Bmyelofibrosis%26aulast%3DRosti%26aufirst%3DVittorio%26date%3D2016%26date%3D2016%26volume%3D91%26issue%3D7%26spage%3D709%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ambra A  Grolla</span>, <span class="hlFld-ContribAuthor ">Cristina  Travelli</span>, <span class="hlFld-ContribAuthor ">Armando A  Genazzani</span>, <span class="hlFld-ContribAuthor ">Jaswinder K  Sethi</span>. </span><span class="cited-content_cbyCitation_article-title">Extracellular nicotinamide phosphoribosyltransferase, a new cancer
              metabokine. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2016,</strong> <em>173 </em>
                                    (14)
                                     , 2182-2194. <a href="https://doi.org/10.1111/bph.13505" title="DOI URL">https://doi.org/10.1111/bph.13505</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.13505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.13505%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DExtracellular%252Bnicotinamide%252Bphosphoribosyltransferase%25252C%252Ba%252Bnew%252Bcancer%252Bmetabokine%26aulast%3DGrolla%26aufirst%3DAmbra%2BA%26date%3D2016%26date%3D2016%26volume%3D173%26issue%3D14%26spage%3D2182%26epage%3D2194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David E.  Clark</span>, <span class="hlFld-ContribAuthor ">Bohdan  Waszkowycz</span>, <span class="hlFld-ContribAuthor ">Melanie  Wong</span>, <span class="hlFld-ContribAuthor ">Peter M.  Lockey</span>, <span class="hlFld-ContribAuthor ">Robert  Adalbert</span>, <span class="hlFld-ContribAuthor ">Jonathan  Gilley</span>, <span class="hlFld-ContribAuthor ">Jonathan  Clark</span>, <span class="hlFld-ContribAuthor ">Michael P.  Coleman</span>. </span><span class="cited-content_cbyCitation_article-title">Application of virtual screening to the discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with potential for the treatment of cancer and axonopathies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (12)
                                     , 2920-2926. <a href="https://doi.org/10.1016/j.bmcl.2016.04.039" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.04.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.04.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.04.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DApplication%252Bof%252Bvirtual%252Bscreening%252Bto%252Bthe%252Bdiscovery%252Bof%252Bnovel%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Binhibitors%252Bwith%252Bpotential%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%252Band%252Baxonopathies%26aulast%3DClark%26aufirst%3DDavid%2BE.%26date%3D2016%26volume%3D26%26issue%3D12%26spage%3D2920%26epage%3D2926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. V.  Aleksandriiskii</span>, <span class="hlFld-ContribAuthor ">G. A.  Gamov</span>, <span class="hlFld-ContribAuthor ">S. V.  Dushina</span>, <span class="hlFld-ContribAuthor ">V. A.  Sharnin</span>, <span class="hlFld-ContribAuthor ">M. N.  Zavalishin</span>. </span><span class="cited-content_cbyCitation_article-title">Solvation State of Nicotinamide in Binary Solvents by 13C NMR Probing at Different Temperatures. </span><span class="cited-content_cbyCitation_journal-name">Applied Magnetic Resonance</span><span> <strong>2016,</strong> <em>47 </em>
                                    (3)
                                     , 349-359. <a href="https://doi.org/10.1007/s00723-016-0760-1" title="DOI URL">https://doi.org/10.1007/s00723-016-0760-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00723-016-0760-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00723-016-0760-1%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Magnetic%2520Resonance%26atitle%3DSolvation%252BState%252Bof%252BNicotinamide%252Bin%252BBinary%252BSolvents%252Bby%252B13C%252BNMR%252BProbing%252Bat%252BDifferent%252BTemperatures%26aulast%3DAleksandriiskii%26aufirst%3DV.%2BV.%26date%3D2016%26date%3D2016%26volume%3D47%26issue%3D3%26spage%3D349%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Shipeng  He</span>, <span class="hlFld-ContribAuthor ">Tianying  Xu</span>, <span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chaoyu  Miao</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of benzothiophene amides as potent inhibitors of human nicotinamide phosphoribosyltransferase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (3)
                                     , 765-768. <a href="https://doi.org/10.1016/j.bmcl.2015.12.101" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.12.101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.12.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.12.101%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bbenzothiophene%252Bamides%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhuman%252Bnicotinamide%252Bphosphoribosyltransferase%26aulast%3DChen%26aufirst%3DWei%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D765%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Preyat</span>, <span class="hlFld-ContribAuthor ">Oberdan  Leo</span>. </span><span class="cited-content_cbyCitation_article-title">Complex role of nicotinamide adenine dinucleotide in the regulation of programmed cell death pathways. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2016,</strong> <em>101 </em>, 13-26. <a href="https://doi.org/10.1016/j.bcp.2015.08.110" title="DOI URL">https://doi.org/10.1016/j.bcp.2015.08.110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2015.08.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2015.08.110%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DComplex%252Brole%252Bof%252Bnicotinamide%252Badenine%252Bdinucleotide%252Bin%252Bthe%252Bregulation%252Bof%252Bprogrammed%252Bcell%252Bdeath%252Bpathways%26aulast%3DPreyat%26aufirst%3DNicolas%26date%3D2016%26volume%3D101%26spage%3D13%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanna  Sociali</span>, <span class="hlFld-ContribAuthor ">Lizzia  Raffaghello</span>, <span class="hlFld-ContribAuthor ">Mirko  Magnone</span>, <span class="hlFld-ContribAuthor ">Federica  Zamporlini</span>, <span class="hlFld-ContribAuthor ">Laura  Emionite</span>, <span class="hlFld-ContribAuthor ">Laura  Sturla</span>, <span class="hlFld-ContribAuthor ">Giovanna  Bianchi</span>, <span class="hlFld-ContribAuthor ">Tiziana  Vigliarolo</span>, <span class="hlFld-ContribAuthor ">Aimable  Nahimana</span>, <span class="hlFld-ContribAuthor ">Alessio  Nencioni</span>, <span class="hlFld-ContribAuthor ">Nadia  Raffaelli</span>, <span class="hlFld-ContribAuthor ">Santina  Bruzzone</span>. </span><span class="cited-content_cbyCitation_article-title">Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 2968-2984. <a href="https://doi.org/10.18632/oncotarget.6502" title="DOI URL">https://doi.org/10.18632/oncotarget.6502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.6502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.6502%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DAntitumor%252Beffect%252Bof%252Bcombined%252BNAMPT%252Band%252BCD73%252Binhibition%252Bin%252Ban%252Bovarian%252Bcancer%252Bmodel%26aulast%3DSociali%26aufirst%3DGiovanna%26date%3D2016%26date%3D2015%26volume%3D7%26issue%3D3%26spage%3D2968%26epage%3D2984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Russell N.  Grimes</span>. </span><span class="cited-content_cbyCitation_article-title">Carboranes in Medicine. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 945-984. <a href="https://doi.org/10.1016/B978-0-12-801894-1.00016-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-801894-1.00016-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-801894-1.00016-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-801894-1.00016-0%26sid%3Dliteratum%253Aachs%26atitle%3DCarboranes%252Bin%252BMedicine%26aulast%3DGrimes%26aufirst%3DRussell%2BN.%26date%3D2016%26spage%3D945%26epage%3D984%26pub%3DElsevier%26atitle%3DCarboranes%26date%3D2016%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kensuke  Tateishi</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Wakimoto</span>, <span class="hlFld-ContribAuthor ">A. John  Iafrate</span>, <span class="hlFld-ContribAuthor ">Shota  Tanaka</span>, <span class="hlFld-ContribAuthor ">Franziska  Loebel</span>, <span class="hlFld-ContribAuthor ">Nina  Lelic</span>, <span class="hlFld-ContribAuthor ">Dmitri  Wiederschain</span>, <span class="hlFld-ContribAuthor ">Olivier  Bedel</span>, <span class="hlFld-ContribAuthor ">Gejing  Deng</span>, <span class="hlFld-ContribAuthor ">Bailin  Zhang</span>, <span class="hlFld-ContribAuthor ">Timothy  He</span>, <span class="hlFld-ContribAuthor ">Xu  Shi</span>, <span class="hlFld-ContribAuthor ">Robert E.  Gerszten</span>, <span class="hlFld-ContribAuthor ">Yiyun  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing-Ruey J.  Yeh</span>, <span class="hlFld-ContribAuthor ">William T.  Curry</span>, <span class="hlFld-ContribAuthor ">Dan  Zhao</span>, <span class="hlFld-ContribAuthor ">Sudhandra  Sundaram</span>, <span class="hlFld-ContribAuthor ">Fares  Nigim</span>, <span class="hlFld-ContribAuthor ">Mara V.A.  Koerner</span>, <span class="hlFld-ContribAuthor ">Quan  Ho</span>, <span class="hlFld-ContribAuthor ">David E.  Fisher</span>, <span class="hlFld-ContribAuthor ">Elisabeth M.  Roider</span>, <span class="hlFld-ContribAuthor ">Lajos V.  Kemeny</span>, <span class="hlFld-ContribAuthor ">Yardena  Samuels</span>, <span class="hlFld-ContribAuthor ">Keith T.  Flaherty</span>, <span class="hlFld-ContribAuthor ">Tracy T.  Batchelor</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Chi</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Cahill</span>. </span><span class="cited-content_cbyCitation_article-title">Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell</span><span> <strong>2015,</strong> <em>28 </em>
                                    (6)
                                     , 773-784. <a href="https://doi.org/10.1016/j.ccell.2015.11.006" title="DOI URL">https://doi.org/10.1016/j.ccell.2015.11.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccell.2015.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccell.2015.11.006%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%26atitle%3DExtreme%252BVulnerability%252Bof%252BIDH1%252BMutant%252BCancers%252Bto%252BNAD%25252B%252BDepletion%26aulast%3DTateishi%26aufirst%3DKensuke%26date%3D2015%26volume%3D28%26issue%3D6%26spage%3D773%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandra P.  OyarzÃºn</span>, <span class="hlFld-ContribAuthor ">Francisco  Westermeier</span>, <span class="hlFld-ContribAuthor ">Christian  Pennanen</span>, <span class="hlFld-ContribAuthor ">Camila  LÃ³pez-Crisosto</span>, <span class="hlFld-ContribAuthor ">Valentina  Parra</span>, <span class="hlFld-ContribAuthor ">Cristian  Sotomayor-Flores</span>, <span class="hlFld-ContribAuthor ">Gina  SÃ¡nchez</span>, <span class="hlFld-ContribAuthor ">Zully  Pedrozo</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Troncoso</span>, <span class="hlFld-ContribAuthor ">Sergio  Lavandero</span>. </span><span class="cited-content_cbyCitation_article-title">FK866 compromises mitochondrial metabolism and adaptive stress responses in cultured cardiomyocytes. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2015,</strong> <em>98 </em>
                                    (1)
                                     , 92-101. <a href="https://doi.org/10.1016/j.bcp.2015.08.097" title="DOI URL">https://doi.org/10.1016/j.bcp.2015.08.097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2015.08.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2015.08.097%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DFK866%252Bcompromises%252Bmitochondrial%252Bmetabolism%252Band%252Badaptive%252Bstress%252Bresponses%252Bin%252Bcultured%252Bcardiomyocytes%26aulast%3DOyarz%25C3%25BAn%26aufirst%3DAlejandra%2BP.%26date%3D2015%26volume%3D98%26issue%3D1%26spage%3D92%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ambra A.  Grolla</span>, <span class="hlFld-ContribAuthor ">Simone  Torretta</span>, <span class="hlFld-ContribAuthor ">Ilaria  Gnemmi</span>, <span class="hlFld-ContribAuthor ">Angela  Amoruso</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Orsomando</span>, <span class="hlFld-ContribAuthor ">Marco  Gatti</span>, <span class="hlFld-ContribAuthor ">Antonio  Caldarelli</span>, <span class="hlFld-ContribAuthor ">Dmitry  Lim</span>, <span class="hlFld-ContribAuthor ">Lorenza  Penengo</span>, <span class="hlFld-ContribAuthor ">Sandra  Brunelleschi</span>, <span class="hlFld-ContribAuthor ">Armando A.  Genazzani</span>, <span class="hlFld-ContribAuthor ">Cristina  Travelli</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma. </span><span class="cited-content_cbyCitation_journal-name">Pigment Cell & Melanoma Research</span><span> <strong>2015,</strong> <em>28 </em>
                                    (6)
                                     , 718-729. <a href="https://doi.org/10.1111/pcmr.12420" title="DOI URL">https://doi.org/10.1111/pcmr.12420</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/pcmr.12420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fpcmr.12420%26sid%3Dliteratum%253Aachs%26jtitle%3DPigment%2520Cell%2520%2526%2520Melanoma%2520Research%26atitle%3DNicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%25252FPBEF%25252Fvisfatin%252529%252Bis%252Ba%252Btumoural%252Bcytokine%252Breleased%252Bfrom%252Bmelanoma%26aulast%3DGrolla%26aufirst%3DAmbra%2BA.%26date%3D2015%26date%3D2015%26volume%3D28%26issue%3D6%26spage%3D718%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Tian-Ying  Xu</span>, <span class="hlFld-ContribAuthor ">Xin-Zhu  Liu</span>, <span class="hlFld-ContribAuthor ">Sai-Long  Zhang</span>, <span class="hlFld-ContribAuthor ">Pei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-Yong  Li</span>, <span class="hlFld-ContribAuthor ">Yun-Feng  Guan</span>, <span class="hlFld-ContribAuthor ">Shu-Na  Wang</span>, <span class="hlFld-ContribAuthor ">Guo-Qiang  Dong</span>, <span class="hlFld-ContribAuthor ">Shu  Zhuo</span>, <span class="hlFld-ContribAuthor ">Ying-Ying  Le</span>, <span class="hlFld-ContribAuthor ">Chun-Quan  Sheng</span>, <span class="hlFld-ContribAuthor ">Chao-Yu  Miao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Inhibitors and Fluorescent Probe Targeting NAMPT. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep12657" title="DOI URL">https://doi.org/10.1038/srep12657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep12657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep12657%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Bof%252BNovel%252BInhibitors%252Band%252BFluorescent%252BProbe%252BTargeting%252BNAMPT%26aulast%3DWang%26aufirst%3DXia%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Venkat K.  Pulla</span>, <span class="hlFld-ContribAuthor ">Dinavahi S.  Sriram</span>, <span class="hlFld-ContribAuthor ">Vijay  Soni</span>, <span class="hlFld-ContribAuthor ">Srikant  Viswanadha</span>, <span class="hlFld-ContribAuthor ">Dharmarajan  Sriram</span>, <span class="hlFld-ContribAuthor ">Perumal  Yogeeswari</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting NAMPT for Therapeutic Intervention in Cancer and Inflammation: Structure-Based Drug Design and Biological Screening. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>86 </em>
                                    (4)
                                     , 881-894. <a href="https://doi.org/10.1111/cbdd.12562" title="DOI URL">https://doi.org/10.1111/cbdd.12562</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12562%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DTargeting%252BNAMPT%252Bfor%252BTherapeutic%252BIntervention%252Bin%252BCancer%252Band%252BInflammation%25253A%252BStructure-Based%252BDrug%252BDesign%252Band%252BBiological%252BScreening%26aulast%3DPulla%26aufirst%3DVenkat%2BK.%26date%3D2015%26date%3D2015%26volume%3D86%26issue%3D4%26spage%3D881%26epage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silverio  Ruggieri</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Orsomando</span>, <span class="hlFld-ContribAuthor ">Leonardo  Sorci</span>, <span class="hlFld-ContribAuthor ">Nadia  Raffaelli</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of NAD biosynthetic enzymes modulates NAD-sensing processes to shape mammalian cell physiology under varying biological cues. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2015,</strong> <em>1854 </em>
                                    (9)
                                     , 1138-1149. <a href="https://doi.org/10.1016/j.bbapap.2015.02.021" title="DOI URL">https://doi.org/10.1016/j.bbapap.2015.02.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2015.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2015.02.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DRegulation%252Bof%252BNAD%252Bbiosynthetic%252Benzymes%252Bmodulates%252BNAD-sensing%252Bprocesses%252Bto%252Bshape%252Bmammalian%252Bcell%252Bphysiology%252Bunder%252Bvarying%252Bbiological%252Bcues%26aulast%3DRuggieri%26aufirst%3DSilverio%26date%3D2015%26volume%3D1854%26issue%3D9%26spage%3D1138%26epage%3D1149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antje  Garten</span>, <span class="hlFld-ContribAuthor ">Susanne  Schuster</span>, <span class="hlFld-ContribAuthor ">Melanie  Penke</span>, <span class="hlFld-ContribAuthor ">Theresa  Gorski</span>, <span class="hlFld-ContribAuthor ">Tommaso  de Giorgis</span>, <span class="hlFld-ContribAuthor ">Wieland  Kiess</span>. </span><span class="cited-content_cbyCitation_article-title">Physiological and pathophysiological roles of NAMPT and NAD metabolism. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Endocrinology</span><span> <strong>2015,</strong> <em>11 </em>
                                    (9)
                                     , 535-546. <a href="https://doi.org/10.1038/nrendo.2015.117" title="DOI URL">https://doi.org/10.1038/nrendo.2015.117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrendo.2015.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrendo.2015.117%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Endocrinology%26atitle%3DPhysiological%252Band%252Bpathophysiological%252Broles%252Bof%252BNAMPT%252Band%252BNAD%252Bmetabolism%26aulast%3DGarten%26aufirst%3DAntje%26date%3D2015%26date%3D2015%26volume%3D11%26issue%3D9%26spage%3D535%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian-Ying  Xu</span>, <span class="hlFld-ContribAuthor ">Sai-Long  Zhang</span>, <span class="hlFld-ContribAuthor ">Guo-Qiang  Dong</span>, <span class="hlFld-ContribAuthor ">Xin-Zhu  Liu</span>, <span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Qun  Lv</span>, <span class="hlFld-ContribAuthor ">Qi-Jun  Qian</span>, <span class="hlFld-ContribAuthor ">Ruo-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Chun-Quan  Sheng</span>, <span class="hlFld-ContribAuthor ">Chao-Yu  Miao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and characterization of novel small-molecule inhibitors targeting nicotinamide phosphoribosyltransferase. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep10043" title="DOI URL">https://doi.org/10.1038/srep10043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep10043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep10043%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Band%252Bcharacterization%252Bof%252Bnovel%252Bsmall-molecule%252Binhibitors%252Btargeting%252Bnicotinamide%252Bphosphoribosyltransferase%26aulast%3DXu%26aufirst%3DTian-Ying%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Horenstein</span>, <span class="hlFld-ContribAuthor ">Antonella  Chillemi</span>, <span class="hlFld-ContribAuthor ">Valeria  Quarona</span>, <span class="hlFld-ContribAuthor ">Andrea  Zito</span>, <span class="hlFld-ContribAuthor ">Ilaria  Roato</span>, <span class="hlFld-ContribAuthor ">Fabio  Morandi</span>, <span class="hlFld-ContribAuthor ">Danilo  Marimpietri</span>, <span class="hlFld-ContribAuthor ">Marina  Bolzoni</span>, <span class="hlFld-ContribAuthor ">Denise  Toscani</span>, <span class="hlFld-ContribAuthor ">Robert  Oldham</span>, <span class="hlFld-ContribAuthor ">Massimiliano  Cuccioloni</span>, <span class="hlFld-ContribAuthor ">A.  Sasser</span>, <span class="hlFld-ContribAuthor ">Vito  Pistoia</span>, <span class="hlFld-ContribAuthor ">Nicola  Giuliani</span>, <span class="hlFld-ContribAuthor ">Fabio  Malavasi</span>. </span><span class="cited-content_cbyCitation_article-title">NAD+-Metabolizing Ectoenzymes in Remodeling TumorâHost Interactions: The Human Myeloma Model. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2015,</strong> <em>4 </em>
                                    (3)
                                     , 520-537. <a href="https://doi.org/10.3390/cells4030520" title="DOI URL">https://doi.org/10.3390/cells4030520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells4030520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells4030520%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DNAD%25252B-Metabolizing%252BEctoenzymes%252Bin%252BRemodeling%252BTumor%2525E2%252580%252593Host%252BInteractions%25253A%252BThe%252BHuman%252BMyeloma%252BModel%26aulast%3DHorenstein%26aufirst%3DAlberto%26date%3D2015%26date%3D2015%26volume%3D4%26issue%3D3%26spage%3D520%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Tanja S.  Zabka</span>, <span class="hlFld-ContribAuthor ">Dinah L.  Misner</span>, <span class="hlFld-ContribAuthor ">Thomas  OâBrien</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2015,</strong> <em>151 </em>, 16-31. <a href="https://doi.org/10.1016/j.pharmthera.2015.02.004" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2015.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2015.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2015.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DInhibition%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bin%252Bcancer%26aulast%3DSampath%26aufirst%3DDeepak%26date%3D2015%26volume%3D151%26spage%3D16%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Alexandre J.  Buckmelter</span>, <span class="hlFld-ContribAuthor ">Karl H.  Clodfelter</span>, <span class="hlFld-ContribAuthor ">Eric  Cheng</span>, <span class="hlFld-ContribAuthor ">Lisa  Crocker</span>, <span class="hlFld-ContribAuthor ">Bang  Fu</span>, <span class="hlFld-ContribAuthor ">Bingsong  Han</span>, <span class="hlFld-ContribAuthor ">Guangkun  Li</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Xiongcai  Liu</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Thomas  OâBrien</span>, <span class="hlFld-ContribAuthor ">Dominic J.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Nicholas  Skelton</span>, <span class="hlFld-ContribAuthor ">Chase C.  Smith</span>, <span class="hlFld-ContribAuthor ">Suzanne  Tay</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (3)
                                     , 529-541. <a href="https://doi.org/10.1016/j.bmcl.2014.12.026" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Binhibitors%252Bwith%252Bno%252Bevidence%252Bof%252BCYP3A4%252Btime-dependent%252Binhibition%252Band%252Bimproved%252Baqueous%252Bsolubility%26aulast%3DZak%26aufirst%3DMark%26date%3D2015%26volume%3D25%26issue%3D3%26spage%3D529%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Theeramunkong</span>, <span class="hlFld-ContribAuthor ">U.  Galli</span>, <span class="hlFld-ContribAuthor ">A. A.  Grolla</span>, <span class="hlFld-ContribAuthor ">A.  Caldarelli</span>, <span class="hlFld-ContribAuthor ">C.  Travelli</span>, <span class="hlFld-ContribAuthor ">A.  Massarotti</span>, <span class="hlFld-ContribAuthor ">M. P.  Troiani</span>, <span class="hlFld-ContribAuthor ">M. A.  Alisi</span>, <span class="hlFld-ContribAuthor ">G.  Orsomando</span>, <span class="hlFld-ContribAuthor ">A. A.  Genazzani</span>, <span class="hlFld-ContribAuthor ">G. C.  Tron</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (10)
                                     , 1891-1897. <a href="https://doi.org/10.1039/C5MD00261C" title="DOI URL">https://doi.org/10.1039/C5MD00261C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00261C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00261C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DIdentification%252Bof%252Ba%252Bnovel%252BNAMPT%252Binhibitor%252Bby%252Bcombinatorial%252Bclick%252Bchemistry%252Band%252Bchemical%252Brefinement%26aulast%3DTheeramunkong%26aufirst%3DS.%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D10%26spage%3D1891%26epage%3D1897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Neubauer</span>, <span class="hlFld-ContribAuthor ">Iwona  Bednarz Misa</span>, <span class="hlFld-ContribAuthor ">Dorota  Diakowska</span>, <span class="hlFld-ContribAuthor ">Bartosz  Kapturkiewicz</span>, <span class="hlFld-ContribAuthor ">Andrzej  Gamian</span>, <span class="hlFld-ContribAuthor ">Malgorzata  Krzystek-Korpacka</span>. </span><span class="cited-content_cbyCitation_article-title">Nampt/PBEF/Visfatin Upregulation in Colorectal Tumors, Mirrored in Normal Tissue and Whole Blood of Colorectal Cancer Patients, Is Associated with Metastasis, Hypoxia, IL1
              Î²
              , and Anemia. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2015,</strong> <em>2015 </em>, 1-12. <a href="https://doi.org/10.1155/2015/523930" title="DOI URL">https://doi.org/10.1155/2015/523930</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2015/523930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2015%2F523930%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DNampt%25252FPBEF%25252FVisfatin%252BUpregulation%252Bin%252BColorectal%252BTumors%25252C%252BMirrored%252Bin%252BNormal%252BTissue%252Band%252BWhole%252BBlood%252Bof%252BColorectal%252BCancer%252BPatients%25252C%252BIs%252BAssociated%252Bwith%252BMetastasis%25252C%252BHypoxia%25252C%252BIL1%252B%2525CE%2525B2%252B%25252C%252Band%252BAnemia%26aulast%3DNeubauer%26aufirst%3DKatarzyna%26date%3D2015%26volume%3D2015%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir  Tolstikov</span>, <span class="hlFld-ContribAuthor ">Alexander  Nikolayev</span>, <span class="hlFld-ContribAuthor ">Sucai  Dong</span>, <span class="hlFld-ContribAuthor ">Genshi  Zhao</span>, <span class="hlFld-ContribAuthor ">Ming-Shang  Kuo</span>, . </span><span class="cited-content_cbyCitation_article-title">Metabolomics Analysis of Metabolic Effects of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibition on Human Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (12)
                                     , e114019. <a href="https://doi.org/10.1371/journal.pone.0114019" title="DOI URL">https://doi.org/10.1371/journal.pone.0114019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0114019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0114019%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DMetabolomics%252BAnalysis%252Bof%252BMetabolic%252BEffects%252Bof%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%252BInhibition%252Bon%252BHuman%252BCancer%252BCells%26aulast%3DTolstikov%26aufirst%3DVladimir%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D12%26spage%3De114019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael. S.  Christodoulou</span>, <span class="hlFld-ContribAuthor ">Adeline  Thomas</span>, <span class="hlFld-ContribAuthor ">StÃ©phane  Poulain</span>, <span class="hlFld-ContribAuthor ">Melita  Vidakovic</span>, <span class="hlFld-ContribAuthor ">Maija  Lahtela-Kakkonen</span>, <span class="hlFld-ContribAuthor ">Daumantas  Matulis</span>, <span class="hlFld-ContribAuthor ">Philippe  Bertrand</span>, <span class="hlFld-ContribAuthor ">Eva  Bartova</span>, <span class="hlFld-ContribAuthor ">Christophe  Blanquart</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Mikros</span>, <span class="hlFld-ContribAuthor ">Nikolas  Fokialakis</span>, <span class="hlFld-ContribAuthor ">Daniele  Passarella</span>, <span class="hlFld-ContribAuthor ">Rachid  Benhida</span>, <span class="hlFld-ContribAuthor ">Nadine  Martinet</span>. </span><span class="cited-content_cbyCitation_article-title">Can we use the epigenetic bioactivity of caloric restriction and phytochemicals to promote healthy ageing?. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2014,</strong> <em>5 </em>
                                    (12)
                                     , 1804-1820. <a href="https://doi.org/10.1039/C4MD00268G" title="DOI URL">https://doi.org/10.1039/C4MD00268G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00268G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00268G%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DCan%252Bwe%252Buse%252Bthe%252Bepigenetic%252Bbioactivity%252Bof%252Bcaloric%252Brestriction%252Band%252Bphytochemicals%252Bto%252Bpromote%252Bhealthy%252Bageing%25253F%26aulast%3DChristodoulou%26aufirst%3DMichael.%2BS.%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D12%26spage%3D1804%26epage%3D1820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renate Hvidsten  Skoge</span>, <span class="hlFld-ContribAuthor ">Christian  DÃ¶lle</span>, <span class="hlFld-ContribAuthor ">Mathias  Ziegler</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of SIRT2-dependent Î±-tubulin deacetylation by cellular NAD levels. </span><span class="cited-content_cbyCitation_journal-name">DNA Repair</span><span> <strong>2014,</strong> <em>23 </em>, 33-38. <a href="https://doi.org/10.1016/j.dnarep.2014.04.011" title="DOI URL">https://doi.org/10.1016/j.dnarep.2014.04.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.dnarep.2014.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.dnarep.2014.04.011%26sid%3Dliteratum%253Aachs%26jtitle%3DDNA%2520Repair%26atitle%3DRegulation%252Bof%252BSIRT2-dependent%252B%2525CE%2525B1-tubulin%252Bdeacetylation%252Bby%252Bcellular%252BNAD%252Blevels%26aulast%3DSkoge%26aufirst%3DRenate%2BHvidsten%26date%3D2014%26volume%3D23%26spage%3D33%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio F.  Santidrian</span>, <span class="hlFld-ContribAuthor ">Sarah E.  LeBoeuf</span>, <span class="hlFld-ContribAuthor ">Erik D.  Wold</span>, <span class="hlFld-ContribAuthor ">Melissa  Ritland</span>, <span class="hlFld-ContribAuthor ">Jane S.  Forsyth</span>, <span class="hlFld-ContribAuthor ">Brunhilde H.  Felding</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">DNA Repair</span><span> <strong>2014,</strong> <em>23 </em>, 79-87. <a href="https://doi.org/10.1016/j.dnarep.2014.08.006" title="DOI URL">https://doi.org/10.1016/j.dnarep.2014.08.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.dnarep.2014.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.dnarep.2014.08.006%26sid%3Dliteratum%253Aachs%26jtitle%3DDNA%2520Repair%26atitle%3DNicotinamide%252Bphosphoribosyltransferase%252Bcan%252Baffect%252Bmetastatic%252Bactivity%252Band%252Bcell%252Badhesive%252Bfunctions%252Bby%252Bregulating%252Bintegrins%252Bin%252Bbreast%252Bcancer%26aulast%3DSantidrian%26aufirst%3DAntonio%2BF.%26date%3D2014%26volume%3D23%26spage%3D79%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">W. T.  Harkcom</span>, <span class="hlFld-ContribAuthor ">A. K.  Ghosh</span>, <span class="hlFld-ContribAuthor ">M. S.  Sung</span>, <span class="hlFld-ContribAuthor ">A.  Matov</span>, <span class="hlFld-ContribAuthor ">K. D.  Brown</span>, <span class="hlFld-ContribAuthor ">P.  Giannakakou</span>, <span class="hlFld-ContribAuthor ">S. R.  Jaffrey</span>. </span><span class="cited-content_cbyCitation_article-title">NAD+ and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2014,</strong> <em>111 </em>
                                    (24)
                                     , E2443-E2452. <a href="https://doi.org/10.1073/pnas.1404269111" title="DOI URL">https://doi.org/10.1073/pnas.1404269111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1404269111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1404269111%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DNAD%25252B%252Band%252BSIRT3%252Bcontrol%252Bmicrotubule%252Bdynamics%252Band%252Breduce%252Bsusceptibility%252Bto%252Bantimicrotubule%252Bagents%26aulast%3DHarkcom%26aufirst%3DW.%2BT.%26date%3D2014%26date%3D2014%26volume%3D111%26issue%3D24%26spage%3DE2443%26epage%3DE2452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Brandon  Bravo</span>, <span class="hlFld-ContribAuthor ">Anthony M.  Giannetti</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Rongbao  Hua</span>, <span class="hlFld-ContribAuthor ">Guangkun  Li</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Ma</span>, <span class="hlFld-ContribAuthor ">Thomas  OâBrien</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Skelton</span>, <span class="hlFld-ContribAuthor ">Chengcheng  Wang</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Yunli  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (3)
                                     , 954-962. <a href="https://doi.org/10.1016/j.bmcl.2013.12.062" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.12.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.12.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.12.062%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFragment-based%252Bdesign%252Bof%252B3-aminopyridine-derived%252Bamides%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhuman%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DDragovich%26aufirst%3DPeter%2BS.%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D954%26epage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Pittelli</span>, <span class="hlFld-ContribAuthor ">Leonardo  Cavone</span>, <span class="hlFld-ContribAuthor ">Andrea  Lapucci</span>, <span class="hlFld-ContribAuthor ">Claudia  Oteri</span>, <span class="hlFld-ContribAuthor ">Roberta  Felici</span>, <span class="hlFld-ContribAuthor ">Elena  Niccolai</span>, <span class="hlFld-ContribAuthor ">Amedeo  Amedei</span>, <span class="hlFld-ContribAuthor ">Alberto  Chiarugi</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes. </span><span class="cited-content_cbyCitation_journal-name">Immunology & Cell Biology</span><span> <strong>2014,</strong> <em>92 </em>
                                    (2)
                                     , 191-199. <a href="https://doi.org/10.1038/icb.2013.85" title="DOI URL">https://doi.org/10.1038/icb.2013.85</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/icb.2013.85&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Ficb.2013.85%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunology%2520%2526%2520Cell%2520Biology%26atitle%3DNicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Bactivity%252Bis%252Bessential%252Bfor%252Bsurvival%252Bof%252Bresting%252Blymphocytes%26aulast%3DPittelli%26aufirst%3DMaria%26date%3D2014%26date%3D2013%26volume%3D92%26issue%3D2%26spage%3D191%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Paul  Bauer</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Krista K.  Bowman</span>, <span class="hlFld-ContribAuthor ">Alexandre J.  Buckmelter</span>, <span class="hlFld-ContribAuthor ">Maureen  Caligiuri</span>, <span class="hlFld-ContribAuthor ">Karl H.  Clodfelter</span>, <span class="hlFld-ContribAuthor ">Yezhen  Feng</span>, <span class="hlFld-ContribAuthor ">Bingsong  Han</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Nikolai  Kley</span>, <span class="hlFld-ContribAuthor ">Hong  Li</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Thomas  OâBrien</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Dominic J.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Geeta  Sharma</span>, <span class="hlFld-ContribAuthor ">Nicholas  Skelton</span>, <span class="hlFld-ContribAuthor ">Chase C.  Smith</span>, <span class="hlFld-ContribAuthor ">Jarrod  Tremayne</span>, <span class="hlFld-ContribAuthor ">Leslie  Wang</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Wang</span>, <span class="hlFld-ContribAuthor ">Hongxing  Wu</span>, <span class="hlFld-ContribAuthor ">Jiansheng  Wu</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Guangxing  Yang</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (20)
                                     , 5488-5497. <a href="https://doi.org/10.1016/j.bmcl.2013.08.074" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.08.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.08.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.08.074%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bamides%252Bderived%252Bfrom%252B1H-pyrazolo%25255B3%25252C4-b%25255Dpyridine-5-carboxylic%252Bacid%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhuman%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DZheng%26aufirst%3DXiaozhang%26date%3D2013%26volume%3D23%26issue%3D20%26spage%3D5488%26epage%3D5497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0026.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of the salvage NAD pathways. Multiple pathways allow NAD biosynthesis from the different sources (QA, NA, Nam, and NR), and these are reviewed elsewhere.<a onclick="showRef(event, 'cit5b cit5c'); return false;" href="javascript:void(0);" class="ref cit5b cit5c">(5b, 5c)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of FK866.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of human NAMPT in complex with FK866 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVJ">2GVJ</a>). One monomer is shown in blue, the other in gold. Carbon atoms of FK866 are shown in green sphere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Different details of X-ray crystal structure of human NAMPT in complex with FK866 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVJ">2GVJ</a>). One monomer is shown in blue, the other in gold. Carbon atoms of FK866 are shown in green sticks. NMN (adapted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVG">2GVG</a>) is in yellow sticks, and the retained molecule of water is a red sphere. Hydrogen bond interactions are plotted as yellow dotted lines. (a) Detail of the FK866 tail group binding pocket. (b) Detail of the overlapping of FK866 and NMN binding sites. (c) Binding mode of FK866.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. SAR studies on <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Constrained analogues and water-soluble prodrug of <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Schematic division of FK866 in three regions of interest for the medicinal chemist: (a) pyridine group; (b) vinylogous amide group; (c) tail group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. NAMPT inhibitors: replacement or chemical modification of the pyridine ring (I).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Details of other crystal structures of NAMPT in complex with <b>6</b> or <b>8</b>. FK866 is shown in green, and NMN is shown in yellow. (a) Binding mode of <b>6</b> (PDB code not available; obtained from the authors). Carbon atoms of <b>6</b> are shown in light yellow. (b) Binding mode of <b>8</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3G8E">3G8E</a>). Carbon atoms of <b>8</b> are shown in purple. (c) Overlay of <b>8</b> and NMN in the NMN binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Synoptic scheme of the heterocycles used as cap groups replacing the pyridine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. NAMPT inhibitors: replacement or chemical modification of the pyridine ring (II).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. NAMPT inhibitors: replacement or chemical modification of the pyridine ring (III).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. NAMPT inhibitors: replacement of the amide group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. SAR of putative NAMPT inhibitors (I).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. General formula for NAMPT and ROCK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. SAR of putative NAMPT inhibitors (II).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Synoptic scheme of the connecting units accepted by NAMPT.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. NAMPT inhibitors: tail group modification (I).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. NAMPT inhibitors: tail group modification (II).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. NAMPT inhibitors: tail group modification (III).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. NAMPT inhibitors: tail group modification (IV).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. NAMPT inhibitors: tail group modification (V).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Structure of a carborane derivative of FK866.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structures of compounds selected by virtual screening.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/medium/jm-2013-001049_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Roadmap to the synthesis of novel NAMPT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4001049/production/images/large/jm-2013-001049_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4001049&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 99 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Vander Heiden, M. G.</span><span> </span><span class="NLM_article-title">Targeting cancer metabolism: a therapeutic window opens</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">â</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1038%2Fnrd3504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=21878982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSltb3J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=671-684&author=M.+G.+Vander+Heiden&title=Targeting+cancer+metabolism%3A+a+therapeutic+window+opens"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer metabolism: a therapeutic window opens</span></div><div class="casAuthors">Vander Heiden, Matthew G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">671-684</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genetic events in cancer activate signalling pathways that alter cell metab.  Clin. evidence has linked cell metab. with cancer outcomes.  Together, these observations have raised interest in targeting metabolic enzymes for cancer therapy, but they have also raised concerns that these therapies would have unacceptable effects on normal cells.  However, some of the first cancer therapies that were developed target the specific metabolic needs of cancer cells and remain effective agents in the clinic today.  Research into how changes in cell metab. promote tumor growth has accelerated in recent years.  This has refocused efforts to target metabolic dependencies of cancer cells as a selective anticancer strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdwef_xmbtRrVg90H21EOLACvtfcHk0lhzQgKtPDDnxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSltb3J&md5=5051a52f70ba7dd0cd99cf6ffce7f4c6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3504%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26atitle%3DTargeting%2520cancer%2520metabolism%253A%2520a%2520therapeutic%2520window%2520opens%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D671%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span> </span><span class="NLM_article-title">Nampt: linking NAD biology, metabolism and cancer</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">â</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.tem.2008.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=19109034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFanu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=130-138&author=A.+Gartenauthor=S.+Petzoldauthor=A.+Kornerauthor=S.+Imaiauthor=W.+Kiess&title=Nampt%3A+linking+NAD+biology%2C+metabolism+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Nampt: linking NAD biology, metabolism and cancer</span></div><div class="casAuthors">Garten, Antje; Petzold, Stefanie; Koerner, Antje; Imai, Shin-ichiro; Kiess, Wieland</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">130-138</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nicotinamide phosphoribosyltransferase (Nampt) converts nicotinamide to NMN, a key NAD intermediate.  Previously identified as a cytokine pre-B-cell colony-enhancing factor and controversially claimed as an insulin-mimetic hormone visfatin, Nampt has recently drawn much attention in several fields, including NAD biol., metab. and inflammation.  As a NAD biosynthetic enzyme, Nampt regulates the activity of NAD-consuming enzymes such as sirtuins and influences a variety of metabolic and stress responses.  Nampt also plays an important part in regulating insulin secretion in pancreatic Î²-cells.  Nampt seems to have another function as an immunomodulatory cytokine and, therefore, has a role in inflammation.  This review summarizes these various functional aspects of Nampt and discusses its potential roles in diseases, including type 2 diabetes and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMtmRWd15knbVg90H21EOLACvtfcHk0lhzQgKtPDDnxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFanu7o%253D&md5=2e6fc10db431e1963b0b827747466c53</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2008.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2008.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DPetzold%26aufirst%3DS.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DKiess%26aufirst%3DW.%26atitle%3DNampt%253A%2520linking%2520NAD%2520biology%252C%2520metabolism%2520and%2520cancer%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2009%26volume%3D20%26spage%3D130%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Galli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rongvaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, O.</span><span> </span><span class="NLM_article-title">The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">â</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=8-11&author=M.+Galliauthor=F.+Van+Goolauthor=A.+Rongvauxauthor=F.+Andrisauthor=O.+Leo&title=The+nicotinamide+phosphoribosyltransferase%3A+a+molecular+link+between+metabolism%2C+inflammation%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DM.%26aulast%3DVan%2BGool%26aufirst%3DF.%26aulast%3DRongvaux%26aufirst%3DA.%26aulast%3DAndris%26aufirst%3DF.%26aulast%3DLeo%26aufirst%3DO.%26atitle%3DThe%2520nicotinamide%2520phosphoribosyltransferase%253A%2520a%2520molecular%2520link%2520between%2520metabolism%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D8%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gholson, R. K.</span><span> </span><span class="NLM_article-title">The pyridine nucleotide cycle</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">â</span> <span class="NLM_lpage">935</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=1966&pages=933-935&author=R.+K.+Gholson&title=The+pyridine+nucleotide+cycle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGholson%26aufirst%3DR.%2BK.%26atitle%3DThe%2520pyridine%2520nucleotide%2520cycle%26jtitle%3DNature%26date%3D1966%26volume%3D212%26spage%3D933%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rechsteiner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catanzarite, V.</span><span> </span><span class="NLM_article-title">The biosynthesis and turnover of nicotinamide adenine dinucleotide in enucleated culture cells</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">â</span> <span class="NLM_lpage">422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1002%2Fjcp.1040840309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADyaE2MXmvFamtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1974&pages=409-422&author=M.+Rechsteinerauthor=V.+Catanzarite&title=The+biosynthesis+and+turnover+of+nicotinamide+adenine+dinucleotide+in+enucleated+culture+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Biosynthesis and turnover of nicotinamide adenine dinucleotide in enucleated culture cells</span></div><div class="casAuthors">Rechsteiner, Martin; Catanzarite, Valerian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-21</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    </div><div class="casAbstract">Nicotinic acid mononucleotide (NaMN) and NMN were proposed as intermediates in the biosynthesis of NAD from nicotinic acid and nicotinamide, resp.  Although NaMN and NMN were not detected in acid exts. from whole D98/AH2 cells following pulses with nicotinic-3H acid and nicotinamide-3H, they were obsd. following pulses of enucleated cells.  Several expts. indicated that enucleated cells were incapable of synthesizing NAD and that biosynthesis stopped with mononucleotide formation.  These results provide support for the idea, based upon fractionation studies, that NAD pyrophosphorylase (which catalyzes the reaction NMN or NaMN + ATP â NAD or desamido-NAD) is localized exclusively in the nucleus.  Acid extn. and chromatog. were also used to compare the stability of NAD-3H in enucleated and whole cells.  In the presence of the glutamine analog, azaserine, the intracellular concn. of NAD-3H decreased exponentially with a half-life of 4 hr in whole cells.  In enucleated cells the intracellular concn. of NAD-3H decreased with a half-life of >14 hr.  The increased stability of NAD in enucleated cells was confirmed by autoradiog.  These results demonstrate the key role of the nucleus in both the biosynthesis and turnover of NAD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRcdeaOaoq_7Vg90H21EOLACvtfcHk0lheU1MCM8CsRQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXmvFamtQ%253D%253D&md5=e2b14ff4b8a1fec9b0614c629192a351</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1002%2Fjcp.1040840309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.1040840309%26sid%3Dliteratum%253Aachs%26aulast%3DRechsteiner%26aufirst%3DM.%26aulast%3DCatanzarite%26aufirst%3DV.%26atitle%3DThe%2520biosynthesis%2520and%2520turnover%2520of%2520nicotinamide%2520adenine%2520dinucleotide%2520in%2520enucleated%2520culture%2520cells%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D1974%26volume%3D84%26spage%3D409%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span> </span><span class="NLM_article-title">Comparative genomics of NAD(P) biosynthesis and novel antibiotic drug targets</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">â</span> <span class="NLM_lpage">340</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1002%2Fjcp.22419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fgt1CksQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2011&pages=331-340&author=J.+Biauthor=H.+Wangauthor=J.+Xie&title=Comparative+genomics+of+NAD%28P%29+biosynthesis+and+novel+antibiotic+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative genomics of NAD(P) biosynthesis and novel antibiotic drug targets</span></div><div class="casAuthors">Bi Jicai; Wang Honghai; Xie Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">331-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NAD(P) is an indispensable cofactor for all organisms and its biosynthetic pathways are proposed as promising novel antibiotics targets against pathogens such as Mycobacterium tuberculosis.  Six NAD(P) biosynthetic pathways were reconstructed by comparative genomics: de novo pathway (Asp), de novo pathway (Try), NmR pathway I (RNK-dependent), NmR pathway II (RNK-independent), Niacin salvage, and Niacin recycling.  Three enzymes pivotal to the key reactions of NAD(P) biosynthesis are shared by almost all organisms, that is, NMN/NaMN adenylyltransferase (NMN/NaMNAT), NAD synthetase (NADS), and NAD kinase (NADK).  They might serve as ideal broad spectrum antibiotic targets.  Studies in M. tuberculosis have in part tested such hypothesis.  Three regulatory factors NadR, NiaR, and NrtR, which regulate NAD biosynthesis, have been identified.  M. tuberculosis NAD(P) metabolism and regulation thereof, potential drug targets and drug development are summarized in this paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlqlWDxtx3xr0AGQpJZWpJfW6udTcc2eZHKApCGmaY8rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fgt1CksQ%253D%253D&md5=9d698872c856c0bbf925ddde4c619e86</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fjcp.22419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.22419%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DJ.%26atitle%3DComparative%2520genomics%2520of%2520NAD%2528P%2529%2520biosynthesis%2520and%2520novel%2520antibiotic%2520drug%2520targets%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2011%26volume%3D226%26spage%3D331%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bieganowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, C.</span><span> </span><span class="NLM_article-title">Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a PreissâHandler independent route to NAD+ in fungi and humans</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">â</span> <span class="NLM_lpage">502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2004&pages=495-502&author=P.+Bieganowskiauthor=C.+Brenner&title=Discoveries+of+nicotinamide+riboside+as+a+nutrient+and+conserved+NRK+genes+establish+a+Preiss%E2%80%93Handler+independent+route+to+NAD%2B+in+fungi+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBieganowski%26aufirst%3DP.%26aulast%3DBrenner%26aufirst%3DC.%26atitle%3DDiscoveries%2520of%2520nicotinamide%2520riboside%2520as%2520a%2520nutrient%2520and%2520conserved%2520NRK%2520genes%2520establish%2520a%2520Preiss%25E2%2580%2593Handler%2520independent%2520route%2520to%2520NAD%252B%2520in%2520fungi%2520and%2520humans%26jtitle%3DCell%26date%3D2004%26volume%3D117%26spage%3D495%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chiarugi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegler, M.</span><span> </span><span class="NLM_article-title">The NAD metabolomeâa key determinant of cancer cell biology</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">â</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1038%2Fnrc3340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=23018234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWnurvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=741-752&author=A.+Chiarugiauthor=C.+Dolleauthor=R.+Feliciauthor=M.+Ziegler&title=The+NAD+metabolome%E2%80%94a+key+determinant+of+cancer+cell+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The NAD metabolome - a key determinant of cancer cell biology</span></div><div class="casAuthors">Chiarugi, Alberto; Doelle, Christian; Felici, Roberta; Ziegler, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">741-752</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  NAD is a vital mol. in all organisms.  It is a key component of both energy and signal transduction - processes that undergo crucial changes in cancer cells.  NAD+-dependent signalling pathways are many and varied, and they regulate fundamental events such as transcription, DNA repair, cell cycle progression, apoptosis and metab.  Many of these processes have been linked to cancer development.  Given that NAD+-dependent signalling reactions involve the degrdn. of the mol., permanent nucleotide resynthesis through different biosynthetic pathways is crucial for incessant cancer cell proliferation.  This necessity supports the targeting of NAD metab. as a new therapeutic concept for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopGSV9JpM_CLVg90H21EOLACvtfcHk0lg1EC6D__PB2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWnurvP&md5=5111918068b9362f6932cff3b3ebd824</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2Fnrc3340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3340%26sid%3Dliteratum%253Aachs%26aulast%3DChiarugi%26aufirst%3DA.%26aulast%3DDolle%26aufirst%3DC.%26aulast%3DFelici%26aufirst%3DR.%26aulast%3DZiegler%26aufirst%3DM.%26atitle%3DThe%2520NAD%2520metabolome%25E2%2580%2594a%2520key%2520determinant%2520of%2520cancer%2520cell%2520biology%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D741%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Magni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsomando, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffelli, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggieri, S.</span><span> </span><span class="NLM_article-title">Enzymology of mammalian NAD metabolism in health and disease</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">6135</span><span class="NLM_x">â</span> <span class="NLM_lpage">6154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.2741%2F3143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOisb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=6135-6154&author=G.+Magniauthor=G.+Orsomandoauthor=N.+Raffelliauthor=S.+Ruggieri&title=Enzymology+of+mammalian+NAD+metabolism+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymology of mammalian NAD metabolism in health and disease</span></div><div class="casAuthors">Magni, Giulio; Orsomando, Giuseppe; Raffelli, Nadia; Ruggieri, Silverio</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6135-6154</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Mounting evidence attests to the paramount importance of the non-redox NAD functions.  Indeed, NAD homeostasis is related to the free radicals-mediated prodn. of reactive oxygen species responsible for irreversible cellular damage in infectious disease, diabetes, inflammatory syndromes, neurodegeneration and cancer.  Because the cellular redox status depends on both the abs. concn. of pyridine dinucleotides and their resp. ratios of oxidized and reduced forms (i.e., NAD/NADH and NADP/NADPH), it is conceivable that an altered regulation of the synthesis and degrdn. of NAD impairs the cell redox state and likely contributes to the mechanisms underlying the pathogenesis of the above mentioned diseases.  Taking into account the recent appearance in the literature of comprehensive reviews covering different aspects of the significance of NAD metab., with particular attention to the enzymes involved in NAD cleavage, this monograph includes the most recent results on NAD biosynthesis in mammals and humans.  Due to recent findings on nicotinamide riboside as a nutrient, its inclusion under "niacins" is proposed.  Here, the enzymes involved in the de novo and reutilization pathways are overviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvX2dsB8dbbrVg90H21EOLACvtfcHk0lg1EC6D__PB2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOisb0%253D&md5=aa02e7cb092b9e7449b5bce49e97fa82</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.2741%2F3143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3143%26sid%3Dliteratum%253Aachs%26aulast%3DMagni%26aufirst%3DG.%26aulast%3DOrsomando%26aufirst%3DG.%26aulast%3DRaffelli%26aufirst%3DN.%26aulast%3DRuggieri%26aufirst%3DS.%26atitle%3DEnzymology%2520of%2520mammalian%2520NAD%2520metabolism%2520in%2520health%2520and%2520disease%26jtitle%3DFront.%2520Biosci.%26date%3D2008%26volume%3D13%26spage%3D6135%26epage%3D6154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Di Pucchio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danese, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cristofaro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutella, S.</span><span> </span><span class="NLM_article-title">Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">â</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1517%2F13543770903512974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=229-250&author=T.+Di+Pucchioauthor=S.+Daneseauthor=R.+De+Cristofaroauthor=S.+Rutella&title=Inhibitors+of+indoleamine+2%2C3-dioxygenase%3A+a+review+of+novel+patented+lead+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds</span></div><div class="casAuthors">Di Pucchio, Tiziana; Danese, Silvio; De Cristofaro, Raimondo; Rutella, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-250</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The enzyme indoleamine 2,3-dioxygenase (IDO) regulates immune responses through the capacity to degrade the essential amino-acid tryptophan into kynurenine and other downstream metabolites that suppress effector T-cell function and favor the differentiation of regulatory T cells.  The current exptl. evidence indicates that IDO can be expressed by a variety of cell types, including dendritic cells, tumor cells and stromal cells.  Recently, IDO has been implicated in B-cell stimulation and autoantibody prodn. in exptl. models of autoimmune diseases.  Areas covered in this review: Advances in the biochem. of IDO and our understanding of the biol. relevance of IDO-mediated tryptophan consumption to the establishment of immune tolerance are summarised and discussed.  A selection of recent patents in the field are also reviewed and analyzed.  What the reader will gain: Readers will gain an overview of the patented compds. with IDO inhibitory activity from an immunologist's perspective.  They will also learn about the companies that are main players in the field.  Take home message: Current evidence points to IDO as a mol. target for therapeutic intervention in order to restrain unwanted inflammatory/autoimmune responses and/or to boost antitumor immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjqWfk1x37f7Vg90H21EOLACvtfcHk0lg1EC6D__PB2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktLc%253D&md5=0ced49cf3450de90c238a862e0d73e94</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F13543770903512974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903512974%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPucchio%26aufirst%3DT.%26aulast%3DDanese%26aufirst%3DS.%26aulast%3DDe%2BCristofaro%26aufirst%3DR.%26aulast%3DRutella%26aufirst%3DS.%26atitle%3DInhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%253A%2520a%2520review%2520of%2520novel%2520patented%2520lead%2520compounds%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D229%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Preiss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handler, P.</span><span> </span><span class="NLM_article-title">Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">â</span> <span class="NLM_lpage">492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1958&pages=488-492&author=J.+Preissauthor=P.+Handler&title=Biosynthesis+of+diphosphopyridine+nucleotide.+I.+Identification+of+intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPreiss%26aufirst%3DJ.%26aulast%3DHandler%26aufirst%3DP.%26atitle%3DBiosynthesis%2520of%2520diphosphopyridine%2520nucleotide.%2520I.%2520Identification%2520of%2520intermediates%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1958%26volume%3D233%26spage%3D488%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bheda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revollo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolberger, C.</span><span> </span><span class="NLM_article-title">Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">â</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1038%2Fnsmb1114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=16783373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1eltLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=661-662&author=T.+Wangauthor=X.+Zhangauthor=P.+Bhedaauthor=J.+R.+Revolloauthor=S.+Imaiauthor=C.+Wolberger&title=Structure+of+Nampt%2FPBEF%2Fvisfatin%2C+a+mammalian+NAD%2B+biosynthetic+enzyme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme</span></div><div class="casAuthors">Wang, Tao; Zhang, Xiangbin; Bheda, Poonam; Revollo, Javier R.; Imai, Shin-ichiro; Wolberger, Cynthia</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">661-662</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (Nampt) synthesizes NMN from nicotinamide in a mammalian NAD+ biosynthetic pathway and is required for SirT1 activity in vivo.  Nampt has also been presumed to be a cytokine (PBEF) or a hormone (visfatin).  The crystal structure of Nampt in the presence and absence of NMN shows that Nampt is a dimeric type II phosphoribosyltransferase and provides insights into the enzymic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZDB0vef67YbVg90H21EOLACvtfcHk0ljR1ZKBRIwruA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1eltLg%253D&md5=ad2fd7f5cf0085896a157d1f1831f8c6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1114%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DBheda%26aufirst%3DP.%26aulast%3DRevollo%26aufirst%3DJ.%2BR.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DWolberger%26aufirst%3DC.%26atitle%3DStructure%2520of%2520Nampt%252FPBEF%252Fvisfatin%252C%2520a%2520mammalian%2520NAD%252B%2520biosynthetic%2520enzyme%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D661%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Revollo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolberger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milbrandt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span> </span><span class="NLM_article-title">Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">â</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.cmet.2007.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlemsr%252FJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=363-375&author=J.+R.+Revolloauthor=A.+Kornerauthor=K.+F.+Millsauthor=A.+Satohauthor=T.+Wangauthor=A.+Gartenauthor=B.+Dasguptaauthor=Y.+Sasakiauthor=C.+Wolbergerauthor=R.+R.+Townsendauthor=J.+Milbrandtauthor=W.+Kiessauthor=S.+Imai&title=Nampt%2FPBEF%2Fvisfatin+regulates+insulin+secretion+in+beta+cells+as+a+systemic+NAD+biosynthetic+enzyme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nampt/PBEF/visfatin regulates insulin secretion in Î² cells as a systemic NAD biosynthetic enzyme</span></div><div class="casAuthors">Revollo, Javier R.; Korner, Antje; Mills, Kathryn F.; Satoh, Akiko; Wang, Tao; Garten, Antje; Dasgupta, Biplab; Sasaki, Yo; Wolberger, Cynthia; Townsend, R. Reid; Milbrandt, Jeffrey; Kiess, Wieland; Imai, Shin-ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">363-375</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Intracellular nicotinamide phosphoribosyltransferase (iNampt) is an essential enzyme in the NAD biosynthetic pathway.  An extracellular form of this protein (eNampt) has been reported to act as a cytokine named PBEF or an insulin-mimetic hormone named visfatin, but its physiol. relevance remains controversial.  The eNampt does not exert insulin-mimetic effects in vitro or in vivo but rather exhibits robust NAD biosynthetic activity.  Haplodeficiency and chem. inhibition of Nampt cause defects in NAD biosynthesis and glucose-stimulated insulin secretion in pancreatic islets in vivo and in vitro.  These defects are cor. by administration of NMN, a product of the Nampt reaction.  A high concn. of NMN is present in mouse plasma, and plasma eNampt and NMN levels are reduced in Nampt heterozygous females.  The authors' results demonstrate that Nampt-mediated systemic NAD biosynthesis is crit. for Î²-cell function, suggesting a vital framework for the regulation of glucose homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp80WTQ18g5f7Vg90H21EOLACvtfcHk0ljR1ZKBRIwruA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlemsr%252FJ&md5=14cf43c42e565a6e9b81856173b0806c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DRevollo%26aufirst%3DJ.%2BR.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DMills%26aufirst%3DK.%2BF.%26aulast%3DSatoh%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DDasgupta%26aufirst%3DB.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DWolberger%26aufirst%3DC.%26aulast%3DTownsend%26aufirst%3DR.%2BR.%26aulast%3DMilbrandt%26aufirst%3DJ.%26aulast%3DKiess%26aufirst%3DW.%26aulast%3DImai%26aufirst%3DS.%26atitle%3DNampt%252FPBEF%252Fvisfatin%2520regulates%2520insulin%2520secretion%2520in%2520beta%2520cells%2520as%2520a%2520systemic%2520NAD%2520biosynthetic%2520enzyme%26jtitle%3DCell%2520Metab.%26date%3D2007%26volume%3D6%26spage%3D363%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Zhang, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heruth, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, S. Q.</span><span> </span><span class="NLM_article-title">Nicotinamide phosphoribosyltransferase in human diseases</span> <span class="citation_source-journal">J. Bioanal. Biomed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">â</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.4172%2F1948-593X.1000038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=22140607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFagur%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=13-25&author=L.+Q.+Zhangauthor=D.+P.+Heruthauthor=S.+Q.+Ye&title=Nicotinamide+phosphoribosyltransferase+in+human+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide phosphoribosyltransferase in human diseases</span></div><div class="casAuthors">Zhang, Li Qin; Heruth, Daniel P.; Ye, Shui Qing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bioanalysis & Biomedicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">013-025</span>CODEN:
                <span class="NLM_cas:coden">JBBOHQ</span>;
        ISSN:<span class="NLM_cas:issn">1948-593X</span>.
    
            (<span class="NLM_cas:orgname">OMICS Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nicotinamide phosphoribosyltransferase (NAMPT) was first reported as a pre-B-cell colony enhancing factor in 1994 with little notice, but it has received increasing attention in recent years due to accumulating evidence indicating that NAMPT is a pleiotropic protein such as a growth factor, a cytokine, an enzyme and a visfatin.  Now, NAMPT has been accepted as an official name of this protein.  Because of NAMPT's multiple functions in a variety of physiol. processes, their dysregulations have been implicated in the pathogenesis of a no. of human diseases or conditions such as acute lung injury, aging, atherosclerosis, cancer, diabetes, rheumatoid arthritis and sepsis.  This review will cover the current understanding of NAMPT's structure and functions with an emphasis on recent progress of nicotinamide phosphoribosyltransferase's pathol. roles in various human diseases and conditions.  Future directions on exploring its Terra incognita will be offered in the end.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZKBmweBE-KLVg90H21EOLACvtfcHk0ljR1ZKBRIwruA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFagur%252FL&md5=b072620549d511fdeeab5dec6e3fb7d7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4172%2F1948-593X.1000038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F1948-593X.1000038%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%2BQ.%26aulast%3DHeruth%26aufirst%3DD.%2BP.%26aulast%3DYe%26aufirst%3DS.%2BQ.%26atitle%3DNicotinamide%2520phosphoribosyltransferase%2520in%2520human%2520diseases%26jtitle%3DJ.%2520Bioanal.%2520Biomed.%26date%3D2011%26volume%3D3%26spage%3D13%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Burgos, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">11086</span><span class="NLM_x">â</span> <span class="NLM_lpage">11096</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi801198m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=11086-11096&author=E.+S.+Burgosauthor=V.+L.+Schramm&title=Weak+coupling+of+ATP+hydrolysis+to+the+chemical+equilibrium+of+human+nicotinamide+phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi801198m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801198m%26sid%3Dliteratum%253Aachs%26aulast%3DBurgos%26aufirst%3DE.%2BS.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DWeak%2520coupling%2520of%2520ATP%2520hydrolysis%2520to%2520the%2520chemical%2520equilibrium%2520of%2520human%2520nicotinamide%2520phosphoribosyltransferase%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D11086%26epage%3D11096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Pittelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formentini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapizzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cialdai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moneti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiarugi, A.</span><span> </span><span class="NLM_article-title">Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">34106</span><span class="NLM_x">â</span> <span class="NLM_lpage">34114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1074%2Fjbc.M110.136739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=20724478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWktrbM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=34106-34114&author=M.+Pittelliauthor=L.+Formentiniauthor=G.+Faracoauthor=A.+Lapucciauthor=E.+Rapizziauthor=F.+Cialdaiauthor=G.+Romanoauthor=G.+Monetiauthor=F.+Moroniauthor=A.+Chiarugi&title=Inhibition+of+nicotinamide+phosphoribosyltransferase%3A+cellular+bioenergetics+reveals+a+mitochondrial+insensitive+NAD+pool"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Nicotinamide Phosphoribosyltransferase: Cellular bioenergetics reveals a mitochondrial insensitive NAD pool</span></div><div class="casAuthors">Pittelli, Maria; Formentini, Laura; Faraco, Giuseppe; Lapucci, Andrea; Rapizzi, Elena; Cialdai, Francesca; Romano, Giovanni; Moneti, Gloriano; Moroni, Flavio; Chiarugi, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">34106-34114</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The NAD rescue pathway consists of two enzymic steps operated by nicotinamide phosphoribosyltransferase (Nampt) and NMN adenylyltransferases.  Recently, the potent Nampt inhibitor FK866 has been identified and evaluated in clin. trials against cancer.  Yet, how Nampt inhibition affects NAD contents and bioenergetics is in part obscure.  It is also unknown whether NAD rescue takes place in mitochondria, and FK866 alters NAD homeostasis within the organelle.  Here, we show that FK866-dependent redn. of the NAD contents is paralleled by a concomitant increase of ATP in various cell types, in keeping with ATP utilization for NAD resynthesis.  We also show that poly- and mono(ADP-ribose) transferases rather than Sirt-1 are responsible for NAD depletion in HeLa cells exposed to FK866.  Mass spectrometry reveals that the drug distributes in the cytosolic and mitochondrial compartment.  However, the cytoplasmic but not the mitochondrial NAD pool is reduced upon acute or chronic exposure to the drug.  Accordingly, Nampt does not localize within the organelles and their bioenergetics is not affected by the drug.  In the mouse, FK866-dependent redn. of NAD contents in various organs is prevented by inhibitors of poly(ADP-ribose) polymerases or the NAD precursor kynurenine.  For the first time, our data indicate that mitochondria lack the canonical NAD rescue pathway, broadening current understanding of cellular bioenergetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGospj_13whivrVg90H21EOLACvtfcHk0lgaA5j8fNPUlg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWktrbM&md5=ee8de3045040ba421dfd6dcf7f05b322</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.136739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.136739%26sid%3Dliteratum%253Aachs%26aulast%3DPittelli%26aufirst%3DM.%26aulast%3DFormentini%26aufirst%3DL.%26aulast%3DFaraco%26aufirst%3DG.%26aulast%3DLapucci%26aufirst%3DA.%26aulast%3DRapizzi%26aufirst%3DE.%26aulast%3DCialdai%26aufirst%3DF.%26aulast%3DRomano%26aufirst%3DG.%26aulast%3DMoneti%26aufirst%3DG.%26aulast%3DMoroni%26aufirst%3DF.%26aulast%3DChiarugi%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%253A%2520cellular%2520bioenergetics%2520reveals%2520a%2520mitochondrial%2520insensitive%2520NAD%2520pool%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D34106%26epage%3D34114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baur, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmona, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamming, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza-Pinto, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohr, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Cabo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauve, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, D. A.</span><span> </span><span class="NLM_article-title">Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1095</span><span class="NLM_x">â</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2007&pages=1095-1107&author=H.+Yangauthor=T.+Yangauthor=J.+A.+Baurauthor=E.+Perezauthor=T.+Matsuiauthor=J.+J.+Carmonaauthor=D.+W.+Lammingauthor=N.+C.+Souza-Pintoauthor=V.+A.+Bohrauthor=A.+Rosenzweigauthor=R.+de+Caboauthor=A.+A.+Sauveauthor=D.+A.+Sinclair&title=Nutrient-sensitive+mitochondrial+NAD%2B+levels+dictate+cell+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DBaur%26aufirst%3DJ.%2BA.%26aulast%3DPerez%26aufirst%3DE.%26aulast%3DMatsui%26aufirst%3DT.%26aulast%3DCarmona%26aufirst%3DJ.%2BJ.%26aulast%3DLamming%26aufirst%3DD.%2BW.%26aulast%3DSouza-Pinto%26aufirst%3DN.%2BC.%26aulast%3DBohr%26aufirst%3DV.%2BA.%26aulast%3DRosenzweig%26aufirst%3DA.%26aulast%3Dde%2BCabo%26aufirst%3DR.%26aulast%3DSauve%26aufirst%3DA.%2BA.%26aulast%3DSinclair%26aufirst%3DD.%2BA.%26atitle%3DNutrient-sensitive%2520mitochondrial%2520NAD%252B%2520levels%2520dictate%2520cell%2520survival%26jtitle%3DCell%26date%3D2007%26volume%3D130%26spage%3D1095%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Samal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suggs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNiece, I.</span><span> </span><span class="NLM_article-title">Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1431</span><span class="NLM_x">â</span> <span class="NLM_lpage">1437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1128%2FMCB.14.2.1431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=8289818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADyaK2cXhvV2gsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=1431-1437&author=B.+Samalauthor=Y.+Sunauthor=G.+Stearnsauthor=C.+Xieauthor=S.+Suggsauthor=I.+McNiece&title=Cloning+and+characterization+of+the+cDNA+encoding+a+novel+human+pre-B-cell+colony-enhancing+factor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor</span></div><div class="casAuthors">Samal, Babru; Sun, Yinghao; Stearns, George; Xie, Chunshan; Suggs, Sidney; McNiece, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1431-7</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">A novel gene coding for the pre-B-cell colony-enhancing factor (PBEF) was isolated from a human peripheral blood lymphocyte cDNA library.  The expression of this gene is induced by pokeweed mitogen and superinduced by cycloheximide.  It is also induced in the T-lymphoblastoid cell line HUT 78 after phorbol ester (phorbol myristate acetate) treatment.  The predominant mRNA for PBEF is â¼2.4 kb long and codes for a 52-kDa secreted protein.  The 3'-untranslated region of the mRNA has multiple TATT motifs, usually found in cytokine and oncogene messages.  The PBEF gene is mainly transcribed in human bone marrow, liver tissue, and muscle.  PBEF was expressed in COS 7 and PA317 cells and the biol. activities were tested in the conditioned medium as well as the antibody-purified protein in different in vitro assays.  PBEF itself had no activity but synergized the pre-B-cell colony formation activity of stem cell factor and interleukin 7.  In the presence of PBEF, the no. of pre-B-cell colonies was increased by â¥70% above the amt. stimulated by stem cell factor plus interleukin 7.  No effect of PBEF was found with cells of myeloid or erythroid lineages.  These data define PBEF as a novel cytokine which acts on early B-lineage precursor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7obiHXnOZbLVg90H21EOLACvtfcHk0lgaA5j8fNPUlg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhvV2gsbw%253D&md5=9b112face0e7a285e04689a99e9eed56</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1128%2FMCB.14.2.1431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.14.2.1431%26sid%3Dliteratum%253Aachs%26aulast%3DSamal%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DStearns%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DSuggs%26aufirst%3DS.%26aulast%3DMcNiece%26aufirst%3DI.%26atitle%3DCloning%2520and%2520characterization%2520of%2520the%2520cDNA%2520encoding%2520a%2520novel%2520human%2520pre-B-cell%2520colony-enhancing%2520factor%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1994%26volume%3D14%26spage%3D1431%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dahl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aukrust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halvorsen, B.</span><span> </span><span class="NLM_article-title">Visfatin/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology</span> <span class="citation_source-journal">Annu. Rev. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">â</span> <span class="NLM_lpage">243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=229-243&author=T.+B.+Dahlauthor=S.+Holmauthor=P.+Aukrustauthor=B.+Halvorsen&title=Visfatin%2FNAMPT%3A+a+multifaceted+molecule+with+diverse+roles+in+physiology+and+pathophysiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDahl%26aufirst%3DT.%2BB.%26aulast%3DHolm%26aufirst%3DS.%26aulast%3DAukrust%26aufirst%3DP.%26aulast%3DHalvorsen%26aufirst%3DB.%26atitle%3DVisfatin%252FNAMPT%253A%2520a%2520multifaceted%2520molecule%2520with%2520diverse%2520roles%2520in%2520physiology%2520and%2520pathophysiology%26jtitle%3DAnnu.%2520Rev.%2520Nutr.%26date%3D2012%26volume%3D32%26spage%3D229%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yammani, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeser, R. F.</span><span> </span><span class="NLM_article-title">Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">R23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=R23&author=R.+R.+Yammaniauthor=R.+F.+Loeser&title=Extracellular+nicotinamide+phosphoribosyltransferase+%28NAMPT%2Fvisfatin%29+inhibits+insulin-like+growth+factor-1+signaling+and+proteoglycan+synthesis+in+human+articular+chondrocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYammani%26aufirst%3DR.%2BR.%26aulast%3DLoeser%26aufirst%3DR.%2BF.%26atitle%3DExtracellular%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%252Fvisfatin%2529%2520inhibits%2520insulin-like%2520growth%2520factor-1%2520signaling%2520and%2520proteoglycan%2520synthesis%2520in%2520human%2520articular%2520chondrocytes%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2012%26volume%3D14%26spage%3DR23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kang, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, S. K.</span><span> </span><span class="NLM_article-title">Visfatin induces neurite outgrowth in PC12 cells via ERK1/2 signaling pathway</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">504</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">â</span> <span class="NLM_lpage">126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2011&pages=121-126&author=Y.+S.+Kangauthor=M.+K.+Baeauthor=J.+Y.+Kimauthor=J.+W.+Jeongauthor=I.+Yunauthor=H.+O.+Jangauthor=S.+K.+Bae&title=Visfatin+induces+neurite+outgrowth+in+PC12+cells+via+ERK1%2F2+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DY.%2BS.%26aulast%3DBae%26aufirst%3DM.%2BK.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DJeong%26aufirst%3DJ.%2BW.%26aulast%3DYun%26aufirst%3DI.%26aulast%3DJang%26aufirst%3DH.%2BO.%26aulast%3DBae%26aufirst%3DS.%2BK.%26atitle%3DVisfatin%2520induces%2520neurite%2520outgrowth%2520in%2520PC12%2520cells%2520via%2520ERK1%252F2%2520signaling%2520pathway%26jtitle%3DNeurosci.%2520Lett.%26date%3D2011%26volume%3D504%26spage%3D121%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuhara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komuro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimomura, I.</span><span> </span><span class="NLM_article-title">Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">â</span> <span class="NLM_lpage">201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2007&pages=194-201&author=M.+Tanakaauthor=M.+Nozakiauthor=A.+Fukuharaauthor=K.+Segawaauthor=N.+Aokiauthor=M.+Matsudaauthor=R.+Komuroauthor=I.+Shimomura&title=Visfatin+is+released+from+3T3-L1+adipocytes+via+a+non-classical+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNozaki%26aufirst%3DM.%26aulast%3DFukuhara%26aufirst%3DA.%26aulast%3DSegawa%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DN.%26aulast%3DMatsuda%26aufirst%3DM.%26aulast%3DKomuro%26aufirst%3DR.%26aulast%3DShimomura%26aufirst%3DI.%26atitle%3DVisfatin%2520is%2520released%2520from%25203T3-L1%2520adipocytes%2520via%2520a%2520non-classical%2520pathway%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2007%26volume%3D359%26spage%3D194%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnikol-Oettler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thasler, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratzsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhardt, R.</span><span> </span><span class="NLM_article-title">Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">â</span> <span class="NLM_lpage">381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2010&pages=376-381&author=A.+Gartenauthor=S.+Petzoldauthor=A.+Barnikol-Oettlerauthor=A.+Kornerauthor=W.+E.+Thaslerauthor=J.+Kratzschauthor=W.+Kiessauthor=R.+Gebhardt&title=Nicotinamide+phosphoribosyltransferase+%28NAMPT%2FPBEF%2Fvisfatin%29+is+constitutively+released+from+human+hepatocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DPetzold%26aufirst%3DS.%26aulast%3DBarnikol-Oettler%26aufirst%3DA.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DThasler%26aufirst%3DW.%2BE.%26aulast%3DKratzsch%26aufirst%3DJ.%26aulast%3DKiess%26aufirst%3DW.%26aulast%3DGebhardt%26aufirst%3DR.%26atitle%3DNicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%252FPBEF%252Fvisfatin%2529%2520is%2520constitutively%2520released%2520from%2520human%2520hepatocytes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2010%26volume%3D391%26spage%3D376%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schilling, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauschildt, S.</span><span> </span><span class="NLM_article-title">Extracellular ATP induces P2X7-dependent nicotinamide phosphoribosyltransferase release in LPS-activated human monocytes</span> <span class="citation_source-journal">Innate Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">â</span> <span class="NLM_lpage">744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1177%2F1753425912439614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVKku7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=738-744&author=E.+Schillingauthor=S.+Hauschildt&title=Extracellular+ATP+induces+P2X7-dependent+nicotinamide+phosphoribosyltransferase+release+in+LPS-activated+human+monocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular ATP induces P2X7-dependent nicotinamide phosphoribosyltransferase release in LPS-activated human monocytes</span></div><div class="casAuthors">Schilling, Erik; Hauschildt, Sunna</div><div class="citationInfo"><span class="NLM_cas:title">Innate Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">738-744, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">IINMCB</span>;
        ISSN:<span class="NLM_cas:issn">1753-4259</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NAMPT), an enzyme involved in NAD biosynthesis, has recently been identified as a novel mediator of innate immunity.  In the present study, we report that treatment of LPS-primed monocytes with ATP greatly enhanced the secretion of NAMPT in a time- and concn.-dependent manner without displaying any cytotoxic effect.  NAMPT release was suppressed by pretreatment with the P2X7 receptor (P2X7R) inhibitors oxidized ATP (oxATP) and KN-62, indicating the engagement of P2X7Rs.  Furthermore, P2X7R was found to be involved in mediating cell permeability caused by the addn. of ATP.  To define a role of endogenous ATP in NAMPT secretion, LPS-primed monocytes were incubated in the presence of oxATP and KN-62, as well as the ATP-hydrolyzing enzymes apyrase and hexokinase.  With the exception of oxATP, neither substance led to a decrease in NAMPT release, suggesting that autocrine/paracrine ATP is unlikely to be responsible for the LPS-induced release of NAMPT.  In conclusion, the enhanced release of NAMPT by extracellular ATP described here indicates the requirement of a second stimulus for the efficient secretion of NAMPT.  This mode of secretion, which also applies to IL-1Î², might represent a general mechanism for the release of leaderless secretory proteins at locally restricted sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK9-0M43_k7LVg90H21EOLACvtfcHk0lhIeHqe-wCL3g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVKku7g%253D&md5=52b1e116c3644c571c219a25c8b523ef</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1177%2F1753425912439614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1753425912439614%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DE.%26aulast%3DHauschildt%26aufirst%3DS.%26atitle%3DExtracellular%2520ATP%2520induces%2520P2X7-dependent%2520nicotinamide%2520phosphoribosyltransferase%2520release%2520in%2520LPS-activated%2520human%2520monocytes%26jtitle%3DInnate%2520Immun.%26date%3D2012%26volume%3D18%26spage%3D738%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pillai, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaresan, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Vinasco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, M.</span><span> </span><span class="NLM_article-title">Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling</span> <span class="citation_source-journal">Am. J. Physiol.: Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">H415</span><span class="NLM_x">â</span> <span class="NLM_lpage">H426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2013&pages=H415-H426&author=V.+B.+Pillaiauthor=N.+R.+Sundaresanauthor=G.+H.+Kimauthor=S.+Samantauthor=L.+Moreno-Vinascoauthor=J.+G.+Garciaauthor=M.+Gupta&title=Nampt+secreted+from+cardiomyocytes+promotes+development+of+cardiac+hypertrophy+and+adverse+ventricular+remodeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPillai%26aufirst%3DV.%2BB.%26aulast%3DSundaresan%26aufirst%3DN.%2BR.%26aulast%3DKim%26aufirst%3DG.%2BH.%26aulast%3DSamant%26aufirst%3DS.%26aulast%3DMoreno-Vinasco%26aufirst%3DL.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%26aulast%3DGupta%26aufirst%3DM.%26atitle%3DNampt%2520secreted%2520from%2520cardiomyocytes%2520promotes%2520development%2520of%2520cardiac%2520hypertrophy%2520and%2520adverse%2520ventricular%2520remodeling%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Heart%2520Circ.%2520Physiol.%26date%3D2013%26volume%3D304%26spage%3DH415%26epage%3DH426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">van der Veer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâNeil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cregan, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, J. G.</span><span> </span><span class="NLM_article-title">Extension of human cell lifespan by nicotinamide phosphoribosyltransferase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">10841</span><span class="NLM_x">â</span> <span class="NLM_lpage">10845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=10841-10845&author=E.+van+der+Veerauthor=C.+Hoauthor=C.+O%E2%80%99Neilauthor=N.+Barbosaauthor=R.+Scottauthor=S.+P.+Creganauthor=J.+G.+Pickering&title=Extension+of+human+cell+lifespan+by+nicotinamide+phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BVeer%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DC.%26aulast%3DBarbosa%26aufirst%3DN.%26aulast%3DScott%26aufirst%3DR.%26aulast%3DCregan%26aufirst%3DS.%2BP.%26aulast%3DPickering%26aufirst%3DJ.%2BG.%26atitle%3DExtension%2520of%2520human%2520cell%2520lifespan%2520by%2520nicotinamide%2520phosphoribosyltransferase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D10841%26epage%3D10845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Nakahata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astarita, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaluzova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassone-Corsi, P.</span><span> </span><span class="NLM_article-title">Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span><span class="NLM_x">â</span> <span class="NLM_lpage">657</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=654-657&author=Y.+Nakahataauthor=S.+Saharauthor=G.+Astaritaauthor=M.+Kaluzovaauthor=P.+Sassone-Corsi&title=Circadian+control+of+the+NAD%2B+salvage+pathway+by+CLOCK-SIRT1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakahata%26aufirst%3DY.%26aulast%3DSahar%26aufirst%3DS.%26aulast%3DAstarita%26aufirst%3DG.%26aulast%3DKaluzova%26aufirst%3DM.%26aulast%3DSassone-Corsi%26aufirst%3DP.%26atitle%3DCircadian%2520control%2520of%2520the%2520NAD%252B%2520salvage%2520pathway%2520by%2520CLOCK-SIRT1%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D654%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Ramsey, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brace, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrassart, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcheva, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhr, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, J.</span><span> </span><span class="NLM_article-title">Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">â</span> <span class="NLM_lpage">654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=651-654&author=K.+M.+Ramseyauthor=J.+Yoshinoauthor=C.+S.+Braceauthor=D.+Abrassartauthor=Y.+Kobayashiauthor=B.+Marchevaauthor=H.+K.+Hongauthor=J.+L.+Chongauthor=E.+D.+Buhrauthor=C.+Leeauthor=J.+S.+Takahashiauthor=S.+Imaiauthor=J.+Bass&title=Circadian+clock+feedback+cycle+through+NAMPT-mediated+NAD%2B+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamsey%26aufirst%3DK.%2BM.%26aulast%3DYoshino%26aufirst%3DJ.%26aulast%3DBrace%26aufirst%3DC.%2BS.%26aulast%3DAbrassart%26aufirst%3DD.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DMarcheva%26aufirst%3DB.%26aulast%3DHong%26aufirst%3DH.%2BK.%26aulast%3DChong%26aufirst%3DJ.%2BL.%26aulast%3DBuhr%26aufirst%3DE.%2BD.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DTakahashi%26aufirst%3DJ.%2BS.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DBass%26aufirst%3DJ.%26atitle%3DCircadian%2520clock%2520feedback%2520cycle%2520through%2520NAMPT-mediated%2520NAD%252B%2520biosynthesis%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D651%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, C. Y.</span><span> </span><span class="NLM_article-title">Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">â</span> <span class="NLM_lpage">380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2009&pages=370-380&author=P.+Wangauthor=T.+Y.+Xuauthor=Y.+F.+Guanauthor=D.+F.+Suauthor=G.+R.+Fanauthor=C.+Y.+Miao&title=Perivascular+adipose+tissue-derived+visfatin+is+a+vascular+smooth+muscle+cell+growth+factor%3A+role+of+nicotinamide+mononucleotide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DT.%2BY.%26aulast%3DGuan%26aufirst%3DY.%2BF.%26aulast%3DSu%26aufirst%3DD.%2BF.%26aulast%3DFan%26aufirst%3DG.%2BR.%26aulast%3DMiao%26aufirst%3DC.%2BY.%26atitle%3DPerivascular%2520adipose%2520tissue-derived%2520visfatin%2520is%2520a%2520vascular%2520smooth%2520muscle%2520cell%2520growth%2520factor%253A%2520role%2520of%2520nicotinamide%2520mononucleotide%26jtitle%3DCardiovasc.%2520Res.%26date%3D2009%26volume%3D81%26spage%3D370%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yoshino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span> </span><span class="NLM_article-title">Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">â</span> <span class="NLM_lpage">536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.cmet.2011.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=21982712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12rtLvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=528-536&author=J.+Yoshinoauthor=K.+F.+Millsauthor=M.+J.+Yoonauthor=S.+Imai&title=Nicotinamide+mononucleotide%2C+a+key+NAD%28%2B%29+intermediate%2C+treats+the+pathophysiology+of+diet-+and+age-induced+diabetes+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice</span></div><div class="casAuthors">Yoshino, Jun; Mills, Kathryn F.; Yoon, Myeong Jin; Imai, Shin-ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">528-536</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Type 2 diabetes (T2D) has become epidemic in our modern lifestyle, likely due to calorie-rich diets overwhelming our adaptive metabolic pathways.  One such pathway is mediated by nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in mammalian NAD+ biosynthesis, and the NAD+-dependent protein deacetylase SIRT1.  Here, we show that NAMPT-mediated NAD+ biosynthesis is severely compromised in metabolic organs by high-fat diet (HFD).  Strikingly, NMN (NMN), a product of the NAMPT reaction and a key NAD+ intermediate, ameliorates glucose intolerance by restoring NAD+ levels in HFD-induced T2D mice.  NMN also enhances hepatic insulin sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian rhythm, partly through SIRT1 activation.  Furthermore, NAD+ and NAMPT levels show significant decreases in multiple organs during aging, and NMN improves glucose intolerance and lipid profiles in age-induced T2D mice.  These findings provide crit. insights into a potential nutriceutical intervention against diet- and age-induced T2D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo62Q7piy8bR7Vg90H21EOLACvtfcHk0lifPO0MZbmS4g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12rtLvK&md5=a33f288cd823d4f85fd7201623e842d4</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DYoshino%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DK.%2BF.%26aulast%3DYoon%26aufirst%3DM.%2BJ.%26aulast%3DImai%26aufirst%3DS.%26atitle%3DNicotinamide%2520mononucleotide%252C%2520a%2520key%2520NAD%2528%252B%2529%2520intermediate%252C%2520treats%2520the%2520pathophysiology%2520of%2520diet-%2520and%2520age-induced%2520diabetes%2520in%2520mice%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D14%26spage%3D528%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span> </span><span class="NLM_article-title">Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-kappaB signaling pathway</span> <span class="citation_source-journal">Int. J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">â</span> <span class="NLM_lpage">615</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.3892%2Fijmm.2011.611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslOisb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2011&pages=607-615&author=Y.+Fanauthor=S.+Mengauthor=Y.+Wangauthor=J.+Caoauthor=C.+Wang&title=Visfatin%2FPBEF%2FNampt+induces+EMMPRIN+and+MMP-9+production+in+macrophages+via+the+NAMPT-MAPK+%28p38%2C+ERK1%2F2%29-NF-kappaB+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Visfatin/PBEF/nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-ÎºB signaling pathway</span></div><div class="casAuthors">Fan, Yuqi; Meng, Shu; Wang, Yue; Cao, Jiatian; Wang, Changqian</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">607-615</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">The adipocytokine visfatin is closely assocd. with metabolic disorders.  This study explored the effects of visfatin on macrophage-induced inflammation in atheroma.  The ability of visfatin to enhance extracellular matrix metalloproteinase inducer (EMMPRIN) expression, matrix metalloproteinase-9 (MMP-9) prodn. and enzymic activity in THP-1 derived macrophages as well as the mechanisms involved were investigated.  EMMPRIN and MMP-9 mRNA levels were investigated by RT-PCR.  EMMPRIN and MMP-9 protein levels, nuclear factor (NF)-ÎºB -p65 protein levels, peroxisome proliferator-activated receptor Î³ (PPARÎ³) protein levels, and mitogen-activated protein kinase (MAPK) phosphorylation were detd. by Western blotting.  MMP-9 enzymic activity was assayed by gelatin zymog.  Visfatin (50-400 ng/mL) induced EMMPRIN and MMP-9 depending on the dosage used.  Visfatin elicited the activation of NF-ÎºB and MAPK (p38, ERK1/2).  Exogenous NMN (NMN), the product of nicotinamide phosphoribosyltransferase (NAMPT) activity, mimicked the effects of visfatin on MAPK (p38, ERK1/2)-NF-ÎºB activation and EMMPRIN/MMP-9 induction.  Using the p38 inhibitor, SB203580, the ERK1/2 inhibitor PD98059, the NF-ÎºB inhibitor, pyrrolidine dithiocarbamate and the NAMPT inhibitor FK866, we demonstrated that the visfatin pro-inflammatory action was through the NAMPT-MAPK (p38, ERK1/2)-NF-ÎºB pathway.  Furthermore, the visfatin pro-inflammatory action was not prevented by insulin receptor blockade or by a PPARÎ³ agonist.  Visfatin did not modulate PPARÎ³ expression.  Retinoid X receptor (RXR) agonist suppressed the effects of visfatin on EMMPRIN/MMP-9, NF-ÎºB, but not on MAPK activation.  In conclusion, we have demonstrated that visfatin enhances atheroma inflammation through the NAMPT-MAPK (p38, ERK1/2)-NF-ÎºB-EMMPRIN/MMP-9 pathway, a key feature of atherosclerotic diseases linked to metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozf42EMGPB_bVg90H21EOLACvtfcHk0ljPH9KxTCy5RA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslOisb0%253D&md5=322f2127e9641d7d2206f737b0c5dafe</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2011.611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2011.611%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DVisfatin%252FPBEF%252FNampt%2520induces%2520EMMPRIN%2520and%2520MMP-9%2520production%2520in%2520macrophages%2520via%2520the%2520NAMPT-MAPK%2520%2528p38%252C%2520ERK1%252F2%2529-NF-kappaB%2520signaling%2520pathway%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2011%26volume%3D27%26spage%3D607%26epage%3D615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Moschen, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enrich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosheimer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theurl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niederegger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilg, H.</span><span> </span><span class="NLM_article-title">Visfatin, an adipocytokine with proinflammatory and immunomodulating properties</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">1748</span><span class="NLM_x">â</span> <span class="NLM_lpage">1758</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=1748-1758&author=A.+R.+Moschenauthor=A.+Kaserauthor=B.+Enrichauthor=B.+Mosheimerauthor=M.+Theurlauthor=H.+Niedereggerauthor=H.+Tilg&title=Visfatin%2C+an+adipocytokine+with+proinflammatory+and+immunomodulating+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoschen%26aufirst%3DA.%2BR.%26aulast%3DKaser%26aufirst%3DA.%26aulast%3DEnrich%26aufirst%3DB.%26aulast%3DMosheimer%26aufirst%3DB.%26aulast%3DTheurl%26aufirst%3DM.%26aulast%3DNiederegger%26aufirst%3DH.%26aulast%3DTilg%26aufirst%3DH.%26atitle%3DVisfatin%252C%2520an%2520adipocytokine%2520with%2520proinflammatory%2520and%2520immunomodulating%2520properties%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D178%26spage%3D1748%26epage%3D1758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Skokowa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakur, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cario, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brechlin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schambach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinrichsen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanulla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welte, K.</span><span> </span><span class="NLM_article-title">NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">â</span> <span class="NLM_lpage">158</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1038%2Fnm.1913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ehu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=151-158&author=J.+Skokowaauthor=D.+Lanauthor=B.+K.+Thakurauthor=F.+Wangauthor=K.+Guptaauthor=G.+Carioauthor=A.+M.+Brechlinauthor=A.+Schambachauthor=L.+Hinrichsenauthor=G.+Meyerauthor=M.+Gaestelauthor=M.+Stanullaauthor=Q.+Tongauthor=K.+Welte&title=NAMPT+is+essential+for+the+G-CSF-induced+myeloid+differentiation+via+a+NAD%28%2B%29-sirtuin-1-dependent+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD+-sirtuin-1-dependent pathway</span></div><div class="casAuthors">Skokowa, Julia; Lan, Dan; Thakur, Basant Kumar; Wang, Fei; Gupta, Kshama; Cario, Gunnar; Brechlin, Annette Mueller; Schambach, Axel; Hinrichsen, Lars; Meyer, Gustav; Gaestel, Matthias; Stanulla, Martin; Tong, Qiang; Welte, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-158</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We identified nicotinamide phosphoribosyltransferase (NAMPT), also known as pre-B cell colony enhancing factor (PBEF), as an essential enzyme mediating granulocyte colony-stimulating factor (G-CSF)-triggered granulopoiesis in healthy individuals and in individuals with severe congenital neutropenia.  Intracellular NAMPT and NAD+ amts. in myeloid cells, as well as plasma NAMPT and NAD+ levels, were increased by G-CSF treatment of both healthy volunteers and individuals with congenital neutropenia.  NAMPT administered both extracellularly and intracellularly induced granulocytic differentiation of CD34+ hematopoietic progenitor cells and of the promyelocytic leukemia cell line HL-60.  Treatment of healthy individuals with high doses of vitamin B3 (nicotinamide), a substrate of NAMPT, induced neutrophilic granulocyte differentiation.  The mol. events triggered by NAMPT include NAD+-dependent sirtuin-1 activation, subsequent induction of CCAAT/enhancer binding protein-Î± and CCAAT/enhancer binding protein-Î², and, ultimately, upregulation of G-CSF synthesis and G-CSF receptor expression.  G-CSF, in turn, further increases NAMPT levels.  These results reveal a decisive role of the NAD+ metabolic pathway in G-CSF-triggered myelopoiesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlJgBC7Y8HNbVg90H21EOLACvtfcHk0ljPH9KxTCy5RA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ehu7s%253D&md5=4aef2263e94dec4da4ea4d2acf204165</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnm.1913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1913%26sid%3Dliteratum%253Aachs%26aulast%3DSkokowa%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DD.%26aulast%3DThakur%26aufirst%3DB.%2BK.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DGupta%26aufirst%3DK.%26aulast%3DCario%26aufirst%3DG.%26aulast%3DBrechlin%26aufirst%3DA.%2BM.%26aulast%3DSchambach%26aufirst%3DA.%26aulast%3DHinrichsen%26aufirst%3DL.%26aulast%3DMeyer%26aufirst%3DG.%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DStanulla%26aufirst%3DM.%26aulast%3DTong%26aufirst%3DQ.%26aulast%3DWelte%26aufirst%3DK.%26atitle%3DNAMPT%2520is%2520essential%2520for%2520the%2520G-CSF-induced%2520myeloid%2520differentiation%2520via%2520a%2520NAD%2528%252B%2529-sirtuin-1-dependent%2520pathway%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D151%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Fukuhara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishizawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichisaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyoshi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makishima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimomura, I.</span><span> </span><span class="NLM_article-title">Retraction</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=565&author=A.+Fukuharaauthor=M.+Matsudaauthor=M.+Nishizawaauthor=K.+Segawaauthor=M.+Tanakaauthor=K.+Kishimotoauthor=Y.+Matsukiauthor=M.+Murakamiauthor=T.+Ichisakaauthor=H.+Murakamiauthor=E.+Watanabeauthor=T.+Takagiauthor=M.+Akiyoshiauthor=T.+Ohtsuboauthor=S.+Kiharaauthor=S.+Yamashitaauthor=M.+Makishimaauthor=T.+Funahashiauthor=S.+Yamanakaauthor=R.+Hiramatsuauthor=Y.+Matsuzawaauthor=I.+Shimomura&title=Retraction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukuhara%26aufirst%3DA.%26aulast%3DMatsuda%26aufirst%3DM.%26aulast%3DNishizawa%26aufirst%3DM.%26aulast%3DSegawa%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DKishimoto%26aufirst%3DK.%26aulast%3DMatsuki%26aufirst%3DY.%26aulast%3DMurakami%26aufirst%3DM.%26aulast%3DIchisaka%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DE.%26aulast%3DTakagi%26aufirst%3DT.%26aulast%3DAkiyoshi%26aufirst%3DM.%26aulast%3DOhtsubo%26aufirst%3DT.%26aulast%3DKihara%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DS.%26aulast%3DMakishima%26aufirst%3DM.%26aulast%3DFunahashi%26aufirst%3DT.%26aulast%3DYamanaka%26aufirst%3DS.%26aulast%3DHiramatsu%26aufirst%3DR.%26aulast%3DMatsuzawa%26aufirst%3DY.%26aulast%3DShimomura%26aufirst%3DI.%26atitle%3DRetraction%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Romacho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azcutia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez-Bella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cercas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevado, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carraro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Manas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Ferrer, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiro, C.</span><span> </span><span class="NLM_article-title">Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2455</span><span class="NLM_x">â</span> <span class="NLM_lpage">2463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2455-2463&author=T.+Romachoauthor=V.+Azcutiaauthor=M.+Vazquez-Bellaauthor=N.+Matesanzauthor=E.+Cercasauthor=J.+Nevadoauthor=R.+Carraroauthor=L.+Rodriguez-Manasauthor=C.+F.+Sanchez-Ferrerauthor=C.+Peiro&title=Extracellular+PBEF%2FNAMPT%2Fvisfatin+activates+pro-inflammatory+signalling+in+human+vascular+smooth+muscle+cells+through+nicotinamide+phosphoribosyltransferase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomacho%26aufirst%3DT.%26aulast%3DAzcutia%26aufirst%3DV.%26aulast%3DVazquez-Bella%26aufirst%3DM.%26aulast%3DMatesanz%26aufirst%3DN.%26aulast%3DCercas%26aufirst%3DE.%26aulast%3DNevado%26aufirst%3DJ.%26aulast%3DCarraro%26aufirst%3DR.%26aulast%3DRodriguez-Manas%26aufirst%3DL.%26aulast%3DSanchez-Ferrer%26aufirst%3DC.%2BF.%26aulast%3DPeiro%26aufirst%3DC.%26atitle%3DExtracellular%2520PBEF%252FNAMPT%252Fvisfatin%2520activates%2520pro-inflammatory%2520signalling%2520in%2520human%2520vascular%2520smooth%2520muscle%2520cells%2520through%2520nicotinamide%2520phosphoribosyltransferase%2520activity%26jtitle%3DDiabetologia%26date%3D2009%26volume%3D52%26spage%3D2455%26epage%3D2463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osago, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, M.</span><span> </span><span class="NLM_article-title">Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e22781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e22781&author=N.+Haraauthor=K.+Yamadaauthor=T.+Shibataauthor=H.+Osagoauthor=M.+Tsuchiya&title=Nicotinamide+phosphoribosyltransferase%2Fvisfatin+does+not+catalyze+nicotinamide+mononucleotide+formation+in+blood+plasma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DN.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DOsago%26aufirst%3DH.%26aulast%3DTsuchiya%26aufirst%3DM.%26atitle%3DNicotinamide%2520phosphoribosyltransferase%252Fvisfatin%2520does%2520not%2520catalyze%2520nicotinamide%2520mononucleotide%2520formation%2520in%2520blood%2520plasma%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De22781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Warburg, O.</span><span> </span><span class="NLM_article-title">On the origin of cancer cells</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1956</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">â</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1126%2Fscience.123.3191.309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=13298683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1956&pages=309-314&author=O.+Warburg&title=On+the+origin+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">On the origin of cancer cells</span></div><div class="casAuthors">WARBURG O</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3191</span>),
    <span class="NLM_cas:pages">309-14</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDsp1coYpQW669lAbTj9rGfW6udTcc2eaH8w5nS88b0bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D&md5=860d5ce9456831968fcc897b37d6d9c2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.123.3191.309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.123.3191.309%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3DOn%2520the%2520origin%2520of%2520cancer%2520cells%26jtitle%3DScience%26date%3D1956%26volume%3D123%26spage%3D309%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Dalamaga, M.</span><span> </span><span class="NLM_article-title">Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges</span> <span class="citation_source-journal">Med. Hypotheses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">â</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.mehy.2012.07.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSlsrbN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=617-621&author=M.+Dalamaga&title=Nicotinamide+phosphoribosyl-transferase%2Fvisfatin%3A+a+missing+link+between+overweight%2Fobesity+and+postmenopausal+breast+cancer%3F+Potential+preventive+and+therapeutic+perspectives+and+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide phosphoribosyl-transferase/visfatin: A missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges</span></div><div class="casAuthors">Dalamaga, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Medical Hypotheses</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">617-621</span>CODEN:
                <span class="NLM_cas:coden">MEHYDY</span>;
        ISSN:<span class="NLM_cas:issn">0306-9877</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Worldwide breast cancer (BC) constitutes a significant public health concern.  Excess body wt. is assocd. with postmenopausal BC (PBC) risk.  Recent studies have shown that the constellation of obesity, insulin resistance and serum adipokine levels are assocd. with the risk and prognosis of PBC.  Nicotinamide phosphoribosyl-transferase (Nampt), also known as visfatin and pre-B-cell-colony-enhancing factor, found in the visceral fat, represents a novel pleiotropic adipokine acting as a cytokine, a growth factor and an enzyme.  It plays an important role in a variety of metabolic and stress responses as well as in the cellular energy metab., particularly NAD biosynthesis.  Nampt exhibits proliferative, anti-apoptotic, pro-inflammatory and pro-angiogenic properties.  Nampt's insulin-mimetic function remains a controversial issue.  Circulating Nampt levels are increased in obese women.  Also, Nampt levels are significantly elevated in women suffering from PBC than in healthy controls independently from known risk factors of BC, anthropometric and metabolic parameters as well as serum concns. of well known adipokines.  High expression of Nampt in BC tissues was reported to be assocd. with more malignant cancer behavior as well as adverse prognosis.  Taking into account the mitogenicity of Nampt as well as its proliferative, anti-apoptotic and pro-angiogenic properties, a novel hypothesis is proposed whereas Nampt may be involved in the etiopathogenesis of PBC and may represent a missing link between overweight/obesity and PBC.  Nampt could exert its effects on the normal and neoplastic mammary tissue by endocrine and paracrine mechanisms; Nampt could also be secreted by tumor epithelial cells in an autocrine manner.  It could stimulate mammary epithelial cell proliferation, invasion, metastasis, and angiogenesis, which is essential for BC development and progression.  Serum Nampt might be a novel risk factor as well as a potential diagnostic and prognostic biomarker in PBC.  In addn., pharmacol. agents that neutralize biochem. Nampt or medications that decrease Nampt levels or downregulate signaling pathways downstream of Nampt may prove to be useful anti-cancer agents.  The potential harmful effect on PBC risk due to vitamin B3 (nicotinic acid, a natural NAD precursor in the biosynthetic route leading to NAD) intake is speculated for the first time.  In this hypothesis, the role of Nampt in BC carcinogenesis and progression is explored as well as the pathophysiol. mechanisms that underlie the assocn. between Nampt and PBC in the context of a dysfunctional adipose tissue in obesity.  Understanding of these mechanisms may be important for the development of preventive and therapeutic strategies against PBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMynKj7qHDj7Vg90H21EOLACvtfcHk0ljfK2Ab1gr7Kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSlsrbN&md5=af34dc3f2602053d9fd97d40956364c5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.mehy.2012.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mehy.2012.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DDalamaga%26aufirst%3DM.%26atitle%3DNicotinamide%2520phosphoribosyl-transferase%252Fvisfatin%253A%2520a%2520missing%2520link%2520between%2520overweight%252Fobesity%2520and%2520postmenopausal%2520breast%2520cancer%253F%2520Potential%2520preventive%2520and%2520therapeutic%2520perspectives%2520and%2520challenges%26jtitle%3DMed.%2520Hypotheses%26date%3D2012%26volume%3D79%26spage%3D617%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. J.</span><span> </span><span class="NLM_article-title">Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review</span> <span class="citation_source-journal">Diabetes Metab. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">â</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1002%2Fdmrr.1201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1CjsLfP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2011&pages=515-527&author=Y.+H.+Changauthor=D.+M.+Changauthor=K.+C.+Linauthor=S.+J.+Shinauthor=Y.+J.+Lee&title=Visfatin+in+overweight%2Fobesity%2C+type+2+diabetes+mellitus%2C+insulin+resistance%2C+metabolic+syndrome+and+cardiovascular+diseases%3A+a+meta-analysis+and+systemic+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review</span></div><div class="casAuthors">Chang, Yu-Hung; Chang, Dao-Ming; Lin, Kun-Cheng; Shin, Shyi-Jang; Lee, Yau-Jiunn</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes/Metabolism Research and Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">515-527</span>CODEN:
                <span class="NLM_cas:coden">DMRRFM</span>;
        ISSN:<span class="NLM_cas:issn">1520-7552</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">There are controversies regarding the assocn. of visfatin with overweight/obesity, type 2 diabetes mellitus, insulin resistance (IR), metabolic syndrome and cardiovascular disease in published articles.  A meta-anal. was performed to identify the significance of visfatin in these diseases.  We searched for relevant articles in Pubmed, Scopus and SCIE.  A total of 1035 articles were surveyed and 46 articles were identified, with 14 reports reporting more than one of our investigated diseases.  A total of 13 (n = 644), 19 (n = 2405), 20 (n = 2249), 5 (n = 527) and 5 (n = 851) articles/(participants) were included in each meta-anal. regarding the assocn. of visfatin and overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases, resp.  Plasma visfatin concns. were increased in participants diagnosed with overweight/obesity, type 2 diabetes mellitus, metabolic syndrome and cardiovascular diseases, with pooled log odds ratios of 1.164 [95% confidence interval (CI): 0.348 to 1.981, p = 0.005], 1.981 (95% CI: 1.377 to 2.584, p < 0.001), 1.094 (95% CI: 0.678 to 1.511, p < 0.001), and 2.902 (95% CI: 0.924 to 4.879, p < 0.005), resp.  The circulating visfatin level was pos. assocd. with insulin resistance, with a Fisher's z of 0.089 (95% CI: 0.013 to 0.165, p = 0.022).  No single study was found to affect the overall result of each anal. by sensitivity testing.  No publication bias was found by the Egger test.  Our study suggests that the use of visfatin may be promising for predicting obesity, diabetes status, insulin resistance, metabolic syndrome and cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEgzSUZLltlbVg90H21EOLACvtfcHk0ljENf2tbg58cA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1CjsLfP&md5=5bc501a85d9d0dbca647dc11e9c28ca7</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1002%2Fdmrr.1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdmrr.1201%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DY.%2BH.%26aulast%3DChang%26aufirst%3DD.%2BM.%26aulast%3DLin%26aufirst%3DK.%2BC.%26aulast%3DShin%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DY.%2BJ.%26atitle%3DVisfatin%2520in%2520overweight%252Fobesity%252C%2520type%25202%2520diabetes%2520mellitus%252C%2520insulin%2520resistance%252C%2520metabolic%2520syndrome%2520and%2520cardiovascular%2520diseases%253A%2520a%2520meta-analysis%2520and%2520systemic%2520review%26jtitle%3DDiabetes%2520Metab.%2520Res.%2520Rev.%26date%3D2011%26volume%3D27%26spage%3D515%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratzsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span> </span><span class="NLM_article-title">Nampt and its potential role in inflammation and type 2 diabetes</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">â</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1007%2F978-3-642-17214-4_7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvVahtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=147-164&author=A.+Gartenauthor=S.+Petzoldauthor=S.+Schusterauthor=A.+Kornerauthor=J.+Kratzschauthor=W.+Kiess&title=Nampt+and+its+potential+role+in+inflammation+and+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Nampt and its potential role in inflammation and type 2 diabetes</span></div><div class="casAuthors">Garten, Antje; Petzold, Stefanie; Schuster, Susanne; Koerner, Antje; Kratzsch, Juergen; Kiess, Wieland</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">Diabetes: Perspectives in Drug Therapy</span>),
    <span class="NLM_cas:pages">147-164</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Nicotinamide phosphoribosyltransferase (Nampt) is a key NAD (NAD) biosynthetic enzyme in mammals, converting nicotinamide into NMN (NMN), an NAD intermediate.  First identified in humans as a cytokine pre-B-cell colony enhancing factor (PBEF) and subsequently described as an insulin-mimetic hormone visfatin, Nampt has recently excited the scientific interest of researchers from diverse fields, including NAD biol., metabolic regulation, and inflammation.  As an NAD biosynthetic enzyme, Nampt regulates the activity of NAD-consuming enzymes such as sirtuins and influences a variety of metabolic and stress responses.  Nampt plays an important role in the regulation of insulin secretion in pancreatic Î²-cells.  Nampt also functions as an immunomodulatory cytokine and is involved in the regulation of inflammatory responses.  This chapter summarizes the various functional aspects of Nampt and discusses its potential roles in diseases, with special focus on type 2 diabetes mellitus (T2DM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq14UyLXNKAlrVg90H21EOLACvtfcHk0ljENf2tbg58cA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvVahtL4%253D&md5=9a5fc4b963255b312ec488a8d1ff34be</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-17214-4_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-17214-4_7%26sid%3Dliteratum%253Aachs%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DPetzold%26aufirst%3DS.%26aulast%3DSchuster%26aufirst%3DS.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DKratzsch%26aufirst%3DJ.%26aulast%3DKiess%26aufirst%3DW.%26atitle%3DNampt%2520and%2520its%2520potential%2520role%2520in%2520inflammation%2520and%2520type%25202%2520diabetes%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2011%26spage%3D147%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Barth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horbach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rascher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knerr, I.</span><span> </span><span class="NLM_article-title">Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: relation to endocrine and clinical parameters</span> <span class="citation_source-journal">Obes. Facts</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">â</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1159%2F000319508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWqt73I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=245-251&author=S.+Barthauthor=P.+Kleinauthor=T.+Horbachauthor=J.+Dotschauthor=M.+Rauhauthor=W.+Rascherauthor=I.+Knerr&title=Expression+of+neuropeptide+Y%2C+omentin+and+visfatin+in+visceral+and+subcutaneous+adipose+tissues+in+humans%3A+relation+to+endocrine+and+clinical+parameters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Neuropeptide Y, Omentin and Visfatin in Visceral and Subcutaneous Adipose Tissues in Humans: Relation to Endocrine and Clinical Parameters</span></div><div class="casAuthors">Barth, Stephanie; Klein, Peter; Horbach, Thomas; Doetsch, Joerg; Rauh, Manfred; Rascher, Wolfgang; Knerr, Ina</div><div class="citationInfo"><span class="NLM_cas:title">Obesity Facts</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">245-251</span>CODEN:
                <span class="NLM_cas:coden">OFBABR</span>;
        ISSN:<span class="NLM_cas:issn">1662-4025</span>.
    
            (<span class="NLM_cas:orgname">S. Karger Verlag fuer Medizin und Naturwissenschaften GmbH</span>)
        </div><div class="casAbstract">Objective: The authors aimed at exploring the expression of neuropeptide Y (NPY), omentin and visfatin in adipose tissues of adults along with clin. parameters and hormones.  Methods: the authors included 168 adult patients (31 surgical obese patients and 31 surgical controls, 76 non-surgical obese patients, 30 non-surgical controls).  The authors measured plasma NPY (by RIA), cortisol (with an electrochemiluminescence immunoassay) and urinary cortisol metabolites (by gas chromatog./mass spectrometry).  Expression of NPY, omentin and visfatin in s.c. and visceral adipose tissue specimens of the surgical patients was quantified using real-time PCR.  Results: NPY was detectable in adipose tissue specimens and, like plasma NPY concns., comparable between groups.  Omentin gene expression was higher in visceral than in s.c. adipose tissues (p < 0.0001).  Visfatin expression was lower in the s.c. tissue of obese patients compared with controls (p < 0.05).  Cortisol was lower in obese adults compared with controls (136.5Â±74.1 vs. 162.2Â±56.1 ng/mL; p < 0.05), cortisol metabolites were comparable between groups.  Conclusion: In the authors' obese adults, plasma NPY levels and the glucocorticoid measures were not elevated.  Even though the expression of NPY, omentin and visfatin was comparable between obese individuals and controls, the authors have to consider differences in the total prodn. rate of adipose tissue-derived factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6IIS8I_8zVbVg90H21EOLACvtfcHk0ljENf2tbg58cA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWqt73I&md5=f2895a8f8fe838e70ed471b1a5c5aa99</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1159%2F000319508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000319508%26sid%3Dliteratum%253Aachs%26aulast%3DBarth%26aufirst%3DS.%26aulast%3DKlein%26aufirst%3DP.%26aulast%3DHorbach%26aufirst%3DT.%26aulast%3DDotsch%26aufirst%3DJ.%26aulast%3DRauh%26aufirst%3DM.%26aulast%3DRascher%26aufirst%3DW.%26aulast%3DKnerr%26aufirst%3DI.%26atitle%3DExpression%2520of%2520neuropeptide%2520Y%252C%2520omentin%2520and%2520visfatin%2520in%2520visceral%2520and%2520subcutaneous%2520adipose%2520tissues%2520in%2520humans%253A%2520relation%2520to%2520endocrine%2520and%2520clinical%2520parameters%26jtitle%3DObes.%2520Facts%26date%3D2010%26volume%3D3%26spage%3D245%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhoutte, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, C. Y.</span><span> </span><span class="NLM_article-title">Visfatin and cardio-cerebro-vascular disease</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2012&pages=1-9&author=P.+Wangauthor=P.+M.+Vanhoutteauthor=C.+Y.+Miao&title=Visfatin+and+cardio-cerebro-vascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DVanhoutte%26aufirst%3DP.%2BM.%26aulast%3DMiao%26aufirst%3DC.%2BY.%26atitle%3DVisfatin%2520and%2520cardio-cerebro-vascular%2520disease%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2012%26volume%3D59%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Benedict, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shostak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schioth, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Born, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oster, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallschmid, M.</span><span> </span><span class="NLM_article-title">Diurnal rhythm of circulating nicotinamide phosphoribosyltransferase (Nampt/visfatin/PBEF): impact of sleep loss and relation to glucose metabolism</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">E218</span><span class="NLM_x">â</span> <span class="NLM_lpage">E222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2012&pages=E218-E222&author=C.+Benedictauthor=A.+Shostakauthor=T.+Langeauthor=S.+J.+Brooksauthor=H.+B.+Schiothauthor=B.+Schultesauthor=J.+Bornauthor=H.+Osterauthor=M.+Hallschmid&title=Diurnal+rhythm+of+circulating+nicotinamide+phosphoribosyltransferase+%28Nampt%2Fvisfatin%2FPBEF%29%3A+impact+of+sleep+loss+and+relation+to+glucose+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenedict%26aufirst%3DC.%26aulast%3DShostak%26aufirst%3DA.%26aulast%3DLange%26aufirst%3DT.%26aulast%3DBrooks%26aufirst%3DS.%2BJ.%26aulast%3DSchioth%26aufirst%3DH.%2BB.%26aulast%3DSchultes%26aufirst%3DB.%26aulast%3DBorn%26aufirst%3DJ.%26aulast%3DOster%26aufirst%3DH.%26aulast%3DHallschmid%26aufirst%3DM.%26atitle%3DDiurnal%2520rhythm%2520of%2520circulating%2520nicotinamide%2520phosphoribosyltransferase%2520%2528Nampt%252Fvisfatin%252FPBEF%2529%253A%2520impact%2520of%2520sleep%2520loss%2520and%2520relation%2520to%2520glucose%2520metabolism%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D97%26spage%3DE218%26epage%3DE222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bluher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratzsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span> </span><span class="NLM_article-title">Molecular characteristics of serum visfatin and differential detection by immunoassays</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">4783</span><span class="NLM_x">â</span> <span class="NLM_lpage">4791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1210%2Fjc.2007-1304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BD2sjhs1Oluw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2007&pages=4783-4791&author=A.+Kornerauthor=A.+Gartenauthor=M.+Bluherauthor=R.+Tauscherauthor=J.+Kratzschauthor=W.+Kiess&title=Molecular+characteristics+of+serum+visfatin+and+differential+detection+by+immunoassays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characteristics of serum visfatin and differential detection by immunoassays</span></div><div class="casAuthors">Korner Antje; Garten Antje; Bluher Matthias; Tauscher Roy; Kratzsch Jurgen; Kiess Wieland</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical endocrinology and metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4783-91</span>
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">CONTEXT:  There are controversial results concerning the association of visfatin with obesity and diabetes.  We aimed to characterize molecular features of visfatin, to assess visfatin detection by different immunoassays, and evaluate the association with human obesity and glucose metabolism.  RESULTS:  Distinct preparations of human visfatin (recombinant, endogenously expressed from human adipocytes, and overexpressed in COS-7 cells) were readily identified by three currently available immunoassays.  However, direct comparison of native human serum samples did reveal great discrepancies between these assays and complete lack of correlation.  To specify putative molecular isoforms of visfatin, we fractionated iodine-125-labeled recombinant visfatin spiked into human serum and supernatants of visfatin-overexpressing COS-7 cells by size exclusion chromatography.  We obtained a distinct peak at approximately 100 kDa that was confirmed by subsequent Western blotting of the fractions and is equivalent to the molecular mass of the dimer.  Only one of the immunoassays detected a similar peak in native human size exclusion chromatography serum fractions, whereas the others detected a peak at more than 500 kDa or did not show any distinct peak.  We did not observe any differences in visfatin serum levels between lean or obese patients.  In addition, there was no correlation between visfatin serum levels with visfatin mRNA expression in sc or visceral fat and with parameters of glucose metabolism.  CONCLUSION:  Differences in the qualitative and quantitative detection of visfatin by immunoassays need to be considered in clinical association studies and may explain the conflicting observations with respect to a putative relation of circulating visfatin to human obesity or insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRooV4qMaINh8ERNNga7KD-fW6udTcc2eZe1sRWYspXOLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjhs1Oluw%253D%253D&md5=04c17b4ef3880892122c7570d130d11d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1210%2Fjc.2007-1304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2007-1304%26sid%3Dliteratum%253Aachs%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DBluher%26aufirst%3DM.%26aulast%3DTauscher%26aufirst%3DR.%26aulast%3DKratzsch%26aufirst%3DJ.%26aulast%3DKiess%26aufirst%3DW.%26atitle%3DMolecular%2520characteristics%2520of%2520serum%2520visfatin%2520and%2520differential%2520detection%2520by%2520immunoassays%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2007%26volume%3D92%26spage%3D4783%26epage%3D4791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Busso, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karababa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobile, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Smedt, T.</span><span> </span><span class="NLM_article-title">Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e2267&author=N.+Bussoauthor=M.+Karababaauthor=M.+Nobileauthor=A.+Rolazauthor=F.+Van+Goolauthor=M.+Galliauthor=O.+Leoauthor=A.+Soauthor=T.+De+Smedt&title=Pharmacological+inhibition+of+nicotinamide+phosphoribosyltransferase%2Fvisfatin+enzymatic+activity+identifies+a+new+inflammatory+pathway+linked+to+NAD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBusso%26aufirst%3DN.%26aulast%3DKarababa%26aufirst%3DM.%26aulast%3DNobile%26aufirst%3DM.%26aulast%3DRolaz%26aufirst%3DA.%26aulast%3DVan%2BGool%26aufirst%3DF.%26aulast%3DGalli%26aufirst%3DM.%26aulast%3DLeo%26aufirst%3DO.%26aulast%3DSo%26aufirst%3DA.%26aulast%3DDe%2BSmedt%26aufirst%3DT.%26atitle%3DPharmacological%2520inhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%252Fvisfatin%2520enzymatic%2520activity%2520identifies%2520a%2520new%2520inflammatory%2520pathway%2520linked%2520to%2520NAD%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De2267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tilg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschen, A. R.</span><span> </span><span class="NLM_article-title">Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases</span> <span class="citation_source-journal">Clin. Sci. (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">â</span> <span class="NLM_lpage">288</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1042%2FCS20070196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=18194136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FktVGqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2008&pages=275-288&author=H.+Tilgauthor=A.+R.+Moschen&title=Role+of+adiponectin+and+PBEF%2Fvisfatin+as+regulators+of+inflammation%3A+involvement+in+obesity-associated+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases</span></div><div class="casAuthors">Tilg Herbert; Moschen Alexander R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical science (London, England : 1979)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">275-88</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Obesity and obesity-related disorders play an important role in clinical medicine.  Adipose tissue, with its soluble mediators called adipocytokines, has emerged as a major endocrine organ.  These adipocytokines comprise many mediators such as adiponectin, PBEF (pre-B-cell-enhancing factor)/visfatin, leptin, resistin, retinol-binding protein-4 and others.  They play major roles in key aspects of metabolism, such as insulin resistance, fatty acid oxidation, inflammation and immunity.  Adiponectin, a prototypic adipocytokine, is of importance in the regulation of insulin resistance, as circulating levels are decreased in obesity and diseases associated with insulin resistance.  Besides its major role in regulation of insulin sensitivity, recent evidence suggests potent anti-inflammatory functions for adiponectin.  These effects are paralleled by other immune-regulatory properties, such as regulation of endothelial cell function.  The in vitro effects of adiponectin have been corroborated by several studies demonstrating potent in vivo anti-inflammatory effects.  Many other adipocytokines, such as PBEF/visfatin, leptin, resistin or retinol binding protein-4, are involved in the physiology and pathophysiology of adipocytes, adipose tissue and related diseases.  PBEF/visfatin, another recently characterized adipocytokine, has been linked to several inflammatory disease states beyond insulin resistance, such as acute lung injury or inflammatory bowel diseases.  It has been recognized for many decades that obesity is accompanied by an increase in cancer and potentially some immune-mediated diseases.  Understanding this new exciting world of adipocytokines will be of importance in the development of novel therapies for obesity-associated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQngrZcsoE2LO98rul4nhSdfW6udTcc2eZe1sRWYspXOLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FktVGqsg%253D%253D&md5=0d07f03ad5807e291377295aaa6f0405</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1042%2FCS20070196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20070196%26sid%3Dliteratum%253Aachs%26aulast%3DTilg%26aufirst%3DH.%26aulast%3DMoschen%26aufirst%3DA.%2BR.%26atitle%3DRole%2520of%2520adiponectin%2520and%2520PBEF%252Fvisfatin%2520as%2520regulators%2520of%2520inflammation%253A%2520involvement%2520in%2520obesity-associated%2520diseases%26jtitle%3DClin.%2520Sci.%2520%2528London%2529%26date%3D2008%26volume%3D114%26spage%3D275%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Huang, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, W. L.</span><span> </span><span class="NLM_article-title">Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection</span> <span class="citation_source-journal">J. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">â</span> <span class="NLM_lpage">535</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1111%2Fj.1440-1746.2010.06438.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1amu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=530-535&author=J.+F.+Huangauthor=C.+F.+Huangauthor=M.+L.+Yuauthor=C.+Y.+Daiauthor=C.+I.+Huangauthor=M.+L.+Yehauthor=M.+H.+Hsiehauthor=J.+F.+Yangauthor=M.+Y.+Hsiehauthor=Z.+Y.+Linauthor=S.+C.+Chenauthor=W.+L.+Chuang&title=Serum+visfatin+is+correlated+with+disease+severity+and+metabolic+syndrome+in+chronic+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection</span></div><div class="casAuthors">Huang, Jee-Fu; Huang, Chung-Feng; Yu, Ming-Lung; Dai, Chia-Yen; Huang, Ching-I.; Yeh, Ming-Lun; Hsieh, Meng-Hsuan; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Chern; Chuang, Wan-Long</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">530-535</span>CODEN:
                <span class="NLM_cas:coden">JGHEEO</span>;
        ISSN:<span class="NLM_cas:issn">0815-9319</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Aim: Cytokines activation is a common feature in chronic hepatitis C (CHC) infection.  Visfatin, as a recently-recognized adipocytokine, may correlate with metabolic abnormalities.  We aimed to elucidate the characteristics of visfatin in CHC patients.  Methods: This retrospective study included 102 treatment-naive CHC patients and 97 sex-/age-matched healthy adults.  Serum visfatin levels were examd. by an enzyme linked immunosorbent assay test.  The correlation between visfatin and hepatitis C virus (HCV) infection in terms of virol., metabolic, and histopathol. profiles was analyzed.  The impact of visfatin on the treatment response to pegylated interferon plus ribavirin (PEGIFN/RBV) therapy was also assessed.  Results: The visfatin level was correlated significantly with fibrosis scores (r = 0.23, P = 0.02) in CHC patients.  A significant higher visfatin level was obsd. in CHC patients with histol. activity index scores of mild and more (p = 0.01) and advanced fibrosis (P = 0.04).  The mean visfatin level (0.81 Â± 0.28 log ng/mL) of 26 CHC patients with metabolic syndrome was significantly lower than their counterparts (0.95 Â± 0.30 log ng/mL) (P = 0.03).  There was no significant correlation between visfatin and HCV genotypes, viral load, and treatment response to PEGIFN/RBV therapy.  Multiple logistic regression analyses demonstrated that metabolic syndrome was the leading neg. variable (odds ratio = 0.09, 95% confidence interval = 0.02-0.46, P = 0.004) assocd. with high visfatin level, followed by advanced fibrosis (odds ratio = 2.88, 95% confidence interval = 1.06-6.78, P = 0.03).  Conclusions: Serum visfatin was correlated with disease severity and metabolic syndrome in CHC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppTFj9qzKSo7Vg90H21EOLACvtfcHk0lgHFR5hTmZ82Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1amu7Y%253D&md5=29ccdcc62aeef7eac215140fe9e6be1c</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1746.2010.06438.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1746.2010.06438.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%2BF.%26aulast%3DHuang%26aufirst%3DC.%2BF.%26aulast%3DYu%26aufirst%3DM.%2BL.%26aulast%3DDai%26aufirst%3DC.%2BY.%26aulast%3DHuang%26aufirst%3DC.%2BI.%26aulast%3DYeh%26aufirst%3DM.%2BL.%26aulast%3DHsieh%26aufirst%3DM.%2BH.%26aulast%3DYang%26aufirst%3DJ.%2BF.%26aulast%3DHsieh%26aufirst%3DM.%2BY.%26aulast%3DLin%26aufirst%3DZ.%2BY.%26aulast%3DChen%26aufirst%3DS.%2BC.%26aulast%3DChuang%26aufirst%3DW.%2BL.%26atitle%3DSerum%2520visfatin%2520is%2520correlated%2520with%2520disease%2520severity%2520and%2520metabolic%2520syndrome%2520in%2520chronic%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Gastroenterol.%2520Hepatol.%26date%3D2011%26volume%3D26%26spage%3D530%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Malam, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waheed, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szaszi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, J. C.</span><span> </span><span class="NLM_article-title">Pre-B cell colony-enhancing factor (PBEF/Nampt/visfatin) primes neutrophils for augmented respiratory burst activity through partial assembly of the NADPH oxidase</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">6474</span><span class="NLM_x">â</span> <span class="NLM_lpage">6484</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=6474-6484&author=Z.+Malamauthor=J.+Parodoauthor=F.+Waheedauthor=K.+Szasziauthor=A.+Kapusauthor=J.+C.+Marshall&title=Pre-B+cell+colony-enhancing+factor+%28PBEF%2FNampt%2Fvisfatin%29+primes+neutrophils+for+augmented+respiratory+burst+activity+through+partial+assembly+of+the+NADPH+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalam%26aufirst%3DZ.%26aulast%3DParodo%26aufirst%3DJ.%26aulast%3DWaheed%26aufirst%3DF.%26aulast%3DSzaszi%26aufirst%3DK.%26aulast%3DKapus%26aufirst%3DA.%26aulast%3DMarshall%26aufirst%3DJ.%2BC.%26atitle%3DPre-B%2520cell%2520colony-enhancing%2520factor%2520%2528PBEF%252FNampt%252Fvisfatin%2529%2520primes%2520neutrophils%2520for%2520augmented%2520respiratory%2520burst%2520activity%2520through%2520partial%2520assembly%2520of%2520the%2520NADPH%2520oxidase%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D6474%26epage%3D6484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Dietrich, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muniz, O.</span><span> </span><span class="NLM_article-title">Inhibition of nicotinamide phosphoribosyltransferase by pyridine nucleotides</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1691</span><span class="NLM_x">â</span> <span class="NLM_lpage">1695</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00759a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1972&pages=1691-1695&author=L.+S.+Dietrichauthor=O.+Muniz&title=Inhibition+of+nicotinamide+phosphoribosyltransferase+by+pyridine+nucleotides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi00759a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00759a025%26sid%3Dliteratum%253Aachs%26aulast%3DDietrich%26aufirst%3DL.%2BS.%26aulast%3DMuniz%26aufirst%3DO.%26atitle%3DInhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520by%2520pyridine%2520nucleotides%26jtitle%3DBiochemistry%26date%3D1972%26volume%3D11%26spage%3D1691%26epage%3D1695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Biedermann, E.; Hasmann, M.; Loser, R.; Rattel, B.; Reiter, F.; Schein, B.; Seibel, K.; Vogt, K.</span><span> </span><span class="NLM_article-title">Preparation and Formulation of Pyridine Derivatives as Antitumor Agents and Immunosuppressants</span>. WO9748397A1,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=E.+Biedermann&author=M.+Hasmann&author=R.+Loser&author=B.+Rattel&author=F.+Reiter&author=B.+Schein&author=K.+Seibel&author=K.+Vogt&title=Preparation+and+Formulation+of+Pyridine+Derivatives+as+Antitumor+Agents+and+Immunosuppressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiedermann%26aufirst%3DE.%26atitle%3DPreparation%2520and%2520Formulation%2520of%2520Pyridine%2520Derivatives%2520as%2520Antitumor%2520Agents%2520and%2520Immunosuppressants%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wosikowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemainda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loser, R.</span><span> </span><span class="NLM_article-title">WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">â</span> <span class="NLM_lpage">1062</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=1057-1062&author=K.+Wosikowskiauthor=K.+Matternauthor=I.+Schemaindaauthor=M.+Hasmannauthor=B.+Rattelauthor=R.+Loser&title=WK175%2C+a+novel+antitumor+agent%2C+decreases+the+intracellular+nicotinamide+adenine+dinucleotide+concentration+and+induces+the+apoptotic+cascade+in+human+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWosikowski%26aufirst%3DK.%26aulast%3DMattern%26aufirst%3DK.%26aulast%3DSchemainda%26aufirst%3DI.%26aulast%3DHasmann%26aufirst%3DM.%26aulast%3DRattel%26aufirst%3DB.%26aulast%3DLoser%26aufirst%3DR.%26atitle%3DWK175%252C%2520a%2520novel%2520antitumor%2520agent%252C%2520decreases%2520the%2520intracellular%2520nicotinamide%2520adenine%2520dinucleotide%2520concentration%2520and%2520induces%2520the%2520apoptotic%2520cascade%2520in%2520human%2520leukemia%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D1057%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hasmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemainda, I.</span><span> </span><span class="NLM_article-title">FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7436</span><span class="NLM_x">â</span> <span class="NLM_lpage">7442</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=14612543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVGltb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7436-7442&author=M.+Hasmannauthor=I.+Schemainda&title=FK866%2C+a+highly+specific+noncompetitive+inhibitor+of+nicotinamide+phosphoribosyltransferase%2C+represents+a+novel+mechanism+for+induction+of+tumor+cell+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36cR"><div class="casContent"><span class="casTitleNuber">36c</span><div class="casTitle"><span class="NLM_cas:atitle">FK866, a Highly Specific Noncompetitive Inhibitor of Nicotinamide Phosphoribosyltransferase, Represents a Novel Mechanism for Induction of Tumor Cell Apoptosis</span></div><div class="casAuthors">Hasmann, Max; Schemainda, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7436-7442</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Deregulation of apoptosis, the physiol. form of cell death, is closely assocd. with immunol. diseases and cancer.  Apoptosis is activated either by death receptor-driven or mitochondrial pathways, both of which may provide potential targets for novel anticancer drugs.  Although several ligands stimulating death receptors have been described, the actual mol. events triggering the mitochondrial pathway are largely unknown.  Here, we show initiation of apoptosis by gradual depletion of the intracellular coenzyme NAD+.  We identified the first low mol. wt. compd., designated FK866, which induces apoptosis by highly specific, noncompetitive inhibition of nicotinamide phosphoribosyltransferase (NAPRT), a key enzyme in the regulation of NAD+ biosynthesis from the natural precursor nicotinamide.  Interference with this enzyme does not primarily intoxicate cells because the mitochondrial respiratory activity and the NAD+-dependent redox reactions involved remain unaffected as long as NAD+ is not effectively depleted by catabolic reactions.  Certain tissues, however, have a high turnover of NAD+ through its cleavage by enzymes like poly(ADP-ribose) polymerase.  Such cells often rely on the more readily available nicotinamide pathway for NAD+ synthesis and undergo apoptosis after inhibition of NAPRT, whereas cells effectively using the nicotinic acid pathway for NAD+ synthesis remain unaffected.  In support of this concept, FK866 effectively induced delayed cell death by apoptosis in HepG2 human liver carcinoma cells with an IC50 of â¼1 nM, did not directly inhibit mitochondrial respiratory activity, but caused gradual NAD+ depletion through specific inhibition of NAPRT.  This enzyme, when partially purified from K562 human leukemia cells, was noncompetitively inhibited by FK866, and the inhibitor consts. were calcd. to be 0.4 nM for the enzyme/substrate complex (Ki) and 0.3 nM for the free enzyme (Ki'), resp.  Nicotinic acid and nicotinamide were both found to have antidote potential for the cellular effects of FK866.  FK866 may be used for treatment of diseases implicating deregulated apoptosis such as cancer for immunosuppression or as a sensitizer for genotoxic agents.  Furthermore, it may provide an important tool for investigation of the mol. triggers of the mitochondrial pathway leading to apoptosis through enabling temporal sepn. of NAD+ decrease from ATP breakdown and apoptosis by several days.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAOS3LOADp6LVg90H21EOLACvtfcHk0lgX4N9FRlPSmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVGltb4%253D&md5=c67fd08fdfc233ba86478967b13d19a2</span></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHasmann%26aufirst%3DM.%26aulast%3DSchemainda%26aufirst%3DI.%26atitle%3DFK866%252C%2520a%2520highly%2520specific%2520noncompetitive%2520inhibitor%2520of%2520nicotinamide%2520phosphoribosyltransferase%252C%2520represents%2520a%2520novel%2520mechanism%2520for%2520induction%2520of%2520tumor%2520cell%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7436%26epage%3D7442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Khan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span> </span><span class="NLM_article-title">Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">582</span><span class="NLM_x">â</span> <span class="NLM_lpage">588</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1038%2Fnsmb1105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=16783377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1elt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=582-588&author=J.+A.+Khanauthor=X.+Taoauthor=L.+Tong&title=Molecular+basis+for+the+inhibition+of+human+NMPRTase%2C+a+novel+target+for+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents</span></div><div class="casAuthors">Khan, Javed A.; Tao, Xiao; Tong, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">582-588</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NMPRTase) has a crucial role in the salvage pathway of NAD+ biosynthesis, and a potent inhibitor of NMPRTase, FK866, can reduce cellular NAD+ levels and induce apoptosis in tumors.  The authors have detd. the crystal structures at up to 2.1-Ã resoln. of human and murine NMPRTase, alone and in complex with the reaction product NMN or the inhibitor FK866.  The structures suggest that Asp219 is a determinant of substrate specificity of NMPRTase, which is confirmed by our mutagenesis studies.  FK866 is bound in a tunnel at the interface of the NMPRTase dimer, and mutations in this binding site can abolish the inhibition by FK866.  Contrary to current knowledge, the structures show that FK866 should compete directly with the nicotinamide substrate.  Our structural and biochem. studies provide a starting point for the development of new anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1s-XY1uB70LVg90H21EOLACvtfcHk0lgX4N9FRlPSmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1elt7k%253D&md5=debef567dbcf629422472ef1b63dc396</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1105%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DTong%26aufirst%3DL.%26atitle%3DMolecular%2520basis%2520for%2520the%2520inhibition%2520of%2520human%2520NMPRTase%252C%2520a%2520novel%2520target%2520for%2520anticancer%2520agents%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D582%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Olesen, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaattela, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, S. J.</span><span> </span><span class="NLM_article-title">Anticancer agent CHS-828 inhibits cellular synthesis of NAD</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">â</span> <span class="NLM_lpage">804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2008&pages=799-804&author=U.+H.+Olesenauthor=M.+K.+Christensenauthor=F.+Bjorklingauthor=M.+Jaattelaauthor=P.+B.+Jensenauthor=M.+Sehestedauthor=S.+J.+Nielsen&title=Anticancer+agent+CHS-828+inhibits+cellular+synthesis+of+NAD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DU.%2BH.%26aulast%3DChristensen%26aufirst%3DM.%2BK.%26aulast%3DBjorkling%26aufirst%3DF.%26aulast%3DJaattela%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DSehested%26aufirst%3DM.%26aulast%3DNielsen%26aufirst%3DS.%2BJ.%26atitle%3DAnticancer%2520agent%2520CHS-828%2520inhibits%2520cellular%2520synthesis%2520of%2520NAD%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D367%26spage%3D799%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Burgos, E. S.</span><span> </span><span class="NLM_article-title">NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1947</span><span class="NLM_x">â</span> <span class="NLM_lpage">1961</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.2174%2F092986711795590101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=21517777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFehurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1947-1961&author=E.+S.+Burgos&title=NAMPT+in+regulated+NAD+biosynthesis+and+its+pivotal+role+in+human+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism</span></div><div class="casAuthors">Burgos, E. S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1947-1961</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the first reversible step in NAD biosynthesis and nicotinamide (NAM) salvage.  The enzyme is designed for efficient capture of nicotinamide by coupling of ATP hydrolysis to assist in extraordinary NAM binding affinity and formation of NMN (NMN).  NAMPT provides the mechanism to replenish the NAD pool in human metab.  In addn. to its role in redox biochem., NAD fuels the sirtuins (SIRTs) to regulate transcription factors involved in pathways linked to inflammation, diabetes and lifespan.  NAMPT-mediated lifespan expansion has caused a focus on the catalytic mechanism, regulation and inhibition of NAMPT.  Structural, mechanistic and inhibitor design all contribute to a developing but yet incomplete story of NAMPT function.  Although the first generation of NAMPT inhibitors has entered clin. trials, disappointing outcomes suggest more powerful and specific inhibitors will be needed.  Understanding the ATP-linked mechanism of NAMPT and the catalytic site machinery may permit the design of improved NAMPT inhibitors as more efficient drugs against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9tpSE0yYDVbVg90H21EOLACvtfcHk0lgX4N9FRlPSmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFehurs%253D&md5=cfbd0c1d081468ef98d43c667714e91d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F092986711795590101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795590101%26sid%3Dliteratum%253Aachs%26aulast%3DBurgos%26aufirst%3DE.%2BS.%26atitle%3DNAMPT%2520in%2520regulated%2520NAD%2520biosynthesis%2520and%2520its%2520pivotal%2520role%2520in%2520human%2520metabolism%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1947%26epage%3D1961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Watson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belec, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billot, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratton, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khadir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavoie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawless, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcotte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauparlant, P.</span><span> </span><span class="NLM_article-title">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5872</span><span class="NLM_x">â</span> <span class="NLM_lpage">5888</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1128%2FMCB.00112-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=19703994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=5872-5888&author=M.+Watsonauthor=A.+Roulstonauthor=L.+Belecauthor=X.+Billotauthor=R.+Marcellusauthor=D.+Bedardauthor=C.+Bernierauthor=S.+Branchaudauthor=H.+Chanauthor=K.+Dairiauthor=K.+Gilbertauthor=D.+Gouletauthor=M.+O.+Grattonauthor=H.+Isakauauthor=A.+Jangauthor=A.+Khadirauthor=E.+Kochauthor=M.+Lavoieauthor=M.+Lawlessauthor=M.+Nguyenauthor=D.+Paquetteauthor=E.+Turcotteauthor=A.+Bergerauthor=M.+Mitchellauthor=G.+C.+Shoreauthor=P.+Beauparlant&title=The+small+molecule+GMX1778+is+a+potent+inhibitor+of+NAD%2B+biosynthesis%3A+strategy+for+enhanced+therapy+in+nicotinic+acid+phosphoribosyltransferase+1-deficient+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span></div><div class="casAuthors">Watson, Mark; Roulston, Anne; Belec, Laurent; Billot, Xavier; Marcellus, Richard; Bedard, Dominique; Bernier, Cynthia; Branchaud, Stephane; Chan, Helen; Dairi, Kenza; Gilbert, Karine; Goulet, Daniel; Gratton, Michel-Olivier; Isakau, Henady; Jang, Anne; Khadir, Abdelkrim; Koch, Elizabeth; Lavoie, Manon; Lawless, Michael; Nguyen, Mai; Paquette, Denis; Turcotte, Emilie; Berger, Alvin; Mitchell, Matthew; Shore, Gordon C.; Beauparlant, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5872-5888</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">GMX1777 is a prodrug of the small mol. GMX1778, currently in phase I clin. trials for the treatment of cancer.  We describe findings indicating that GMX1778 is a potent and specific inhibitor of the NAD+ biosynthesis enzyme nicotinamide phosphoribosyltransferase (NAMPT).  Cancer cells have a very high rate of NAD+ turnover, which makes NAD+ modulation an attractive target for anticancer therapy.  Selective inhibition by GMX1778 of NAMPT blocks the prodn. of NAD+ and results in tumor cell death.  Furthermore, GMX1778 is phosphoribosylated by NAMPT, which increases its cellular retention.  The cytotoxicity of GMX1778 can be bypassed with exogenous nicotinic acid (NA), which permits NAD+ repletion via NA phosphoribosyltransferase 1 (NAPRT1).  The cytotoxicity of GMX1778 in cells with NAPRT1 deficiency, however, cannot be rescued by NA.  Analyses of NAPRT1 mRNA and protein levels in cell lines and primary tumor tissue indicate that high frequencies of glioblastomas, neuroblastomas, and sarcomas are deficient in NAPRT1 and not susceptible to rescue with NA.  As a result, the therapeutic index of GMX1777 can be widended in the treatment animals bearing NAPRT1-deficient tumors by coadministration with NA.  This provides the rationale for a novel therapeutic approach for the use of GMX1777 in the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT7TUeIRTTIrVg90H21EOLACvtfcHk0lhYbOn5yEwrmQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE&md5=a6157117d7e67368954ff5ae11986879</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FMCB.00112-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00112-09%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DM.%26aulast%3DRoulston%26aufirst%3DA.%26aulast%3DBelec%26aufirst%3DL.%26aulast%3DBillot%26aufirst%3DX.%26aulast%3DMarcellus%26aufirst%3DR.%26aulast%3DBedard%26aufirst%3DD.%26aulast%3DBernier%26aufirst%3DC.%26aulast%3DBranchaud%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DDairi%26aufirst%3DK.%26aulast%3DGilbert%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DD.%26aulast%3DGratton%26aufirst%3DM.%2BO.%26aulast%3DIsakau%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DA.%26aulast%3DKhadir%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DE.%26aulast%3DLavoie%26aufirst%3DM.%26aulast%3DLawless%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DPaquette%26aufirst%3DD.%26aulast%3DTurcotte%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DMitchell%26aufirst%3DM.%26aulast%3DShore%26aufirst%3DG.%2BC.%26aulast%3DBeauparlant%26aufirst%3DP.%26atitle%3DThe%2520small%2520molecule%2520GMX1778%2520is%2520a%2520potent%2520inhibitor%2520of%2520NAD%252B%2520biosynthesis%253A%2520strategy%2520for%2520enhanced%2520therapy%2520in%2520nicotinic%2520acid%2520phosphoribosyltransferase%25201-deficient%2520tumors%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D5872%26epage%3D5888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Cea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnetta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulciniti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roccaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calimeri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubikova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">3519</span><span class="NLM_x">â</span> <span class="NLM_lpage">3529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=3519-3529&author=M.+Ceaauthor=A.+Cagnettaauthor=M.+Fulcinitiauthor=Y.+T.+Taiauthor=T.+Hideshimaauthor=D.+Chauhanauthor=A.+Roccaroauthor=A.+Saccoauthor=T.+Calimeriauthor=F.+Cottiniauthor=J.+Jakubikovaauthor=S.+Y.+Kongauthor=F.+Patroneauthor=A.+Nencioniauthor=M.+Gobbiauthor=P.+Richardsonauthor=N.+Munshiauthor=K.+C.+Anderson&title=Targeting+NAD%2B+salvage+pathway+induces+autophagy+in+multiple+myeloma+cells+via+mTORC1+and+extracellular+signal-regulated+kinase+%28ERK1%2F2%29+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCea%26aufirst%3DM.%26aulast%3DCagnetta%26aufirst%3DA.%26aulast%3DFulciniti%26aufirst%3DM.%26aulast%3DTai%26aufirst%3DY.%2BT.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DRoccaro%26aufirst%3DA.%26aulast%3DSacco%26aufirst%3DA.%26aulast%3DCalimeri%26aufirst%3DT.%26aulast%3DCottini%26aufirst%3DF.%26aulast%3DJakubikova%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DS.%2BY.%26aulast%3DPatrone%26aufirst%3DF.%26aulast%3DNencioni%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DTargeting%2520NAD%252B%2520salvage%2520pathway%2520induces%2520autophagy%2520in%2520multiple%2520myeloma%2520cells%2520via%2520mTORC1%2520and%2520extracellular%2520signal-regulated%2520kinase%2520%2528ERK1%252F2%2529%2520inhibition%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D3519%26epage%3D3529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Billington, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condorelli, F.</span><span> </span><span class="NLM_article-title">NAD depletion by FK866 induces autophagy</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">â</span> <span class="NLM_lpage">387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=385-387&author=R.+A.+Billingtonauthor=A.+A.+Genazzaniauthor=C.+Travelliauthor=F.+Condorelli&title=NAD+depletion+by+FK866+induces+autophagy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBillington%26aufirst%3DR.%2BA.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DTravelli%26aufirst%3DC.%26aulast%3DCondorelli%26aufirst%3DF.%26atitle%3DNAD%2520depletion%2520by%2520FK866%2520induces%2520autophagy%26jtitle%3DAutophagy%26date%3D2008%26volume%3D4%26spage%3D385%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnetta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Intracellular NAD (+) depletion induces autophagic death in multiple myeloma cells</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">3</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=1-3&author=M.+Ceaauthor=A.+Cagnettaauthor=F.+Patroneauthor=A.+Nencioniauthor=M.+Gobbiauthor=K.+C.+Anderson&title=Intracellular+NAD+%28%2B%29+depletion+induces+autophagic+death+in+multiple+myeloma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCea%26aufirst%3DM.%26aulast%3DCagnetta%26aufirst%3DA.%26aulast%3DPatrone%26aufirst%3DF.%26aulast%3DNencioni%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DIntracellular%2520NAD%2520%2528%252B%2529%2520depletion%2520induces%2520autophagic%2520death%2520in%2520multiple%2520myeloma%2520cells%26jtitle%3DAutophagy%26date%3D2013%26volume%3D9%26spage%3D1%26epage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bruzzone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruscione, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morando, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garuti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DâUrso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selmo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benvenuto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoppoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballestrero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sordat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mostoslavsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uccelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencioni, A.</span><span> </span><span class="NLM_article-title">Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e7897</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7897&author=S.+Bruzzoneauthor=F.+Fruscioneauthor=S.+Morandoauthor=T.+Ferrandoauthor=A.+Poggiauthor=A.+Garutiauthor=A.+D%E2%80%99Ursoauthor=M.+Selmoauthor=F.+Benvenutoauthor=M.+Ceaauthor=G.+Zoppoliauthor=E.+Moranauthor=D.+Sonciniauthor=A.+Ballestreroauthor=B.+Sordatauthor=F.+Patroneauthor=R.+Mostoslavskyauthor=A.+Uccelliauthor=A.+Nencioni&title=Catastrophic+NAD%2B+depletion+in+activated+T+lymphocytes+through+Nampt+inhibition+reduces+demyelination+and+disability+in+EAE"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBruzzone%26aufirst%3DS.%26aulast%3DFruscione%26aufirst%3DF.%26aulast%3DMorando%26aufirst%3DS.%26aulast%3DFerrando%26aufirst%3DT.%26aulast%3DPoggi%26aufirst%3DA.%26aulast%3DGaruti%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Urso%26aufirst%3DA.%26aulast%3DSelmo%26aufirst%3DM.%26aulast%3DBenvenuto%26aufirst%3DF.%26aulast%3DCea%26aufirst%3DM.%26aulast%3DZoppoli%26aufirst%3DG.%26aulast%3DMoran%26aufirst%3DE.%26aulast%3DSoncini%26aufirst%3DD.%26aulast%3DBallestrero%26aufirst%3DA.%26aulast%3DSordat%26aufirst%3DB.%26aulast%3DPatrone%26aufirst%3DF.%26aulast%3DMostoslavsky%26aufirst%3DR.%26aulast%3DUccelli%26aufirst%3DA.%26aulast%3DNencioni%26aufirst%3DA.%26atitle%3DCatastrophic%2520NAD%252B%2520depletion%2520in%2520activated%2520T%2520lymphocytes%2520through%2520Nampt%2520inhibition%2520reduces%2520demyelination%2520and%2520disability%2520in%2520EAE%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De7897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit43b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Travelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drago, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaludercic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldorini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Lisa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonico, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span> </span><span class="NLM_article-title">Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">â</span> <span class="NLM_lpage">840</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1124%2Fjpet.111.184630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaktLjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=829-840&author=C.+Travelliauthor=V.+Dragoauthor=E.+Maldiauthor=N.+Kaludercicauthor=U.+Galliauthor=R.+Boldoriniauthor=F.+Di+Lisaauthor=G.+C.+Tronauthor=P.+L.+Canonicoauthor=A.+A.+Genazzani&title=Reciprocal+potentiation+of+the+antitumoral+activities+of+FK866%2C+an+inhibitor+of+nicotinamide+phosphoribosyltransferase%2C+and+etoposide+or+cisplatin+in+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43bR"><div class="casContent"><span class="casTitleNuber">43b</span><div class="casTitle"><span class="NLM_cas:atitle">Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells</span></div><div class="casAuthors">Travelli, Cristina; Drago, Valentina; Maldi, Elena; Kaludercic, Nina; Galli, Ubaldina; Boldorini, Renzo; Di Lisa, Fabio; Tron, Gian Cesare; Canonico, Pier Luigi; Genazzani, Armando A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">829-840</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">NAD is an essential coenzyme involved in numerous metabolic pathways.  Its principal role is in redox reactions, and as such it is not heavily "consumed" by cells.  Yet a no. of signaling pathways that bring about its consumption have recently emerged.  This has brought about the hypothesis that the enzymes that lead to its biosynthesis may be targets for anticancer therapy.  In particular, inhibition of the enzyme nicotinamide phosphoribosyl transferase has been shown to be an effective treatment in a no. of preclin. studies, and two lead mols. [N-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2E-propenamide (FK866) and (E)-1-[6-(4-chlorophenoxy)hexyl]-2-cyano-3-(pyridin-4-yl)guanidine (CHS 828)] have now entered preclin. trials.  Yet, the full potential of these drugs is still unclear.  In the present study we have investigated the role of FK866 in neuroblastoma cell lines.  We now confirm that FK866 alone in neuroblastoma cells induces autophagy, and its effects are potentiated by chloroquine and antagonized by 3-methyladenine or by down-regulating autophagy-related protein 7.  Autophagy, in this model, seems to be crucial for FK866-induced cell death.  On the other hand, a striking potentiation of the effects of cisplatin and etoposide is given by cotreatment of cells with ineffective concns. of FK866 (1 nM).  The effect of etoposide on DNA damage is potentiated by FK866 treatment, whereas the effect of FK866 on cytosolic NAD depletion is potentiated by etoposide.  Even more strikingly, cotreatment with etoposide/cisplatin and FK866 unmasks an effect on mitochondrial NAD depletion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo66wjnRQYbE7Vg90H21EOLACvtfcHk0ljXhwHLc9mWLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaktLjI&md5=62a97a2e2fa748dba251128b93723a81</span></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.184630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.184630%26sid%3Dliteratum%253Aachs%26aulast%3DTravelli%26aufirst%3DC.%26aulast%3DDrago%26aufirst%3DV.%26aulast%3DMaldi%26aufirst%3DE.%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DGalli%26aufirst%3DU.%26aulast%3DBoldorini%26aufirst%3DR.%26aulast%3DDi%2BLisa%26aufirst%3DF.%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26atitle%3DReciprocal%2520potentiation%2520of%2520the%2520antitumoral%2520activities%2520of%2520FK866%252C%2520an%2520inhibitor%2520of%2520nicotinamide%2520phosphoribosyltransferase%252C%2520and%2520etoposide%2520or%2520cisplatin%2520in%2520neuroblastoma%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D338%26spage%3D829%26epage%3D840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. D.</span><span> </span><span class="NLM_article-title">A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity</span> <span class="citation_source-journal">Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">â</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1258%2Febm.2010.010001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslSnt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=2010&pages=869-876&author=H.+J.+Yangauthor=M.+C.+Yenauthor=C.+C.+Linauthor=C.+M.+Linauthor=Y.+L.+Chenauthor=T.+Y.+Wengauthor=T.+T.+Huangauthor=C.+L.+Wuauthor=M.+D.+Lai&title=A+combination+of+the+metabolic+enzyme+inhibitor+APO866+and+the+immune+adjuvant+L-1-methyl+tryptophan+induces+additive+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44aR"><div class="casContent"><span class="casTitleNuber">44a</span><div class="casTitle"><span class="NLM_cas:atitle">A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity</span></div><div class="casAuthors">Yang, Huei-Jiun; Yen, Meng-Chi; Lin, Chi-Chen; Lin, Chiu-Mei; Chen, Yi-Ling; Weng, Tzu-Yang; Huang, Tzu-Ting; Wu, Chao-Liang; Lai, Ming-Derg</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">869-876</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Medicine Press Ltd.</span>)
        </div><div class="casAbstract">Many types of malignant cells have a higher NAD (NAD) turnover rate than normal cells, as well as the ability to escape immune responses.  Indoleamine 2,3-dioxygenase (IDO) is reported to be a neg. immune regulator.  Overexpression of IDO in dendritic cells is obsd. in tumor-draining lymph nodes.  IDO-expressing dendritic cells suppress T-cell activation and promote immune tolerance.  The nicotinamide phosphoribosyl transferase (NAMPT) inhibitor APO866 (also called FK866 or WK175) selectively inhibits tumor growth through intracellular NAD depletion.  The IDO-specific inhibitor L-1-methyl-tryptophan (L-1MT) activates immune responses and reduces tumor vol. in murine tumor models.  We combined L-1MT and APO866 treatments and tested their antitumor effects in the murine gastric and bladder tumor models.  In immune-competent mice, a combination of APO866 and L-1MT had a better therapeutic effect than did either L-1MT or APO866 alone.  The intracellular level of NAD was suppressed by APO866 but not L-1MT.  However, an additive inhibitory effect on tumor growth was not obsd. in tumor-bearing immune-deficient mice.  The new strategy of combining a metabolic inhibitor and an immune adjuvant induced a potent therapeutic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZFPY0uzNVZrVg90H21EOLACvtfcHk0ljXhwHLc9mWLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslSnt7o%253D&md5=0b1e98f3c5af5014574fe9a1a3569bd6</span></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=10.1258%2Febm.2010.010001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252Febm.2010.010001%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%2BJ.%26aulast%3DYen%26aufirst%3DM.%2BC.%26aulast%3DLin%26aufirst%3DC.%2BC.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DWeng%26aufirst%3DT.%2BY.%26aulast%3DHuang%26aufirst%3DT.%2BT.%26aulast%3DWu%26aufirst%3DC.%2BL.%26aulast%3DLai%26aufirst%3DM.%2BD.%26atitle%3DA%2520combination%2520of%2520the%2520metabolic%2520enzyme%2520inhibitor%2520APO866%2520and%2520the%2520immune%2520adjuvant%2520L-1-methyl%2520tryptophan%2520induces%2520additive%2520antitumor%2520activity%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D2010%26volume%3D235%26spage%3D869%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit44b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bajrami, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kigozi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Weverwijk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1087</span><span class="NLM_x">â</span> <span class="NLM_lpage">1096</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1002%2Femmm.201201250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44b&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=22933245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVeiur7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1087-1096&author=I.+Bajramiauthor=A.+Kigoziauthor=A.+Van+Weverwijkauthor=R.+Broughauthor=J.+Frankumauthor=C.+J.+Lordauthor=A.+Ashworth&title=Synthetic+lethality+of+PARP+and+NAMPT+inhibition+in+triple-negative+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44bR"><div class="casContent"><span class="casTitleNuber">44b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells</span></div><div class="casAuthors">Bajrami, Ilirjana; Kigozi, Asha; Van Weverwijk, Antoinette; Brough, Rachel; Frankum, Jessica; Lord, Christopher J.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1087-1096</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">PARP inhibitors have been proposed as a potential targeted therapy for patients with triple-neg. (ER-, PR-, HER2-neg.) breast cancers.  However, it is as yet unclear as to whether single agent or combination therapy using PARP inhibitors would be most beneficial.  To better understand the mechanisms that det. the response to PARP inhibitors, we investigated whether enzymes involved in metab. of the PARP substrate, Î²-NAD+, might alter the response to a clin. PARP inhibitor.  Using an olaparib sensitization screen in a triple-neg. (TN) breast cancer model, we identified nicotinamide phosphoribosyltransferase (NAMPT) as a non-redundant modifier of olaparib response.  NAMPT is a rate-limiting enzyme involved in the generation of the PARP substrate Î²-NAD+ and the suppression of Î²-NAD+ levels by NAMPT inhibition most likely explains these observations.  Importantly, the combination of a NAMPT small mol. inhibitor, FK866, with olaparib inhibited TN breast tumor growth in vivo to a greater extent than either single agent alone suggesting that assessing NAMPT/PARP inhibitor combinations for the treatment of TN breast cancer may be warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDlMhMk2Q7WbVg90H21EOLACvtfcHk0lj27X5RQTw83A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVeiur7M&md5=c97061b1a3505cce8230352f5bb9f07e</span></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=10.1002%2Femmm.201201250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201201250%26sid%3Dliteratum%253Aachs%26aulast%3DBajrami%26aufirst%3DI.%26aulast%3DKigozi%26aufirst%3DA.%26aulast%3DVan%2BWeverwijk%26aufirst%3DA.%26aulast%3DBrough%26aufirst%3DR.%26aulast%3DFrankum%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DSynthetic%2520lethality%2520of%2520PARP%2520and%2520NAMPT%2520inhibition%2520in%2520triple-negative%2520breast%2520cancer%2520cells%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D1087%26epage%3D1096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit44c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Okumura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsaki, Y.</span><span> </span><span class="NLM_article-title">Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation</span> <span class="citation_source-journal">J. Thorac. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44c&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1097%2FJTO.0b013e318233d686" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44c&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFGqu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=49-56&author=S.+Okumuraauthor=T.+Sasakiauthor=Y.+Minamiauthor=Y.+Ohsaki&title=Nicotinamide+phosphoribosyltransferase%3A+a+potent+therapeutic+target+in+non-small+cell+lung+cancer+with+epidermal+growth+factor+receptor-gene+mutation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44cR"><div class="casContent"><span class="casTitleNuber">44c</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation</span></div><div class="casAuthors">Okumura, Shunsuke; Sasaki, Takaaki; Minami, Yoshinori; Ohsaki, Yoshinobu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thoracic Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">JTOOB7</span>;
        ISSN:<span class="NLM_cas:issn">1556-0864</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background: Non-small cell lung cancer (NSCLC) often has an epidermal growth factor receptor (EGFR) gene mutation.  Growth of EGFR-gene-mutated NSCLC depends predominantly on EGFR signaling and requires a large amt. of intracellular ATP to activate EGFR signal transduction.  Nicotinamide phosphoribosyltransferase (NAMPT) is a rate-limiting enzyme in NAD biosynthesis, and it regulates intracellular ATP levels in mammalian cells.  The effect of NAMPT inhibition on NSCLC has not been completely understood.  Methods: We aimed to clarify the hypothesis that NAMPT inhibition suppresses growth of EGFR-gene-mutated NSCLC through redn. of intracellular ATP levels, using NAMPT-siRNA transfection and NAMPT inhibitor FK866.  We used four lung adenocarcinoma cell lines, including H358 (Wild type EGFR), LC2 (EGFRL858R), PC9 (EGFRDel E746-A750), and H1975 (EGFRL858R+T790M), and evaluated the effect of FK866 on these cells and its mechanisms, using cell proliferation, Western blot, ATP, and apoptosis assay.  Results: We found that (1) H358, LC2, and H1975 cell lines highly expressed NAMPT-mRNA; (2) NAMPT-specific siRNA and FK866 suppressed proliferation of these NSCLCs; (3) FK866 reduced intracellular ATP levels in H1975 cells; (4) FK866 dephosphorylated EGFR signal proteins, including EGFR, Akt, Map kinase kinase 1/2, and extracellular signal-regulated kinase 1/2 (ERK 1/2); (5) FK866 induced apoptosis of H1975 cells; and (6) FK866 suppressed growth of H1975 xenograft tumors and attenuated expression of phospho-ERK 1/2 in the tumors in a tumor-bearing mouse model.  Conclusion: These findings indicate that NAMPT is a potent therapeutic target in the treatment of EGFR-gene-mutated NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXgZLJx_HCaLVg90H21EOLACvtfcHk0lj27X5RQTw83A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFGqu7s%253D&md5=8c8388659fb8d06aeb0420b3dc4cc775</span></div><a href="/servlet/linkout?suffix=cit44c&amp;dbid=16384&amp;doi=10.1097%2FJTO.0b013e318233d686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJTO.0b013e318233d686%26sid%3Dliteratum%253Aachs%26aulast%3DOkumura%26aufirst%3DS.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DMinami%26aufirst%3DY.%26aulast%3DOhsaki%26aufirst%3DY.%26atitle%3DNicotinamide%2520phosphoribosyltransferase%253A%2520a%2520potent%2520therapeutic%2520target%2520in%2520non-small%2520cell%2520lung%2520cancer%2520with%2520epidermal%2520growth%2520factor%2520receptor-gene%2520mutation%26jtitle%3DJ.%2520Thorac.%2520Oncol.%26date%3D2012%26volume%3D7%26spage%3D49%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit44d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Munk Jensen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnbeck, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzorek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hojgaard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kjaer, A.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]FLT and [<sup>18</sup>F]FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenografts</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e53410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e53410&author=M.+Munk+Jensenauthor=K.+D.+Erichsenauthor=C.+B.+Johnbeckauthor=F.+Bjorklingauthor=J.+Madsenauthor=M.+Bzorekauthor=P.+B.+Jensenauthor=L.+Hojgaardauthor=M.+Sehestedauthor=A.+Kjaer&title=%5B18F%5DFLT+and+%5B18F%5DFDG+PET+for+non-invasive+treatment+monitoring+of+the+nicotinamide+phosphoribosyltransferase+inhibitor+APO866+in+human+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMunk%2BJensen%26aufirst%3DM.%26aulast%3DErichsen%26aufirst%3DK.%2BD.%26aulast%3DJohnbeck%26aufirst%3DC.%2BB.%26aulast%3DBjorkling%26aufirst%3DF.%26aulast%3DMadsen%26aufirst%3DJ.%26aulast%3DBzorek%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DHojgaard%26aufirst%3DL.%26aulast%3DSehested%26aufirst%3DM.%26aulast%3DKjaer%26aufirst%3DA.%26atitle%3D%255B18F%255DFLT%2520and%2520%255B18F%255DFDG%2520PET%2520for%2520non-invasive%2520treatment%2520monitoring%2520of%2520the%2520nicotinamide%2520phosphoribosyltransferase%2520inhibitor%2520APO866%2520in%2520human%2520xenografts%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De53410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lee, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, M. N.</span><span> </span><span class="NLM_article-title">Pre-B-cell colony-enhancing factor and its clinical correlates with acute lung injury and sepsis</span> <span class="citation_source-journal">Chest</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">â</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2011&pages=382-390&author=K.+A.+Leeauthor=M.+N.+Gong&title=Pre-B-cell+colony-enhancing+factor+and+its+clinical+correlates+with+acute+lung+injury+and+sepsis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BA.%26aulast%3DGong%26aufirst%3DM.%2BN.%26atitle%3DPre-B-cell%2520colony-enhancing%2520factor%2520and%2520its%2520clinical%2520correlates%2520with%2520acute%2520lung%2520injury%2520and%2520sepsis%26jtitle%3DChest%26date%3D2011%26volume%3D140%26spage%3D382%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit45b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Esposito, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Impellizzeri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fakhfouri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzocrea, S.</span><span> </span><span class="NLM_article-title">The NAMPT inhibitor FK866 reverts the damage in spinal cord injury</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1186%2F1742-2094-9-66" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=22490786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlWjtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=66&author=E.+Espositoauthor=D.+Impellizzeriauthor=E.+Mazzonauthor=G.+Fakhfouriauthor=R.+Rahimianauthor=C.+Travelliauthor=G.+C.+Tronauthor=A.+A.+Genazzaniauthor=S.+Cuzzocrea&title=The+NAMPT+inhibitor+FK866+reverts+the+damage+in+spinal+cord+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45bR"><div class="casContent"><span class="casTitleNuber">45b</span><div class="casTitle"><span class="NLM_cas:atitle">The NAMPT inhibitor FK866 reverts the damage in spinal cord injury</span></div><div class="casAuthors">Esposito, Emanuela; Impellizzeri, Daniela; Mazzon, Emanuela; Fakhfouri, Gohar; Rahimian, Reza; Travelli, Cristina; Tron, Gian Cesare; Genazzani, Armando A.; Cuzzocrea, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Emerging data implicate nicotinamide phosphoribosyl transferase (NAMPT) in the pathogenesis of cancer and inflammation.  NAMPT inhibitors have proven beneficial in inflammatory animal models of arthritis and endotoxic shock as well as in autoimmune encephalitis.  Given the role of inflammatory responses in spinal cord injury (SCI), the effect of NAMPT inhibitors was examd. in this setting.  Methods: We investigated the effects of the NAMPT inhibitor FK866 in an exptl. compression model of SCI.  Results: Twenty-four hr following induction of SCI, a significant functional deficit accompanied widespread edema, demyelination, neuron loss and a substantial increase in TNF-Î±, IL-1Î², PAR, NAMPT, Bax, MPO activity, NF-ÎºB activation, astrogliosis and microglial activation was obsd.  Meanwhile, the expression of neurotrophins BDNF, GDNF, NT3 and anti-apoptotic Bcl-2 decreased significantly.  Treatment with FK866 (10 mg/kg), the best known and characterized NAMPT inhibitor, at 1 h and 6 h after SCI rescued motor function, preserved perilesional gray and white matter, restored anti-apoptotic and neurotrophic factors, prevented the activation of neutrophils, microglia and astrocytes and inhibited the elevation of NAMPT, PAR, TNF-Î±, IL-1Î², Bax expression and NF-ÎºB activity.  We show for the first time that FK866, a specific inhibitor of NAMPT, administered after SCI, is capable of reducing the secondary inflammatory injury and partly reduce permanent damage.  We also show that NAMPT protein levels are increased upon SCI in the perilesional area which can be cor. by administration of FK866.  Conclusions: Our findings suggest that the inflammatory component assocd. to SCI is the primary target of these inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh5Ird8GZC07Vg90H21EOLACvtfcHk0ljcuQ9B-szb1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlWjtrk%253D&md5=5f87d4adfae52844d3510da4bdfcb608</span></div><a href="/servlet/linkout?suffix=cit45b&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-9-66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-9-66%26sid%3Dliteratum%253Aachs%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DImpellizzeri%26aufirst%3DD.%26aulast%3DMazzon%26aufirst%3DE.%26aulast%3DFakhfouri%26aufirst%3DG.%26aulast%3DRahimian%26aufirst%3DR.%26aulast%3DTravelli%26aufirst%3DC.%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DCuzzocrea%26aufirst%3DS.%26atitle%3DThe%2520NAMPT%2520inhibitor%2520FK866%2520reverts%2520the%2520damage%2520in%2520spinal%2520cord%2520injury%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2012%26volume%3D9%26spage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Schou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottosen, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BjÃ¶rkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjarnaa, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binderup, L.</span><span> </span><span class="NLM_article-title">Novel cyanoguanidines with potent oral antitumour activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3095</span><span class="NLM_x">â</span> <span class="NLM_lpage">3100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=3095-3100&author=C.+Schouauthor=E.+R.+Ottosenauthor=H.+J.+Petersenauthor=F.+Bj%C3%B6rklingauthor=S.+Latiniauthor=P.+V.+Hjarnaaauthor=E.+Brammauthor=L.+Binderup&title=Novel+cyanoguanidines+with+potent+oral+antitumour+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchou%26aufirst%3DC.%26aulast%3DOttosen%26aufirst%3DE.%2BR.%26aulast%3DPetersen%26aufirst%3DH.%2BJ.%26aulast%3DBj%25C3%25B6rkling%26aufirst%3DF.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DHjarnaa%26aufirst%3DP.%2BV.%26aulast%3DBramm%26aufirst%3DE.%26aulast%3DBinderup%26aufirst%3DL.%26atitle%3DNovel%2520cyanoguanidines%2520with%2520potent%2520oral%2520antitumour%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D3095%26epage%3D3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Hjarnaa, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skov, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binderup, L.</span><span> </span><span class="NLM_article-title">CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5751</span><span class="NLM_x">â</span> <span class="NLM_lpage">5757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5751-5757&author=P.+J.+Hjarnaaauthor=E.+Jonssonauthor=S.+Latiniauthor=S.+Dharauthor=R.+Larssonauthor=E.+Brammauthor=T.+Skovauthor=L.+Binderup&title=CHS+828%2C+a+novel+pyridyl+cyanoguanidine+with+potent+antitumor+activity+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHjarnaa%26aufirst%3DP.%2BJ.%26aulast%3DJonsson%26aufirst%3DE.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DBramm%26aufirst%3DE.%26aulast%3DSkov%26aufirst%3DT.%26aulast%3DBinderup%26aufirst%3DL.%26atitle%3DCHS%2520828%252C%2520a%2520novel%2520pyridyl%2520cyanoguanidine%2520with%2520potent%2520antitumor%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D5751%26epage%3D5757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Lovborg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullbo, J.</span><span> </span><span class="NLM_article-title">Structureâactivity relationship analysis of cytotoxic cyanoguanidines: selection of CHS 828 as candidate drug</span> <span class="citation_source-journal">BMC Res. Notes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1186%2F1756-0500-2-114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BD1MvotFersw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=114&author=H.+Lovborgauthor=R.+Burmanauthor=J.+Gullbo&title=Structure%E2%80%93activity+relationship+analysis+of+cytotoxic+cyanoguanidines%3A+selection+of+CHS+828+as+candidate+drug"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship analysis of cytotoxic cyanoguanidines: selection of CHS 828 as candidate drug</span></div><div class="casAuthors">Lovborg Henrik; Burman Robert; Gullbo Joachim</div><div class="citationInfo"><span class="NLM_cas:title">BMC research notes</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  N-(6-(4-chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridyl guanidine) (CHS 828) is the first candidate drug from a novel group of anti-tumour agents - the pyridyl cyanoguanidines, shown to be potent compounds interfering with cellular metabolism (inhibition of nicotinamide phosphoribosyl transferase) and NF-kappaB signalling.  Substituted cyanoguanidines are also found in anti-hypertensive agents such as the potassium channel opener pinacidil (N-cyano-N'-(4-pyridyl)-N''-(1,2,2-trimethylpropyl)guanidine) and histamine-II receptor antagonists (e.g. cimetidine, N-cyano-N'-methyl-N''-[2-[[(5-methylimidazol-4-yl]methyl]thio]ethyl)guanidine).  In animal studies, CHS 828 has shown very promising activity, and phase I and II studies resulted in further development of a with a water soluble prodrug.  FINDINGS:  To study the structural requirements for cyanoguanidine cytotoxicity a set of 19 analogues were synthesized.  The cytotoxic effects were then studied in ten cell lines selected for different origins and mechanisms of resistance, using the fluorometric microculture cytotoxicity assay (FMCA).  The compounds showed varying cytotoxic activity even though the dose-response curves for some analogues were very shallow.  Pinacidil and cimetidine were found to be non-toxic in all ten cell lines.  Starting with cyanoguanidine as the crucial core it was shown that 4-pyridyl substitution was more efficient than was 3-pyridyl substitution.  The 4-pyridyl cyanoguanidine moiety should be linked by an alkyl chain, optimally a hexyl, heptyl or octyl chain, to a bulky end group.  The exact composition of this end group did not seem to be of crucial importance; when the end group was a mono-substituted phenyl ring it was shown that the preferred position was 4-substitution, followed by 3- and, finally, 2-substitution as the least active.  Whether the substituent was a chloro, nitro or methoxy substituent seemed to be of minor importance.  Finally, the activity patterns in the ten cell lines were compared.  Substances with similar structures correlated well, whilst substances with large differences in molecular structure demonstrated lower correlation coefficients.  CONCLUSION:  According to this structure-activity relationship (SAR) study, CHS 828 meets the requirements for optimal cytotoxic activity for this class of compounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRO7KHacRtCzzC850By6mxpfW6udTcc2ebi_Gk21dFk0rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvotFersw%253D%253D&md5=a6fbe2d2b3ad093afd3bf0c8dc4668b9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2F1756-0500-2-114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-0500-2-114%26sid%3Dliteratum%253Aachs%26aulast%3DLovborg%26aufirst%3DH.%26aulast%3DBurman%26aufirst%3DR.%26aulast%3DGullbo%26aufirst%3DJ.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520analysis%2520of%2520cytotoxic%2520cyanoguanidines%253A%2520selection%2520of%2520CHS%2520828%2520as%2520candidate%2520drug%26jtitle%3DBMC%2520Res.%2520Notes%26date%3D2009%26volume%3D2%26spage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Chern, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, H. Y.</span><span> </span><span class="NLM_article-title">Synthesis and in vitro cytotoxicity of 5-substituted 2-cyanoimino-4-imidazodinone and 2-cyanoimino-4-pyrimidinone derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1169</span><span class="NLM_x">â</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1169-1172&author=J.+H.+Chernauthor=K.+S.+Shiaauthor=C.+M.+Changauthor=C.+C.+Leeauthor=Y.+C.+Leeauthor=C.+L.+Taiauthor=Y.+T.+Linauthor=C.+S.+Changauthor=H.+Y.+Tseng&title=Synthesis+and+in+vitro+cytotoxicity+of+5-substituted+2-cyanoimino-4-imidazodinone+and+2-cyanoimino-4-pyrimidinone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChern%26aufirst%3DJ.%2BH.%26aulast%3DShia%26aufirst%3DK.%2BS.%26aulast%3DChang%26aufirst%3DC.%2BM.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DTai%26aufirst%3DC.%2BL.%26aulast%3DLin%26aufirst%3DY.%2BT.%26aulast%3DChang%26aufirst%3DC.%2BS.%26aulast%3DTseng%26aufirst%3DH.%2BY.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520cytotoxicity%2520of%25205-substituted%25202-cyanoimino-4-imidazodinone%2520and%25202-cyanoimino-4-pyrimidinone%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1169%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Beauparlant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratton, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavoie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcotte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, M.</span><span> </span><span class="NLM_article-title">Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">â</span> <span class="NLM_lpage">354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=346-354&author=P.+Beauparlantauthor=D.+Bedardauthor=C.+Bernierauthor=H.+Chanauthor=K.+Gilbertauthor=D.+Gouletauthor=M.+O.+Grattonauthor=M.+Lavoieauthor=A.+Roulstonauthor=E.+Turcotteauthor=M.+Watson&title=Preclinical+development+of+the+nicotinamide+phosphoribosyl+transferase+inhibitor+prodrug+GMX1777"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeauparlant%26aufirst%3DP.%26aulast%3DBedard%26aufirst%3DD.%26aulast%3DBernier%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DGilbert%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DD.%26aulast%3DGratton%26aufirst%3DM.%2BO.%26aulast%3DLavoie%26aufirst%3DM.%26aulast%3DRoulston%26aufirst%3DA.%26aulast%3DTurcotte%26aufirst%3DE.%26aulast%3DWatson%26aufirst%3DM.%26atitle%3DPreclinical%2520development%2520of%2520the%2520nicotinamide%2520phosphoribosyl%2520transferase%2520inhibitor%2520prodrug%2520GMX1777%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2009%26volume%3D20%26spage%3D346%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Binderup, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjarnaa, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltzer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binderup, L.</span><span> </span><span class="NLM_article-title">EB1627: a soluble prodrug of the potent anticancer cyanoguanidine CHS828</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2491</span><span class="NLM_x">â</span> <span class="NLM_lpage">2494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2491-2494&author=E.+Binderupauthor=F.+Bjorklingauthor=P.+V.+Hjarnaaauthor=S.+Latiniauthor=B.+Baltzerauthor=M.+Carlsenauthor=L.+Binderup&title=EB1627%3A+a+soluble+prodrug+of+the+potent+anticancer+cyanoguanidine+CHS828"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBinderup%26aufirst%3DE.%26aulast%3DBjorkling%26aufirst%3DF.%26aulast%3DHjarnaa%26aufirst%3DP.%2BV.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DBaltzer%26aufirst%3DB.%26aulast%3DCarlsen%26aufirst%3DM.%26aulast%3DBinderup%26aufirst%3DL.%26atitle%3DEB1627%253A%2520a%2520soluble%2520prodrug%2520of%2520the%2520potent%2520anticancer%2520cyanoguanidine%2520CHS828%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2491%26epage%3D2494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Olesen, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fristrup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thougaard, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span> </span><span class="NLM_article-title">Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=677&author=U.+H.+Olesenauthor=J.+G.+Petersenauthor=A.+Gartenauthor=W.+Kiessauthor=J.+Yoshinoauthor=S.+Imaiauthor=M.+K.+Christensenauthor=P.+Fristrupauthor=A.+V.+Thougaardauthor=F.+Bjorklingauthor=P.+B.+Jensenauthor=S.+J.+Nielsenauthor=M.+Sehested&title=Target+enzyme+mutations+are+the+molecular+basis+for+resistance+towards+pharmacological+inhibition+of+nicotinamide+phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DU.%2BH.%26aulast%3DPetersen%26aufirst%3DJ.%2BG.%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DKiess%26aufirst%3DW.%26aulast%3DYoshino%26aufirst%3DJ.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DChristensen%26aufirst%3DM.%2BK.%26aulast%3DFristrup%26aufirst%3DP.%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DBjorkling%26aufirst%3DF.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DNielsen%26aufirst%3DS.%2BJ.%26aulast%3DSehested%26aufirst%3DM.%26atitle%3DTarget%2520enzyme%2520mutations%2520are%2520the%2520molecular%2520basis%2520for%2520resistance%2520towards%2520pharmacological%2520inhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%26jtitle%3DBMC%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">von Heideman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nygren, P.</span><span> </span><span class="NLM_article-title">Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1165</span><span class="NLM_x">â</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1007%2Fs00280-009-1125-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=19789873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BC3c7ot1ehsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2010&pages=1165-1172&author=A.+von+Heidemanauthor=A.+Berglundauthor=R.+Larssonauthor=P.+Nygren&title=Safety+and+efficacy+of+NAD+depleting+cancer+drugs%3A+results+of+a+phase+I+clinical+trial+of+CHS+828+and+overview+of+published+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data</span></div><div class="casAuthors">von Heideman Anne; Berglund Ake; Larsson Rolf; Nygren Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cancer chemotherapy and pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1165-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Depletion of cellular nicotinamide adenine dinucleotide (NAD) by inhibition of its synthesis is a new pharmacological principle for cancer treatment currently in early phases of clinical development.  We present new and previously published data on the safety and efficacy of these drugs based on early clinical trials.  METHODS:  A phase I clinical trial of CHS 828 in patients with advanced solid tumours was performed.  Published clinical trials on NAD depleting drugs for cancer treatment were summarised for safety and efficacy.  RESULTS:  Seven patients with previously treated solid tumours received oral administration of CHS 828 in the dose range 20-80 mg once weekly for 3 weeks in 4 weeks cycles.  Toxicity was dominated by gastrointestinal symptoms including nausea, vomiting, diarrhoea, constipation, subileus and gastric ulcer.  One patient had thrombocytopenia grade 2.  There were two cases each of grade 3-4 hyperuricemia and hypokalemia.  Safety and efficacy of the NAD depleting drugs CHS 828 and FK866 have been reported from four phase I clinical trials, including a total of 97 patients with previously treated solid tumours.  Outstanding toxicity reported was thrombocytopenia and various gastrointestinal symptoms.  No objective tumour remission has been observed in the total of 104 patients treated in the above early trials.  CONCLUSIONS:  Critical toxicity from NAD depleting cancer drugs to consider in future trials seems to be thrombocytopenia and various gastrointestinal symptoms.  Efficacy of NAD depleting drugs when used alone is expected to be low.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSg0_xmYRnTuDAEfvC7EH1LfW6udTcc2eaJOJH3IRz8zbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7ot1ehsA%253D%253D&md5=a6520fe98a1a59f2686a949f919943e5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs00280-009-1125-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-009-1125-3%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BHeideman%26aufirst%3DA.%26aulast%3DBerglund%26aufirst%3DA.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DNygren%26aufirst%3DP.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520NAD%2520depleting%2520cancer%2520drugs%253A%2520results%2520of%2520a%2520phase%2520I%2520clinical%2520trial%2520of%2520CHS%2520828%2520and%2520overview%2520of%2520published%2520data%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2010%26volume%3D65%26spage%3D1165%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Maldi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agazzone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cintura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scatolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miglino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiorino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldorini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span> </span><span class="NLM_article-title">Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions</span> <span class="citation_source-journal">Pigm. Cell Melanoma Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">â</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1111%2Fpcmr.12037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislygsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=144-146&author=E.+Maldiauthor=C.+Travelliauthor=A.+Caldarelliauthor=N.+Agazzoneauthor=S.+Cinturaauthor=U.+Galliauthor=M.+Scatoliniauthor=P.+Ostanoauthor=B.+Miglinoauthor=G.+Chiorinoauthor=R.+Boldoriniauthor=A.+A.+Genazzani&title=Nicotinamide+phosphoribosyltransferase+%28NAMPT%29+is+over-expressed+in+melanoma+lesions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions</span></div><div class="casAuthors">Maldi, Elena; Travelli, Cristina; Caldarelli, Antonio; Agazzone, Nicolo; Cintura, Sara; Galli, Ubaldina; Scatolini, Maria; Ostano, Paola; Miglino, Benedetta; Chiorino, Giovanna; Boldorini, Renzo; Genazzani, Armando A.</div><div class="citationInfo"><span class="NLM_cas:title">Pigment Cell & Melanoma Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">144-146</span>CODEN:
                <span class="NLM_cas:coden">PCMRCM</span>;
        ISSN:<span class="NLM_cas:issn">1755-1471</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaw-bW4I2sr7Vg90H21EOLACvtfcHk0lj8TQ6Fu1W4Cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislygsLc%253D&md5=bfb1fd9746b119d2c13287cf10144365</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fpcmr.12037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpcmr.12037%26sid%3Dliteratum%253Aachs%26aulast%3DMaldi%26aufirst%3DE.%26aulast%3DTravelli%26aufirst%3DC.%26aulast%3DCaldarelli%26aufirst%3DA.%26aulast%3DAgazzone%26aufirst%3DN.%26aulast%3DCintura%26aufirst%3DS.%26aulast%3DGalli%26aufirst%3DU.%26aulast%3DScatolini%26aufirst%3DM.%26aulast%3DOstano%26aufirst%3DP.%26aulast%3DMiglino%26aufirst%3DB.%26aulast%3DChiorino%26aufirst%3DG.%26aulast%3DBoldorini%26aufirst%3DR.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26atitle%3DNicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520is%2520over-expressed%2520in%2520melanoma%2520lesions%26jtitle%3DPigm.%2520Cell%2520Melanoma%2520Res.%26date%3D2013%26volume%3D26%26spage%3D144%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Holen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollywood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanauske, A. R.</span><span> </span><span class="NLM_article-title">The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">â</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=45-51&author=K.+Holenauthor=L.+B.+Saltzauthor=E.+Hollywoodauthor=K.+Burkauthor=A.+R.+Hanauske&title=The+pharmacokinetics%2C+toxicities%2C+and+biologic+effects+of+FK866%2C+a+nicotinamide+adenine+dinucleotide+biosynthesis+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolen%26aufirst%3DK.%26aulast%3DSaltz%26aufirst%3DL.%2BB.%26aulast%3DHollywood%26aufirst%3DE.%26aulast%3DBurk%26aufirst%3DK.%26aulast%3DHanauske%26aufirst%3DA.%2BR.%26atitle%3DThe%2520pharmacokinetics%252C%2520toxicities%252C%2520and%2520biologic%2520effects%2520of%2520FK866%252C%2520a%2520nicotinamide%2520adenine%2520dinucleotide%2520biosynthesis%2520inhibitor%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2008%26volume%3D26%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Ravaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerny, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Droz, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumoleau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twelves, C.</span><span> </span><span class="NLM_article-title">Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">â</span> <span class="NLM_lpage">707</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=702-707&author=A.+Ravaudauthor=T.+Cernyauthor=C.+Terretauthor=J.+Wandersauthor=B.+N.+Buiauthor=D.+Hessauthor=J.+P.+Drozauthor=P.+Fumoleauauthor=C.+Twelves&title=Phase+I+study+and+pharmacokinetic+of+CHS-828%2C+a+guanidino-containing+compound%2C+administered+orally+as+a+single+dose+every+3+weeks+in+solid+tumours%3A+an+ECSG%2FEORTC+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavaud%26aufirst%3DA.%26aulast%3DCerny%26aufirst%3DT.%26aulast%3DTerret%26aufirst%3DC.%26aulast%3DWanders%26aufirst%3DJ.%26aulast%3DBui%26aufirst%3DB.%2BN.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DDroz%26aufirst%3DJ.%2BP.%26aulast%3DFumoleau%26aufirst%3DP.%26aulast%3DTwelves%26aufirst%3DC.%26atitle%3DPhase%2520I%2520study%2520and%2520pharmacokinetic%2520of%2520CHS-828%252C%2520a%2520guanidino-containing%2520compound%252C%2520administered%2520orally%2520as%2520a%2520single%2520dose%2520every%25203%2520weeks%2520in%2520solid%2520tumours%253A%2520an%2520ECSG%252FEORTC%2520study%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2005%26volume%3D41%26spage%3D702%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">You, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eom, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span> </span><span class="NLM_article-title">Design, synthesis and X-ray crystallographic study of NAmPRTase inhibitors as anti-cancer agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1153</span><span class="NLM_x">â</span> <span class="NLM_lpage">1164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=1153-1164&author=H.+Youauthor=H.+S.+Younauthor=I.+Imauthor=M.+H.+Baeauthor=S.+K.+Leeauthor=H.+Koauthor=S.+H.+Eomauthor=Y.+C.+Kim&title=Design%2C+synthesis+and+X-ray+crystallographic+study+of+NAmPRTase+inhibitors+as+anti-cancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYou%26aufirst%3DH.%26aulast%3DYoun%26aufirst%3DH.%2BS.%26aulast%3DIm%26aufirst%3DI.%26aulast%3DBae%26aufirst%3DM.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DKo%26aufirst%3DH.%26aulast%3DEom%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DY.%2BC.%26atitle%3DDesign%252C%2520synthesis%2520and%2520X-ray%2520crystallographic%2520study%2520of%2520NAmPRTase%2520inhibitors%2520as%2520anti-cancer%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D1153%26epage%3D1164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Nahimana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greaney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ireson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thougaard, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjornelund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duchosal, M. A.</span><span> </span><span class="NLM_article-title">The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">3276</span><span class="NLM_x">â</span> <span class="NLM_lpage">3286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=3276-3286&author=A.+Nahimanaauthor=A.+Attingerauthor=D.+Aubryauthor=P.+Greaneyauthor=C.+Iresonauthor=A.+V.+Thougaardauthor=J.+Tjornelundauthor=K.+M.+Dawsonauthor=M.+Dupuisauthor=M.+A.+Duchosal&title=The+NAD+biosynthesis+inhibitor+APO866+has+potent+antitumor+activity+against+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNahimana%26aufirst%3DA.%26aulast%3DAttinger%26aufirst%3DA.%26aulast%3DAubry%26aufirst%3DD.%26aulast%3DGreaney%26aufirst%3DP.%26aulast%3DIreson%26aufirst%3DC.%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DTjornelund%26aufirst%3DJ.%26aulast%3DDawson%26aufirst%3DK.%2BM.%26aulast%3DDupuis%26aufirst%3DM.%26aulast%3DDuchosal%26aufirst%3DM.%2BA.%26atitle%3DThe%2520NAD%2520biosynthesis%2520inhibitor%2520APO866%2520has%2520potent%2520antitumor%2520activity%2520against%2520hematologic%2520malignancies%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D3276%26epage%3D3286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Kang, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eom, S. H.</span><span> </span><span class="NLM_article-title">Crystal structure of <i>Rattus norvegicus</i> visfatin/PBEF/Nampt in complex with an FK866-based inhibitor</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">â</span> <span class="NLM_lpage">671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=667-671&author=G.+B.+Kangauthor=M.+H.+Baeauthor=M.+K.+Kimauthor=I.+Imauthor=Y.+C.+Kimauthor=S.+H.+Eom&title=Crystal+structure+of+Rattus+norvegicus+visfatin%2FPBEF%2FNampt+in+complex+with+an+FK866-based+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DG.%2BB.%26aulast%3DBae%26aufirst%3DM.%2BH.%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DIm%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DEom%26aufirst%3DS.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520Rattus%2520norvegicus%2520visfatin%252FPBEF%252FNampt%2520in%2520complex%2520with%2520an%2520FK866-based%2520inhibitor%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D27%26spage%3D667%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Gillig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majjigapu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sordat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, P.</span><span> </span><span class="NLM_article-title">Synthesis of a <i>C</i>-iminoribofuranoside analog of the nicotinamide phosphoribosyltransferase (NAMPT) inhibitor FK866</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">â</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2012&pages=34-42&author=A.+Gilligauthor=S.+R.+Majjigapuauthor=B.+Sordatauthor=P.+Vogel&title=Synthesis+of+a+C-iminoribofuranoside+analog+of+the+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+inhibitor+FK866"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGillig%26aufirst%3DA.%26aulast%3DMajjigapu%26aufirst%3DS.%2BR.%26aulast%3DSordat%26aufirst%3DB.%26aulast%3DVogel%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520a%2520C-iminoribofuranoside%2520analog%2520of%2520the%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520inhibitor%2520FK866%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2012%26volume%3D95%26spage%3D34%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bair, K. W.; Baumeister, T.; Buckmelter, A. J.; Clodfelter, K. H.; Dragovich, P.; Gosselin, F.; Han, B.; Lin, J.; Reynolds, D. J.; Roth, B.; Smith, C. C.; Wang, Z.; Yuen, P.-W.; Zheng, X.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Sulfonylbenzyl)heteroarylcarboxamide Derivatives as Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors and Their Preparation and Use for the Treatment of Diseases</span>. WO2012031197A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+W.+Bair&author=T.+Baumeister&author=A.+J.+Buckmelter&author=K.+H.+Clodfelter&author=P.+Dragovich&author=F.+Gosselin&author=B.+Han&author=J.+Lin&author=D.+J.+Reynolds&author=B.+Roth&author=C.+C.+Smith&author=Z.+Wang&author=P.-W.+Yuen&author=X.+Zheng&title=N-%28Sulfonylbenzyl%29heteroarylcarboxamide+Derivatives+as+Nicotinamide+Phosphoribosyltransferase+%28NAMPT%29+Inhibitors+and+Their+Preparation+and+Use+for+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DN-%2528Sulfonylbenzyl%2529heteroarylcarboxamide%2520Derivatives%2520as%2520Nicotinamide%2520Phosphoribosyltransferase%2520%2528NAMPT%2529%2520Inhibitors%2520and%2520Their%2520Preparation%2520and%2520Use%2520for%2520the%2520Treatment%2520of%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit61b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bair, K. W.; Baumeister, T.; Buckmelter, A. J.; Clodfelter, K. H.; Han, B.; Kuntz, J. D.; Lin, J.; Reynolds, D. J.; Smith, C. C.; Wang, Z.; Zheng, X.</span><span> </span><span class="NLM_article-title">Piperidine Derivatives and Compositions for the Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT) and Their Preparation</span>. WO2012154194A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+W.+Bair&author=T.+Baumeister&author=A.+J.+Buckmelter&author=K.+H.+Clodfelter&author=B.+Han&author=J.+D.+Kuntz&author=J.+Lin&author=D.+J.+Reynolds&author=C.+C.+Smith&author=Z.+Wang&author=X.+Zheng&title=Piperidine+Derivatives+and+Compositions+for+the+Inhibition+of+Nicotinamide+Phosphoribosyltransferase+%28NAMPT%29+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DPiperidine%2520Derivatives%2520and%2520Compositions%2520for%2520the%2520Inhibition%2520of%2520Nicotinamide%2520Phosphoribosyltransferase%2520%2528NAMPT%2529%2520and%2520Their%2520Preparation%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckmelter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clodfelter, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kley, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liederer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukadam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâBrien, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodhi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, P.-w.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bair, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span> </span><span class="NLM_article-title">Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3531</span><span class="NLM_x">â</span> <span class="NLM_lpage">3538</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3531-3538&author=J.+Gunzner-Tosteauthor=G.+Zhaoauthor=P.+Bauerauthor=T.+Baumeisterauthor=A.+J.+Buckmelterauthor=M.+Caligiuriauthor=K.+H.+Clodfelterauthor=B.+Fuauthor=B.+Hanauthor=Y.-C.+Hoauthor=N.+Kleyauthor=X.+Liangauthor=B.+M.+Liedererauthor=J.+Linauthor=S.+Mukadamauthor=T.+O%E2%80%99Brienauthor=A.+Ohauthor=D.+J.+Reynoldsauthor=G.+Sharmaauthor=N.+Skeltonauthor=C.+C.+Smithauthor=J.+Sodhiauthor=W.+Wangauthor=Z.+Wangauthor=Y.+Xiaoauthor=P.-w.+Yuenauthor=M.+Zakauthor=L.+Zhangauthor=X.+Zhengauthor=K.+W.+Bairauthor=P.+S.+Dragovich&title=Discovery+of+potent+and+efficacious+urea-containing+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+inhibitors+with+reduced+CYP2C9+inhibition+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DBauer%26aufirst%3DP.%26aulast%3DBaumeister%26aufirst%3DT.%26aulast%3DBuckmelter%26aufirst%3DA.%2BJ.%26aulast%3DCaligiuri%26aufirst%3DM.%26aulast%3DClodfelter%26aufirst%3DK.%2BH.%26aulast%3DFu%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DHo%26aufirst%3DY.-C.%26aulast%3DKley%26aufirst%3DN.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DReynolds%26aufirst%3DD.%2BJ.%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DSkelton%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DC.%2BC.%26aulast%3DSodhi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYuen%26aufirst%3DP.-w.%26aulast%3DZak%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520efficacious%2520urea-containing%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520inhibitors%2520with%2520reduced%2520CYP2C9%2520inhibition%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3531%26epage%3D3538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Zheng, X.; Bauer, P.; Baumeister, T.; Buckmelter, A. J.; Caligiuri, M.; Clodfelter, K. H.; Han, B.; Ho, Y. C.; Kley, N.; Lin, J.; Reynolds, D. J.; Sharma, G.; Smith, C. C.; Wang, Z.; Dragovich, P. S.; Oh, A.; Wang, W.; Zak, M.; Gunzner-Toste, J.; Zhao, G.; Yuen, P. W.; Bair, K. W.</span><span> </span><span class="NLM_article-title">Structure-based identification of novel nicotinamide phosphoribosyltransferase (Nampt) Inhibitors</span>.  <span class="citation_source-journal">J. Med. Chem.</span> [Online early access]. DOI: <span class="refDoi">Â DOI: 10.1021/jm400186h</span> . Published Online: Apr 25,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm400186h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=X.+Zheng&author=P.+Bauer&author=T.+Baumeister&author=A.+J.+Buckmelter&author=M.+Caligiuri&author=K.+H.+Clodfelter&author=B.+Han&author=Y.+C.+Ho&author=N.+Kley&author=J.+Lin&author=D.+J.+Reynolds&author=G.+Sharma&author=C.+C.+Smith&author=Z.+Wang&author=P.+S.+Dragovich&author=A.+Oh&author=W.+Wang&author=M.+Zak&author=J.+Gunzner-Toste&author=G.+Zhao&author=P.+W.+Yuen&author=K.+W.+Bair&title=Structure-based+identification+of+novel+nicotinamide+phosphoribosyltransferase+%28Nampt%29+Inhibitors&doi=10.1021%2Fjm400186h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm400186h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400186h%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26atitle%3DStructure-based%2520identification%2520of%2520novel%2520nicotinamide%2520phosphoribosyltransferase%2520%2528Nampt%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm400186h%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">A medicinal chemistâs guide to molecular interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">â</span> <span class="NLM_lpage">5084</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Colombano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonico, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifulco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span> </span><span class="NLM_article-title">A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">â</span> <span class="NLM_lpage">623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9010669" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWhsLzL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=616-623&author=G.+Colombanoauthor=C.+Travelliauthor=U.+Galliauthor=A.+Caldarelliauthor=M.+G.+Chiniauthor=P.+L.+Canonicoauthor=G.+Sorbaauthor=G.+Bifulcoauthor=G.+C.+Tronauthor=A.+A.+Genazzani&title=A+novel+potent+nicotinamide+phosphoribosyltransferase+inhibitor+synthesized+via+click+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Potent Nicotinamide Phosphoribosyltransferase Inhibitor Synthesized via Click Chemistry</span></div><div class="casAuthors">Colombano, Giampiero; Travelli, Cristina; Galli, Ubaldina; Caldarelli, Antonio; Chini, Maria Giovanna; Canonico, Pier Luigi; Sorba, Giovanni; Bifulco, Giuseppe; Tron, Gian Cesare; Genazzani, Armando A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">616-623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of NAD synthesis or salvage pathways has been proposed as a novel target for antitumor drugs.  In the search for mols. with this mechanism of action, the copper-catalyzed [3 + 2] cycloaddn. reaction between azides and alkynes (click chem.) was exploited to synthesize 185 novel analogs.  The most promising compd. I displays an IC50 for cytotoxicity in vitro of 3.8 Â± 0.3 nM and an IC50 for NAD depletion of 3.0 Â± 0.4 nM.  Also, the previous data suggesting that this class of compds. induces autophagic cell death were confirmed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8ImgtuD64qbVg90H21EOLACvtfcHk0li-pwETDEe3ww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWhsLzL&md5=1fed5cfce463e08cdcbd91328c2842bf</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm9010669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9010669%26sid%3Dliteratum%253Aachs%26aulast%3DColombano%26aufirst%3DG.%26aulast%3DTravelli%26aufirst%3DC.%26aulast%3DGalli%26aufirst%3DU.%26aulast%3DCaldarelli%26aufirst%3DA.%26aulast%3DChini%26aufirst%3DM.%2BG.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DBifulco%26aufirst%3DG.%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26atitle%3DA%2520novel%2520potent%2520nicotinamide%2520phosphoribosyltransferase%2520inhibitor%2520synthesized%2520via%2520click%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D616%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirali, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billington, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonico, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span> </span><span class="NLM_article-title">Click chemistry reactions in medicinal chemistry: applications of the 1,3-dipolar cycloaddition between azides and alkynes</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">â</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1002%2Fmed.20107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=17763363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsVerurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=278-308&author=G.+C.+Tronauthor=T.+Piraliauthor=R.+A.+Billingtonauthor=P.+L.+Canonicoauthor=G.+Sorbaauthor=A.+A.+Genazzani&title=Click+chemistry+reactions+in+medicinal+chemistry%3A+applications+of+the+1%2C3-dipolar+cycloaddition+between+azides+and+alkynes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry reactions in medicinal chemistry: applications of the 1,3-dipolar cycloaddition between azides and alkynes</span></div><div class="casAuthors">Tron, Gian Cesare; Pirali, Tracey; Billington, Richard A.; Canonico, Pier Luigi; Sorba, Giovanni; Genazzani, Armando A.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">278-308</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  In recent years, there has been an ever-increasing need for rapid reactions that meet the three main criteria of an ideal synthesis: efficiency, versatility, and selectivity.  Such reactions would allow medicinal chem. to keep pace with the multitude of information derived from modern biol. screening techniques.  The present review describes one of these reactions, the 1,3-dipolar cycloaddn. ("click-reaction") between azides and alkynes catalyzed by copper (I) salts.  The simplicity of this reaction and the ease of purifn. of the resulting products have opened new opportunities in generating vast arrays of compds. with biol. potential.  The present review will outline the accomplishments of this strategy achieved so far and outline some of medicinal chem. applications in which click-chem. might be relevant in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbqDBrdkhYXrVg90H21EOLACvtfcHk0li-pwETDEe3ww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsVerurg%253D&md5=ef565fc46c50047a6181e85711cb5c37</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fmed.20107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20107%26sid%3Dliteratum%253Aachs%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DPirali%26aufirst%3DT.%26aulast%3DBillington%26aufirst%3DR.%2BA.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26atitle%3DClick%2520chemistry%2520reactions%2520in%2520medicinal%2520chemistry%253A%2520applications%2520of%2520the%25201%252C3-dipolar%2520cycloaddition%2520between%2520azides%2520and%2520alkynes%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D278%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Galli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercolano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carraro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasi Roman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonico, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billington, R. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">â</span> <span class="NLM_lpage">779</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=771-779&author=U.+Galliauthor=E.+Ercolanoauthor=L.+Carraroauthor=C.+R.+Blasi+Romanauthor=G.+Sorbaauthor=P.+L.+Canonicoauthor=A.+A.+Genazzaniauthor=G.+C.+Tronauthor=R.+A.+Billington&title=Synthesis+and+biological+evaluation+of+isosteric+analogues+of+FK866%2C+an+inhibitor+of+NAD+salvage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DU.%26aulast%3DErcolano%26aufirst%3DE.%26aulast%3DCarraro%26aufirst%3DL.%26aulast%3DBlasi%2BRoman%26aufirst%3DC.%2BR.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DBillington%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520isosteric%2520analogues%2520of%2520FK866%252C%2520an%2520inhibitor%2520of%2520NAD%2520salvage%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D771%26epage%3D779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Curtin, M. L.; Sorensen, B. K.; Heyman, H. R.; Clark, R. F.; Woller, K. R.; Shah, O. J.; Michaelides, M.; Tse, C.; Vasudevan, A.; Mack, H.; Hansen, T. M.; Sweis, R.; Pliushchev, M. A.</span><span> </span><span class="NLM_article-title">Dihydroisoindolecarboxamide Derivatives as NAMPT and ROCK Inhibitors and Their Preparation</span>. US20120122842A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+L.+Curtin&author=B.+K.+Sorensen&author=H.+R.+Heyman&author=R.+F.+Clark&author=K.+R.+Woller&author=O.+J.+Shah&author=M.+Michaelides&author=C.+Tse&author=A.+Vasudevan&author=H.+Mack&author=T.+M.+Hansen&author=R.+Sweis&author=M.+A.+Pliushchev&title=Dihydroisoindolecarboxamide+Derivatives+as+NAMPT+and+ROCK+Inhibitors+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCurtin%26aufirst%3DM.%2BL.%26atitle%3DDihydroisoindolecarboxamide%2520Derivatives%2520as%2520NAMPT%2520and%2520ROCK%2520Inhibitors%2520and%2520Their%2520Preparation%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Christensen, M. K.; Bjoerkling, F.</span><span> </span><span class="NLM_article-title">Preparation of Squaric Acid Derivatives for Treating Diseases Caused by an Elevated Level of Nicotinamide Phosphoribosyltransferase (NAMPRT)</span>. WO2009156421A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+K.+Christensen&author=F.+Bjoerkling&title=Preparation+of+Squaric+Acid+Derivatives+for+Treating+Diseases+Caused+by+an+Elevated+Level+of+Nicotinamide+Phosphoribosyltransferase+%28NAMPRT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DM.%2BK.%26atitle%3DPreparation%2520of%2520Squaric%2520Acid%2520Derivatives%2520for%2520Treating%2520Diseases%2520Caused%2520by%2520an%2520Elevated%2520Level%2520of%2520Nicotinamide%2520Phosphoribosyltransferase%2520%2528NAMPRT%2529%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Bjoerkling, F.; Christensen, M. K.</span><span> </span><span class="NLM_article-title">Preparation of Cyanoguanidines for Treating Diseases Caused by an Elevated Level of Nicotinamide Phosphoribosyltransferase</span>. WO2009086835A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=F.+Bjoerkling&author=M.+K.+Christensen&title=Preparation+of+Cyanoguanidines+for+Treating+Diseases+Caused+by+an+Elevated+Level+of+Nicotinamide+Phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBjoerkling%26aufirst%3DF.%26atitle%3DPreparation%2520of%2520Cyanoguanidines%2520for%2520Treating%2520Diseases%2520Caused%2520by%2520an%2520Elevated%2520Level%2520of%2520Nicotinamide%2520Phosphoribosyltransferase%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Fleischer, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry-Lorenzo, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostanin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boniface, J. J.</span><span> </span><span class="NLM_article-title">Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">â</span> <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.chembiol.2010.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=20609415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVWqsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=659-664&author=T.+C.+Fleischerauthor=B.+R.+Murphyauthor=J.+S.+Flickauthor=R.+T.+Terry-Lorenzoauthor=Z.+H.+Gaoauthor=T.+Davisauthor=R.+McKinnonauthor=K.+Ostaninauthor=J.+A.+Willardsenauthor=J.+J.+Boniface&title=Chemical+proteomics+identifies+Nampt+as+the+target+of+CB30865%2C+an+orphan+cytotoxic+compound"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Proteomics Identifies Nampt as the Target of CB30865, An Orphan Cytotoxic Compound</span></div><div class="casAuthors">Fleischer, Tracey C.; Murphy, Brett R.; Flick, Jeffrey S.; Terry-Lorenzo, Ryan T.; Gao, Zhong-Hua; Davis, Thaylon; McKinnon, Rena; Ostanin, Kirill; Willardsen, J. Adam; Boniface, J. Jay</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">659-664</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Drug discovery based on cellular phenotypes is impeded by the challenge of identifying the mol. target.  To alleviate this problem, we developed a chem. proteomic process to identify cellular proteins that bind to small mols.  CB30865 is a potent (subnanomolar) and selective cytotoxic compd. of previously unknown mechanism of action.  By combining chem. proteomics with biochem. and cellular pharmacol. we have detd. that CB30865 cytotoxicity is due to subnanomolar inhibition of nicotinamide phosphoribosyltransferase (Nampt), an enzyme present in the NAD biosynthetic pathway.  Cancer cells develop dependence on Nampt due to increased energy requirements and the elevated activity of NAD consuming enzymes such as sirtuins and mono and poly(ADP-ribose) polymerases (PARPs).  These findings suggest new chem. starting points for Nampt inhibitors and further implicate this enzyme as a target in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLnL_Bki8MfLVg90H21EOLACvtfcHk0ljMT_OE_wd8TA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVWqsL4%253D&md5=cb496f614b057ec84e67e4fa940662cc</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DFleischer%26aufirst%3DT.%2BC.%26aulast%3DMurphy%26aufirst%3DB.%2BR.%26aulast%3DFlick%26aufirst%3DJ.%2BS.%26aulast%3DTerry-Lorenzo%26aufirst%3DR.%2BT.%26aulast%3DGao%26aufirst%3DZ.%2BH.%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DBoniface%26aufirst%3DJ.%2BJ.%26atitle%3DChemical%2520proteomics%2520identifies%2520Nampt%2520as%2520the%2520target%2520of%2520CB30865%252C%2520an%2520orphan%2520cytotoxic%2520compound%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D659%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Lockman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zigar, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slattum, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostanin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry-Lorenzo, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleischer, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boniface, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenderovich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span> </span><span class="NLM_article-title">Analogues of 4-[(7-bromo-2-methyl-4-oxo-3<i>H</i>-quinazolin-6-yl)methylprop-2-ynylamino]-<i>N</i>-(3-pyridy lmethyl)benzamide (CB-30865) as potent inhibitors of nicotinamide phosphoribosyltransferase (Nampt)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8734</span><span class="NLM_x">â</span> <span class="NLM_lpage">8746</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101145b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8734-8746&author=J.+W.+Lockmanauthor=B.+R.+Murphyauthor=D.+F.+Zigarauthor=W.+R.+Juddauthor=P.+M.+Slattumauthor=Z.+H.+Gaoauthor=K.+Ostaninauthor=J.+Greenauthor=R.+McKinnonauthor=R.+T.+Terry-Lorenzoauthor=T.+C.+Fleischerauthor=J.+J.+Bonifaceauthor=M.+Shenderovichauthor=J.+A.+Willardsen&title=Analogues+of+4-%5B%287-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl%29methylprop-2-ynylamino%5D-N-%283-pyridy+lmethyl%29benzamide+%28CB-30865%29+as+potent+inhibitors+of+nicotinamide+phosphoribosyltransferase+%28Nampt%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm101145b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101145b%26sid%3Dliteratum%253Aachs%26aulast%3DLockman%26aufirst%3DJ.%2BW.%26aulast%3DMurphy%26aufirst%3DB.%2BR.%26aulast%3DZigar%26aufirst%3DD.%2BF.%26aulast%3DJudd%26aufirst%3DW.%2BR.%26aulast%3DSlattum%26aufirst%3DP.%2BM.%26aulast%3DGao%26aufirst%3DZ.%2BH.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DTerry-Lorenzo%26aufirst%3DR.%2BT.%26aulast%3DFleischer%26aufirst%3DT.%2BC.%26aulast%3DBoniface%26aufirst%3DJ.%2BJ.%26aulast%3DShenderovich%26aufirst%3DM.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26atitle%3DAnalogues%2520of%25204-%255B%25287-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl%2529methylprop-2-ynylamino%255D-N-%25283-pyridy%2520lmethyl%2529benzamide%2520%2528CB-30865%2529%2520as%2520potent%2520inhibitors%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520%2528Nampt%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8734%26epage%3D8746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Bair, K. W.; Baumeister, T. B.; Buckmelter, A. J.; Clodfelter, K. H.; Han, B.; Lin, J.; Reynolds, D. J.; Smith, C. C.; Wang, Z.; Zheng, X.; Yuen, P.-W.</span><span> </span><span class="NLM_article-title">Preparation of 4-[[(Pyridin-3-ylmethyl)aminocarbonyl]amino]benzenesulfone Derivatives as NAMPT Inhibitors for Therapy of Diseases Such as Cancer</span>. WO2012031196A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+W.+Bair&author=T.+B.+Baumeister&author=A.+J.+Buckmelter&author=K.+H.+Clodfelter&author=B.+Han&author=J.+Lin&author=D.+J.+Reynolds&author=C.+C.+Smith&author=Z.+Wang&author=X.+Zheng&author=P.-W.+Yuen&title=Preparation+of+4-%5B%5B%28Pyridin-3-ylmethyl%29aminocarbonyl%5Damino%5Dbenzenesulfone+Derivatives+as+NAMPT+Inhibitors+for+Therapy+of+Diseases+Such+as+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DPreparation%2520of%25204-%255B%255B%2528Pyridin-3-ylmethyl%2529aminocarbonyl%255Damino%255Dbenzenesulfone%2520Derivatives%2520as%2520NAMPT%2520Inhibitors%2520for%2520Therapy%2520of%2520Diseases%2520Such%2520as%2520Cancer%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Bair, K. W.; Buckmelter, A. J.; Han, B.; Lin, J.; Reynolds, D. J.; Smith, C. C.; Wang, Z.; Zheng, X.</span><span> </span><span class="NLM_article-title">Guanidine Compounds and Compositions for the Inhibition of NAMPT and Their Preparation</span>. WO2012031199A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+W.+Bair&author=A.+J.+Buckmelter&author=B.+Han&author=J.+Lin&author=D.+J.+Reynolds&author=C.+C.+Smith&author=Z.+Wang&author=X.+Zheng&title=Guanidine+Compounds+and+Compositions+for+the+Inhibition+of+NAMPT+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DGuanidine%2520Compounds%2520and%2520Compositions%2520for%2520the%2520Inhibition%2520of%2520NAMPT%2520and%2520Their%2520Preparation%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Bair, K. W.; Baumeister, T.; Buckmelter, A. J.; Clodfelter, K. H.; Han, B.; Lin, J.; Reynolds, D. J.; Smith, C. C.; Wang, Z.; Zheng, X.</span><span> </span><span class="NLM_article-title">Preparation of Pyridinylprop-2-enamide Compounds as NAMPT Inhibitors</span>. WO2012150952A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+W.+Bair&author=T.+Baumeister&author=A.+J.+Buckmelter&author=K.+H.+Clodfelter&author=B.+Han&author=J.+Lin&author=D.+J.+Reynolds&author=C.+C.+Smith&author=Z.+Wang&author=X.+Zheng&title=Preparation+of+Pyridinylprop-2-enamide+Compounds+as+NAMPT+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DPreparation%2520of%2520Pyridinylprop-2-enamide%2520Compounds%2520as%2520NAMPT%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Lee, M. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevryugina, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, S. Q.</span><span> </span><span class="NLM_article-title">Carboranes increase the potency of small molecule inhibitors of nicotinamide phosphoribosyltranferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7290</span><span class="NLM_x">â</span> <span class="NLM_lpage">7294</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300740t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7290-7294&author=M.+W.+Leeauthor=Y.+V.+Sevryuginaauthor=A.+Khanauthor=S.+Q.+Ye&title=Carboranes+increase+the+potency+of+small+molecule+inhibitors+of+nicotinamide+phosphoribosyltranferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm300740t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300740t%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BW.%26aulast%3DSevryugina%26aufirst%3DY.%2BV.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DS.%2BQ.%26atitle%3DCarboranes%2520increase%2520the%2520potency%2520of%2520small%2520molecule%2520inhibitors%2520of%2520nicotinamide%2520phosphoribosyltranferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7290%26epage%3D7294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Chandra, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagavat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreekanthreddy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somasundaram, K.</span><span> </span><span class="NLM_article-title">Virtual screening, identification and experimental testing of novel inhibitors of PBEF1/visfatin/NMPRTase for glioma therapy</span> <span class="citation_source-journal">J. Clin. Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1186%2F2043-9113-1-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFShur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=5&author=N.+Chandraauthor=R.+Bhagavatauthor=E.+Sharmaauthor=P.+Sreekanthreddyauthor=K.+Somasundaram&title=Virtual+screening%2C+identification+and+experimental+testing+of+novel+inhibitors+of+PBEF1%2Fvisfatin%2FNMPRTase+for+glioma+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual screening, identification and experimental testing of novel inhibitors of PBEF1/visfatin/NMPRTase for glioma therapy</span></div><div class="casAuthors">Chandra, Nagasuma; Bhagavat, Raghu; Sharma, Eshita; Sreekanthreddy, P.; Somasundaram, Kumaravel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Bioinformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5</span>CODEN:
                <span class="NLM_cas:coden">JCBOBR</span>;
        ISSN:<span class="NLM_cas:issn">2043-9113</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Pre-B-cell colony enhancing factor 1 gene (PBEF1) encodes nicotinamide phosphoribosyltransferase (NMPRTase), which catalyzes the rate limiting step in the salvage pathway of NAD+ metab. in mammalian cells.  PBEF1 transcript and protein levels have been shown to be elevated in glioblastoma and a chem. inhibitor of NMPRTase has been shown to specifically inhibit cancer cells.  Methods: Virtual screening using docking was used to screen a library of more than 13,000 chem. compds.  A shortlisted set of compds. were tested for their inhibition activity in vitro by an NMPRTase enzyme assay.  Further, the ability of the compds. to inhibit glioma cell proliferation was carried out.  Results: Virtual screening resulted in short listing of 34 possible ligands, of which six were tested exptl., using the NMPRTase enzyme inhibition assay and further with the glioma cell viability assays.  Of these, two compds. were found to be significantly efficacious in inhibiting the conversion of nicotinamide to NAD+, and out of which, one compd., 3-amino-2-benzyl-7-nitro-4-(2-quinolyl-)-1,2-dihydroisoquinolin-1-one, was found to inhibit the growth of a PBEF1 over expressing glioma derived cell line U87 as well.  Conclusions: Thus, a novel inhibitor has been identified through a structure based drug discovery approach and is further supported by exptl. evidence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpJpygBbJb1LVg90H21EOLACvtfcHk0ljBkFNqbjmQSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFShur4%253D&md5=b39873fb098f5ffcf1c31d9a44ed35f7</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1186%2F2043-9113-1-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2043-9113-1-5%26sid%3Dliteratum%253Aachs%26aulast%3DChandra%26aufirst%3DN.%26aulast%3DBhagavat%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DE.%26aulast%3DSreekanthreddy%26aufirst%3DP.%26aulast%3DSomasundaram%26aufirst%3DK.%26atitle%3DVirtual%2520screening%252C%2520identification%2520and%2520experimental%2520testing%2520of%2520novel%2520inhibitors%2520of%2520PBEF1%252Fvisfatin%252FNMPRTase%2520for%2520glioma%2520therapy%26jtitle%3DJ.%2520Clin.%2520Bioinf.%26date%3D2011%26volume%3D1%26spage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Lee, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S. S.</span><span> </span><span class="NLM_article-title">High visfatin expression in breast cancer tissue is associated with poor survival</span> <span class="citation_source-journal">Cancer Epidemiol., Biomarkers Prev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1892</span><span class="NLM_x">â</span> <span class="NLM_lpage">1901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1892-1901&author=Y.+C.+Leeauthor=Y.+H.+Yangauthor=J.+H.+Suauthor=H.+L.+Changauthor=M.+F.+Houauthor=S.+S.+Yuan&title=High+visfatin+expression+in+breast+cancer+tissue+is+associated+with+poor+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DYang%26aufirst%3DY.%2BH.%26aulast%3DSu%26aufirst%3DJ.%2BH.%26aulast%3DChang%26aufirst%3DH.%2BL.%26aulast%3DHou%26aufirst%3DM.%2BF.%26aulast%3DYuan%26aufirst%3DS.%2BS.%26atitle%3DHigh%2520visfatin%2520expression%2520in%2520breast%2520cancer%2520tissue%2520is%2520associated%2520with%2520poor%2520survival%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D2011%26volume%3D20%26spage%3D1892%26epage%3D1901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Dalamaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karmaniolas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadavid, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelekanos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotiropoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lekka, A.</span><span> </span><span class="NLM_article-title">Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters</span> <span class="citation_source-journal">Menopause</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1198</span><span class="NLM_x">â</span> <span class="NLM_lpage">1204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1097%2Fgme.0b013e31821e21f5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FksVaqtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1198-1204&author=M.+Dalamagaauthor=K.+Karmaniolasauthor=E.+Papadavidauthor=N.+Pelekanosauthor=G.+Sotiropoulosauthor=A.+Lekka&title=Elevated+serum+visfatin%2Fnicotinamide+phosphoribosyl-transferase+levels+are+associated+with+risk+of+postmenopausal+breast+cancer+independently+from+adiponectin%2C+leptin%2C+and+anthropometric+and+metabolic+parameters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters</span></div><div class="casAuthors">Dalamaga Maria; Karmaniolas Konstantinos; Papadavid Evangelia; Pelekanos Nicolaos; Sotiropoulos George; Lekka Antigoni</div><div class="citationInfo"><span class="NLM_cas:title">Menopause (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1198-204</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Obesity has been implicated in the etiology of postmenopausal breast cancer (PBC).  We hypothesized that altered secretion of visfatin may underlie this association.  We thus investigated the association of serum visfatin with PBC risk, taking into account known risk factors including adipokines and anthropometric and metabolic parameters.  METHODS:  In a case-control study, we studied 102 postmenopausal women with pathologically confirmed, incident invasive breast cancer and 102 control women matched on age and time of diagnosis between 2003 and 2010 at Army Share Fund Hospital, Veterans' Hospital (NIMTS).  Levels of serum visfatin, adiponectin, leptin, metabolic parameters, carcinoembryonic antigen, and CA 15-3 were determined.  RESULTS:  The mean serum visfatin level was significantly higher in case than in control participants (P < 0.001).  Women in the highest quartile of visfatin concentration presented significantly higher odds for PBC, adjusting for age, date of diagnosis, education, body mass index, waist circumference, years with menstruation, parity/age at first full-term pregnancy, breast-feeding, family history of cancer, use of exogenous hormones, alcohol consumption, smoking status, homeostasis model assessment score, and serum leptin and adiponectin concentrations (odds ratio, 7.93; 95% CI, 2.52-24.9).  In case participants, the visfatin level correlated significantly with the tumor marker CA 15-3 (P = 0.03) but not with metabolic and anthropometric variables (P > 0.05).  CONCLUSIONS:  Further prospective studies are needed to determine whether an elevated serum visfatin level is implicated in the etiopathogenesis of PBC or reflects changes during PBC progression and could therefore be used as a biomarker for PBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9GcvvCbsuQN0Q2ypr7jHkfW6udTcc2ebHS9PPatKKnrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FksVaqtA%253D%253D&md5=384f754022ff1793452f7a6411e510e5</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1097%2Fgme.0b013e31821e21f5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fgme.0b013e31821e21f5%26sid%3Dliteratum%253Aachs%26aulast%3DDalamaga%26aufirst%3DM.%26aulast%3DKarmaniolas%26aufirst%3DK.%26aulast%3DPapadavid%26aufirst%3DE.%26aulast%3DPelekanos%26aufirst%3DN.%26aulast%3DSotiropoulos%26aufirst%3DG.%26aulast%3DLekka%26aufirst%3DA.%26atitle%3DElevated%2520serum%2520visfatin%252Fnicotinamide%2520phosphoribosyl-transferase%2520levels%2520are%2520associated%2520with%2520risk%2520of%2520postmenopausal%2520breast%2520cancer%2520independently%2520from%2520adiponectin%252C%2520leptin%252C%2520and%2520anthropometric%2520and%2520metabolic%2520parameters%26jtitle%3DMenopause%26date%3D2011%26volume%3D18%26spage%3D1198%26epage%3D1204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Bi, T. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span> </span><span class="NLM_article-title">Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">â</span> <span class="NLM_lpage">1257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtleku7zK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=1251-1257&author=T.+Q.+Biauthor=X.+M.+Cheauthor=X.+H.+Liaoauthor=D.+J.+Zhangauthor=H.+L.+Longauthor=H.+J.+Liauthor=W.+Zhao&title=Overexpression+of+Nampt+in+gastric+cancer+and+chemopotentiating+effects+of+the+Nampt+inhibitor+FK866+in+combination+with+fluorouracil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil</span></div><div class="casAuthors">Bi, Tie-Qiang; Che, Xiang-Ming; Liao, Xin-Hua; Zhang, Dan-Jie; Long, Hou-Long; Li, Hai-Jun; Zhao, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1251-1257</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (Nampt), an enzyme involved in the NAD+ salvage pathway, is overexpressed and important in the carcinogenesis in several types of cancers.  The expression of Nampt and its role in gastric cancer remain largely unknown.  In this study, using real-time PCR and Western blotting we found that Nampt was overexpressed at the mRNA and protein levels, resp., in established gastric cancer cells and human gastric cancer tissues.  The specific Nampt inhibitor FK866 repressed gastric cancer cell proliferation, as assessed by MTT assay.  Using transwell and soft agar clonogenic assays, we also found that FK866 suppressed gastric cancer cell migration and anchorage-independent growth, resp.  These inhibitory effects of FK866 were accompanied by significantly decreased expression of VEGF, MMP2, MMP9 and NF-ÎºB.  As detd. by MTT assay and flow cytometry, FK866 also increased the chemosensitivity of gastric cancer cells to fluorouracil by greater inhibition of cell proliferation and the induction of apoptosis.  Our findings indicate that Nampt may be a new therapeutic target for gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDdcXVj4ZRwLVg90H21EOLACvtfcHk0ljBkFNqbjmQSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtleku7zK&md5=753c14ed24ee84c8415560b9c87efcf1</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DT.%2BQ.%26aulast%3DChe%26aufirst%3DX.%2BM.%26aulast%3DLiao%26aufirst%3DX.%2BH.%26aulast%3DZhang%26aufirst%3DD.%2BJ.%26aulast%3DLong%26aufirst%3DH.%2BL.%26aulast%3DLi%26aufirst%3DH.%2BJ.%26aulast%3DZhao%26aufirst%3DW.%26atitle%3DOverexpression%2520of%2520Nampt%2520in%2520gastric%2520cancer%2520and%2520chemopotentiating%2520effects%2520of%2520the%2520Nampt%2520inhibitor%2520FK866%2520in%2520combination%2520with%2520fluorouracil%26jtitle%3DOncol.%2520Rep.%26date%3D2011%26volume%3D26%26spage%3D1251%26epage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Nakajima, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span> </span><span class="NLM_article-title">Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer</span> <span class="citation_source-journal">J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">â</span> <span class="NLM_lpage">690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1007%2Fs00535-009-0063-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotlehtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=685-690&author=T.+E.+Nakajimaauthor=Y.+Yamadaauthor=T.+Hamanoauthor=K.+Furutaauthor=T.+Gotodaauthor=H.+Kataiauthor=K.+Katoauthor=T.+Hamaguchiauthor=Y.+Shimada&title=Adipocytokine+levels+in+gastric+cancer+patients%3A+resistin+and+visfatin+as+biomarkers+of+gastric+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer</span></div><div class="casAuthors">Nakajima, Takako Eguchi; Yamada, Yasuhide; Hamano, Tetsutaro; Furuta, Koh; Gotoda, Takuji; Katai, Hitoshi; Kato, Ken; Hamaguchi, Tetsuya; Shimada, Yasuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">685-690</span>CODEN:
                <span class="NLM_cas:coden">JOGAET</span>;
        ISSN:<span class="NLM_cas:issn">0944-1174</span>.
    
            (<span class="NLM_cas:orgname">Springer Japan</span>)
        </div><div class="casAbstract">Purpose: Adipocytokines are adipocyte-secreted hormones assocd. with some malignancies.  We investigated the assocn. of adipocytokines with gastric cancer.  Methods: The levels of body mass index (BMI) and adiponectin, leptin, resistin, visfatin, and C-peptide in blood at diagnosis were measured in 156 gastric cancer patients and 156 age- and sex-matched controls.  Logistic regression models were used to est. odds ratio, and one-way anal. of variance was performed to examine the prevalence of each variable between 2 or more groups.  Results: Adiponectin, C-peptide and BMI levels were significantly lower, and resistin and visfatin levels were significantly higher in the patients on multivariate anal. (P = 0.0004, 0.0006, 0.0051, 0.0006 and 0.0013, resp.).  In the controls, the inverse correlation between BMI and adiponectin was comparatively strong, but was weak in the patients.  The correlation between BMI and leptin was strong in both the controls and the patients.  The correlation between BMI and resistin or visfatin was not clear in either the patients or the controls.  The correlation between BMI and C-peptide was not clear in the controls, but might be weak in the patients.  Leptin, C-peptide and BMI levels gradually decreased with stage progression, and resistin and visfatin levels gradually increased with stage progression (P < 0.0001 for all).  Comparison between 38 patients with Stage I gastric cancer and the controls showed that adiponectin level tended to decrease in the patients (P = 0.0582), and BMI level was not different between two groups (P = 0.2480).  Conclusions: Resistin and visfatin may be good biomarkers of gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolOu4PrQRgILVg90H21EOLACvtfcHk0lhDsGBhZpFzJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotlehtrk%253D&md5=1bb21b8661c1bb716bd5ae3f0c0e9384</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1007%2Fs00535-009-0063-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00535-009-0063-5%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DT.%2BE.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DHamano%26aufirst%3DT.%26aulast%3DFuruta%26aufirst%3DK.%26aulast%3DGotoda%26aufirst%3DT.%26aulast%3DKatai%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DHamaguchi%26aufirst%3DT.%26aulast%3DShimada%26aufirst%3DY.%26atitle%3DAdipocytokine%2520levels%2520in%2520gastric%2520cancer%2520patients%253A%2520resistin%2520and%2520visfatin%2520as%2520biomarkers%2520of%2520gastric%2520cancer%26jtitle%3DJ.%2520Gastroenterol.%26date%3D2009%26volume%3D44%26spage%3D685%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Long, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, T. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D. W.</span><span> </span><span class="NLM_article-title">The expression of nicotinamide phosphoribosyl transferase and vascular endothelial growth factor-A in gastric carcinoma and their clinical significance</span> <span class="citation_source-journal">Zhonghua Waike Zazhi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">â</span> <span class="NLM_lpage">842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2012&pages=839-842&author=H.+L.+Longauthor=X.+M.+Cheauthor=T.+Q.+Biauthor=H.+J.+Liauthor=J.+S.+Liuauthor=D.+W.+Li&title=The+expression+of+nicotinamide+phosphoribosyl+transferase+and+vascular+endothelial+growth+factor-A+in+gastric+carcinoma+and+their+clinical+significance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DH.%2BL.%26aulast%3DChe%26aufirst%3DX.%2BM.%26aulast%3DBi%26aufirst%3DT.%2BQ.%26aulast%3DLi%26aufirst%3DH.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%2BS.%26aulast%3DLi%26aufirst%3DD.%2BW.%26atitle%3DThe%2520expression%2520of%2520nicotinamide%2520phosphoribosyl%2520transferase%2520and%2520vascular%2520endothelial%2520growth%2520factor-A%2520in%2520gastric%2520carcinoma%2520and%2520their%2520clinical%2520significance%26jtitle%3DZhonghua%2520Waike%2520Zazhi%26date%3D2012%26volume%3D50%26spage%3D839%26epage%3D842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Olesen, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastrup, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span> </span><span class="NLM_article-title">Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas</span> <span class="citation_source-journal">APMIS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">â</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1111%2Fj.1600-0463.2011.02733.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVegt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2011&pages=296-303&author=U.+H.+Olesenauthor=N.+Hastrupauthor=M.+Sehested&title=Expression+patterns+of+nicotinamide+phosphoribosyltransferase+and+nicotinic+acid+phosphoribosyltransferase+in+human+malignant+lymphomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas</span></div><div class="casAuthors">Olesen, Uffe Hoegh; Hastrup, Nina; Sehested, Maxwell</div><div class="citationInfo"><span class="NLM_cas:title">APMIS</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">296-303</span>CODEN:
                <span class="NLM_cas:coden">APMSEL</span>;
        ISSN:<span class="NLM_cas:issn">0903-4641</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The purpose of the study was to det. in human malignant lymphomas the expression patterns of nicotinamide phosphoribosyltransferase (NAMPT) and nicotinic acid phosphoribosyltransferase (NAPRT), the primary, rate-limiting enzymes in the synthesis of NAD+.  NAMPT is a potential biomarker for sensitivity to NAMPT inhibitors and NAPRT is a biomarker for the use of nicotinic acid as a chemoprotectant in treatment with NAMPT inhibitors.  The NAMPT inhibitor, APO866, is currently in clin. phase II trials in lymphomas.  The expression of NAMPT and NAPRT was investigated in 53 samples of malignant lymphomas (diffuse large B-cell lymphoma, follicular B-cell lymphoma, Hodgkin's lymphoma and peripheral T-cell lymphoma).  The expression of NAMPT was generally high in the more aggressive malignant lymphomas, with >80% strong expression, whereas the expression in the more indolent follicular lymphoma (FL) was significantly lower (>75% moderate or low expression, p = 0.0002).  NAMPT was very highly expressed in Hodgkin Reed-Sternberg cells in Hodgkin's lymphoma.  NAPRT expression was more varied (p > 0.0001) with 30-50% low expression except for Hodgkin's lymphoma where 85% displayed low expression (p = 0.0024).  In conclusion, FL are a promising target for NAMPT inhibitors whereas substantial subsets of malignant lymphomas esp. in Hodgkin lymphoma may be suitable for a combination treatment with nicotinic acid and NAMPT inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoba8znTBOxiLVg90H21EOLACvtfcHk0lhDsGBhZpFzJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVegt7o%253D&md5=eda747b3441bfa67095e71a64e1b6a16</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0463.2011.02733.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0463.2011.02733.x%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DU.%2BH.%26aulast%3DHastrup%26aufirst%3DN.%26aulast%3DSehested%26aufirst%3DM.%26atitle%3DExpression%2520patterns%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520and%2520nicotinic%2520acid%2520phosphoribosyltransferase%2520in%2520human%2520malignant%2520lymphomas%26jtitle%3DAPMIS%26date%3D2011%26volume%3D119%26spage%3D296%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Patel, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digby, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randeva, H. S.</span><span> </span><span class="NLM_article-title">A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">â</span> <span class="NLM_lpage">57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=51-57&author=S.+T.+Patelauthor=T.+Mistryauthor=J.+E.+Brownauthor=J.+E.+Digbyauthor=R.+Adyaauthor=K.+M.+Desaiauthor=H.+S.+Randeva&title=A+novel+role+for+the+adipokine+visfatin%2Fpre-B+cell+colony-enhancing+factor+1+in+prostate+carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%2BT.%26aulast%3DMistry%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DJ.%2BE.%26aulast%3DDigby%26aufirst%3DJ.%2BE.%26aulast%3DAdya%26aufirst%3DR.%26aulast%3DDesai%26aufirst%3DK.%2BM.%26aulast%3DRandeva%26aufirst%3DH.%2BS.%26atitle%3DA%2520novel%2520role%2520for%2520the%2520adipokine%2520visfatin%252Fpre-B%2520cell%2520colony-enhancing%2520factor%25201%2520in%2520prostate%2520carcinogenesis%26jtitle%3DPeptides%26date%3D2010%26volume%3D31%26spage%3D51%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Shackelford, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakam, A.</span><span> </span><span class="NLM_article-title">Over-expression of nicotinamide phosphoribosyltransferase in ovarian cancers</span> <span class="citation_source-journal">Int. J. Clin. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">â</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVyrtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=522-527&author=R.+E.+Shackelfordauthor=M.+M.+Buiauthor=D.+Coppolaauthor=A.+Hakam&title=Over-expression+of+nicotinamide+phosphoribosyltransferase+in+ovarian+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Over-expression of niotinamide phosphoribosyltransferase in ovarian cancers</span></div><div class="casAuthors">Shackelford, Rodney E.; Bui, Marilyn M.; Coppola, Domenico; Hakam, Ardeshir</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">522-527</span>CODEN:
                <span class="NLM_cas:coden">IJCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1936-2625</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (Nampt) catalyzes the rate-limiting step of NAD (NAD+) synthesis and is required for cell growth, survival, DNA replication and repair, and angiogenesis.  Nampt expression increases gene expression which promotes cell survival and increases SirT1 activity, promoting angiogenesis, and it is increased in several human malignancies.  Recently, others have shown that ovarian serous adenocarcinomas (OSAs) express high levels of activated Stat3.  Since Nampt expression is increased by Stat3, we hypothesized that Nampt protein might be highly expressed in OSAs.  Using tissue microarray (TMA) and the avidinbiotin complex immunohistochem. technique we examd. Nampt expression in 47 samples of benign ovarian tissue and 49 samples of ovarian serous adenoacarcinomas.  Our data show that Nampt protein expression is significantly increased in OSAs as compared to benign ovarian tissue (0.49+/-0.12 benign vs. 4.78+/-0.46 malignant; +/- std. error of the mean).  This is the first report demonstrating Nampt overexpression in OSA, which may shed light on the pathogenesis of OSA.  Further studies of the role of Nampt overexpresion in OSA may shed light on the prognosis and clin. course of OSA.  Last, since an effective pharmacol. Nampt inhibitor is currently in clin. use, further studies of Nampt overexpression in OSA may be used in selecting patients for Nampt inhibitor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxJ45cA4F99rVg90H21EOLACvtfcHk0lhaOt7q-ff0Fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVyrtLk%253D&md5=84616aa3a69e58bd876351a00e55f881</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShackelford%26aufirst%3DR.%2BE.%26aulast%3DBui%26aufirst%3DM.%2BM.%26aulast%3DCoppola%26aufirst%3DD.%26aulast%3DHakam%26aufirst%3DA.%26atitle%3DOver-expression%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520in%2520ovarian%2520cancers%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2010%26volume%3D3%26spage%3D522%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Nakajima, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span> </span><span class="NLM_article-title">Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1286</span><span class="NLM_x">â</span> <span class="NLM_lpage">1291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1111%2Fj.1349-7006.2010.01518.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsF2qu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2010&pages=1286-1291&author=T.+E.+Nakajimaauthor=Y.+Yamadaauthor=T.+Hamanoauthor=K.+Furutaauthor=T.+Matsudaauthor=S.+Fujitaauthor=K.+Katoauthor=T.+Hamaguchiauthor=Y.+Shimada&title=Adipocytokines+as+new+promising+markers+of+colorectal+tumors%3A+adiponectin+for+colorectal+adenoma%2C+and+resistin+and+visfatin+for+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer</span></div><div class="casAuthors">Nakajima, Takako Eguchi; Yamada, Yasuhide; Hamano, Tetsutaro; Furuta, Koh; Matsuda, Takahisa; Fujita, Shin; Kato, Ken; Hamaguchi, Tetsuya; Shimada, Yasuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1286-1291</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Adipocytokines are adipocyte-secreted hormones assocd. with some malignancies such as colorectal, breast, and prostate cancer.  We hypothesized that changes in the levels of adipocytokines may indicate the carcinogenesis and progression of colorectal cancer and adenoma, and investigated the assocn. of the blood levels of several adipocytokines through a case-control study.  Blood levels of adiponectin, leptin, resistin, visfatin, and C-peptide at diagnosis were measured in 115 colorectal cancer patients and 115 age-, sex-, and body mass index-matched controls.  The same anal. was performed in 72 colorectal adenoma patients and 72 controls.  Logistic regression models were used for estg. odds ratios and 95% confidence intervals, and one-way ANOVA was performed to det. the prevalence of each variable between two or more groups.  Resistin and visfatin levels in cancer patients were significantly higher than those of controls on multivariate anal. (P = 0.03 and P < 0.01, resp.).  Stage progression significantly correlated with resistin and visfatin levels (P < 0.01 for both).  The adiponectin level in adenoma patients was significantly lower than that of controls on multivariate anal. (P = 0.04).  Its level was inversely correlated with the no. of adenoma (P = 0.02), but not correlated with the size of adenoma.  Resistin and visfatin may be good biomarkers of colorectal malignant potential and stage progression.  Adiponectin level may be a good biomarker of colorectal adenoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0esinIQPQabVg90H21EOLACvtfcHk0lhaOt7q-ff0Fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsF2qu78%253D&md5=b46592da1f736341215d4f5e7a223b9c</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2010.01518.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2010.01518.x%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DT.%2BE.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DHamano%26aufirst%3DT.%26aulast%3DFuruta%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DHamaguchi%26aufirst%3DT.%26aulast%3DShimada%26aufirst%3DY.%26atitle%3DAdipocytokines%2520as%2520new%2520promising%2520markers%2520of%2520colorectal%2520tumors%253A%2520adiponectin%2520for%2520colorectal%2520adenoma%252C%2520and%2520resistin%2520and%2520visfatin%2520for%2520colorectal%2520cancer%26jtitle%3DCancer%2520Sci.%26date%3D2010%26volume%3D101%26spage%3D1286%26epage%3D1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Reddy, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thota, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramaniam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandramouli, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santosh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondaiah, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somasundaram, K.</span><span> </span><span class="NLM_article-title">PBEF1/NAmPRTase/visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">â</span> <span class="NLM_lpage">668</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.4161%2Fcbt.7.5.5663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVeisLjN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=663-668&author=P.+S.+Reddyauthor=S.+Umeshauthor=B.+Thotaauthor=A.+Tandonauthor=P.+Pandeyauthor=A.+S.+Hegdeauthor=A.+Balasubramaniamauthor=B.+A.+Chandramouliauthor=V.+Santoshauthor=M.+R.+Raoauthor=P.+Kondaiahauthor=K.+Somasundaram&title=PBEF1%2FNAmPRTase%2Fvisfatin%3A+a+potential+malignant+astrocytoma%2Fglioblastoma+serum+marker+with+prognostic+value"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">PBEF1/NAmPRTase/visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value</span></div><div class="casAuthors">Reddy, P. Sreekanth; Umesh, Srikantha; Thota, Balaram; Tandon, Ashwani; Pandey, Paritosh; Hegde, A. S.; Balasubramaniam, Anandh; Chandramouli, B. A.; Santosh, Vani; Rao, M. R. S.; Kondaiah, Paturu; Somasundaram, Kumaravel</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">663-668</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Malignant astrocytomas comprise anaplastic astrocytoma (AA; grade III) and Glioblastoma (GBM; grade IV).  GBM is the most malignant with a median survival of 10-12 mo in patients.  Using cDNA microarray based expression profiling of different grades of astrocytomas, we identified several fold increased levels of PBEF1 transcripts in GBM samples.  Pre-B-cell colony enhancing factor 1 gene (PBEF1) encodes Nicotinamide phosphoribosyl-transferase (NAmPRTase), which catalyzes the rate limiting step in the salvage pathway of NAD metab. in mammalian cells.  Further validation using real time RT-qPCR on an independent set of tumor samples (n = 91) and normal brain samples (n = 9), GBM specific higher expression of PBEF1 was confirmed.  Immunohistochem. staining for PBEF1 on a subset of the above samples largely reinforced our finding.  We carried out ELISA anal. on serum samples of astrocytoma patients to det. whether this protein levels would correlate with the presence of tumor and tumor grade.  PBEF1 serum levels were substantially elevated in many of the AA and GBM patients.  Statistical anal. of these data indicates that in patients with astrocytoma, serum PBEF1 levels correlate with tumor grade and is highest in GBM.  Immunohistochem. anal. of an independent set of 51 retrospective GBM cases with known survival data revealed that PBEF1 expression in the tumor tissue along with its co-expression with p53 was assocd. with poor survival.  Thus, we have identified PBEF1 as a potential malignant astrocytoma serum marker and prognostic indicator among GBMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-kqvIx3lhFLVg90H21EOLACvtfcHk0lhaOt7q-ff0Fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVeisLjN&md5=367bab489808e3ac18bb8d278a5d8922</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.4161%2Fcbt.7.5.5663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.7.5.5663%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BS.%26aulast%3DUmesh%26aufirst%3DS.%26aulast%3DThota%26aufirst%3DB.%26aulast%3DTandon%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DP.%26aulast%3DHegde%26aufirst%3DA.%2BS.%26aulast%3DBalasubramaniam%26aufirst%3DA.%26aulast%3DChandramouli%26aufirst%3DB.%2BA.%26aulast%3DSantosh%26aufirst%3DV.%26aulast%3DRao%26aufirst%3DM.%2BR.%26aulast%3DKondaiah%26aufirst%3DP.%26aulast%3DSomasundaram%26aufirst%3DK.%26atitle%3DPBEF1%252FNAmPRTase%252Fvisfatin%253A%2520a%2520potential%2520malignant%2520astrocytoma%252Fglioblastoma%2520serum%2520marker%2520with%2520prognostic%2520value%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D663%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsubokura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, G.</span><span> </span><span class="NLM_article-title">Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study</span> <span class="citation_source-journal">J. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1186%2F1479-5876-8-103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A280%3ADC%252BC3cbmsVGisg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=103&author=S.+Takahashiauthor=N.+Miuraauthor=T.+Haradaauthor=Z.+Wangauthor=X.+Wangauthor=H.+Tsubokuraauthor=Y.+Oshimaauthor=J.+Hasegawaauthor=Y.+Inagakiauthor=G.+Shiota&title=Prognostic+impact+of+clinical+course-specific+mRNA+expression+profiles+in+the+serum+of+perioperative+patients+with+esophageal+cancer+in+the+ICU%3A+a+case+control+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study</span></div><div class="casAuthors">Takahashi Shunsaku; Miura Norimasa; Harada Tomomi; Wang ZhongZhi; Wang Xinhui; Tsubokura Hideyuki; Oshima Yoshiaki; Hasegawa Junichi; Inagaki Yoshimi; Shiota Goshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  We previously reported that measuring circulating serum mRNAs using quantitative one-step real-time RT-PCR was clinically useful for detecting malignancies and determining prognosis.  The aim of our study was to find crucial serum mRNA biomarkers in esophageal cancer that would provide prognostic information for post-esophagectomy patients in the critical care setting.  METHODS:  We measured serum mRNA levels of 11 inflammatory-related genes in 27 post-esophagectomy patients admitted to the intensive care unit (ICU).  We tracked these levels chronologically, perioperatively and postoperatively, until the two-week mark, investigating their clinical and prognostic significance as compared with clinical parameters.  Furthermore, we investigated whether gene expression can accurately predict clinical outcome and prognosis.  RESULTS:  Circulating mRNAs in postoperative esophagectomy patients had gene-specific expression profiles that varied with the clinical phase of their treatment.  Multivariate regression analysis showed that upregulation of IL-6, VWF and TGF-Î²1 mRNA in the intraoperative phase (p = 0.016, 0.0021 and 0.009) and NAMPT and MUC1 mRNA on postoperative day 3 (p < 0.01) were independent factors of mortality in the first year of follow-up.  Duration of ventilator dependence (DVD) and ICU stay were independent factors of poor prognosis (p < 0.05).  Therapeutic use of Sivelestat (ElaspolÂ®, Ono Pharmaceutical Co., Ltd.) significantly correlated with MUC1 and NAMPT mRNA expression (p = 0.048 and 0.045).  IL-6 mRNA correlated with hypercytokinemia and recovery from hypercytokinemia (sensitivity 80.9%) and was a significant biomarker in predicting the onset of severe inflammatory diseases.  CONCLUSION:  Chronological tracking of postoperative mRNA levels of inflammatory-related genes in esophageal cancer patients may facilitate early institution of pharamacologic therapy, prediction of treatment response, and prognostication during ICU management in the perioperative period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3kysQSgJNz1vAgqb2vdc5fW6udTcc2eZQ_-PAFuX4r7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbmsVGisg%253D%253D&md5=8ac179e10d1ccbe5a4009af5765baf2b</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-8-103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-8-103%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DMiura%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTsubokura%26aufirst%3DH.%26aulast%3DOshima%26aufirst%3DY.%26aulast%3DHasegawa%26aufirst%3DJ.%26aulast%3DInagaki%26aufirst%3DY.%26aulast%3DShiota%26aufirst%3DG.%26atitle%3DPrognostic%2520impact%2520of%2520clinical%2520course-specific%2520mRNA%2520expression%2520profiles%2520in%2520the%2520serum%2520of%2520perioperative%2520patients%2520with%2520esophageal%2520cancer%2520in%2520the%2520ICU%253A%2520a%2520case%2520control%2520study%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2010%26volume%3D8%26spage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Thakur, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittrich, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehnau, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klusmann, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welte, K.</span><span> </span><span class="NLM_article-title">Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">â</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1002%2Fijc.27726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOmtLbP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=766-774&author=B.+K.+Thakurauthor=T.+Dittrichauthor=P.+Chandraauthor=A.+Beckerauthor=W.+Kuehnauauthor=J.+H.+Klusmannauthor=D.+Reinhardtauthor=K.+Welte&title=Involvement+of+p53+in+the+cytotoxic+activity+of+the+NAMPT+inhibitor+FK866+in+myeloid+leukemic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells</span></div><div class="casAuthors">Thakur, Basant Kumar; Dittrich, Tino; Chandra, Prakash; Becker, Annette; Kuehnau, Wolfgang; Klusmann, Jan-Henning; Reinhardt, Dirk; Welte, Karl</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">766-774</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">FK866 is a specific inhibitor of NAMPT and induces apoptosis of leukemic cells by depletion of intracellular NAD+.  Since up-regulation of NAMPT is assocd. with several cases of cancers, including leukemias, we asked whether in leukemic cells inhibition of NAMPT involves p53 pathway.  We obsd. that FK866 induced apoptosis and reduced cell proliferation in NB-4, OCI-AML3 and MOLM-13 cell lines.  In contrast, the leukemia cell lines, K-562 and Kasumi, contg. nonfunctional p53 were relatively unaffected by FK866 treatment.  Importantly, direct inhibition of sirtuins significantly reduced the viability of NB-4, OCI-AML3 and MOLM-13 cell lines.  Activation of p53 by FK866 involved increased acetylation of p53 at lysine 382 with subsequent increase in the expression of p21 and BAX.  Further, knockdown of p53 attenuated the effects of FK866 on apoptosis and cell cycle arrest, which was partly assocd. with decreased expression of p21 and BAX.  Our results suggest the role of p53 acetylation pathway in the anti-leukemic effect of FK866.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0ex_g8bdch7Vg90H21EOLACvtfcHk0lheB0AAAYwXAA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOmtLbP&md5=68c9e5ac20ef921ca71fd59883e3d4ae</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1002%2Fijc.27726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27726%26sid%3Dliteratum%253Aachs%26aulast%3DThakur%26aufirst%3DB.%2BK.%26aulast%3DDittrich%26aufirst%3DT.%26aulast%3DChandra%26aufirst%3DP.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DKuehnau%26aufirst%3DW.%26aulast%3DKlusmann%26aufirst%3DJ.%2BH.%26aulast%3DReinhardt%26aufirst%3DD.%26aulast%3DWelte%26aufirst%3DK.%26atitle%3DInvolvement%2520of%2520p53%2520in%2520the%2520cytotoxic%2520activity%2520of%2520the%2520NAMPT%2520inhibitor%2520FK866%2520in%2520myeloid%2520leukemic%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2013%26volume%3D132%26spage%3D766%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Pogrebniak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemainda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelka-Fleischer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasmann, M.</span><span> </span><span class="NLM_article-title">Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents</span> <span class="citation_source-journal">Eur. J. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">â</span> <span class="NLM_lpage">321</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Wms7rL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=313-321&author=A.+Pogrebniakauthor=I.+Schemaindaauthor=K.+Azzamauthor=R.+Pelka-Fleischerauthor=V.+Nusslerauthor=M.+Hasmann&title=Chemopotentiating+effects+of+a+novel+NAD+biosynthesis+inhibitor%2C+FK866%2C+in+combination+with+antineoplastic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents</span></div><div class="casAuthors">Pogrebniak, A.; Schemainda, I.; Azzam, K.; Pelka-Fleischer, R.; Nuessler, V.; Hasmann, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">EJMRFL</span>;
        ISSN:<span class="NLM_cas:issn">0949-2321</span>.
    
            (<span class="NLM_cas:orgname">I. Holzapfel Verlag GmbH</span>)
        </div><div class="casAbstract">FK866 is a novel anticancer agent that was previously shown to interfere with NAD+ biosynthesis by inhibition of nicotinamide phosphoribosyltransferase and to initiate apoptosis in cancer cells.  As NAD+ is involved in cellular DNA repair processes, the present in vitro study on THP-1 and K562 leukemia cells was conducted to investigate the cytotoxicity of FK866 combination treatment with various cytotoxic agents: the antimetabolite Ara-C, the DNA-intercalating agent daunorubicin and the alkylating compds. 1-methyl-3-nitro-1-nitrosoguanidinium (MNNG) and melphalan.  Cell viability after drug exposure was assessed by propidium iodide (PI) staining.  Non-cytotoxic concns. of FK866 (10-9M or less), applied simultaneously or 24 h before adding cytotoxic agents, caused a depletion in the intracellular NAD+ and - to a lesser extent - NADH levels in THP-1 cells.  After 48 and 72 h treatment with daunorubicin and Ara-C, resp., increased cell death was obsd. in THP-1 cells that were pretreated with FK866, as compared to cells exposed to antineoplastic drugs alone.  However, this effect was transient, and there was no difference in cell survival after 72 h incubation with daunorubicin or 96 h with Ara-C.  Non-toxic concns. of FK866 added 8, 16, or 24 h before starting treatment with the PARP-activating agent MNNG synergistically decreased intracellular NAD+ contents, and increased MNNG-induced cytotoxicity both in THP-1 and K562 cells for at least 72 h.  This effect was less pronounced when FK866 was used in combination with another alkylating agent, melphalan.  The PARP inhibitor 3-aminobenzamide delayed MNNG-induced cytotoxicity by 24 h both in cells that were pretreated with FK866 and in non-pretreated cells.  48 H later, the protective effect of 3-aminobenzamide could no longer be obsd., but FK866-pretreated cells retained increased sensitivity to MNNG.  In conclusion, the chemosensitizing effect of FK866 on cell death induced by antineoplastic drugs was particularly obvious in combination with substances like MNNG that cause NAD+ depletion per se.  It was less pronounced and only transiently measurable in combination with daunorubicin, Ara-C, and melphalan, resp.  These results may indicate different levels of DNA damage implicated in the action of the cytotoxic agents used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeOtVq11EFxrVg90H21EOLACvtfcHk0lgAqZ6R6ltNuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Wms7rL&md5=6dba2ba494a33d5ab3146ed3407db74c</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPogrebniak%26aufirst%3DA.%26aulast%3DSchemainda%26aufirst%3DI.%26aulast%3DAzzam%26aufirst%3DK.%26aulast%3DPelka-Fleischer%26aufirst%3DR.%26aulast%3DNussler%26aufirst%3DV.%26aulast%3DHasmann%26aufirst%3DM.%26atitle%3DChemopotentiating%2520effects%2520of%2520a%2520novel%2520NAD%2520biosynthesis%2520inhibitor%252C%2520FK866%252C%2520in%2520combination%2520with%2520antineoplastic%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Res.%26date%3D2006%26volume%3D11%26spage%3D313%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Cea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruscione, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffaghello, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garuti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emionite, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoppoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reverberi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnetta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamaschi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casciaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierri, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damonte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansaldi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistoia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballestrero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencioni, A.</span><span> </span><span class="NLM_article-title">Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e22739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e22739&author=M.+Ceaauthor=D.+Sonciniauthor=F.+Fruscioneauthor=L.+Raffaghelloauthor=A.+Garutiauthor=L.+Emioniteauthor=E.+Moranauthor=M.+Magnoneauthor=G.+Zoppoliauthor=D.+Reverberiauthor=I.+Caffaauthor=A.+Salisauthor=A.+Cagnettaauthor=M.+Bergamaschiauthor=S.+Casciaroauthor=I.+Pierriauthor=G.+Damonteauthor=F.+Ansaldiauthor=M.+Gobbiauthor=V.+Pistoiaauthor=A.+Ballestreroauthor=F.+Patroneauthor=S.+Bruzzoneauthor=A.+Nencioni&title=Synergistic+interactions+between+HDAC+and+sirtuin+inhibitors+in+human+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCea%26aufirst%3DM.%26aulast%3DSoncini%26aufirst%3DD.%26aulast%3DFruscione%26aufirst%3DF.%26aulast%3DRaffaghello%26aufirst%3DL.%26aulast%3DGaruti%26aufirst%3DA.%26aulast%3DEmionite%26aufirst%3DL.%26aulast%3DMoran%26aufirst%3DE.%26aulast%3DMagnone%26aufirst%3DM.%26aulast%3DZoppoli%26aufirst%3DG.%26aulast%3DReverberi%26aufirst%3DD.%26aulast%3DCaffa%26aufirst%3DI.%26aulast%3DSalis%26aufirst%3DA.%26aulast%3DCagnetta%26aufirst%3DA.%26aulast%3DBergamaschi%26aufirst%3DM.%26aulast%3DCasciaro%26aufirst%3DS.%26aulast%3DPierri%26aufirst%3DI.%26aulast%3DDamonte%26aufirst%3DG.%26aulast%3DAnsaldi%26aufirst%3DF.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DPistoia%26aufirst%3DV.%26aulast%3DBallestrero%26aufirst%3DA.%26aulast%3DPatrone%26aufirst%3DF.%26aulast%3DBruzzone%26aufirst%3DS.%26aulast%3DNencioni%26aufirst%3DA.%26atitle%3DSynergistic%2520interactions%2520between%2520HDAC%2520and%2520sirtuin%2520inhibitors%2520in%2520human%2520leukemia%2520cells%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De22739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Zoppoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruscione, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedognetti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrando, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballestrero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencioni, A.</span><span> </span><span class="NLM_article-title">Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells</span> <span class="citation_source-journal">Exp. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">â</span> <span class="NLM_lpage">988</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.exphem.2010.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCgs7%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=979-988&author=G.+Zoppoliauthor=M.+Ceaauthor=D.+Sonciniauthor=F.+Fruscioneauthor=J.+Rudnerauthor=E.+Moranauthor=I.+Caffaauthor=D.+Bedognettiauthor=G.+Mottaauthor=R.+Ghioauthor=F.+Ferrandoauthor=A.+Ballestreroauthor=S.+Parodiauthor=C.+Belkaauthor=F.+Patroneauthor=S.+Bruzzoneauthor=A.+Nencioni&title=Potent+synergistic+interaction+between+the+Nampt+inhibitor+APO866+and+the+apoptosis+activator+TRAIL+in+human+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells</span></div><div class="casAuthors">Zoppoli, Gabriele; Cea, Michele; Soncini, Debora; Fruscione, Floriana; Rudner, Justine; Moran, Eva; Caffa, Irene; Bedognetti, Davide; Motta, Giulia; Ghio, Riccardo; Ferrando, Fabio; Ballestrero, Alberto; Parodi, Silvio; Belka, Claus; Patrone, Franco; Bruzzone, Santina; Nencioni, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Hematology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">979-988</span>CODEN:
                <span class="NLM_cas:coden">EXHMA6</span>;
        ISSN:<span class="NLM_cas:issn">0301-472X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The nicotinamide phosphoribosyltransferase (Nampt) inhibitor APO866 depletes intracellular NAD (NAD+) and shows promising anticancer activity in preclin. studies.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) binds to plasma membrane receptors DR4 and DR5 and induces apoptosis via caspase-8 and -10.  Here we have explored the interaction between APO866 and TRAIL in leukemia cell lines and in primary B-cell chronic lymphocytic leukemia cells.  Cells were treated with APO866, TRAIL, or their combination.  Viability and mitochondrial transmembrane potential (ÎÎ¨m) were detd. by cell staining with propidium iodide and tetramethylrhodamine Et ester, resp., and flow cytometry.  Nampt and Î³-tubulin levels, as well as caspase-3 cleavage were detected by immunoblotting.  DR4 and DR5 expression were assessed by immunostaining and flow cytometry.  Caspases were inhibited with zVAD-FMK and zDEVD-FMK; autophagy with 3-methyladenine, LY294002, and wortmannin.  Intracellular NAD+ and ATP were measured by cycling assays and high-performance liq. chromatog. (HPLC), resp.  Results: APO866 induced NAD+ depletion, ÎÎ¨m dissipation, and ATP shortage in leukemia cells, thereby leading to autophagic cell death.  TRAIL induced caspase-dependent apoptosis.  TRAIL addn. to APO866 synergistically increased its activity in leukemia cells by enhancing NAD+ depletion, ÎÎ¨m dissipation, and ATP shortage.  No DR5 upregulation at the cell surface in response to APO866 was obsd.  Remarkably, in healthy leukocytes APO866 and TRAIL were poorly active and failed to show any cooperation.  Activation of the extrinsic apoptotic cascade with TRAIL selectively amplifies the sequelae of Nampt inhibition in leukemia cells, and appears as a promising strategy to enhance APO866 activity in hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Zj_ImaCce7Vg90H21EOLACvtfcHk0lgAqZ6R6ltNuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCgs7%252FF&md5=de5c9d8134a8e1c0ccbd50e8e2da15e8</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.exphem.2010.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exphem.2010.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DZoppoli%26aufirst%3DG.%26aulast%3DCea%26aufirst%3DM.%26aulast%3DSoncini%26aufirst%3DD.%26aulast%3DFruscione%26aufirst%3DF.%26aulast%3DRudner%26aufirst%3DJ.%26aulast%3DMoran%26aufirst%3DE.%26aulast%3DCaffa%26aufirst%3DI.%26aulast%3DBedognetti%26aufirst%3DD.%26aulast%3DMotta%26aufirst%3DG.%26aulast%3DGhio%26aufirst%3DR.%26aulast%3DFerrando%26aufirst%3DF.%26aulast%3DBallestrero%26aufirst%3DA.%26aulast%3DParodi%26aufirst%3DS.%26aulast%3DBelka%26aufirst%3DC.%26aulast%3DPatrone%26aufirst%3DF.%26aulast%3DBruzzone%26aufirst%3DS.%26aulast%3DNencioni%26aufirst%3DA.%26atitle%3DPotent%2520synergistic%2520interaction%2520between%2520the%2520Nampt%2520inhibitor%2520APO866%2520and%2520the%2520apoptosis%2520activator%2520TRAIL%2520in%2520human%2520leukemia%2520cells%26jtitle%3DExp.%2520Hematol.%26date%3D2010%26volume%3D38%26spage%3D979%26epage%3D988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Muruganandham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfieri, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukenick, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemainda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koutcher, J. A.</span><span> </span><span class="NLM_article-title">Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by <sup>1</sup>H-decoupledâ<sup>31</sup>P magnetic resonance spectroscopy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3503</span><span class="NLM_x">â</span> <span class="NLM_lpage">3513</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1158%2F1078-0432.CCR-04-1399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslOqtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=3503-3513&author=M.+Muruganandhamauthor=A.+A.+Alfieriauthor=C.+Mateiauthor=Y.+Chenauthor=G.+Sukenickauthor=I.+Schemaindaauthor=M.+Hasmannauthor=L.+B.+Saltzauthor=J.+A.+Koutcher&title=Metabolic+signatures+associated+with+a+NAD+synthesis+inhibitor-induced+tumor+apoptosis+identified+by+1H-decoupled%E2%80%9331P+magnetic+resonance+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Signatures Associated with a NAD Synthesis Inhibitor-Induced Tumor Apoptosis Identified by 1H-Decoupled-31P Magnetic Resonance Spectroscopy</span></div><div class="casAuthors">Muruganandham, Manickam; Alfieri, Alan A.; Matei, Cornelia; Chen, Yuchun; Sukenick, George; Schemainda, Isabel; Hasmann, Max; Saltz, Leonard B.; Koutcher, Jason A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3503-3513</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Attempts to selectively initiate tumor cell death through inducible apoptotic pathways are increasingly being exploited as a potential anticancer strategy.  Inhibition of NAD+ synthesis by a novel agent FK866 has been recently reported to induce apoptosis in human leukemia, hepatocarcinoma cells in vitro, and various types of tumor xenografts in vivo.  In the present study, we used 1H-decoupled phosphorus (31P) magnetic resonance spectroscopy (MRS) to examine the metabolic changes assocd. with FK866 induced tumor cell death in a mouse mammary carcinoma.  Exptl. Design: Induction of apoptosis in FK866-treated tumors was confirmed by histol. and cytofluorometric anal.  FK866-induced changes in mammary carcinoma tumor metab. in vivo were investigated using 1H-decoupled 31P MRS.  To discern further the changes in metabolic profiles of tumors obsd. in vivo, high-resoln. in vitro 1H-decoupled 31P MRS studies were carried out with perchloric acid exts. of mammary carcinoma tumors excised after similar treatments.  In addn., the effects of FK866 on mammary carcinoma tumor growth and radiation sensitivity were studied.  RESULTS: Treatment with FK866 induced a tumor growth delay and enhanced radiation sensitivity in mammary carcinoma tumors that was assocd. with significant increases in the 31P MR signal in the phosphomonoester region and a decrease in NAD+ levels, pH, and bioenergetic status.  The 31P MRS of perchloric acid exts. of treated tumors identified the large unresolved signal in the phosphomonoester region as the resultant of resonances originating from intermediates of tumor glycolysis and guanylate synthesis in addn. to alterations in pyridine nucleotide pools and phospholipid metab.  CONCLUSION: The present results suggest that FK866 interferes with multiple biochem. pathways that contribute to the increased cell death (apoptosis) and subsequent radiation sensitivity obsd. in the mammary carcinoma that could be serially monitored by 31P MRS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsKhDQoeDkGrVg90H21EOLACvtfcHk0lhR6CZp7fHbYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslOqtLg%253D&md5=b942df22d36ef74cb7f948b2e3cb5dc3</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1399%26sid%3Dliteratum%253Aachs%26aulast%3DMuruganandham%26aufirst%3DM.%26aulast%3DAlfieri%26aufirst%3DA.%2BA.%26aulast%3DMatei%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSukenick%26aufirst%3DG.%26aulast%3DSchemainda%26aufirst%3DI.%26aulast%3DHasmann%26aufirst%3DM.%26aulast%3DSaltz%26aufirst%3DL.%2BB.%26aulast%3DKoutcher%26aufirst%3DJ.%2BA.%26atitle%3DMetabolic%2520signatures%2520associated%2520with%2520a%2520NAD%2520synthesis%2520inhibitor-induced%2520tumor%2520apoptosis%2520identified%2520by%25201H-decoupled%25E2%2580%259331P%2520magnetic%2520resonance%2520spectroscopy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D3503%26epage%3D3513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Drevs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esser, N.</span><span> </span><span class="NLM_article-title">Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">â</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvVGnsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=4853-4858&author=J.+Drevsauthor=R.+Loserauthor=B.+Rattelauthor=N.+Esser&title=Antiangiogenic+potency+of+FK866%2FK22.175%2C+a+new+inhibitor+of+intracellular+NAD+biosynthesis%2C+in+murine+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma</span></div><div class="casAuthors">Drevs, Joachim; Loeser, Roland; Rattel, Benno; Esser, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6C</span>),
    <span class="NLM_cas:pages">4853-4858</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">FK 866/ K 22.175 (FK-866), developed as an anticancer agent, interferes with the NAD+ biosynthesis and therefore might have characteristics distinct from conventional chemotherapeutic agents.  We investigated FK-866 in a murine renal cell carcinoma model (RENCA) to assess its antitumor, antimetastatic and antiangiogenic potency.  FK-866 was administered twice daily on days 10 to 15 after intrarenal inoculation of RENCA cells in syngenic Balb/c mice at oral doses of 6, 10, 14 and 18 mg/kg to define the optimal dose related to toxicity.  For efficacy studies, FK-866 was administered orally twice daily at doses of 6 and 10 mg/kg or twice daily at doses of 3 and 5 mg/kg on days 14 to 19 after tumor cell inoculation.  Animals in the pos. control group received 30 mg/kg TNP 470 s.c. on every other day beginning on day 1.  On day 17, all animals were examd. for blood flow in the left renal artery by color Doppler imaging (CDI).  The animals were sacrificed on day 21 and analyzed for primary tumor wt. and vol., no. of metastases to the lung and abdominal lymph nodes and vessel d. in tumor tissues.  Doses of up to 6 mg/kg FK-866 were less toxic than treatment with TNP-470.  Significant antitumor efficacy was obsd. for doses of â¥10 mg/kg FK-866 only.  In contrast, a significant decrease of vessel d. in tumor tissues by up to 70% could be detected for all dose groups.  Changes in blood flow in the tumor feeding renal artery could not be detected because of the profound strong tumor redn.  FK-866 has antitumoral and antimetastatic activity in RENCA mice.  Furthermore, this is the first report to describe a strong antiangiogenic potency of FK-866.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX_hbEmmix1LVg90H21EOLACvtfcHk0lhR6CZp7fHbYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvVGnsbs%253D&md5=b1e66d6be66a4a37b0fe7991c158ba13</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrevs%26aufirst%3DJ.%26aulast%3DLoser%26aufirst%3DR.%26aulast%3DRattel%26aufirst%3DB.%26aulast%3DEsser%26aufirst%3DN.%26atitle%3DAntiangiogenic%2520potency%2520of%2520FK866%252FK22.175%252C%2520a%2520new%2520inhibitor%2520of%2520intracellular%2520NAD%2520biosynthesis%252C%2520in%2520murine%2520renal%2520cell%2520carcinoma%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Zhang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qie, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. P.</span><span> </span><span class="NLM_article-title">Anti-proliferation effect of APO866 on C6 glioblastoma cells by inhibiting nicotinamide phosphoribosyltransferase</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">674</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">â</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1016%2Fj.ejphar.2011.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1Gqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=674&publication_year=2012&pages=163-170&author=L.+Y.+Zhangauthor=L.+Y.+Liuauthor=L.+L.+Qieauthor=K.+N.+Lingauthor=L.+H.+Xuauthor=F.+Wangauthor=S.+H.+Fangauthor=Y.+B.+Luauthor=H.+Huauthor=E.+Q.+Weiauthor=W.+P.+Zhang&title=Anti-proliferation+effect+of+APO866+on+C6+glioblastoma+cells+by+inhibiting+nicotinamide+phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-proliferation effect of APO866 on C6 glioblastoma cells by inhibiting nicotinamide phosphoribosyltransferase</span></div><div class="casAuthors">Zhang, Li-Yuan; Liu, Li-Ying; Qie, Ling-Ling; Ling, Ka-Na; Xu, Li-Hua; Wang, Feng; Fang, San-Hua; Lu, Yun-Bi; Hu, Hua; Wei, Er-Qing; Zhang, Wei-Ping</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">674</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">163-170</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NAMPT) is a key enzyme in the salvaging pathway for the synthesis of NAD that is involved in cell metab. and proliferation.  NAMPT is normally absent in astrocyte but highly expressed in glioblastoma, suggesting that it may promote cell survival through synthesizing more NAD.  In this report, we evaluated the effect of APO866, a potent inhibitor of NAMPT against C6 glioblastoma.  We found that APO866 inhibited the growth of C6 glioblastoma cells with IC50 in nano-molar range.  APO866 depleted intracellular NAD, caused marked inhibition of ERK activation and induced G2/M cell-cycle arrest.  The effects by APO866 were abrogated by NMN, the direct product of NAMPT.  Administration of U0126, an ERK1/2 inhibitor, inhibited cell growth but displayed no synergistic effect with APO866.  Taken together, our results indicated that APO866 is a potent growth inhibitor against glioblastoma through targeting NAMPT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2SOUIUHqm_7Vg90H21EOLACvtfcHk0li9FP5oGwfe6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1Gqsg%253D%253D&md5=dcb583b7f14776812cd02e45520b268e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%2BY.%26aulast%3DLiu%26aufirst%3DL.%2BY.%26aulast%3DQie%26aufirst%3DL.%2BL.%26aulast%3DLing%26aufirst%3DK.%2BN.%26aulast%3DXu%26aufirst%3DL.%2BH.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DFang%26aufirst%3DS.%2BH.%26aulast%3DLu%26aufirst%3DY.%2BB.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DE.%2BQ.%26aulast%3DZhang%26aufirst%3DW.%2BP.%26atitle%3DAnti-proliferation%2520effect%2520of%2520APO866%2520on%2520C6%2520glioblastoma%2520cells%2520by%2520inhibiting%2520nicotinamide%2520phosphoribosyltransferase%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D674%26spage%3D163%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Goellner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimme, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugrue, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobol, R. W.</span><span> </span><span class="NLM_article-title">Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">2308</span><span class="NLM_x">â</span> <span class="NLM_lpage">2317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=2308-2317&author=E.+M.+Goellnerauthor=B.+Grimmeauthor=A.+R.+Brownauthor=Y.+C.+Linauthor=X.+H.+Wangauthor=K.+F.+Sugrueauthor=L.+Mitchellauthor=R.+N.+Trivediauthor=J.+B.+Tangauthor=R.+W.+Sobol&title=Overcoming+temozolomide+resistance+in+glioblastoma+via+dual+inhibition+of+NAD%2B+biosynthesis+and+base+excision+repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoellner%26aufirst%3DE.%2BM.%26aulast%3DGrimme%26aufirst%3DB.%26aulast%3DBrown%26aufirst%3DA.%2BR.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DX.%2BH.%26aulast%3DSugrue%26aufirst%3DK.%2BF.%26aulast%3DMitchell%26aufirst%3DL.%26aulast%3DTrivedi%26aufirst%3DR.%2BN.%26aulast%3DTang%26aufirst%3DJ.%2BB.%26aulast%3DSobol%26aufirst%3DR.%2BW.%26atitle%3DOvercoming%2520temozolomide%2520resistance%2520in%2520glioblastoma%2520via%2520dual%2520inhibition%2520of%2520NAD%252B%2520biosynthesis%2520and%2520base%2520excision%2520repair%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D2308%26epage%3D2317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Le, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouw, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinavahi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deck, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royer, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vander Jagt, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenza, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">2037</span><span class="NLM_x">â</span> <span class="NLM_lpage">2042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1073%2Fpnas.0914433107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=20133848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFCit7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=2037-2042&author=A.+Leauthor=C.+R.+Cooperauthor=A.+M.+Gouwauthor=R.+Dinavahiauthor=A.+Maitraauthor=L.+M.+Deckauthor=R.+E.+Royerauthor=D.+L.+Vander+Jagtauthor=G.+L.+Semenzaauthor=C.+V.+Dang&title=Inhibition+of+lactate+dehydrogenase+A+induces+oxidative+stress+and+inhibits+tumor+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression</span></div><div class="casAuthors">Le, Anne; Cooper, Charles R.; Gouw, Arvin M.; Dinavahi, Ramani; Maitra, Anirban; Deck, Lorraine M.; Royer, Robert E.; Vander Jagt, David L.; Semenza, Gregg L.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2037-2042, S2037/1-S2037/12</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">As the result of genetic alterations and tumor hypoxia, many cancer cells avidly take up glucose and generate lactate through lactate dehydrogenase A (LDHA), which is encoded by a target gene of c-Myc and hypoxia-inducible factor (HIF-1).  Previous studies with redn. of LDHA expression indicate that LDHA is involved in tumor initiation, but its role in tumor maintenance and progression has not been established.  Furthermore, how redn. of LDHA expression by interference or antisense RNA inhibits tumorigenesis is not well understood.  Here, we report that redn. of LDHA by siRNA or its inhibition by a small-mol. inhibitor (FX11 [3-dihydroxy-6-methyl-7-(phenylmethyl)-4-propylnaphthalene-1-carboxylic acid]) reduced ATP levels and induced significant oxidative stress and cell death that could be partially reversed by the antioxidant N-acetylcysteine (NAC).  Furthermore, we document that FX11 inhibited the progression of sizable human lymphoma and pancreatic cancer xenografts.  When used in combination with the NAD+ synthesis inhibitor FK866, FX11 induced lymphoma regression.  Hence, inhibition of LDHA with FX11 is an achievable and tolerable treatment for LDHA-dependent tumors.  Our studies document a therapeutical approach to the Warburg effect and demonstrate that oxidative stress and metabolic phenotyping of cancers are crit. aspects of cancer biol. to consider for the therapeutical targeting of cancer energy metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1h1YikQKAn7Vg90H21EOLACvtfcHk0li9FP5oGwfe6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFCit7g%253D&md5=714af2ec2bc79ffcba57d6987c52a87a</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0914433107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0914433107%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DA.%26aulast%3DCooper%26aufirst%3DC.%2BR.%26aulast%3DGouw%26aufirst%3DA.%2BM.%26aulast%3DDinavahi%26aufirst%3DR.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DDeck%26aufirst%3DL.%2BM.%26aulast%3DRoyer%26aufirst%3DR.%2BE.%26aulast%3DVander%2BJagt%26aufirst%3DD.%2BL.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DInhibition%2520of%2520lactate%2520dehydrogenase%2520A%2520induces%2520oxidative%2520stress%2520and%2520inhibits%2520tumor%2520progression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D2037%26epage%3D2042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Olesen, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thougaard, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span> </span><span class="NLM_article-title">A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1609</span><span class="NLM_x">â</span> <span class="NLM_lpage">1617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm4001049&amp;key=10.1158%2F1535-7163.MCT-09-1130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm4001049&amp;key=20515945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm4001049&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFGgsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1609-1617&author=U.+H.+Olesenauthor=A.+V.+Thougaardauthor=P.+B.+Jensenauthor=M.+Sehested&title=A+preclinical+study+on+the+rescue+of+normal+tissue+by+nicotinic+acid+in+high-dose+treatment+with+APO866%2C+a+specific+nicotinamide+phosphoribosyltransferase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">A Preclinical Study on the Rescue of Normal Tissue by Nicotinic Acid in High-Dose Treatment with APO866, a Specific Nicotinamide Phosphoribosyltransferase Inhibitor</span></div><div class="casAuthors">Olesen, Uffe Hogh; Thougaard, Annemette V.; Jensen, Peter Buhl; Sehested, Maxwell</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1609-1617</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibitor of nicotinamide phosphoribosyltransferase APO866 is a promising cancer drug currently in phase II clin. trials in oncol.  Here, we present a strategy for increasing the therapeutic potential of APO866 through the rescue of normal tissues by coadministration of nicotinic acid (Vitamin B3).  We examd. the toxicity profile of APO866 in B6D2F1 mice and the effect of oral administration of nicotinic acid on tissue toxicity.  Nicotinic acid (50 mg/kg) protects mice from death and severe toxicity from an APO866 dose (60 mg/kg) four times the monotherapy max. tolerated dose (15 mg/kg).  In a panel of six cancer cell lines, we find that three (including ML-2 cells) are protected by nicotinic acid in vitro, whereas the cytotoxicity of APO866 remains unaffected in the remaining three (including A2780 cells).  A selective biomarker for the protection by nicotinic acid was subsequently identified by quant. RT-PCR.  The expression of nicotinic acid phosphoribosyltransferase is low in the cell lines not rescued from APO866 by nicotinic acid compared with protected cell lines.  The findings in cell lines translated into xenograft models in which the combination of 50 mg/kg nicotinic acid and 50 mg/kg APO866 in mouse xenografts of A2780 cells increased life span by >3-fold compared with std. treatment of 15 mg/kg, and the effect of APO866 was clearly decreased when using the same treatment paradigm in ML-2 xenografts.  In conclusion, the combination of high doses of APO866 with rescue by nicotinic acid may significantly increase the therapeutic potential in a subset of cancers with low expression of nicotinic acid phosphoribosyltransferase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEEVf5ZtCvXrVg90H21EOLACvtfcHk0lgMAH-re9wA5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFGgsbg%253D&md5=353e954d2fd5308992a0ce8039ef081c</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1130%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DU.%2BH.%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DSehested%26aufirst%3DM.%26atitle%3DA%2520preclinical%2520study%2520on%2520the%2520rescue%2520of%2520normal%2520tissue%2520by%2520nicotinic%2520acid%2520in%2520high-dose%2520treatment%2520with%2520APO866%252C%2520a%2520specific%2520nicotinamide%2520phosphoribosyltransferase%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1609%26epage%3D1617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Tan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parthasarathy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkholder, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geeganage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span> </span><span class="NLM_article-title">Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">3500</span><span class="NLM_x">â</span> <span class="NLM_lpage">3511</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=3500-3511&author=B.+Tanauthor=D.+A.+Youngauthor=Z.+H.+Luauthor=T.+Wangauthor=T.+I.+Meierauthor=R.+L.+Shepardauthor=K.+Rothauthor=Y.+Zhaiauthor=K.+Hussauthor=M.+S.+Kuoauthor=J.+Gilligauthor=S.+Parthasarathyauthor=T.+P.+Burkholderauthor=M.+C.+Smithauthor=S.+Geeganageauthor=G.+Zhao&title=Pharmacological+inhibition+of+nicotinamide+phosphoribosyltransferase+%28NAMPT%29%2C+an+enzyme+essential+for+NAD%2B+biosynthesis%2C+in+human+cancer+cells%3A+metabolic+basis+and+potential+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DB.%26aulast%3DYoung%26aufirst%3DD.%2BA.%26aulast%3DLu%26aufirst%3DZ.%2BH.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DMeier%26aufirst%3DT.%2BI.%26aulast%3DShepard%26aufirst%3DR.%2BL.%26aulast%3DRoth%26aufirst%3DK.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DHuss%26aufirst%3DK.%26aulast%3DKuo%26aufirst%3DM.%2BS.%26aulast%3DGillig%26aufirst%3DJ.%26aulast%3DParthasarathy%26aufirst%3DS.%26aulast%3DBurkholder%26aufirst%3DT.%2BP.%26aulast%3DSmith%26aufirst%3DM.%2BC.%26aulast%3DGeeganage%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DG.%26atitle%3DPharmacological%2520inhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%252C%2520an%2520enzyme%2520essential%2520for%2520NAD%252B%2520biosynthesis%252C%2520in%2520human%2520cancer%2520cells%253A%2520metabolic%2520basis%2520and%2520potential%2520clinical%2520implications%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D3500%26epage%3D3511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVJ','PDB','2GVJ'); return false;">PDB: 2GVJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVG','PDB','2GVG'); return false;">PDB: 2GVG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3G8E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3G8E','PDB','3G8E'); return false;">PDB: 3G8E</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4001049&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm4001049%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-16%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4001049" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b36322af023e0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
